,geneId,geneSymbol,DSI,DPI,diseaseId,diseaseName,diseaseType,diseaseClass,diseaseSemanticType,score,EI,YearInitial,YearFinal,NofPmids,NofSnps,source
49215,6697,SPR,0.667,0.379,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2009.0,2009.0,1,0,PSYGENET
49216,6697,SPR,0.667,0.379,C0268468,"Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency",disease,C10;C16;C18;C23;F01,Disease or Syndrome,0.71,0.0,1993.0,2015.0,4,7,CTD_human;ORPHANET;UNIPROT
49217,6697,SPR,0.667,0.379,C0525045,Mood Disorders,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2009.0,2009.0,1,0,PSYGENET
57930,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C0282577,Congenital Disorders of Glycosylation,group,C16;C18,Disease or Syndrome,0.3,,2004.0,2014.0,2,0,GENOMICS_ENGLAND
57931,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
57932,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C1836824,Amish Infantile Epilepsy Syndrome,disease,C10,Disease or Syndrome,0.6,,2004.0,2017.0,0,5,CTD_human;ORPHANET
57933,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2014.0,2017.0,4,0,GENOMICS_ENGLAND
8003,925,CD8A,0.648,0.414,C0000786,Spontaneous abortion,phenotype,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
8004,925,CD8A,0.648,0.414,C0000822,"Abortion, Tubal",disease,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
8005,925,CD8A,0.648,0.414,C0024117,Chronic Obstructive Airway Disease,disease,C08,Disease or Syndrome,0.31,,2008.0,2008.0,1,0,CTD_human
8006,925,CD8A,0.648,0.414,C1527303,Chronic Airflow Obstruction,disease,C08,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
8007,925,CD8A,0.648,0.414,C1837065,"CD8 Deficiency, Familial",disease,C20,Disease or Syndrome,0.7,,2001.0,2001.0,1,1,CTD_human;ORPHANET;UNIPROT
13574,1615,DARS,0.8340000000000001,0.207,C3809008,HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY,disease,,Disease or Syndrome,0.71,1.0,2013.0,2015.0,1,10,CTD_human;ORPHANET;UNIPROT
700,90,ACVR1,0.573,0.552,C0004114,Astrocytoma,disease,C04,Neoplastic Process,0.32,1.0,2014.0,2015.0,1,0,CTD_human
701,90,ACVR1,0.573,0.552,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
702,90,ACVR1,0.573,0.552,C0013720,Ehlers-Danlos Syndrome,disease,C14;C15;C16;C17,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
703,90,ACVR1,0.573,0.552,C0016037,Fibrodysplasia Ossificans Progressiva,disease,C05,Disease or Syndrome,1.0,1.0,1972.0,2018.0,3,9,CTD_human;ORPHANET;UNIPROT
704,90,ACVR1,0.573,0.552,C0017638,Glioma,disease,C04,Neoplastic Process,0.51,1.0,2014.0,2014.0,3,0,CGI;CTD_human
705,90,ACVR1,0.573,0.552,C0025202,melanoma,disease,C04,Neoplastic Process,0.3,,,,0,0,UNIPROT
706,90,ACVR1,0.573,0.552,C0027122,Myositis Ossificans,disease,C05,Disease or Syndrome,0.31,,2007.0,2007.0,0,0,CTD_human
707,90,ACVR1,0.573,0.552,C0205768,Subependymal Giant Cell Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
708,90,ACVR1,0.573,0.552,C0242488,Acute Lung Injury,disease,C08,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
709,90,ACVR1,0.573,0.552,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,3,0,CTD_human
710,90,ACVR1,0.573,0.552,C0280783,Juvenile Pilocytic Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
711,90,ACVR1,0.573,0.552,C0280785,Diffuse Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
712,90,ACVR1,0.573,0.552,C0334579,Anaplastic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
713,90,ACVR1,0.573,0.552,C0334580,Protoplasmic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
714,90,ACVR1,0.573,0.552,C0334581,Gemistocytic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
715,90,ACVR1,0.573,0.552,C0334582,Fibrillary Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
716,90,ACVR1,0.573,0.552,C0334583,Pilocytic Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
717,90,ACVR1,0.573,0.552,C0338070,Childhood Cerebral Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
718,90,ACVR1,0.573,0.552,C0345050,Congenital aneurysm of ascending aorta,disease,C14,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
719,90,ACVR1,0.573,0.552,C0547065,Mixed oligoastrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
720,90,ACVR1,0.573,0.552,C0555198,Malignant Glioma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,3,0,CTD_human
721,90,ACVR1,0.573,0.552,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
722,90,ACVR1,0.573,0.552,C0750935,Cerebral Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
723,90,ACVR1,0.573,0.552,C0750936,Intracranial Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
724,90,ACVR1,0.573,0.552,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
725,90,ACVR1,0.573,0.552,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
726,90,ACVR1,0.573,0.552,C1704230,Grade I Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
727,90,ACVR1,0.573,0.552,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
70812,57007,ACKR3,0.494,0.759,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.32,1.0,1999.0,2010.0,1,0,CTD_human
70813,57007,ACKR3,0.494,0.759,C0007097,Carcinoma,group,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70814,57007,ACKR3,0.494,0.759,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.31,1.0,2012.0,2015.0,1,0,CTD_human
70815,57007,ACKR3,0.494,0.759,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70816,57007,ACKR3,0.494,0.759,C0022658,Kidney Diseases,group,C12;C13,Disease or Syndrome,0.31,1.0,2013.0,2017.0,1,0,CTD_human
70817,57007,ACKR3,0.494,0.759,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
70818,57007,ACKR3,0.494,0.759,C0027627,Neoplasm Metastasis,phenotype,C04;C23,Neoplastic Process,0.4,0.9629629999999999,2005.0,2017.0,1,0,CTD_human
70819,57007,ACKR3,0.494,0.759,C0205696,Anaplastic carcinoma,disease,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70820,57007,ACKR3,0.494,0.759,C0205697,"Carcinoma, Spindle-Cell",disease,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70821,57007,ACKR3,0.494,0.759,C0205698,Undifferentiated carcinoma,phenotype,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70822,57007,ACKR3,0.494,0.759,C0205699,Carcinomatosis,phenotype,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70823,57007,ACKR3,0.494,0.759,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.31,1.0,2012.0,2015.0,1,0,CTD_human
69437,54995,OXSM,1.0,0.069,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,,,0,0,UNIPROT
63380,11277,TREX1,0.58,0.621,C0006111,Brain Diseases,group,C10,Disease or Syndrome,0.31,1.0,2006.0,2007.0,1,0,CTD_human
63381,11277,TREX1,0.58,0.621,C0021368,Inflammation,phenotype,C23,Pathologic Function,0.3,,2006.0,2006.0,1,0,CTD_human
63382,11277,TREX1,0.58,0.621,C0021400,Influenza,disease,C02;C08,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
63383,11277,TREX1,0.58,0.621,C0023520,Leukodystrophy,disease,,Disease or Syndrome,0.44,1.0,2007.0,2015.0,0,0,GENOMICS_ENGLAND
63384,11277,TREX1,0.58,0.621,C0024141,"Lupus Erythematosus, Systemic",disease,C17;C20,Disease or Syndrome,0.6,0.9375,2007.0,2017.0,3,8,CTD_human;UNIPROT
63385,11277,TREX1,0.58,0.621,C0024145,Chilblain lupus 1,disease,C17;C26,Disease or Syndrome,0.68,1.0,2007.0,2016.0,3,1,CTD_human;ORPHANET;UNIPROT
63386,11277,TREX1,0.58,0.621,C0085584,Encephalopathies,group,C10,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
63387,11277,TREX1,0.58,0.621,C0242380,Libman-Sacks Disease,disease,C17;C20,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
63388,11277,TREX1,0.58,0.621,C0263666,"Dermatomyositis, Childhood Type",disease,C05;C10;C17,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
63389,11277,TREX1,0.58,0.621,C0393591,AICARDI-GOUTIERES SYNDROME,disease,,Disease or Syndrome,0.4,1.0,2000.0,2017.0,0,0,ORPHANET
63390,11277,TREX1,0.58,0.621,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
63391,11277,TREX1,0.58,0.621,C0796126,AICARDI-GOUTIERES SYNDROME 1,disease,C10;C16;C20,Disease or Syndrome,0.9,1.0,1993.0,2017.0,8,24,CTD_human;UNIPROT
63392,11277,TREX1,0.58,0.621,C1835308,EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA,phenotype,,Finding,0.3,,2007.0,2013.0,3,8,UNIPROT
63393,11277,TREX1,0.58,0.621,C1835309,EXCESS LMW-DNA,phenotype,,Finding,0.3,,2007.0,2013.0,3,8,UNIPROT
63394,11277,TREX1,0.58,0.621,C1860518,"Vasculopathy, Retinal, With Cerebral Leukodystrophy",disease,C10;C11;C14;C16;C18,Disease or Syndrome,0.51,1.0,2011.0,2011.0,0,0,CTD_human;ORPHANET
63395,11277,TREX1,0.58,0.621,C3150315,"AICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT",disease,,Disease or Syndrome,0.6,,2004.0,2017.0,8,6,UNIPROT
63396,11277,TREX1,0.58,0.621,C3489724,Aicardi-Goutieres Syndrome 2,disease,C10;C16;C20,Disease or Syndrome,0.5,,2004.0,2017.0,1,0,CTD_human
63397,11277,TREX1,0.58,0.621,C3489725,Pseudo-TORCH syndrome,disease,C10;C16;C20,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
63398,11277,TREX1,0.58,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
66978,29925,GMPPB,0.645,0.345,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
66979,29925,GMPPB,0.645,0.345,C0020255,Hydrocephalus,disease,C10,Disease or Syndrome,0.4,,,,0,0,GENOMICS_ENGLAND
66980,29925,GMPPB,0.645,0.345,C0086543,Cataract,disease,C11,Acquired Abnormality,0.4,,,,0,0,GENOMICS_ENGLAND
66981,29925,GMPPB,0.645,0.345,C0265221,Walker-Warburg congenital muscular dystrophy,disease,C10;C11;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
66982,29925,GMPPB,0.645,0.345,C0266470,Cerebellar Hypoplasia,disease,C10;C16;F03,Congenital Abnormality,0.4,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
66983,29925,GMPPB,0.645,0.345,C0282577,Congenital Disorders of Glycosylation,group,C16;C18,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
66984,29925,GMPPB,0.645,0.345,C0410174,Fukuyama Type Congenital Muscular Dystrophy,disease,C10;C11;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
66985,29925,GMPPB,0.645,0.345,C0457133,Muscle eye brain disease,disease,C10;C11;C16,Disease or Syndrome,0.5,,,,0,0,CTD_human;ORPHANET
66986,29925,GMPPB,0.645,0.345,C0686353,"Muscular Dystrophies, Limb-Girdle",group,C05;C10;C16,Disease or Syndrome,0.35,1.0,2013.0,2018.0,0,0,GENOMICS_ENGLAND
66987,29925,GMPPB,0.645,0.345,C0699743,Congenital muscular dystrophy (disorder),disease,,Disease or Syndrome,0.4,,2013.0,2015.0,2,0,GENOMICS_ENGLAND
66988,29925,GMPPB,0.645,0.345,C0751882,"Myasthenic Syndromes, Congenital",disease,C10;C16,Disease or Syndrome,0.32,1.0,2015.0,2018.0,2,0,GENOMICS_ENGLAND
66989,29925,GMPPB,0.645,0.345,C1836373,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K",disease,C10;C11;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
66990,29925,GMPPB,0.645,0.345,C1955869,Malformations of Cortical Development,group,C10;C16,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
66991,29925,GMPPB,0.645,0.345,C2936406,alpha-Dystroglycanopathies,disease,C10;C11;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
66992,29925,GMPPB,0.645,0.345,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.42,1.0,2013.0,2018.0,4,0,GENOMICS_ENGLAND
66993,29925,GMPPB,0.645,0.345,C3714932,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14",disease,,Disease or Syndrome,0.7,,2013.0,2018.0,4,16,CTD_human;ORPHANET;UNIPROT
66994,29925,GMPPB,0.645,0.345,C3809216,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14",disease,,Disease or Syndrome,0.4,,2013.0,2017.0,1,4,UNIPROT
66995,29925,GMPPB,0.645,0.345,C3809221,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14",disease,,Disease or Syndrome,0.6,,2009.0,2017.0,1,5,CTD_human;UNIPROT
25744,3373,HYAL1,0.648,0.483,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
25745,3373,HYAL1,0.648,0.483,C1291490,Hyaluronidase Deficiency,disease,C16;C17;C18,Disease or Syndrome,0.9,,1996.0,2008.0,1,1,CTD_human;ORPHANET;UNIPROT
25746,3373,HYAL1,0.648,0.483,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
66280,27086,FOXP1,0.528,0.69,C0006413,Burkitt Lymphoma,disease,C02;C04;C15;C20,Neoplastic Process,0.3,,,,0,0,ORPHANET
66281,27086,FOXP1,0.528,0.69,C0024232,Lymphatic Metastasis,disease,C04;C23,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
66282,27086,FOXP1,0.528,0.69,C0027626,Neoplasm Invasiveness,phenotype,C04;C23,Pathologic Function,0.3,,2015.0,2015.0,1,0,CTD_human
66283,27086,FOXP1,0.528,0.69,C0030297,Pancreatic Neoplasm,disease,C04;C06;C19,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
66284,27086,FOXP1,0.528,0.69,C0042900,Vitiligo,disease,C17,Disease or Syndrome,0.4,,2010.0,2017.0,1,2,CTD_human
66285,27086,FOXP1,0.528,0.69,C0087031,Juvenile-Onset Still Disease,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66286,27086,FOXP1,0.528,0.69,C0242647,Mucosa-Associated Lymphoid Tissue Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.4,1.0,2005.0,2015.0,0,0,ORPHANET
66287,27086,FOXP1,0.528,0.69,C0279628,Adenocarcinoma Of Esophagus,disease,C04;C06,Neoplastic Process,0.31,1.0,2014.0,2016.0,1,0,CTD_human
66288,27086,FOXP1,0.528,0.69,C0346647,Malignant neoplasm of pancreas,disease,C04;C06;C19,Neoplastic Process,0.31,1.0,2015.0,2015.0,1,0,CTD_human
66289,27086,FOXP1,0.528,0.69,C1292769,Precursor B-cell lymphoblastic leukemia,disease,,Neoplastic Process,0.3,,,,0,0,ORPHANET
66290,27086,FOXP1,0.528,0.69,C1510586,Autism Spectrum Disorders,disease,F03,Mental or Behavioral Dysfunction,0.42,1.0,2011.0,2018.0,1,1,CTD_human
66291,27086,FOXP1,0.528,0.69,C1535926,Neurodevelopmental Disorders,group,F03,Mental or Behavioral Dysfunction,0.35,1.0,2016.0,2018.0,1,0,CTD_human
66292,27086,FOXP1,0.528,0.69,C3495559,Juvenile arthritis,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66293,27086,FOXP1,0.528,0.69,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.46,1.0,2010.0,2018.0,0,0,GENOMICS_ENGLAND
66294,27086,FOXP1,0.528,0.69,C3714758,Juvenile psoriatic arthritis,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66295,27086,FOXP1,0.528,0.69,C4013764,MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES,disease,,Disease or Syndrome,0.6,,2011.0,2016.0,2,3,CTD_human;ORPHANET;UNIPROT
50821,7012,TERC,0.514,0.655,C0007137,Squamous cell carcinoma,disease,C04,Neoplastic Process,0.32,0.5,2006.0,2011.0,1,0,CTD_human
50822,7012,TERC,0.514,0.655,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,,,0,0,GENOMICS_ENGLAND
50823,7012,TERC,0.514,0.655,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
50824,7012,TERC,0.514,0.655,C0040411,Tongue Neoplasms,group,C04;C07,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
50825,7012,TERC,0.514,0.655,C0085786,Hamman-Rich syndrome,disease,C08,Disease or Syndrome,0.33,1.0,2008.0,2015.0,0,0,ORPHANET
50826,7012,TERC,0.514,0.655,C0153349,Malignant neoplasm of tongue,disease,C04;C07,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
50827,7012,TERC,0.514,0.655,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50828,7012,TERC,0.514,0.655,C0265965,Dyskeratosis Congenita,disease,C16;C17,Disease or Syndrome,0.6,0.9375,2003.0,2015.0,1,0,CTD_human;ORPHANET
50829,7012,TERC,0.514,0.655,C0348890,"Aplastic anemia, idiopathic",disease,C15,Disease or Syndrome,0.3,,,,0,0,ORPHANET
50830,7012,TERC,0.514,0.655,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.32,1.0,2000.0,2018.0,1,0,CTD_human
50831,7012,TERC,0.514,0.655,C0376545,Hematologic Neoplasms,group,C04;C15,Neoplastic Process,0.3,,2017.0,2017.0,2,0,GENOMICS_ENGLAND
50832,7012,TERC,0.514,0.655,C1148551,X-Linked Dyskeratosis Congenita,disease,C16;C17,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
50833,7012,TERC,0.514,0.655,C1800706,Idiopathic Pulmonary Fibrosis,disease,C08,Disease or Syndrome,0.53,1.0,2007.0,2015.0,3,1,CTD_human;ORPHANET
50834,7012,TERC,0.514,0.655,C1851970,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT",disease,C16;C17,Disease or Syndrome,0.36,1.0,2005.0,2014.0,0,16,CTD_human
50835,7012,TERC,0.514,0.655,C3553622,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2",disease,,Disease or Syndrome,0.3,,,,0,5,CTD_human
76609,131118,DNAJC19,0.743,0.414,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,2006.0,2017.0,5,0,GENOMICS_ENGLAND
76610,131118,DNAJC19,0.743,0.414,C0007193,"Cardiomyopathy, Dilated",group,C14,Disease or Syndrome,0.44,1.0,2006.0,2017.0,5,0,GENOMICS_ENGLAND
76611,131118,DNAJC19,0.743,0.414,C0264886,Conduction disorder of the heart,group,C14,Disease or Syndrome,0.3,,2006.0,2017.0,5,0,GENOMICS_ENGLAND
76612,131118,DNAJC19,0.743,0.414,C0751651,Mitochondrial Diseases,group,C18,Disease or Syndrome,0.3,,2006.0,2017.0,5,0,GENOMICS_ENGLAND
76613,131118,DNAJC19,0.743,0.414,C1857776,"3-@METHYLGLUTACONIC ACIDURIA, TYPE V",disease,C10;C14;C16;C18;C23,Disease or Syndrome,0.63,1.0,2006.0,2014.0,0,2,CTD_human;ORPHANET
76614,131118,DNAJC19,0.743,0.414,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2006.0,2017.0,3,0,GENOMICS_ENGLAND
76615,131118,DNAJC19,0.743,0.414,C4021133,Left ventricular noncompaction cardiomyopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
58003,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
58004,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C0023520,Leukodystrophy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
58005,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C0152013,Adenocarcinoma of lung (disorder),disease,C04;C08,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
58006,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
58007,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C1847967,OVARIOLEUKODYSTROPHY,disease,C10;C13;C19,Disease or Syndrome,0.9,,2001.0,2016.0,6,24,CTD_human;ORPHANET;UNIPROT
58008,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C1858991,Childhood Ataxia with Central Nervous System Hypomyelinization,disease,C10,Disease or Syndrome,0.87,1.0,2001.0,2016.0,6,29,ORPHANET;UNIPROT
51887,7096,TLR1,0.529,0.7929999999999999,C0013221,Drug toxicity,group,C25,Injury or Poisoning,0.3,,2008.0,2008.0,1,0,CTD_human
51888,7096,TLR1,0.529,0.7929999999999999,C0023343,Leprosy,disease,C01,Disease or Syndrome,0.36,1.0,2007.0,2017.0,0,0,CTD_human
51889,7096,TLR1,0.529,0.7929999999999999,C0041755,Adverse reaction to drug,group,C25,Pathologic Function,0.3,,2008.0,2008.0,1,0,CTD_human
51890,7096,TLR1,0.529,0.7929999999999999,C0085742,"Injuries, Acute Brain",group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51891,7096,TLR1,0.529,0.7929999999999999,C0270611,Brain Injuries,group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51892,7096,TLR1,0.529,0.7929999999999999,C0272945,Brain Lacerations,disease,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51893,7096,TLR1,0.529,0.7929999999999999,C0452047,"Brain Injuries, Focal",group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
77282,152926,PPM1K,0.785,0.24100000000000002,C0024776,Maple Syrup Urine Disease,disease,C10;C16;C18,Disease or Syndrome,0.52,0.5,2009.0,2013.0,0,0,CTD_human
77283,152926,PPM1K,0.785,0.24100000000000002,C0268568,Classic Maple Syrup Urine Disease,disease,C10;C16;C18,Disease or Syndrome,0.3,,,,0,0,CTD_human
77284,152926,PPM1K,0.785,0.24100000000000002,C0268569,Intermittent Maple Syrup Urine Disease,disease,C10;C16;C18,Disease or Syndrome,0.3,,,,0,0,CTD_human
77285,152926,PPM1K,0.785,0.24100000000000002,C0751285,"Maple Syrup Urine Disease, Thiamine Responsive",disease,C10;C16;C18,Disease or Syndrome,0.3,,,,0,0,CTD_human
77286,152926,PPM1K,0.785,0.24100000000000002,C1621920,Intermediate Maple Syrup Urine Disease,disease,C10;C16;C18,Disease or Syndrome,0.5,,,,0,0,CTD_human;ORPHANET
47179,6507,SLC1A3,0.619,0.552,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
47180,6507,SLC1A3,0.619,0.552,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2001.0,2017.0,1,0,CTD_human
47181,6507,SLC1A3,0.619,0.552,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2002.0,2002.0,1,0,PSYGENET
47182,6507,SLC1A3,0.619,0.552,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
47183,6507,SLC1A3,0.619,0.552,C0014544,Epilepsy,disease,C10,Disease or Syndrome,0.41,0.0,1995.0,2010.0,1,0,CTD_human
47184,6507,SLC1A3,0.619,0.552,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.36,1.0,2002.0,2016.0,4,0,PSYGENET
47185,6507,SLC1A3,0.619,0.552,C0086237,"Epilepsy, Cryptogenic",disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
47186,6507,SLC1A3,0.619,0.552,C0178417,Anhedonia,disease,C10;C23;F01,Mental or Behavioral Dysfunction,0.3,1.0,2009.0,2009.0,1,0,PSYGENET
47187,6507,SLC1A3,0.619,0.552,C0236018,Aura,phenotype,C10,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
47188,6507,SLC1A3,0.619,0.552,C0338488,Alternating hemiplegia of childhood,disease,C10;C23,Disease or Syndrome,0.33,1.0,2006.0,2009.0,0,0,ORPHANET
47189,6507,SLC1A3,0.619,0.552,C0751111,Awakening Epilepsy,disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
47190,6507,SLC1A3,0.619,0.552,C2675211,"EPISODIC ATAXIA, TYPE 6 (disorder)",disease,C10;C23,Disease or Syndrome,0.72,1.0,2006.0,2017.0,1,2,CTD_human;ORPHANET;UNIPROT
38636,5144,PDE4D,0.5720000000000001,0.69,C0004096,Asthma,disease,C08;C20,Disease or Syndrome,0.48,0.75,2001.0,2016.0,2,4,CTD_human
38637,5144,PDE4D,0.5720000000000001,0.69,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.5,1.0,2002.0,2012.0,2,0,PSYGENET
38638,5144,PDE4D,0.5720000000000001,0.69,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2002.0,2013.0,3,0,PSYGENET
38639,5144,PDE4D,0.5720000000000001,0.69,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2006.0,2018.0,2,0,CTD_human
38640,5144,PDE4D,0.5720000000000001,0.69,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2009.0,2011.0,1,1,PSYGENET
38641,5144,PDE4D,0.5720000000000001,0.69,C0038454,Cerebrovascular accident,group,C10;C14,Disease or Syndrome,0.4,0.9375,2002.0,2017.0,0,0,CTD_human
38642,5144,PDE4D,0.5720000000000001,0.69,C0220659,Acrodysostosis,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.59,0.8888889000000001,2012.0,2018.0,0,0,CTD_human;ORPHANET
38643,5144,PDE4D,0.5720000000000001,0.69,C0236733,Amphetamine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38644,5144,PDE4D,0.5720000000000001,0.69,C0236804,Amphetamine Addiction,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38645,5144,PDE4D,0.5720000000000001,0.69,C0236807,Amphetamine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38646,5144,PDE4D,0.5720000000000001,0.69,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.31,1.0,2006.0,2018.0,2,0,CTD_human
38647,5144,PDE4D,0.5720000000000001,0.69,C0751956,Acute Cerebrovascular Accidents,disease,C10;C14,Disease or Syndrome,0.3,,,,0,0,CTD_human
38648,5144,PDE4D,0.5720000000000001,0.69,C3276228,ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.3,,,,0,0,CTD_human
38649,5144,PDE4D,0.5720000000000001,0.69,C3553250,ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.61,1.0,2001.0,2018.0,4,9,CTD_human;UNIPROT
38650,5144,PDE4D,0.5720000000000001,0.69,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.41,1.0,2014.0,2014.0,0,0,GENOMICS_ENGLAND
49134,6695,SPOCK1,0.701,0.172,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.31,1.0,2008.0,2016.0,1,0,CTD_human
49135,6695,SPOCK1,0.701,0.172,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.31,1.0,2008.0,2016.0,1,0,CTD_human
21256,2741,GLRA1,0.642,0.379,C0393593,Dystonia Disorders,group,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21257,2741,GLRA1,0.642,0.379,C0393598,Idiopathic familial dystonia,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21258,2741,GLRA1,0.642,0.379,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
21259,2741,GLRA1,0.642,0.379,C0743332,Focal Dystonia,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21260,2741,GLRA1,0.642,0.379,C0752197,Adult-Onset Dystonias,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21261,2741,GLRA1,0.642,0.379,C0752198,Adult-Onset Idiopathic Focal Dystonias,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21262,2741,GLRA1,0.642,0.379,C0752199,Adult-Onset Idiopathic Torsion Dystonias,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21263,2741,GLRA1,0.642,0.379,C0752200,Autosomal Dominant Familial Dystonia,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21264,2741,GLRA1,0.642,0.379,C0752201,Autosomal Recessive Familial Dystonia,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21265,2741,GLRA1,0.642,0.379,C0752202,Childhood Onset Dystonias,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21266,2741,GLRA1,0.642,0.379,C0752203,"Dystonia, Primary",disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21267,2741,GLRA1,0.642,0.379,C0752205,"Dystonia, Secondary",disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21268,2741,GLRA1,0.642,0.379,C0752206,"Dystonias, Sporadic",disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21269,2741,GLRA1,0.642,0.379,C0752207,Familial Dystonia,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21270,2741,GLRA1,0.642,0.379,C0752208,Pseudodystonia,disease,C10,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
21271,2741,GLRA1,0.642,0.379,C1835614,Hereditary Hyperexplexia,disease,C05;C10;C23,Disease or Syndrome,0.72,1.0,1993.0,2017.0,12,25,CTD_human;ORPHANET;UNIPROT
21272,2741,GLRA1,0.642,0.379,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2017.0,2018.0,2,0,GENOMICS_ENGLAND
21273,2741,GLRA1,0.642,0.379,C4316810,Writer's Cramp,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
72547,64777,RMND5B,1.0,0.034,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
70040,55651,NHP2,0.652,0.552,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,2008.0,2008.0,1,0,GENOMICS_ENGLAND
70041,55651,NHP2,0.652,0.552,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,GENOMICS_ENGLAND
70042,55651,NHP2,0.652,0.552,C0265965,Dyskeratosis Congenita,disease,C16;C17,Disease or Syndrome,0.52,1.0,2001.0,2015.0,4,0,CLINGEN;ORPHANET
70043,55651,NHP2,0.652,0.552,C0376545,Hematologic Neoplasms,group,C04;C15,Neoplastic Process,0.3,,2017.0,2017.0,2,0,GENOMICS_ENGLAND
70044,55651,NHP2,0.652,0.552,C1148551,X-Linked Dyskeratosis Congenita,disease,C16;C17,Disease or Syndrome,0.3,,2001.0,2015.0,4,0,CLINGEN
70045,55651,NHP2,0.652,0.552,C3151441,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2",disease,,Disease or Syndrome,0.6,,2008.0,2008.0,1,3,CTD_human;UNIPROT
70046,55651,NHP2,0.652,0.552,C3502105,"Dyskeratosis Congenita, Autosomal Recessive",disease,C16;C17,Congenital Abnormality; Disease or Syndrome,0.31,1.0,2008.0,2008.0,0,0,CTD_human
70047,55651,NHP2,0.652,0.552,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,1993.0,2015.0,4,0,GENOMICS_ENGLAND
72554,64780,MICAL1,0.9279999999999999,0.069,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,,,0,0,UNIPROT
3848,383,ARG1,0.551,0.7240000000000001,C0002514,"Amino Acid Metabolism, Inborn Errors",group,C16;C18,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3849,383,ARG1,0.551,0.7240000000000001,C0003949,Asbestosis,disease,C08;C24,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
3850,383,ARG1,0.551,0.7240000000000001,C0004096,Asthma,disease,C08;C20,Disease or Syndrome,0.4,0.9,2003.0,2014.0,2,0,CTD_human
3851,383,ARG1,0.551,0.7240000000000001,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.5,,2005.0,2005.0,0,0,GENOMICS_ENGLAND
3852,383,ARG1,0.551,0.7240000000000001,C0018500,Hair Diseases,group,C17,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3853,383,ARG1,0.551,0.7240000000000001,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2013.0,2013.0,1,0,CTD_human
3854,383,ARG1,0.551,0.7240000000000001,C0021053,Immune System Diseases,group,C20,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3855,383,ARG1,0.551,0.7240000000000001,C0023281,Leishmaniasis,disease,C03;C17,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3856,383,ARG1,0.551,0.7240000000000001,C0026848,Myopathy,group,C05;C10,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3857,383,ARG1,0.551,0.7240000000000001,C0032927,Precancerous Conditions,group,C04,Neoplastic Process,0.31,1.0,2012.0,2016.0,1,0,CTD_human
3858,383,ARG1,0.551,0.7240000000000001,C0037116,Silicosis,disease,C08;C24,Disease or Syndrome,0.5,,2004.0,2007.0,1,0,CTD_human
3859,383,ARG1,0.551,0.7240000000000001,C0152013,Adenocarcinoma of lung (disorder),disease,C04;C08,Neoplastic Process,0.3,,2016.0,2016.0,1,0,CTD_human
3860,383,ARG1,0.551,0.7240000000000001,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.44,0.75,2013.0,2016.0,0,0,GENOMICS_ENGLAND
3861,383,ARG1,0.551,0.7240000000000001,C0268548,Hyperargininemia,phenotype,C10;C16;C18,Disease or Syndrome,1.0,1.0,1979.0,2018.0,4,9,CTD_human;ORPHANET;UNIPROT
3862,383,ARG1,0.551,0.7240000000000001,C0282313,"Condition, Preneoplastic",phenotype,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
3863,383,ARG1,0.551,0.7240000000000001,C0750905,"Amino Acid Metabolism, Inherited Disorders",disease,C16;C18,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3864,383,ARG1,0.551,0.7240000000000001,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
3865,383,ARG1,0.551,0.7240000000000001,C1112213,Cholestasis in newborn,disease,,Disease or Syndrome,0.31,1.0,2016.0,2016.0,0,0,GENOMICS_ENGLAND
3866,383,ARG1,0.551,0.7240000000000001,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
3867,383,ARG1,0.551,0.7240000000000001,C2930617,Pulmonary Fibrosis - from Asbestos Exposure,disease,C08;C24,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
3868,383,ARG1,0.551,0.7240000000000001,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
3869,383,ARG1,0.551,0.7240000000000001,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
3870,383,ARG1,0.551,0.7240000000000001,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
3871,383,ARG1,0.551,0.7240000000000001,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
59304,9439,MED23,0.69,0.379,C3280265,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18",disease,,Disease or Syndrome,0.6,,2011.0,2011.0,1,3,CTD_human;UNIPROT
59305,9439,MED23,0.69,0.379,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.43,1.0,2011.0,2016.0,4,0,GENOMICS_ENGLAND
64432,23345,SYNE1,0.594,0.621,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.31,1.0,2009.0,2009.0,0,0,GENOMICS_ENGLAND
64433,23345,SYNE1,0.594,0.621,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
64434,23345,SYNE1,0.594,0.621,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.42,0.6666667,2011.0,2018.0,3,3,PSYGENET
64435,23345,SYNE1,0.594,0.621,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
64436,23345,SYNE1,0.594,0.621,C0007193,"Cardiomyopathy, Dilated",group,C14,Disease or Syndrome,0.31,1.0,2017.0,2017.0,0,0,GENOMICS_ENGLAND
64437,23345,SYNE1,0.594,0.621,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.32,1.0,2007.0,2015.0,2,0,CTD_human
64438,23345,SYNE1,0.594,0.621,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2008.0,2011.0,2,0,CTD_human
64439,23345,SYNE1,0.594,0.621,C0013146,Drug abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64440,23345,SYNE1,0.594,0.621,C0013170,Drug habituation,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64441,23345,SYNE1,0.594,0.621,C0013222,Drug Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64442,23345,SYNE1,0.594,0.621,C0029231,"Organic Mental Disorders, Substance-Induced",disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64443,23345,SYNE1,0.594,0.621,C0038580,Substance Dependence,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64444,23345,SYNE1,0.594,0.621,C0038586,Substance Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64445,23345,SYNE1,0.594,0.621,C0154409,Recurrent major depressive episodes,disease,,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
64446,23345,SYNE1,0.594,0.621,C0236969,Substance-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64447,23345,SYNE1,0.594,0.621,C0264886,Conduction disorder of the heart,group,C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
64448,23345,SYNE1,0.594,0.621,C0410189,"Muscular Dystrophy, Emery-Dreifuss",disease,C05;C10;C16,Disease or Syndrome,0.56,1.0,2008.0,2017.0,0,0,CTD_human
64449,23345,SYNE1,0.594,0.621,C0410190,Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder),disease,C05;C10;C16,Disease or Syndrome,0.5,,,,0,0,CTD_human;ORPHANET
64450,23345,SYNE1,0.594,0.621,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.33,1.0,1998.0,2008.0,1,0,CTD_human
64451,23345,SYNE1,0.594,0.621,C0686353,"Muscular Dystrophies, Limb-Girdle",group,C05;C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
64452,23345,SYNE1,0.594,0.621,C0699743,Congenital muscular dystrophy (disorder),disease,,Disease or Syndrome,0.31,1.0,2009.0,2018.0,2,0,GENOMICS_ENGLAND
64453,23345,SYNE1,0.594,0.621,C0740858,Substance abuse problem,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64454,23345,SYNE1,0.594,0.621,C0751337,X-Linked Emery-Dreifuss Muscular Dystrophy,disease,C05;C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
64455,23345,SYNE1,0.594,0.621,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
64456,23345,SYNE1,0.594,0.621,C1450051,Autosomal Recessive Emery-Dreifuss Muscular Dystrophy,disease,C05;C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
64457,23345,SYNE1,0.594,0.621,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
64458,23345,SYNE1,0.594,0.621,C1510472,Drug Dependence,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64459,23345,SYNE1,0.594,0.621,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.52,1.0,2006.0,2015.0,3,3,CTD_human;UNIPROT
64460,23345,SYNE1,0.594,0.621,C1853116,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8 (disorder)",disease,C10;C16,Disease or Syndrome,0.6,,2007.0,2017.0,0,27,CTD_human;ORPHANET
64461,23345,SYNE1,0.594,0.621,C2751807,Emery-Dreifuss Muscular Dystrophy 4,disease,C05;C10;C16,Disease or Syndrome,0.4,,2008.0,2008.0,1,10,UNIPROT
64462,23345,SYNE1,0.594,0.621,C2931822,Nasopharyngeal carcinoma,disease,C04;C07;C09,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
64463,23345,SYNE1,0.594,0.621,C3683483,Autosomal Recessive Cerebellar Ataxia Type 1,disease,C10;C23,Disease or Syndrome,0.3,,,,0,0,ORPHANET
64464,23345,SYNE1,0.594,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2014.0,2016.0,2,0,GENOMICS_ENGLAND
64465,23345,SYNE1,0.594,0.621,C4316881,Prescription Drug Abuse,phenotype,C25;F03,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
78006,221895,JAZF1,0.616,0.44799999999999995,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",disease,C18;C19,Disease or Syndrome,0.5,0.9375,2008.0,2018.0,1,4,CTD_human
78007,221895,JAZF1,0.616,0.44799999999999995,C0014170,Endometrial Neoplasms,group,C04;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
78008,221895,JAZF1,0.616,0.44799999999999995,C0024141,"Lupus Erythematosus, Systemic",disease,C17;C20,Disease or Syndrome,0.43,0.6666667,2009.0,2016.0,1,3,CTD_human
78009,221895,JAZF1,0.616,0.44799999999999995,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
78010,221895,JAZF1,0.616,0.44799999999999995,C0206630,Endometrial Stromal Sarcoma,disease,C04;C13,Neoplastic Process,0.4,0.9,2006.0,2016.0,0,0,ORPHANET
78011,221895,JAZF1,0.616,0.44799999999999995,C0242380,Libman-Sacks Disease,disease,C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
78012,221895,JAZF1,0.616,0.44799999999999995,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.37,0.8571429,2008.0,2015.0,1,0,CTD_human
78013,221895,JAZF1,0.616,0.44799999999999995,C0476089,Endometrial Carcinoma,disease,C04;C13,Neoplastic Process,0.31,1.0,2008.0,2008.0,1,0,CTD_human
64480,23362,PSD3,0.685,0.379,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,GENOMICS_ENGLAND
64481,23362,PSD3,0.685,0.379,C0017638,Glioma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64482,23362,PSD3,0.685,0.379,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2013.0,2016.0,1,1,PSYGENET
64483,23362,PSD3,0.685,0.379,C0236733,Amphetamine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64484,23362,PSD3,0.685,0.379,C0236804,Amphetamine Addiction,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64485,23362,PSD3,0.685,0.379,C0236807,Amphetamine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64486,23362,PSD3,0.685,0.379,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64487,23362,PSD3,0.685,0.379,C0555198,Malignant Glioma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64488,23362,PSD3,0.685,0.379,C1867439,"Pterygium, Antecubital",disease,C05;C16,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CLINGEN
68922,54704,PDP1,0.713,0.379,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2018.0,2018.0,1,0,CTD_human
68923,54704,PDP1,0.713,0.379,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2018.0,2018.0,1,0,CTD_human
68924,54704,PDP1,0.713,0.379,C0751651,Mitochondrial Diseases,group,C18,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
68925,54704,PDP1,0.713,0.379,C1837429,Pyruvate dehydrogenase phosphatase deficiency,disease,C18,Disease or Syndrome,0.6,,2009.0,2009.0,0,1,CTD_human;ORPHANET
73065,79581,SLC52A2,0.528,0.759,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
73066,79581,SLC52A2,0.528,0.759,C0796274,Brown-Vialetto-Van Laere syndrome,disease,C09;C10;C23,Disease or Syndrome,0.54,1.0,2013.0,2017.0,0,0,CTD_human;ORPHANET
73067,79581,SLC52A2,0.528,0.759,C1849094,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,ORPHANET
73068,79581,SLC52A2,0.528,0.759,C3553538,BROWN-VIALETTO-VAN LAERE SYNDROME 2,disease,,Disease or Syndrome,0.4,,1993.0,2017.0,5,18,UNIPROT
72709,65217,PCDH15,0.627,0.44799999999999995,C0009197,Cochlear Diseases,group,C09,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72710,65217,PCDH15,0.627,0.44799999999999995,C0011052,Prelingual Deafness,disease,C09;C10;C23,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72711,65217,PCDH15,0.627,0.44799999999999995,C0011053,Deafness,phenotype,C09;C10;C23,Finding,0.41,,2000.0,2008.0,1,0,CTD_human
72712,65217,PCDH15,0.627,0.44799999999999995,C0013146,Drug abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72713,65217,PCDH15,0.627,0.44799999999999995,C0013170,Drug habituation,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72714,65217,PCDH15,0.627,0.44799999999999995,C0013222,Drug Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72715,65217,PCDH15,0.627,0.44799999999999995,C0029231,"Organic Mental Disorders, Substance-Induced",disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72716,65217,PCDH15,0.627,0.44799999999999995,C0038580,Substance Dependence,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72717,65217,PCDH15,0.627,0.44799999999999995,C0038586,Substance Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72718,65217,PCDH15,0.627,0.44799999999999995,C0086395,"Hearing Loss, Extreme",phenotype,C09;C10;C23,Sign or Symptom,0.3,,2000.0,2000.0,1,0,CTD_human
72719,65217,PCDH15,0.627,0.44799999999999995,C0236969,Substance-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72720,65217,PCDH15,0.627,0.44799999999999995,C0271097,Usher Syndrome,disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.47,1.0,2001.0,2015.0,1,1,CTD_human
72721,65217,PCDH15,0.627,0.44799999999999995,C0581883,Complete Hearing Loss,phenotype,C09;C10;C23,Finding,0.3,,2000.0,2000.0,1,0,CTD_human
72722,65217,PCDH15,0.627,0.44799999999999995,C0740858,Substance abuse problem,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72723,65217,PCDH15,0.627,0.44799999999999995,C0751068,"Deafness, Acquired",disease,C09;C10;C23,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72724,65217,PCDH15,0.627,0.44799999999999995,C1510472,Drug Dependence,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72725,65217,PCDH15,0.627,0.44799999999999995,C1568247,"Usher Syndrome, Type I",disease,,Disease or Syndrome,0.49,0.8888889000000001,1993.0,2015.0,0,3,ORPHANET
72726,65217,PCDH15,0.627,0.44799999999999995,C1568248,"Usher Syndrome, Type III",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
72727,65217,PCDH15,0.627,0.44799999999999995,C1568249,"Usher Syndrome, Type II",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
72728,65217,PCDH15,0.627,0.44799999999999995,C1832845,"USHER SYNDROME, TYPE ID",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.4,,2003.0,2017.0,2,3,UNIPROT
72729,65217,PCDH15,0.627,0.44799999999999995,C1836027,"Deafness, Autosomal Recessive 23",disease,C09;C10;C23,Disease or Syndrome,0.82,1.0,2003.0,2017.0,3,6,CTD_human;UNIPROT
72730,65217,PCDH15,0.627,0.44799999999999995,C1865885,"Usher Syndrome, Type IF",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.87,1.0,2001.0,2017.0,9,49,CLINGEN;UNIPROT
72731,65217,PCDH15,0.627,0.44799999999999995,C2931205,"Usher syndrome, type 1A",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.34,1.0,2008.0,2012.0,1,0,CTD_human
72732,65217,PCDH15,0.627,0.44799999999999995,C2931208,"Usher syndrome, type 1D",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.3,,,,0,0,CTD_human
72733,65217,PCDH15,0.627,0.44799999999999995,C2931210,"Usher syndrome, type 1F",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.38,0.875,2001.0,2016.0,0,0,CTD_human
72734,65217,PCDH15,0.627,0.44799999999999995,C3152102,"USH1D/F, CDH23/PCDH15, DIGENIC",disease,,Disease or Syndrome,0.3,,2005.0,2008.0,2,0,UNIPROT
72735,65217,PCDH15,0.627,0.44799999999999995,C3275872,"USHER SYNDROME, TYPE ID/F, CDH23/PCDH15, DIGENIC",disease,,Disease or Syndrome,0.3,,2005.0,2008.0,2,0,UNIPROT
72736,65217,PCDH15,0.627,0.44799999999999995,C3665473,Bilateral Deafness,phenotype,C09;C10;C23,Finding,0.3,,2000.0,2000.0,1,0,CTD_human
72737,65217,PCDH15,0.627,0.44799999999999995,C4082305,Deaf Mutism,disease,C09;C10;C23,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72738,65217,PCDH15,0.627,0.44799999999999995,C4316881,Prescription Drug Abuse,phenotype,C25;F03,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
75150,85363,TRIM5,0.799,0.24100000000000002,C0019693,HIV Infections,group,C02;C20,Disease or Syndrome,0.36,1.0,2004.0,2015.0,1,0,CTD_human
75151,85363,TRIM5,0.799,0.24100000000000002,C4505456,HIV Coinfection,disease,C02;C20,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
44168,5897,RAG2,0.525,0.759,C0003865,"Arthritis, Adjuvant-Induced",disease,C05,Experimental Model of Disease,0.3,,2010.0,2010.0,1,0,CTD_human
44169,5897,RAG2,0.525,0.759,C0014457,Eosinophilia,disease,C15,Disease or Syndrome,0.41,1.0,2007.0,2017.0,1,0,CTD_human
44170,5897,RAG2,0.525,0.759,C0014458,"Eosinophilia, Tropical",disease,C15,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
44171,5897,RAG2,0.525,0.759,C0025568,Metaplasia,phenotype,C23,Cell or Molecular Dysfunction,0.3,,2017.0,2017.0,1,0,CTD_human
44172,5897,RAG2,0.525,0.759,C0400966,Non-alcoholic Fatty Liver Disease,disease,C06,Disease or Syndrome,0.3,,2014.0,2014.0,1,0,CTD_human
44173,5897,RAG2,0.525,0.759,C0971858,"Arthritis, Collagen-Induced",disease,C05,Experimental Model of Disease,0.3,,2010.0,2010.0,1,0,CTD_human
44174,5897,RAG2,0.525,0.759,C0993582,"Arthritis, Experimental",disease,C05,Experimental Model of Disease,0.3,,2010.0,2010.0,1,0,CTD_human
44175,5897,RAG2,0.525,0.759,C1832322,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive",disease,C20,Disease or Syndrome,0.9,,1992.0,2017.0,1,3,CTD_human;ORPHANET;UNIPROT
44176,5897,RAG2,0.525,0.759,C2673536,Combined Cellular And Humoral Immune Defects With Granulomas,disease,C15;C16;C18;C20,Disease or Syndrome,0.7,,2008.0,2008.0,1,2,CTD_human;ORPHANET;UNIPROT
44177,5897,RAG2,0.525,0.759,C2700553,Omenn Syndrome,disease,C16;C18;C20,Disease or Syndrome,0.8,1.0,1998.0,2016.0,1,2,ORPHANET;UNIPROT
44178,5897,RAG2,0.525,0.759,C2931884,"Reticuloendotheliosis, familial, with eosinophilia",disease,C15;C16;C18;C20,Disease or Syndrome,0.7,,1998.0,2007.0,1,2,CTD_human;UNIPROT
44179,5897,RAG2,0.525,0.759,C3241937,Nonalcoholic Steatohepatitis,disease,C06,Disease or Syndrome,0.3,,2014.0,2014.0,1,0,CTD_human
69825,55343,SLC35C1,0.773,0.414,C0282577,Congenital Disorders of Glycosylation,group,C16;C18,Disease or Syndrome,0.3,,2001.0,2004.0,2,0,GENOMICS_ENGLAND
69826,55343,SLC35C1,0.773,0.414,C0398739,"Congenital disorder of glycosylation, type 2C",disease,C16;C18,Disease or Syndrome,0.7,,1992.0,2015.0,1,4,CTD_human;ORPHANET;UNIPROT
69827,55343,SLC35C1,0.773,0.414,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
59228,9415,FADS2,0.627,0.552,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2011.0,2018.0,1,2,PSYGENET
59229,9415,FADS2,0.627,0.552,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
59230,9415,FADS2,0.627,0.552,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
59231,9415,FADS2,0.627,0.552,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2015.0,2015.0,1,0,CTD_human
59232,9415,FADS2,0.627,0.552,C0023794,Lipoidosis,disease,C16;C18,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
59233,9415,FADS2,0.627,0.552,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2009.0,2009.0,1,0,PSYGENET
59234,9415,FADS2,0.627,0.552,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59235,9415,FADS2,0.627,0.552,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59236,9415,FADS2,0.627,0.552,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.4,,2014.0,2018.0,1,1,CTD_human
59237,9415,FADS2,0.627,0.552,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59238,9415,FADS2,0.627,0.552,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59239,9415,FADS2,0.627,0.552,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
57318,8722,CTSF,0.735,0.31,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
57319,8722,CTSF,0.735,0.31,C3715049,"CEROID LIPOFUSCINOSIS, NEURONAL, 13",disease,,Disease or Syndrome,0.7,,2013.0,2015.0,1,6,CTD_human;ORPHANET;UNIPROT
65218,23705,CADM1,0.537,0.655,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.31,,2008.0,2008.0,1,0,CTD_human
65219,23705,CADM1,0.537,0.655,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.33,1.0,2002.0,2013.0,1,0,CTD_human
65220,23705,CADM1,0.537,0.655,C0011573,Endogenous depression,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65221,23705,CADM1,0.537,0.655,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65222,23705,CADM1,0.537,0.655,C0025193,Melancholia,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65223,23705,CADM1,0.537,0.655,C0041696,Unipolar Depression,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65224,23705,CADM1,0.537,0.655,C0086133,Depressive Syndrome,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65225,23705,CADM1,0.537,0.655,C0282126,"Depression, Neurotic",disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65226,23705,CADM1,0.537,0.655,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.32,1.0,2002.0,2007.0,1,0,CTD_human
65227,23705,CADM1,0.537,0.655,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
65228,23705,CADM1,0.537,0.655,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.32,,2002.0,2007.0,1,0,CTD_human
7984,917,CD3G,0.735,0.276,C3810107,IMMUNODEFICIENCY 17,disease,,Disease or Syndrome,0.6,,1991.0,2007.0,0,3,CTD_human;ORPHANET
44765,5994,RFXAP,0.701,0.517,C2931418,Bare lymphocyte syndrome 2,disease,C16;C18;C20,Disease or Syndrome,0.64,0.75,2000.0,2012.0,0,1,CTD_human;ORPHANET
65954,26277,TINF2,0.586,0.69,C0005956,Bone Marrow Diseases,group,C15,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
65955,26277,TINF2,0.586,0.69,C0007760,Cerebellar Diseases,group,C10,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
65956,26277,TINF2,0.586,0.69,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,,,0,0,GENOMICS_ENGLAND
65957,26277,TINF2,0.586,0.69,C0018273,Growth Disorders,group,C23,Pathologic Function,0.3,,2008.0,2008.0,1,0,CTD_human
65958,26277,TINF2,0.586,0.69,C0027339,Nail Diseases,group,C17,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
65959,26277,TINF2,0.586,0.69,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
65960,26277,TINF2,0.586,0.69,C0265965,Dyskeratosis Congenita,disease,C16;C17,Disease or Syndrome,0.9,0.9444444,2008.0,2018.0,1,1,CTD_human;ORPHANET
65961,26277,TINF2,0.586,0.69,C0266470,Cerebellar Hypoplasia,disease,C10;C16;F03,Congenital Abnormality,0.4,,2008.0,2009.0,2,0,GENOMICS_ENGLAND
65962,26277,TINF2,0.586,0.69,C0376545,Hematologic Neoplasms,group,C04;C15,Neoplastic Process,0.3,,2017.0,2017.0,2,0,GENOMICS_ENGLAND
65963,26277,TINF2,0.586,0.69,C1148551,X-Linked Dyskeratosis Congenita,disease,C16;C17,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
65964,26277,TINF2,0.586,0.69,C1327916,REVESZ SYNDROME (disorder),disease,C05;C18,Disease or Syndrome,0.71,1.0,2008.0,2012.0,1,2,CTD_human;ORPHANET;UNIPROT
65965,26277,TINF2,0.586,0.69,C1846142,HOYERAAL-HREIDARSSON SYNDROME,disease,C05;C10;C13;C16;C17;C23;F01;F03,Disease or Syndrome,0.3,,,,0,0,ORPHANET
65966,26277,TINF2,0.586,0.69,C1851970,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT",disease,C16;C17,Disease or Syndrome,0.41,1.0,1993.0,2009.0,0,10,CTD_human
65967,26277,TINF2,0.586,0.69,C3151445,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3",disease,,Disease or Syndrome,0.6,,2008.0,2015.0,1,7,CTD_human;UNIPROT
65968,26277,TINF2,0.586,0.69,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
32739,4247,MGAT2,0.642,0.414,C0000786,Spontaneous abortion,phenotype,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
32740,4247,MGAT2,0.642,0.414,C0000822,"Abortion, Tubal",disease,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
32741,4247,MGAT2,0.642,0.414,C0282577,Congenital Disorders of Glycosylation,group,C16;C18,Disease or Syndrome,0.31,1.0,1996.0,2009.0,1,0,GENOMICS_ENGLAND
32742,4247,MGAT2,0.642,0.414,C2931008,Congenital disorder of glycosylation type 2A,disease,C05;C16;C18,Disease or Syndrome,0.92,1.0,1996.0,2012.0,1,5,CTD_human;ORPHANET;UNIPROT
32743,4247,MGAT2,0.642,0.414,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
69715,55237,VRTN,1.0,0.069,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.3,,2006.0,2006.0,1,1,UNIPROT
62092,10577,NPC2,0.607,0.655,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
62093,10577,NPC2,0.607,0.655,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
62094,10577,NPC2,0.607,0.655,C0023520,Leukodystrophy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
62095,10577,NPC2,0.607,0.655,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
62096,10577,NPC2,0.607,0.655,C1112213,Cholestasis in newborn,disease,,Disease or Syndrome,0.3,,2001.0,2007.0,4,0,GENOMICS_ENGLAND
62097,10577,NPC2,0.607,0.655,C1843366,"NIEMANN-PICK DISEASE, TYPE C2",disease,C10;C15;C16;C18,Disease or Syndrome,0.67,1.0,1993.0,2017.0,6,15,CTD_human;UNIPROT
62098,10577,NPC2,0.607,0.655,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2001.0,2007.0,4,0,GENOMICS_ENGLAND
26888,3507,IGHM,0.672,0.517,C0001768,Agammaglobulinemia,disease,C15;C20,Disease or Syndrome,0.4,,,,0,0,CTD_human
26889,3507,IGHM,0.672,0.517,C0086438,Hypogammaglobulinemia,disease,C15;C20,Disease or Syndrome,0.3,,,,0,0,CTD_human
26890,3507,IGHM,0.672,0.517,C1832241,"Agammaglobulinemia, non-Bruton type",disease,C15;C20,Disease or Syndrome,0.4,,2002.0,2002.0,0,0,ORPHANET
12834,1544,CYP1A2,0.509,0.828,C0007137,Squamous cell carcinoma,disease,C04,Neoplastic Process,0.33,0.666666666666667,2007.0,2012.0,1,0,CTD_human
12835,1544,CYP1A2,0.509,0.828,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12836,1544,CYP1A2,0.509,0.828,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.4,1.0,1993.0,2015.0,1,0,CTD_human
12837,1544,CYP1A2,0.509,0.828,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.32,,2007.0,2011.0,1,0,CTD_human
12838,1544,CYP1A2,0.509,0.828,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",disease,C18;C19,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
12839,1544,CYP1A2,0.509,0.828,C0011999,Diastematomyelia,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12840,1544,CYP1A2,0.509,0.828,C0013221,Drug toxicity,group,C25,Injury or Poisoning,0.3,,1999.0,1999.0,1,0,CTD_human
12841,1544,CYP1A2,0.509,0.828,C0018273,Growth Disorders,group,C23,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
12842,1544,CYP1A2,0.509,0.828,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2018.0,2018.0,1,0,CTD_human
12843,1544,CYP1A2,0.509,0.828,C0019207,"Hepatoma, Morris",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12844,1544,CYP1A2,0.509,0.828,C0019208,"Hepatoma, Novikoff",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12845,1544,CYP1A2,0.509,0.828,C0019209,Hepatomegaly,phenotype,C06;C23,Finding,0.3,,1999.0,1999.0,1,0,CTD_human
12846,1544,CYP1A2,0.509,0.828,C0023452,Childhood Acute Lymphoblastic Leukemia,disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12847,1544,CYP1A2,0.509,0.828,C0023453,"Leukemia, Lymphocytic, Acute, L2",disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12848,1544,CYP1A2,0.509,0.828,C0023890,Liver Cirrhosis,disease,C06,Disease or Syndrome,0.31,1.0,1995.0,2017.0,1,0,CTD_human
12849,1544,CYP1A2,0.509,0.828,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2007.0,2007.0,1,0,CTD_human
12850,1544,CYP1A2,0.509,0.828,C0023895,Liver diseases,group,C06,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
12851,1544,CYP1A2,0.509,0.828,C0023904,"Liver Neoplasms, Experimental",group,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12852,1544,CYP1A2,0.509,0.828,C0024117,Chronic Obstructive Airway Disease,disease,C08,Disease or Syndrome,0.33,1.0,2008.0,2010.0,1,0,CTD_human
12853,1544,CYP1A2,0.509,0.828,C0024121,Lung Neoplasms,group,C04;C08,Neoplastic Process,0.31,,2007.0,2012.0,1,0,CTD_human
12854,1544,CYP1A2,0.509,0.828,C0025637,Methemoglobinemia,disease,C15,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
12855,1544,CYP1A2,0.509,0.828,C0027794,Neural Tube Defects,group,C10;C16,Congenital Abnormality,0.31,1.0,2010.0,2010.0,1,0,CTD_human
12856,1544,CYP1A2,0.509,0.828,C0027806,Neurenteric Cyst,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12857,1544,CYP1A2,0.509,0.828,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.4,1.0,2000.0,2014.0,1,0,PSYGENET
12858,1544,CYP1A2,0.509,0.828,C0037997,Splenic Diseases,group,C15,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
12859,1544,CYP1A2,0.509,0.828,C0038002,Splenomegaly,phenotype,C23,Finding,0.3,,1999.0,1999.0,1,0,CTD_human
12860,1544,CYP1A2,0.509,0.828,C0041755,Adverse reaction to drug,group,C25,Pathologic Function,0.3,,1999.0,1999.0,1,0,CTD_human
12861,1544,CYP1A2,0.509,0.828,C0080218,Tethered Cord Syndrome,disease,C10;C16,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
12862,1544,CYP1A2,0.509,0.828,C0086404,Experimental Hepatoma,disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12863,1544,CYP1A2,0.509,0.828,C0086565,Liver Dysfunction,phenotype,C06,Finding,0.3,,2004.0,2004.0,1,0,CTD_human
12864,1544,CYP1A2,0.509,0.828,C0152234,Iniencephaly,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12865,1544,CYP1A2,0.509,0.828,C0152426,Craniorachischisis,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12866,1544,CYP1A2,0.509,0.828,C0162566,Porphyria Cutanea Tarda,disease,C06;C16;C17;C18,Disease or Syndrome,0.36,0.666666666666667,2001.0,2012.0,1,0,CTD_human
12867,1544,CYP1A2,0.509,0.828,C0239946,"Fibrosis, Liver",disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12868,1544,CYP1A2,0.509,0.828,C0242379,Malignant neoplasm of lung,disease,C04;C08,Neoplastic Process,0.39,0.8888888888888891,2001.0,2016.0,1,0,CTD_human
12869,1544,CYP1A2,0.509,0.828,C0266453,Exencephaly,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12870,1544,CYP1A2,0.509,0.828,C0273115,Lung Injury,disease,C08;C26,Injury or Poisoning,0.3,,2015.0,2015.0,1,0,CTD_human
12871,1544,CYP1A2,0.509,0.828,C0333641,Atrophic,phenotype,C23,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
12872,1544,CYP1A2,0.509,0.828,C0344479,Spinal Cord Myelodysplasia,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12873,1544,CYP1A2,0.509,0.828,C0400966,Non-alcoholic Fatty Liver Disease,disease,C06,Disease or Syndrome,0.31,1.0,2010.0,2017.0,1,0,CTD_human
12874,1544,CYP1A2,0.509,0.828,C0702169,Acrania,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12875,1544,CYP1A2,0.509,0.828,C0809983,Schizophrenia and related disorders,group,,Disease or Syndrome,0.31,1.0,2011.0,2011.0,1,0,PSYGENET
12876,1544,CYP1A2,0.509,0.828,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12877,1544,CYP1A2,0.509,0.828,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12878,1544,CYP1A2,0.509,0.828,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.4,1.0,1993.0,2015.0,1,0,CTD_human
12879,1544,CYP1A2,0.509,0.828,C1527303,Chronic Airflow Obstruction,disease,C08,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
12880,1544,CYP1A2,0.509,0.828,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12881,1544,CYP1A2,0.509,0.828,C2350344,Chronic Lung Injury,disease,C08;C26,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
12882,1544,CYP1A2,0.509,0.828,C3241937,Nonalcoholic Steatohepatitis,disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12883,1544,CYP1A2,0.509,0.828,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12884,1544,CYP1A2,0.509,0.828,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12885,1544,CYP1A2,0.509,0.828,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
72657,65057,ACD,0.624,0.69,C0376545,Hematologic Neoplasms,group,C04;C15,Neoplastic Process,0.3,,2017.0,2017.0,1,0,GENOMICS_ENGLAND
72658,65057,ACD,0.624,0.69,C1846142,HOYERAAL-HREIDARSSON SYNDROME,disease,C05;C10;C13;C16;C17;C23;F01;F03,Disease or Syndrome,0.31,1.0,2014.0,2014.0,0,0,ORPHANET
72659,65057,ACD,0.624,0.69,C2314896,Familial Atypical Mole Melanoma Syndrome,disease,,Neoplastic Process,0.3,,,,0,0,ORPHANET
72660,65057,ACD,0.624,0.69,C4225283,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 7",phenotype,,Finding,0.5,,2014.0,2014.0,1,1,CTD_human;UNIPROT
72661,65057,ACD,0.624,0.69,C4225284,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6",disease,,Disease or Syndrome,0.6,,1993.0,2015.0,1,2,CTD_human;UNIPROT
74652,84342,COG8,0.773,0.207,C0282577,Congenital Disorders of Glycosylation,group,C16;C18,Disease or Syndrome,0.31,1.0,2002.0,2014.0,3,0,GENOMICS_ENGLAND
74653,84342,COG8,0.773,0.207,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
74654,84342,COG8,0.773,0.207,C1970021,"Congenital Disorder Of Glycosylation, Type IIH",disease,C16;C18,Disease or Syndrome,0.62,1.0,2007.0,2007.0,0,1,CTD_human;ORPHANET
74655,84342,COG8,0.773,0.207,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
25833,3394,IRF8,0.579,0.7240000000000001,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
25834,3394,IRF8,0.579,0.7240000000000001,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.32,0.5,2013.0,2018.0,0,0,UNIPROT
25835,3394,IRF8,0.579,0.7240000000000001,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
25836,3394,IRF8,0.579,0.7240000000000001,C0026769,Multiple Sclerosis,disease,C10;C20,Disease or Syndrome,0.38,0.875,2009.0,2016.0,1,0,CTD_human
25837,3394,IRF8,0.579,0.7240000000000001,C0079744,Diffuse Large B-Cell Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.32,1.0,2014.0,2018.0,0,0,CGI
25838,3394,IRF8,0.579,0.7240000000000001,C0751324,"Multiple Sclerosis, Acute Fulminating",disease,C10;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
25839,3394,IRF8,0.579,0.7240000000000001,C3808589,IMMUNODEFICIENCY 32A,disease,,Disease or Syndrome,0.7,,2011.0,2011.0,1,1,CTD_human;ORPHANET;UNIPROT
25840,3394,IRF8,0.579,0.7240000000000001,C4016741,IMMUNODEFICIENCY 32B,disease,,Disease or Syndrome,0.6,,2011.0,2017.0,2,1,CTD_human;UNIPROT
34585,4597,MVD,0.642,0.44799999999999995,C0265970,"Porokeratosis, Disseminated Superficial Actinic",disease,C16;C17,Disease or Syndrome,0.4,,2011.0,2016.0,0,2,ORPHANET
34586,4597,MVD,0.642,0.44799999999999995,C3553549,"POROKERATOSIS 7, MULTIPLE TYPES",disease,,Disease or Syndrome,0.5,,2008.0,2016.0,2,8,CTD_human;UNIPROT
18112,2235,FECH,0.636,0.414,C0005395,Bile Duct Diseases,group,C06,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
18113,2235,FECH,0.636,0.414,C0016059,Fibrosis,phenotype,C23,Pathologic Function,0.3,,1999.0,1999.0,1,0,CTD_human
18114,2235,FECH,0.636,0.414,C0162568,Erythropoietic Protoporphyria,disease,C06;C16;C17;C18,Disease or Syndrome,1.0,0.956043956043956,1982.0,2018.0,17,18,CTD_human;ORPHANET;UNIPROT
18115,2235,FECH,0.636,0.414,C0349426,Ferrochelatase deficiency,disease,C06;C16;C17;C18,Disease or Syndrome,0.5,,1992.0,2007.0,17,8,CTD_human;UNIPROT
18116,2235,FECH,0.636,0.414,C1623038,Cirrhosis,disease,C23,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
56991,8625,RFXANK,0.6809999999999999,0.483,C1859534,"Bare Lymphocyte Syndrome, Type II, Complementation Group A",disease,C16;C18;C20,Disease or Syndrome,0.3,,1998.0,2012.0,4,1,UNIPROT
56992,8625,RFXANK,0.6809999999999999,0.483,C1859535,"Bare Lymphocyte Syndrome, Type II, Complementation Group B",disease,C16;C18;C20,Disease or Syndrome,0.4,,1998.0,2012.0,4,2,UNIPROT
56993,8625,RFXANK,0.6809999999999999,0.483,C1859536,"Bare Lymphocyte Syndrome, Type II, Complementation Group C",disease,C16;C18;C20,Disease or Syndrome,0.3,,1998.0,2012.0,4,1,UNIPROT
56994,8625,RFXANK,0.6809999999999999,0.483,C1859537,"Bare Lymphocyte Syndrome, Type II, Complementation Group D",disease,C16;C18;C20,Disease or Syndrome,0.3,,1998.0,2012.0,4,1,UNIPROT
56995,8625,RFXANK,0.6809999999999999,0.483,C1859538,"Bare Lymphocyte Syndrome, Type II, Complementation Group E",disease,C16;C18;C20,Disease or Syndrome,0.3,,1998.0,2012.0,4,1,UNIPROT
56996,8625,RFXANK,0.6809999999999999,0.483,C2931418,Bare lymphocyte syndrome 2,disease,C16;C18;C20,Disease or Syndrome,0.64,0.75,1998.0,2016.0,4,1,CTD_human;ORPHANET;UNIPROT
74274,83636,C19orf12,0.667,0.379,C0030567,Parkinson Disease,disease,C10,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
74275,83636,C19orf12,0.667,0.379,C0037773,"Spastic Paraplegia, Hereditary",disease,C10;C16,Disease or Syndrome,0.4,,2018.0,2018.0,0,1,GENOMICS_ENGLAND
74276,83636,C19orf12,0.667,0.379,C0751651,Mitochondrial Diseases,group,C18,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
74277,83636,C19orf12,0.667,0.379,C0919267,ovarian neoplasm,disease,C04;C13;C19,Neoplastic Process,0.3,,2011.0,2011.0,1,0,CTD_human
74278,83636,C19orf12,0.667,0.379,C1140680,Malignant neoplasm of ovary,disease,C04;C13;C19,Neoplastic Process,0.3,,2011.0,2011.0,1,0,CTD_human
74279,83636,C19orf12,0.667,0.379,C2680446,"SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE",disease,,Disease or Syndrome,0.71,1.0,2010.0,2017.0,1,2,CTD_human;ORPHANET;UNIPROT
74280,83636,C19orf12,0.667,0.379,C3280371,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4,disease,,Disease or Syndrome,0.7,,1993.0,2016.0,10,11,CTD_human;ORPHANET;UNIPROT
74281,83636,C19orf12,0.667,0.379,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2016.0,3,0,GENOMICS_ENGLAND
73874,80331,DNAJC5,0.735,0.207,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,2011.0,2016.0,2,0,GENOMICS_ENGLAND
73875,80331,DNAJC5,0.735,0.207,C1834207,"Ceroid Lipofuscinosis, Neuronal, Parry Type",disease,C10;C16;C18,Disease or Syndrome,0.62,1.0,1971.0,2013.0,5,2,ORPHANET;UNIPROT
7616,861,RUNX1,0.467,0.69,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.38,0.875,2004.0,2013.0,1,0,CTD_human
7617,861,RUNX1,0.467,0.69,C0006413,Burkitt Lymphoma,disease,C02;C04;C15;C20,Neoplastic Process,0.3,,,,0,0,ORPHANET
7618,861,RUNX1,0.467,0.69,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,2008.0,2012.0,3,0,GENOMICS_ENGLAND
7619,861,RUNX1,0.467,0.69,C0017636,Glioblastoma,disease,C04,Neoplastic Process,0.32,1.0,2012.0,2017.0,1,0,CTD_human
7620,861,RUNX1,0.467,0.69,C0023452,Childhood Acute Lymphoblastic Leukemia,disease,C04;C15;C20,Neoplastic Process,0.4,0.97979797979798,1996.0,2018.0,1,0,CTD_human
7621,861,RUNX1,0.467,0.69,C0023453,"Leukemia, Lymphocytic, Acute, L2",disease,C04;C15;C20,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
7622,861,RUNX1,0.467,0.69,C0023467,"Leukemia, Myelocytic, Acute",disease,C04,Neoplastic Process,0.7,0.9829059829059829,1990.0,2018.0,2,4,CGI;CTD_human
7623,861,RUNX1,0.467,0.69,C0023473,"Myeloid Leukemia, Chronic",disease,C04;C15,Neoplastic Process,0.4,1.0,1993.0,2014.0,0,0,ORPHANET
7624,861,RUNX1,0.467,0.69,C0023485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.38,1.0,1999.0,2016.0,2,0,CTD_human
7625,861,RUNX1,0.467,0.69,C0026998,"Acute Myeloid Leukemia, M1",disease,C04,Neoplastic Process,0.3,,2008.0,2016.0,2,0,CTD_human
7626,861,RUNX1,0.467,0.69,C0032197,Platelet Storage Pool Deficiency,disease,C15,Disease or Syndrome,0.32,1.0,2004.0,2018.0,0,0,ORPHANET
7627,861,RUNX1,0.467,0.69,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
7628,861,RUNX1,0.467,0.69,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,2008.0,2012.0,3,0,GENOMICS_ENGLAND
7629,861,RUNX1,0.467,0.69,C0334588,Giant Cell Glioblastoma,disease,C04,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
7630,861,RUNX1,0.467,0.69,C0349639,Juvenile Myelomonocytic Leukemia,disease,C04;C15,Neoplastic Process,0.33,1.0,1998.0,2016.0,1,0,CTD_human
7631,861,RUNX1,0.467,0.69,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.32,1.0,2007.0,2016.0,1,0,CTD_human
7632,861,RUNX1,0.467,0.69,C0376545,Hematologic Neoplasms,group,C04;C15,Neoplastic Process,0.4,1.0,1998.0,2017.0,2,0,GENOMICS_ENGLAND
7633,861,RUNX1,0.467,0.69,C1292769,Precursor B-cell lymphoblastic leukemia,disease,,Neoplastic Process,0.4,0.95,1997.0,2016.0,0,0,ORPHANET
7634,861,RUNX1,0.467,0.69,C1621958,Glioblastoma Multiforme,disease,C04,Neoplastic Process,0.31,1.0,2013.0,2017.0,1,0,CTD_human
7635,861,RUNX1,0.467,0.69,C1832388,"Platelet Disorder, Familial, with Associated Myeloid Malignancy",disease,C04;C15;C16,Disease or Syndrome,0.72,1.0,1999.0,2017.0,7,11,CLINGEN;CTD_human;ORPHANET;UNIPROT
7636,861,RUNX1,0.467,0.69,C1879321,Acute Myeloid Leukemia (AML-M2),disease,C04,Neoplastic Process,0.34,1.0,1994.0,2016.0,2,0,CTD_human
7637,861,RUNX1,0.467,0.69,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.4,1.0,1994.0,2017.0,1,0,CTD_human
7638,861,RUNX1,0.467,0.69,C2713368,Hematopoetic Myelodysplasia,disease,C15,Pathologic Function,0.3,,2017.0,2017.0,1,0,CTD_human
7639,861,RUNX1,0.467,0.69,C2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,disease,C11;C15;C16;C17;C18,Disease or Syndrome,0.3,,,,0,0,ORPHANET
7640,861,RUNX1,0.467,0.69,C3463824,MYELODYSPLASTIC SYNDROME,group,C15,Neoplastic Process,0.5,0.9859154929577459,1993.0,2017.0,1,0,CTD_human
31178,3976,LIF,0.528,0.655,C0000786,Spontaneous abortion,phenotype,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
31179,3976,LIF,0.528,0.655,C0000822,"Abortion, Tubal",disease,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
31180,3976,LIF,0.528,0.655,C0011206,Delirium,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,0.6666667,2007.0,2011.0,3,0,PSYGENET
31181,3976,LIF,0.528,0.655,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.3,1.0,2004.0,2004.0,1,0,PSYGENET
31182,3976,LIF,0.528,0.655,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2004.0,2004.0,1,0,PSYGENET
31183,3976,LIF,0.528,0.655,C0012684,Blastocyst Disintegration,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31184,3976,LIF,0.528,0.655,C0018800,Cardiomegaly,phenotype,C14;C23,Finding,0.3,,2004.0,2004.0,1,0,CTD_human
31185,3976,LIF,0.528,0.655,C0021361,Female infertility,phenotype,C13,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31186,3976,LIF,0.528,0.655,C0032460,Polycystic Ovary Syndrome,disease,C04;C13;C19,Disease or Syndrome,0.31,1.0,2011.0,2011.0,1,0,CTD_human
31187,3976,LIF,0.528,0.655,C0038279,"Sterility, Postpartum",phenotype,C13,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31188,3976,LIF,0.528,0.655,C0341869,"Subfertility, Female",disease,C13,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
31189,3976,LIF,0.528,0.655,C0400966,Non-alcoholic Fatty Liver Disease,disease,C06,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
31190,3976,LIF,0.528,0.655,C0752351,Embryo Loss,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31191,3976,LIF,0.528,0.655,C0917730,Female sterility,phenotype,C13,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
31192,3976,LIF,0.528,0.655,C1136082,Embryo Disintegration,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31193,3976,LIF,0.528,0.655,C1136382,Sclerocystic Ovaries,disease,C04;C13;C19,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
31194,3976,LIF,0.528,0.655,C1262477,Weight decreased,phenotype,C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
31195,3976,LIF,0.528,0.655,C1383860,Cardiac Hypertrophy,phenotype,C14;C23,Pathologic Function,0.3,,2004.0,2004.0,1,0,CTD_human
31196,3976,LIF,0.528,0.655,C1720887,Female Urogenital Diseases,group,C13,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
31197,3976,LIF,0.528,0.655,C3241937,Nonalcoholic Steatohepatitis,disease,C06,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
56443,8398,PLA2G6,0.494,0.7240000000000001,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
56444,8398,PLA2G6,0.494,0.7240000000000001,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
56445,8398,PLA2G6,0.494,0.7240000000000001,C0027960,Nevus,disease,C04,Neoplastic Process,0.41,1.0,2009.0,2016.0,1,2,CTD_human
56446,8398,PLA2G6,0.494,0.7240000000000001,C0030567,Parkinson Disease,disease,C10,Disease or Syndrome,0.36,1.0,2012.0,2017.0,0,0,GENOMICS_ENGLAND
56447,8398,PLA2G6,0.494,0.7240000000000001,C0033975,Psychotic Disorders,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
56448,8398,PLA2G6,0.494,0.7240000000000001,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.36,1.0,2003.0,2016.0,1,0,PSYGENET
56449,8398,PLA2G6,0.494,0.7240000000000001,C0270724,Infantile Neuroaxonal Dystrophy,disease,C10,Disease or Syndrome,1.0,1.0,2004.0,2018.0,3,11,CTD_human;ORPHANET;UNIPROT
56450,8398,PLA2G6,0.494,0.7240000000000001,C0349204,Nonorganic psychosis,disease,,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
56451,8398,PLA2G6,0.494,0.7240000000000001,C1857747,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2 (disorder),disease,C10;C18,Disease or Syndrome,0.62,1.0,2006.0,2017.0,1,6,CTD_human;UNIPROT
56452,8398,PLA2G6,0.494,0.7240000000000001,C2750220,Karak Syndrome,disease,C10,Disease or Syndrome,0.43,1.0,2006.0,2015.0,1,2,UNIPROT
56453,8398,PLA2G6,0.494,0.7240000000000001,C2751842,"PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE",disease,C10,Disease or Syndrome,0.74,1.0,2009.0,2017.0,1,5,CTD_human;ORPHANET;UNIPROT
56454,8398,PLA2G6,0.494,0.7240000000000001,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
72899,79087,ALG12,0.799,0.207,C0282577,Congenital Disorders of Glycosylation,group,C16;C18,Disease or Syndrome,0.3,,2002.0,2016.0,3,0,GENOMICS_ENGLAND
72900,79087,ALG12,0.799,0.207,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
72901,79087,ALG12,0.799,0.207,C2931001,Congenital disorder of glycosylation type 1G,disease,C16;C18,Disease or Syndrome,0.72,1.0,2002.0,2014.0,4,8,CTD_human;ORPHANET;UNIPROT
72902,79087,ALG12,0.799,0.207,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2002.0,2003.0,3,0,GENOMICS_ENGLAND
54060,7355,SLC35A2,0.636,0.44799999999999995,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.32,1.0,2006.0,2011.0,0,0,UNIPROT
54061,7355,SLC35A2,0.636,0.44799999999999995,C0282577,Congenital Disorders of Glycosylation,group,C16;C18,Disease or Syndrome,0.32,1.0,2013.0,2017.0,3,0,GENOMICS_ENGLAND
54062,7355,SLC35A2,0.636,0.44799999999999995,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.42,1.0,2014.0,2017.0,2,1,GENOMICS_ENGLAND
54063,7355,SLC35A2,0.636,0.44799999999999995,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
54064,7355,SLC35A2,0.636,0.44799999999999995,C3806688,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm",disease,,Disease or Syndrome,0.7,,2013.0,2016.0,2,7,CTD_human;ORPHANET;UNIPROT
66692,28952,CCDC22,0.6759999999999999,0.44799999999999995,C0796137,3C syndrome,disease,C05;C10;C14;C16,Disease or Syndrome,0.51,1.0,2016.0,2016.0,0,0,CTD_human;ORPHANET
66693,28952,CCDC22,0.6759999999999999,0.44799999999999995,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.42,1.0,2016.0,2016.0,0,0,GENOMICS_ENGLAND
66694,28952,CCDC22,0.6759999999999999,0.44799999999999995,C4225419,RITSCHER-SCHINZEL SYNDROME 2,disease,,Disease or Syndrome,0.4,,2009.0,2016.0,2,2,UNIPROT
67379,50943,FOXP3,0.408,0.759,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.4,1.0,2006.0,2017.0,1,0,CTD_human
67380,50943,FOXP3,0.408,0.759,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2011.0,2011.0,1,0,PSYGENET
67381,50943,FOXP3,0.408,0.759,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.4,1.0,2007.0,2018.0,1,0,CTD_human
67382,50943,FOXP3,0.408,0.759,C0011854,"Diabetes Mellitus, Insulin-Dependent",disease,C18;C19;C20,Disease or Syndrome,0.5,0.9333333,2003.0,2016.0,0,1,CTD_human
67383,50943,FOXP3,0.408,0.759,C0020305,Hydrops Fetalis,disease,C13;C15;C16;C20;C23,Disease or Syndrome,0.3,,2015.0,2016.0,2,0,GENOMICS_ENGLAND
67384,50943,FOXP3,0.408,0.759,C0023493,Adult T-Cell Lymphoma/Leukemia,disease,C04;C15;C20,Neoplastic Process,0.4,1.0,2004.0,2016.0,1,0,CTD_human
67385,50943,FOXP3,0.408,0.759,C0032460,Polycystic Ovary Syndrome,disease,C04;C13;C19,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
67386,50943,FOXP3,0.408,0.759,C0205734,"Diabetes, Autoimmune",disease,C18;C19;C20,Disease or Syndrome,0.3,,,,0,0,CTD_human
67387,50943,FOXP3,0.408,0.759,C0342288,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,disease,C16;C18;C19;C20;C23,Disease or Syndrome,1.0,0.9411765,1991.0,2016.0,6,11,CTD_human;ORPHANET;UNIPROT
67388,50943,FOXP3,0.408,0.759,C0342302,Brittle diabetes,disease,C18;C19;C20,Disease or Syndrome,0.3,,,,0,0,CTD_human
67389,50943,FOXP3,0.408,0.759,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.4,1.0,2007.0,2018.0,1,0,CTD_human
67390,50943,FOXP3,0.408,0.759,C1136382,Sclerocystic Ovaries,disease,C04;C13;C19,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
67391,50943,FOXP3,0.408,0.759,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
67392,50943,FOXP3,0.408,0.759,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.37,1.0,2007.0,2016.0,1,0,CTD_human
67393,50943,FOXP3,0.408,0.759,C1844663,"ISLETS OF LANGERHANS, ABSENCE OF",phenotype,,Finding,0.5,,1991.0,2011.0,6,6,UNIPROT
67394,50943,FOXP3,0.408,0.759,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2001.0,2007.0,5,0,GENOMICS_ENGLAND
67395,50943,FOXP3,0.408,0.759,C3837958,"Diabetes Mellitus, Ketosis-Prone",disease,C18;C19;C20,Disease or Syndrome,0.3,,,,0,0,CTD_human
67396,50943,FOXP3,0.408,0.759,C4302111,Familial Ménière disease,disease,,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,GENOMICS_ENGLAND
3089,331,XIAP,0.499,0.759,C0014859,Esophageal Neoplasms,group,C04;C06,Neoplastic Process,0.32,1.0,2008.0,2018.0,1,0,CTD_human
3090,331,XIAP,0.499,0.759,C0024314,Lymphoproliferative Disorders,group,C15;C20,Neoplastic Process,0.31,1.0,2010.0,2010.0,0,0,CTD_human
3091,331,XIAP,0.499,0.759,C0024668,"Mammary Neoplasms, Experimental",group,C04,Experimental Model of Disease; Neoplastic Process,0.3,,2003.0,2003.0,1,0,CTD_human
3092,331,XIAP,0.499,0.759,C0027055,Myocardial Reperfusion Injury,phenotype,C14;C23,Pathologic Function,0.3,,2004.0,2004.0,1,0,CTD_human
3093,331,XIAP,0.499,0.759,C0546837,Malignant neoplasm of esophagus,disease,C04;C06,Neoplastic Process,0.31,1.0,2008.0,2018.0,1,0,CTD_human
3094,331,XIAP,0.499,0.759,C0549463,X-Linked Lymphoproliferative Disorder,disease,C15;C20,Neoplastic Process,0.6,1.0,2006.0,2018.0,0,0,CTD_human;ORPHANET
3095,331,XIAP,0.499,0.759,C0919267,ovarian neoplasm,disease,C04;C13;C19,Neoplastic Process,0.32,1.0,2001.0,2011.0,1,0,CTD_human
3096,331,XIAP,0.499,0.759,C1140680,Malignant neoplasm of ovary,disease,C04;C13;C19,Neoplastic Process,0.37,0.857142857142857,2000.0,2018.0,1,0,CTD_human
3097,331,XIAP,0.499,0.759,C1845076,"Lymphoproliferative Syndrome, X-Linked, 2",disease,C15;C16;C20,Disease or Syndrome,0.46,1.0,2006.0,2016.0,0,2,CTD_human
3098,331,XIAP,0.499,0.759,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,disease,C10;C18,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
3099,331,XIAP,0.499,0.759,C1862941,"Amyotrophic Lateral Sclerosis, Sporadic",disease,C10;C18,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
3100,331,XIAP,0.499,0.759,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2015.0,2016.0,3,0,GENOMICS_ENGLAND
8207,959,CD40LG,0.447,0.828,C0002736,Amyotrophic Lateral Sclerosis,disease,C10;C18,Disease or Syndrome,0.31,1.0,2010.0,2010.0,1,0,CTD_human
8208,959,CD40LG,0.447,0.828,C0004364,Autoimmune Diseases,group,C20,Disease or Syndrome,0.4,1.0,1996.0,2017.0,1,0,CTD_human
8209,959,CD40LG,0.447,0.828,C0010054,Coronary Arteriosclerosis,disease,C14,Disease or Syndrome,0.51,1.0,2006.0,2013.0,1,0,CTD_human
8210,959,CD40LG,0.447,0.828,C0020517,Hypersensitivity,group,C20,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
8211,959,CD40LG,0.447,0.828,C0020542,Pulmonary Hypertension,phenotype,C08,Pathologic Function,0.5,,2005.0,2015.0,1,0,CTD_human
8212,959,CD40LG,0.447,0.828,C0027540,Necrosis,phenotype,C23,Organ or Tissue Function,0.3,,2012.0,2012.0,1,0,CTD_human
8213,959,CD40LG,0.447,0.828,C0032285,Pneumonia,disease,C08,Disease or Syndrome,0.32,1.0,2011.0,2014.0,1,0,CTD_human
8214,959,CD40LG,0.447,0.828,C0032300,Lobar Pneumonia,disease,C08,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
8215,959,CD40LG,0.447,0.828,C0333704,Chromosome Breaks,phenotype,C23,Cell or Molecular Dysfunction,0.3,,2016.0,2016.0,1,0,CTD_human
8216,959,CD40LG,0.447,0.828,C0376628,Chromosome Breakage,phenotype,C23,Cell or Molecular Dysfunction,0.3,,2016.0,2016.0,1,0,CTD_human
8217,959,CD40LG,0.447,0.828,C0393554,Amyotrophic Lateral Sclerosis With Dementia,disease,C10;C18,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
8218,959,CD40LG,0.447,0.828,C0398689,"Hyper-IgM Immunodeficiency Syndrome, Type 1",disease,C15;C16;C20,Disease or Syndrome,0.8,0.967032967032967,1992.0,2017.0,8,12,CTD_human;ORPHANET;UNIPROT
8219,959,CD40LG,0.447,0.828,C0543859,"Amyotrophic Lateral Sclerosis, Guam Form",disease,C10;C18,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
8220,959,CD40LG,0.447,0.828,C0887898,Experimental Lung Inflammation,disease,C08,Experimental Model of Disease,0.3,,2011.0,2011.0,1,0,CTD_human
8221,959,CD40LG,0.447,0.828,C1527304,Allergic Reaction,phenotype,C20,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
8222,959,CD40LG,0.447,0.828,C1956346,Coronary Artery Disease,disease,C14,Disease or Syndrome,0.34,1.0,2004.0,2011.0,1,0,CTD_human
8223,959,CD40LG,0.447,0.828,C3714636,Pneumonitis,disease,C08,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
50424,6901,TAZ,0.5429999999999999,0.655,C0007193,"Cardiomyopathy, Dilated",group,C14,Disease or Syndrome,0.46,1.0,2002.0,2014.0,0,0,GENOMICS_ENGLAND
50425,6901,TAZ,0.5429999999999999,0.655,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50426,6901,TAZ,0.5429999999999999,0.655,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,,,0,0,GENOMICS_ENGLAND
50427,6901,TAZ,0.5429999999999999,0.655,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50428,6901,TAZ,0.5429999999999999,0.655,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50429,6901,TAZ,0.5429999999999999,0.655,C0264886,Conduction disorder of the heart,group,C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50430,6901,TAZ,0.5429999999999999,0.655,C0340427,Familial dilated cardiomyopathy,disease,C14,Disease or Syndrome,0.3,,,,0,0,ORPHANET
50431,6901,TAZ,0.5429999999999999,0.655,C0574083,3-Methylglutaconic aciduria type 2,disease,C14;C16;C18,Disease or Syndrome,0.8,0.9574468,1973.0,2017.0,5,18,CTD_human;ORPHANET;UNIPROT
50432,6901,TAZ,0.5429999999999999,0.655,C0751651,Mitochondrial Diseases,group,C18,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50433,6901,TAZ,0.5429999999999999,0.655,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,1996.0,1996.0,1,0,GENOMICS_ENGLAND
50434,6901,TAZ,0.5429999999999999,0.655,C4021133,Left ventricular noncompaction cardiomyopathy,disease,,Disease or Syndrome,0.31,1.0,2010.0,2010.0,0,0,GENOMICS_ENGLAND
75346,90529,STPG1,1.0,0.069,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,,,0,0,UNIPROT
73351,79753,SNIP1,0.685,0.345,C3281055,"PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM",disease,,Disease or Syndrome,0.4,,2012.0,2012.0,1,1,UNIPROT
73352,79753,SNIP1,0.685,0.345,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,GENOMICS_ENGLAND
44983,6121,RPE65,0.479,0.759,C0015398,"Eye Diseases, Hereditary",group,C11;C16,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
44984,6121,RPE65,0.479,0.759,C0035304,Retinal Degeneration,phenotype,C11,Pathologic Function,0.4,,2014.0,2015.0,1,1,CTD_human
44985,6121,RPE65,0.479,0.759,C0035334,Retinitis Pigmentosa,disease,C11;C16,Disease or Syndrome,0.69,1.0,1998.0,2016.0,3,2,CTD_human;ORPHANET
44986,6121,RPE65,0.479,0.759,C0155003,"Blindness, Transient",phenotype,C10;C11;C23,Pathologic Function,0.3,,2005.0,2006.0,2,0,CTD_human
44987,6121,RPE65,0.479,0.759,C0221473,"Blindness, Hysterical",disease,C10;C11;C23,Mental or Behavioral Dysfunction,0.3,,2005.0,2006.0,2,0,CTD_human
44988,6121,RPE65,0.479,0.759,C0271215,"Blindness, Legal",disease,C10;C11;C23,Disease or Syndrome,0.4,,2005.0,2006.0,2,0,CTD_human
44989,6121,RPE65,0.479,0.759,C0339527,Leber Congenital Amaurosis,disease,C11,Disease or Syndrome,0.6,0.9833333000000001,1997.0,2018.0,3,0,CTD_human;ORPHANET
44990,6121,RPE65,0.479,0.759,C0339730,"Blindness, Acquired",disease,C10;C11;C23,Disease or Syndrome,0.3,,2005.0,2006.0,2,0,CTD_human
44991,6121,RPE65,0.479,0.759,C0376288,Amaurosis,disease,C10;C11;C23,Disease or Syndrome,0.3,,2005.0,2006.0,2,0,CTD_human
44992,6121,RPE65,0.479,0.759,C0456909,Blindness,phenotype,C10;C11;C23,Finding,0.45,,2001.0,2008.0,2,0,CTD_human
44993,6121,RPE65,0.479,0.759,C0750958,"Blindness, Monocular",disease,C10;C11;C23,Disease or Syndrome,0.3,,2005.0,2006.0,2,0,CTD_human
44994,6121,RPE65,0.479,0.759,C0854723,Retinal Dystrophies,group,C11,Disease or Syndrome,0.5,1.0,1997.0,2017.0,1,2,CTD_human
44995,6121,RPE65,0.479,0.759,C0917796,"Optic Atrophy, Hereditary, Leber",disease,C10;C11;C16;C18,Disease or Syndrome,0.31,1.0,2006.0,2014.0,2,0,CTD_human
44996,6121,RPE65,0.479,0.759,C1858080,"Retinal Dystrophy, Early Onset Severe",disease,C11;C16,Disease or Syndrome,0.33,1.0,2004.0,2015.0,0,0,ORPHANET
44997,6121,RPE65,0.479,0.759,C1859844,"LEBER CONGENITAL AMAUROSIS, TYPE II (disorder)",disease,C11,Disease or Syndrome,0.94,0.75,1959.0,2017.0,27,28,CLINGEN;CTD_human;UNIPROT
44998,6121,RPE65,0.479,0.759,C1879328,Blindness both eyes NOS (disorder),phenotype,C10;C11;C23,Finding,0.3,,2005.0,2006.0,2,0,CTD_human
44999,6121,RPE65,0.479,0.759,C3151086,Retinitis Pigmentosa 20,disease,C11;C16,Disease or Syndrome,0.9,,1959.0,2017.0,11,19,CLINGEN;CTD_human;UNIPROT
45000,6121,RPE65,0.479,0.759,C3540662,Congenital Amaurosis of Retinal Origin,disease,C11,Disease or Syndrome,0.3,,1997.0,2009.0,3,0,CTD_human
45001,6121,RPE65,0.479,0.759,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
9619,1141,CHRNB2,0.619,0.207,C0002395,Alzheimer's Disease,disease,C10;F03,Disease or Syndrome,0.34,1.0,2000.0,2007.0,1,0,CTD_human
9620,1141,CHRNB2,0.619,0.207,C0003469,Anxiety Disorders,group,F03,Mental or Behavioral Dysfunction,0.3,,2013.0,2013.0,1,0,CTD_human
9621,1141,CHRNB2,0.619,0.207,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.51,,2003.0,2008.0,1,0,CTD_human
9622,1141,CHRNB2,0.619,0.207,C0011265,Presenile dementia,disease,C10;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
9623,1141,CHRNB2,0.619,0.207,C0020672,"Hypothermia, natural",phenotype,C23,Finding,0.3,,2004.0,2004.0,1,0,CTD_human
9624,1141,CHRNB2,0.619,0.207,C0021368,Inflammation,phenotype,C23,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
9625,1141,CHRNB2,0.619,0.207,C0027746,Nerve Degeneration,phenotype,C23,Cell or Molecular Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
9626,1141,CHRNB2,0.619,0.207,C0034933,"Reflex, Abnormal",phenotype,C10;C23,Sign or Symptom,0.3,,2013.0,2013.0,1,0,CTD_human
9627,1141,CHRNB2,0.619,0.207,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.32,0.5,2007.0,2008.0,2,0,PSYGENET
9628,1141,CHRNB2,0.619,0.207,C0038587,Substance Withdrawal Syndrome,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
9629,1141,CHRNB2,0.619,0.207,C0038644,Sudden infant death syndrome,disease,C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
9630,1141,CHRNB2,0.619,0.207,C0041671,Attention Deficit Disorder,disease,F03,Mental or Behavioral Dysfunction,0.5,,2003.0,2012.0,1,0,CTD_human
9631,1141,CHRNB2,0.619,0.207,C0085541,"Epilepsy, Frontal Lobe",disease,C10,Disease or Syndrome,0.4,1.0,2002.0,2016.0,1,0,CTD_human
9632,1141,CHRNB2,0.619,0.207,C0086189,Drug Withdrawal Symptoms,phenotype,C25;F03,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
9633,1141,CHRNB2,0.619,0.207,C0087169,Withdrawal Symptoms,phenotype,C25;F03,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
9634,1141,CHRNB2,0.619,0.207,C0151572,"Reflex, Corneal, Decreased",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9635,1141,CHRNB2,0.619,0.207,C0151888,Hyporeflexia,phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9636,1141,CHRNB2,0.619,0.207,C0151889,Hyperreflexia,phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9637,1141,CHRNB2,0.619,0.207,C0234146,Absent reflex,phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9638,1141,CHRNB2,0.619,0.207,C0234784,"Reflex, Gag, Absent",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9639,1141,CHRNB2,0.619,0.207,C0241772,"Reflex, Deep Tendon, Absent",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9640,1141,CHRNB2,0.619,0.207,C0274285,"Hypothermia, Accidental",disease,C23,Injury or Poisoning,0.3,,2004.0,2004.0,1,0,CTD_human
9641,1141,CHRNB2,0.619,0.207,C0276496,Familial Alzheimer Disease (FAD),disease,C10;F03,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
9642,1141,CHRNB2,0.619,0.207,C0277839,Hoffman's Reflex,phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9643,1141,CHRNB2,0.619,0.207,C0277850,"Reflex, Pendular",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9644,1141,CHRNB2,0.619,0.207,C0278211,"Reflex, Corneal, Absent",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9645,1141,CHRNB2,0.619,0.207,C0376280,"Anxiety States, Neurotic",disease,F03,Mental or Behavioral Dysfunction,0.3,,2013.0,2013.0,1,0,CTD_human
9646,1141,CHRNB2,0.619,0.207,C0393671,"Frontal Epilepsy, Benign, Childhood",disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
9647,1141,CHRNB2,0.619,0.207,C0393683,"Epilepsy, Supplementary Motor",disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
9648,1141,CHRNB2,0.619,0.207,C0393684,"Epilepsy, Cingulate",disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
9649,1141,CHRNB2,0.619,0.207,C0393688,"Epilepsy, Opercular",disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
9650,1141,CHRNB2,0.619,0.207,C0494463,"Alzheimer Disease, Late Onset",disease,C10;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
9651,1141,CHRNB2,0.619,0.207,C0522345,"Reflex, Acoustic, Abnormal",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9652,1141,CHRNB2,0.619,0.207,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
9653,1141,CHRNB2,0.619,0.207,C0546126,Acute Confusional Senile Dementia,disease,C10;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
9654,1141,CHRNB2,0.619,0.207,C0558845,"Reflex, Ankle, Absent",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9655,1141,CHRNB2,0.619,0.207,C0558846,"Reflex, Triceps, Absent",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9656,1141,CHRNB2,0.619,0.207,C0558847,"Reflex, Biceps, Absent",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9657,1141,CHRNB2,0.619,0.207,C0576612,"Reflex, Anal, Absent",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9658,1141,CHRNB2,0.619,0.207,C0743002,Abnormal Deep Tendon Reflex,phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9659,1141,CHRNB2,0.619,0.207,C0750900,"Alzheimer's Disease, Focal Onset",disease,C10;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
9660,1141,CHRNB2,0.619,0.207,C0750901,"Alzheimer Disease, Early Onset",disease,C10;F03,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
9661,1141,CHRNB2,0.619,0.207,C0751468,"Bulbocavernosus Reflex, Decreased",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9662,1141,CHRNB2,0.619,0.207,C0751469,Bulbocavernousus Reflex Absent,phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9663,1141,CHRNB2,0.619,0.207,C0751470,Palmo-Mental Reflex,phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9664,1141,CHRNB2,0.619,0.207,C0751471,"Reflex, Anal, Decreased",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9665,1141,CHRNB2,0.619,0.207,C0751472,"Reflex, Ankle, Abnormal",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9666,1141,CHRNB2,0.619,0.207,C0751473,"Reflex, Ankle, Decreased",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9667,1141,CHRNB2,0.619,0.207,C0751474,"Reflex, Biceps, Abnormal",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9668,1141,CHRNB2,0.619,0.207,C0751475,"Reflex, Biceps, Decreased",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9669,1141,CHRNB2,0.619,0.207,C0751476,"Reflex, Gag, Decreased",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9670,1141,CHRNB2,0.619,0.207,C0751477,"Reflex, Knee, Abnormal",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9671,1141,CHRNB2,0.619,0.207,C0751478,"Reflex, Knee, Decreased",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9672,1141,CHRNB2,0.619,0.207,C0751479,"Reflex, Moro, Asymmetric",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9673,1141,CHRNB2,0.619,0.207,C0751480,"Reflex, Triceps, Abnormal",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9674,1141,CHRNB2,0.619,0.207,C0751481,"Reflex, Triceps, Decreased",phenotype,C10;C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
9675,1141,CHRNB2,0.619,0.207,C0751508,Long Sleeper Syndrome,disease,C10;C23;F03,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
9676,1141,CHRNB2,0.619,0.207,C0751509,Short Sleeper Syndrome,disease,C10;C23;F03,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
9677,1141,CHRNB2,0.619,0.207,C0751510,Sleep-Related Neurogenic Tachypnea,disease,C10;C23;F03,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
9678,1141,CHRNB2,0.619,0.207,C0751511,Subwakefullness Syndrome,disease,C10;C23;F03,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
9679,1141,CHRNB2,0.619,0.207,C0751642,"Epilepsy, Anterior Fronto-Polar",disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
9680,1141,CHRNB2,0.619,0.207,C0751643,"Epilepsy, Orbito-Frontal",disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
9681,1141,CHRNB2,0.619,0.207,C0851578,Sleep Disorders,group,C10;C23;F03,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
9682,1141,CHRNB2,0.619,0.207,C1263846,Attention deficit hyperactivity disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
9683,1141,CHRNB2,0.619,0.207,C1279420,Anxiety neurosis (finding),disease,F03,Mental or Behavioral Dysfunction,0.3,,2013.0,2013.0,1,0,CTD_human
9684,1141,CHRNB2,0.619,0.207,C1321905,Minimal Brain Dysfunction,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
9685,1141,CHRNB2,0.619,0.207,C1854335,"Epilepsy, Nocturnal Frontal Lobe, Type 3",disease,C10,Disease or Syndrome,0.8,,1993.0,2012.0,1,5,CTD_human;UNIPROT
9686,1141,CHRNB2,0.619,0.207,C3696898,Autosomal Dominant Nocturnal Frontal Lobe Epilepsy,disease,C10,Disease or Syndrome,0.39,1.0,2001.0,2013.0,0,0,ORPHANET
9687,1141,CHRNB2,0.619,0.207,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2001.0,2013.0,2,0,GENOMICS_ENGLAND
9688,1141,CHRNB2,0.619,0.207,C4042891,Sleep Wake Disorders,group,C10;C23;F03,Mental or Behavioral Dysfunction,0.3,,2002.0,2002.0,1,0,CTD_human
51377,7044,LEFTY2,0.752,0.172,C0000772,Multiple congenital anomalies,group,C16,Congenital Abnormality,0.3,,1999.0,1999.0,1,0,CTD_human
51378,7044,LEFTY2,0.752,0.172,C0175707,Asplenia Syndrome,disease,C14;C15;C16,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
51379,7044,LEFTY2,0.752,0.172,C0265357,Polysplenia Syndrome,disease,C14;C15;C16,Congenital Abnormality,0.3,,1999.0,1999.0,1,0,CTD_human
51380,7044,LEFTY2,0.752,0.172,C0266642,Situs ambiguus,disease,C14;C15;C16,Congenital Abnormality,0.5,,1999.0,1999.0,1,0,CTD_human;ORPHANET
51381,7044,LEFTY2,0.752,0.172,C1167664,Situs ambiguous,disease,,Congenital Abnormality,0.3,,,,0,0,ORPHANET
51382,7044,LEFTY2,0.752,0.172,C1866091,Left-Right Axis Malformations,disease,C14;C15;C16,Disease or Syndrome,0.3,,1999.0,1999.0,1,1,UNIPROT
51383,7044,LEFTY2,0.752,0.172,C3178805,Heterotaxy Syndrome,disease,C14;C15;C16,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
51384,7044,LEFTY2,0.752,0.172,C3178806,Right Atrial Isomerism,disease,C14;C15;C16,Congenital Abnormality,0.3,,1999.0,1999.0,1,0,CTD_human
51385,7044,LEFTY2,0.752,0.172,C3178807,Left Atrial Isomerism,disease,C14;C15;C16,Congenital Abnormality,0.3,,1999.0,1999.0,1,0,CTD_human
77725,200150,PLD5,,,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
57930,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C0282577,Congenital Disorders of Glycosylation,group,C16;C18,Disease or Syndrome,0.3,,2004.0,2014.0,2,0,GENOMICS_ENGLAND
57931,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
57932,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C1836824,Amish Infantile Epilepsy Syndrome,disease,C10,Disease or Syndrome,0.6,,2004.0,2017.0,0,5,CTD_human;ORPHANET
57933,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2014.0,2017.0,4,0,GENOMICS_ENGLAND
70488,55997,CFC1,0.5720000000000001,0.552,C0013069,Double Outlet Right Ventricle,disease,C14;C16,Congenital Abnormality,0.62,1.0,1999.0,2008.0,1,0,CTD_human
70489,55997,CFC1,0.5720000000000001,0.552,C0040761,Transposition of Great Vessels,disease,C14;C16,Congenital Abnormality,0.31,1.0,2002.0,2002.0,1,0,CTD_human
70490,55997,CFC1,0.5720000000000001,0.552,C0041207,"Truncus Arteriosus, Persistent",disease,C14;C16,Congenital Abnormality,0.3,,,,0,0,CTD_human
70491,55997,CFC1,0.5720000000000001,0.552,C0152419,Interrupted aortic arch,disease,,Congenital Abnormality,0.3,,,,0,0,CTD_human
70492,55997,CFC1,0.5720000000000001,0.552,C0266642,Situs ambiguus,disease,C14;C15;C16,Congenital Abnormality,0.4,,,,0,0,ORPHANET
70493,55997,CFC1,0.5720000000000001,0.552,C0795907,CONOTRUNCAL ANOMALY FACE SYNDROME,disease,C05;C14;C15;C16;C19,Disease or Syndrome,0.3,,,,0,0,CTD_human
70494,55997,CFC1,0.5720000000000001,0.552,C1167664,Situs ambiguous,disease,,Congenital Abnormality,0.3,,,,0,0,ORPHANET
70495,55997,CFC1,0.5720000000000001,0.552,C1415817,"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",disease,,Disease or Syndrome,0.8,,2000.0,2002.0,2,3,CTD_human;UNIPROT
70496,55997,CFC1,0.5720000000000001,0.552,C1857586,CONOTRUNCAL HEART MALFORMATIONS (disorder),disease,C14;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
70497,55997,CFC1,0.5720000000000001,0.552,C1956410,"Double Outlet Right Ventricle, Noncommitted VSD",disease,C14;C16,Congenital Abnormality,0.3,,2002.0,2002.0,1,0,CTD_human
70498,55997,CFC1,0.5720000000000001,0.552,C1956411,"Double Outlet Right Ventricle, Subaortic VSD",disease,C14;C16,Congenital Abnormality; Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
70499,55997,CFC1,0.5720000000000001,0.552,C1956412,"Double Outlet Right Ventricle, Subpulmonary VSD",disease,C14;C16,Congenital Abnormality,0.3,,2002.0,2002.0,1,0,CTD_human
70500,55997,CFC1,0.5720000000000001,0.552,C1956413,Taussig-Bing Anomaly,disease,C14;C16,Congenital Abnormality,0.3,,2002.0,2002.0,1,0,CTD_human
70501,55997,CFC1,0.5720000000000001,0.552,C4274029,Biliary atresia with splenic malformation syndrome,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
70502,55997,CFC1,0.5720000000000001,0.552,C4277690,Ciliopathies,group,C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
13574,1615,DARS,0.8340000000000001,0.207,C3809008,HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY,disease,,Disease or Syndrome,0.71,1.0,2013.0,2015.0,1,10,CTD_human;ORPHANET;UNIPROT
60252,9839,ZEB2,0.513,0.655,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.37,1.0,2006.0,2017.0,1,0,CTD_human
60253,9839,ZEB2,0.513,0.655,C0007621,Neoplastic Cell Transformation,phenotype,C04;C23,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
60254,9839,ZEB2,0.513,0.655,C0010278,Craniosynostosis,disease,C05;C16,Disease or Syndrome,0.3,,2008.0,2015.0,4,0,GENOMICS_ENGLAND
60255,9839,ZEB2,0.513,0.655,C0018798,Congenital Heart Defects,group,C14;C16,Congenital Abnormality,0.31,1.0,2005.0,2007.0,1,0,CTD_human
60256,9839,ZEB2,0.513,0.655,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
60257,9839,ZEB2,0.513,0.655,C0025958,Microcephaly,disease,C05;C10;C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
60258,9839,ZEB2,0.513,0.655,C0027626,Neoplasm Invasiveness,phenotype,C04;C23,Pathologic Function,0.3,,2012.0,2012.0,1,0,CTD_human
60259,9839,ZEB2,0.513,0.655,C0037773,"Spastic Paraplegia, Hereditary",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
60260,9839,ZEB2,0.513,0.655,C0235874,Disease Exacerbation,phenotype,C23,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
60261,9839,ZEB2,0.513,0.655,C0238463,Papillary thyroid carcinoma,disease,C04;C19,Neoplastic Process,0.3,,2017.0,2017.0,1,0,CTD_human
60262,9839,ZEB2,0.513,0.655,C0431350,Primary microcephaly,disease,,Congenital Abnormality,0.3,,1993.0,1993.0,1,0,GENOMICS_ENGLAND
60263,9839,ZEB2,0.513,0.655,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
60264,9839,ZEB2,0.513,0.655,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.38,1.0,2005.0,2017.0,1,0,CTD_human
60265,9839,ZEB2,0.513,0.655,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2010.0,2010.0,1,0,CTD_human
60266,9839,ZEB2,0.513,0.655,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.32,1.0,2006.0,2016.0,1,0,CTD_human
60267,9839,ZEB2,0.513,0.655,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.33,1.0,2010.0,2014.0,0,0,UNIPROT
60268,9839,ZEB2,0.513,0.655,C1856113,Mowat-Wilson syndrome,disease,C05;C06;C10;C16;C23;F01;F03,Disease or Syndrome,0.9,1.0,1991.0,2018.0,7,83,CTD_human;UNIPROT
60269,9839,ZEB2,0.513,0.655,C3501843,Non-medullary thyroid carcinoma,disease,C04;C19,Neoplastic Process,0.3,,2017.0,2017.0,1,0,CTD_human
60270,9839,ZEB2,0.513,0.655,C3501844,Familial Nonmedullary Thyroid Cancer,disease,C04;C19,Neoplastic Process,0.3,,2017.0,2017.0,1,0,CTD_human
60271,9839,ZEB2,0.513,0.655,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.34,1.0,2002.0,2013.0,0,0,GENOMICS_ENGLAND
700,90,ACVR1,0.573,0.552,C0004114,Astrocytoma,disease,C04,Neoplastic Process,0.32,1.0,2014.0,2015.0,1,0,CTD_human
701,90,ACVR1,0.573,0.552,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
702,90,ACVR1,0.573,0.552,C0013720,Ehlers-Danlos Syndrome,disease,C14;C15;C16;C17,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
703,90,ACVR1,0.573,0.552,C0016037,Fibrodysplasia Ossificans Progressiva,disease,C05,Disease or Syndrome,1.0,1.0,1972.0,2018.0,3,9,CTD_human;ORPHANET;UNIPROT
704,90,ACVR1,0.573,0.552,C0017638,Glioma,disease,C04,Neoplastic Process,0.51,1.0,2014.0,2014.0,3,0,CGI;CTD_human
705,90,ACVR1,0.573,0.552,C0025202,melanoma,disease,C04,Neoplastic Process,0.3,,,,0,0,UNIPROT
706,90,ACVR1,0.573,0.552,C0027122,Myositis Ossificans,disease,C05,Disease or Syndrome,0.31,,2007.0,2007.0,0,0,CTD_human
707,90,ACVR1,0.573,0.552,C0205768,Subependymal Giant Cell Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
708,90,ACVR1,0.573,0.552,C0242488,Acute Lung Injury,disease,C08,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
709,90,ACVR1,0.573,0.552,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,3,0,CTD_human
710,90,ACVR1,0.573,0.552,C0280783,Juvenile Pilocytic Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
711,90,ACVR1,0.573,0.552,C0280785,Diffuse Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
712,90,ACVR1,0.573,0.552,C0334579,Anaplastic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
713,90,ACVR1,0.573,0.552,C0334580,Protoplasmic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
714,90,ACVR1,0.573,0.552,C0334581,Gemistocytic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
715,90,ACVR1,0.573,0.552,C0334582,Fibrillary Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
716,90,ACVR1,0.573,0.552,C0334583,Pilocytic Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
717,90,ACVR1,0.573,0.552,C0338070,Childhood Cerebral Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
718,90,ACVR1,0.573,0.552,C0345050,Congenital aneurysm of ascending aorta,disease,C14,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
719,90,ACVR1,0.573,0.552,C0547065,Mixed oligoastrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
720,90,ACVR1,0.573,0.552,C0555198,Malignant Glioma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,3,0,CTD_human
721,90,ACVR1,0.573,0.552,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
722,90,ACVR1,0.573,0.552,C0750935,Cerebral Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
723,90,ACVR1,0.573,0.552,C0750936,Intracranial Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
724,90,ACVR1,0.573,0.552,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
725,90,ACVR1,0.573,0.552,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
726,90,ACVR1,0.573,0.552,C1704230,Grade I Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
727,90,ACVR1,0.573,0.552,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
24678,3239,HOXD13,0.541,0.621,C0002871,Anemia,disease,C15,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CTD_human
24679,3239,HOXD13,0.541,0.621,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.31,1.0,1997.0,2007.0,1,0,CTD_human
24680,3239,HOXD13,0.541,0.621,C0024312,Lymphopenia,disease,C15;C20,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CTD_human
24681,3239,HOXD13,0.541,0.621,C0027947,Neutropenia,disease,C15,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CTD_human
24682,3239,HOXD13,0.541,0.621,C0039075,Syndactyly,disease,C05;C16,Congenital Abnormality,0.45,1.0,2004.0,2015.0,0,0,CTD_human
24683,3239,HOXD13,0.541,0.621,C0152427,Polydactyly,disease,C05;C16,Congenital Abnormality,0.31,1.0,2009.0,2009.0,0,0,GENOMICS_ENGLAND
24684,3239,HOXD13,0.541,0.621,C0206762,"Limb Deformities, Congenital",group,C05;C16,Congenital Abnormality,0.4,0.9285714,1996.0,2015.0,1,0,CTD_human
24685,3239,HOXD13,0.541,0.621,C0220664,"BRACHYDACTYLY, TYPE D",disease,C05;C16,Congenital Abnormality,0.6,,2003.0,2014.0,2,2,CTD_human;UNIPROT
24686,3239,HOXD13,0.541,0.621,C0220708,VATER Association,disease,C06;C14;C16,Disease or Syndrome,0.5,,2009.0,2009.0,1,0,CTD_human;ORPHANET
24687,3239,HOXD13,0.541,0.621,C0265312,Brachydactyly syndrome type E,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
24688,3239,HOXD13,0.541,0.621,C0265553,Polysyndactyly,disease,C05;C16,Congenital Abnormality,0.3,,,,0,0,CTD_human
24689,3239,HOXD13,0.541,0.621,C1735591,VACTERL Association,disease,C05;C14;C16,Congenital Abnormality,0.31,1.0,2009.0,2009.0,0,0,ORPHANET
24690,3239,HOXD13,0.541,0.621,C1853137,BRACHYDACTYLY-SYNDACTYLY SYNDROME,disease,C05;C16,Disease or Syndrome,0.71,1.0,2007.0,2014.0,2,2,CTD_human;ORPHANET;UNIPROT
24691,3239,HOXD13,0.541,0.621,C1861348,"Syndactyly, type v",disease,C05;C16,Congenital Abnormality,0.71,1.0,2005.0,2014.0,2,2,CTD_human;ORPHANET;UNIPROT
24692,3239,HOXD13,0.541,0.621,C1862102,"BRACHYDACTYLY, TYPE E1",phenotype,C05;C16,Finding,0.6,,2003.0,2015.0,3,2,CTD_human;UNIPROT
24693,3239,HOXD13,0.541,0.621,C2699746,"Syndactyly, type 2",disease,C05;C16,Congenital Abnormality,1.0,0.9523809999999999,1993.0,2016.0,6,8,CTD_human;ORPHANET;UNIPROT
24694,3239,HOXD13,0.541,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
24695,3239,HOXD13,0.541,0.621,C4310807,BRACHYDACTYLY-SYNDACTYLY-OLIGODACTYLY SYNDROME,disease,,Disease or Syndrome,0.5,,2014.0,2014.0,1,1,ORPHANET;UNIPROT
65733,26058,GIGYF2,0.743,0.207,C1535926,Neurodevelopmental Disorders,group,F03,Mental or Behavioral Dysfunction,0.3,,2017.0,2017.0,1,0,CTD_human
65734,26058,GIGYF2,0.743,0.207,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
65735,26058,GIGYF2,0.743,0.207,C4083045,"PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO",phenotype,,Finding,0.5,,2008.0,2016.0,4,8,CTD_human;UNIPROT
65736,26058,GIGYF2,0.743,0.207,C4274355,Autosomal dominant late onset Parkinson disease,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
29718,3769,KCNJ13,0.6809999999999999,0.172,C0339527,Leber Congenital Amaurosis,disease,C11,Disease or Syndrome,0.42,1.0,2016.0,2016.0,0,1,ORPHANET
29719,3769,KCNJ13,0.6809999999999999,0.172,C1860405,Snowflake vitreoretinal degeneration,disease,C11,Disease or Syndrome,0.74,1.0,2008.0,2017.0,1,1,CTD_human;ORPHANET;UNIPROT
29720,3769,KCNJ13,0.6809999999999999,0.172,C3280062,LEBER CONGENITAL AMAUROSIS 16,disease,,Disease or Syndrome,0.61,1.0,2011.0,2016.0,1,5,CTD_human;UNIPROT
70812,57007,ACKR3,0.494,0.759,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.32,1.0,1999.0,2010.0,1,0,CTD_human
70813,57007,ACKR3,0.494,0.759,C0007097,Carcinoma,group,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70814,57007,ACKR3,0.494,0.759,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.31,1.0,2012.0,2015.0,1,0,CTD_human
70815,57007,ACKR3,0.494,0.759,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70816,57007,ACKR3,0.494,0.759,C0022658,Kidney Diseases,group,C12;C13,Disease or Syndrome,0.31,1.0,2013.0,2017.0,1,0,CTD_human
70817,57007,ACKR3,0.494,0.759,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
70818,57007,ACKR3,0.494,0.759,C0027627,Neoplasm Metastasis,phenotype,C04;C23,Neoplastic Process,0.4,0.9629629999999999,2005.0,2017.0,1,0,CTD_human
70819,57007,ACKR3,0.494,0.759,C0205696,Anaplastic carcinoma,disease,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70820,57007,ACKR3,0.494,0.759,C0205697,"Carcinoma, Spindle-Cell",disease,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70821,57007,ACKR3,0.494,0.759,C0205698,Undifferentiated carcinoma,phenotype,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70822,57007,ACKR3,0.494,0.759,C0205699,Carcinomatosis,phenotype,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70823,57007,ACKR3,0.494,0.759,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.31,1.0,2012.0,2015.0,1,0,CTD_human
72770,78987,CRELD1,0.743,0.207,C0344735,Partial atrioventricular canal,disease,C14;C16,Congenital Abnormality,0.3,,,,0,0,ORPHANET
72771,78987,CRELD1,0.743,0.207,C1853508,"ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2",phenotype,,Finding,0.4,,2003.0,2013.0,2,5,UNIPROT
72772,78987,CRELD1,0.743,0.207,C1853509,"Atrioventricular Septal Defect, Partial, with Heterotaxy Syndrome",disease,C14;C15;C16,Disease or Syndrome,0.5,,2003.0,2005.0,2,4,CTD_human;UNIPROT
72773,78987,CRELD1,0.743,0.207,C4277690,Ciliopathies,group,C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
69437,54995,OXSM,1.0,0.069,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,,,0,0,UNIPROT
63380,11277,TREX1,0.58,0.621,C0006111,Brain Diseases,group,C10,Disease or Syndrome,0.31,1.0,2006.0,2007.0,1,0,CTD_human
63381,11277,TREX1,0.58,0.621,C0021368,Inflammation,phenotype,C23,Pathologic Function,0.3,,2006.0,2006.0,1,0,CTD_human
63382,11277,TREX1,0.58,0.621,C0021400,Influenza,disease,C02;C08,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
63383,11277,TREX1,0.58,0.621,C0023520,Leukodystrophy,disease,,Disease or Syndrome,0.44,1.0,2007.0,2015.0,0,0,GENOMICS_ENGLAND
63384,11277,TREX1,0.58,0.621,C0024141,"Lupus Erythematosus, Systemic",disease,C17;C20,Disease or Syndrome,0.6,0.9375,2007.0,2017.0,3,8,CTD_human;UNIPROT
63385,11277,TREX1,0.58,0.621,C0024145,Chilblain lupus 1,disease,C17;C26,Disease or Syndrome,0.68,1.0,2007.0,2016.0,3,1,CTD_human;ORPHANET;UNIPROT
63386,11277,TREX1,0.58,0.621,C0085584,Encephalopathies,group,C10,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
63387,11277,TREX1,0.58,0.621,C0242380,Libman-Sacks Disease,disease,C17;C20,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
63388,11277,TREX1,0.58,0.621,C0263666,"Dermatomyositis, Childhood Type",disease,C05;C10;C17,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
63389,11277,TREX1,0.58,0.621,C0393591,AICARDI-GOUTIERES SYNDROME,disease,,Disease or Syndrome,0.4,1.0,2000.0,2017.0,0,0,ORPHANET
63390,11277,TREX1,0.58,0.621,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
63391,11277,TREX1,0.58,0.621,C0796126,AICARDI-GOUTIERES SYNDROME 1,disease,C10;C16;C20,Disease or Syndrome,0.9,1.0,1993.0,2017.0,8,24,CTD_human;UNIPROT
63392,11277,TREX1,0.58,0.621,C1835308,EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA,phenotype,,Finding,0.3,,2007.0,2013.0,3,8,UNIPROT
63393,11277,TREX1,0.58,0.621,C1835309,EXCESS LMW-DNA,phenotype,,Finding,0.3,,2007.0,2013.0,3,8,UNIPROT
63394,11277,TREX1,0.58,0.621,C1860518,"Vasculopathy, Retinal, With Cerebral Leukodystrophy",disease,C10;C11;C14;C16;C18,Disease or Syndrome,0.51,1.0,2011.0,2011.0,0,0,CTD_human;ORPHANET
63395,11277,TREX1,0.58,0.621,C3150315,"AICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT",disease,,Disease or Syndrome,0.6,,2004.0,2017.0,8,6,UNIPROT
63396,11277,TREX1,0.58,0.621,C3489724,Aicardi-Goutieres Syndrome 2,disease,C10;C16;C20,Disease or Syndrome,0.5,,2004.0,2017.0,1,0,CTD_human
63397,11277,TREX1,0.58,0.621,C3489725,Pseudo-TORCH syndrome,disease,C10;C16;C20,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
63398,11277,TREX1,0.58,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
30634,3913,LAMB2,0.639,0.483,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
30635,3913,LAMB2,0.639,0.483,C0268747,Diffuse mesangial sclerosis (disorder),disease,C12;C13;C23,Disease or Syndrome,0.43,1.0,2005.0,2008.0,1,0,CTD_human
30636,3913,LAMB2,0.639,0.483,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
30637,3913,LAMB2,0.639,0.483,C0751882,"Myasthenic Syndromes, Congenital",disease,C10;C16,Disease or Syndrome,0.32,1.0,2009.0,2016.0,2,0,GENOMICS_ENGLAND
30638,3913,LAMB2,0.639,0.483,C1836876,Pierson syndrome,disease,C10;C11;C12;C13;C16;C23,Disease or Syndrome,1.0,1.0,1963.0,2017.0,2,9,CTD_human;ORPHANET;UNIPROT
30639,3913,LAMB2,0.639,0.483,C1855670,Abnormality of the cornea,group,,Finding,0.3,,1963.0,2005.0,3,0,GENOMICS_ENGLAND
30640,3913,LAMB2,0.639,0.483,C3280113,"NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES",disease,,Disease or Syndrome,0.7,,2006.0,2011.0,2,6,CTD_human;ORPHANET;UNIPROT
30641,3913,LAMB2,0.639,0.483,C3489732,Familial mesangial sclerosis,disease,C12;C13;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
30642,3913,LAMB2,0.639,0.483,C3501249,"Nephrotic Syndrome, Congenital, With Ocular Abnormalities And Congenital Myasthenic Syndrome",disease,C10;C11;C12;C13;C16;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
62224,10641,NPRL2,0.701,0.276,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
62225,10641,NPRL2,0.701,0.276,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
62226,10641,NPRL2,0.701,0.276,C1858477,"Epilepsy, Partial, with Variable Foci",disease,C10,Disease or Syndrome,0.3,,,,0,0,CTD_human
62227,10641,NPRL2,0.701,0.276,C4310709,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2",disease,,Disease or Syndrome,0.4,,2016.0,2017.0,2,6,UNIPROT
66280,27086,FOXP1,0.528,0.69,C0006413,Burkitt Lymphoma,disease,C02;C04;C15;C20,Neoplastic Process,0.3,,,,0,0,ORPHANET
66281,27086,FOXP1,0.528,0.69,C0024232,Lymphatic Metastasis,disease,C04;C23,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
66282,27086,FOXP1,0.528,0.69,C0027626,Neoplasm Invasiveness,phenotype,C04;C23,Pathologic Function,0.3,,2015.0,2015.0,1,0,CTD_human
66283,27086,FOXP1,0.528,0.69,C0030297,Pancreatic Neoplasm,disease,C04;C06;C19,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
66284,27086,FOXP1,0.528,0.69,C0042900,Vitiligo,disease,C17,Disease or Syndrome,0.4,,2010.0,2017.0,1,2,CTD_human
66285,27086,FOXP1,0.528,0.69,C0087031,Juvenile-Onset Still Disease,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66286,27086,FOXP1,0.528,0.69,C0242647,Mucosa-Associated Lymphoid Tissue Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.4,1.0,2005.0,2015.0,0,0,ORPHANET
66287,27086,FOXP1,0.528,0.69,C0279628,Adenocarcinoma Of Esophagus,disease,C04;C06,Neoplastic Process,0.31,1.0,2014.0,2016.0,1,0,CTD_human
66288,27086,FOXP1,0.528,0.69,C0346647,Malignant neoplasm of pancreas,disease,C04;C06;C19,Neoplastic Process,0.31,1.0,2015.0,2015.0,1,0,CTD_human
66289,27086,FOXP1,0.528,0.69,C1292769,Precursor B-cell lymphoblastic leukemia,disease,,Neoplastic Process,0.3,,,,0,0,ORPHANET
66290,27086,FOXP1,0.528,0.69,C1510586,Autism Spectrum Disorders,disease,F03,Mental or Behavioral Dysfunction,0.42,1.0,2011.0,2018.0,1,1,CTD_human
66291,27086,FOXP1,0.528,0.69,C1535926,Neurodevelopmental Disorders,group,F03,Mental or Behavioral Dysfunction,0.35,1.0,2016.0,2018.0,1,0,CTD_human
66292,27086,FOXP1,0.528,0.69,C3495559,Juvenile arthritis,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66293,27086,FOXP1,0.528,0.69,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.46,1.0,2010.0,2018.0,0,0,GENOMICS_ENGLAND
66294,27086,FOXP1,0.528,0.69,C3714758,Juvenile psoriatic arthritis,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66295,27086,FOXP1,0.528,0.69,C4013764,MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES,disease,,Disease or Syndrome,0.6,,2011.0,2016.0,2,3,CTD_human;ORPHANET;UNIPROT
63317,11235,PDCD10,0.713,0.379,C0007820,Cerebrovascular Disorders,group,C10;C14,Disease or Syndrome,0.3,,1993.0,1993.0,1,0,GENOMICS_ENGLAND
63318,11235,PDCD10,0.713,0.379,C1864040,Cerebral Cavernous Malformations 3,disease,C05;C07;C10;C16;C23;F01;F03,Disease or Syndrome,0.38,1.0,2008.0,2016.0,0,0,CTD_human
63319,11235,PDCD10,0.713,0.379,C2931263,Familial cerebral cavernous malformation,disease,C04;C10;C14;C15;C16,Neoplastic Process,0.3,,,,0,0,ORPHANET
63320,11235,PDCD10,0.713,0.379,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
48904,6657,SOX2,0.45899999999999996,0.759,C0003119,Anophthalmos,disease,C11;C16,Congenital Abnormality,0.5,0.9,2003.0,2016.0,1,0,CTD_human
48905,6657,SOX2,0.45899999999999996,0.759,C0006118,Brain Neoplasms,group,C04;C10,Neoplastic Process,0.34,1.0,2012.0,2017.0,1,0,CTD_human
48906,6657,SOX2,0.45899999999999996,0.759,C0007131,Non-Small Cell Lung Carcinoma,disease,C04;C08,Neoplastic Process,0.38,0.875,2010.0,2017.0,0,0,CGI
48907,6657,SOX2,0.45899999999999996,0.759,C0007137,Squamous cell carcinoma,disease,C04,Neoplastic Process,0.4,0.9565216999999999,2009.0,2016.0,1,0,CTD_human
48908,6657,SOX2,0.45899999999999996,0.759,C0009363,Congenital ocular coloboma (disorder),disease,C11;C16,Congenital Abnormality,0.45,0.6,2003.0,2016.0,1,0,GENOMICS_ENGLAND
48909,6657,SOX2,0.45899999999999996,0.759,C0014859,Esophageal Neoplasms,group,C04;C06,Neoplastic Process,0.31,1.0,2014.0,2014.0,0,0,CGI
48910,6657,SOX2,0.45899999999999996,0.759,C0024121,Lung Neoplasms,group,C04;C08,Neoplastic Process,0.35,1.0,2009.0,2015.0,1,0,CTD_human
48911,6657,SOX2,0.45899999999999996,0.759,C0027643,"Neoplasm Recurrence, Local",phenotype,C04;C23,Neoplastic Process,0.3,,2017.0,2017.0,1,0,CTD_human
48912,6657,SOX2,0.45899999999999996,0.759,C0029434,Osteogenesis Imperfecta,disease,C05;C16;C17,Congenital Abnormality; Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
48913,6657,SOX2,0.45899999999999996,0.759,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.31,1.0,2010.0,2017.0,1,0,CTD_human
48914,6657,SOX2,0.45899999999999996,0.759,C0039981,Thoracic Neoplasms,group,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
48915,6657,SOX2,0.45899999999999996,0.759,C0086543,Cataract,disease,C11,Acquired Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
48916,6657,SOX2,0.45899999999999996,0.759,C0149925,Small cell carcinoma of lung,disease,C04;C08,Neoplastic Process,0.35,1.0,2000.0,2016.0,1,0,CTD_human
48917,6657,SOX2,0.45899999999999996,0.759,C0152013,Adenocarcinoma of lung (disorder),disease,C04;C08,Neoplastic Process,0.34,1.0,2012.0,2018.0,1,0,CTD_human
48918,6657,SOX2,0.45899999999999996,0.759,C0153633,Malignant neoplasm of brain,disease,C04;C10,Neoplastic Process,0.3,,2017.0,2017.0,1,0,CTD_human
48919,6657,SOX2,0.45899999999999996,0.759,C0162809,Kallmann Syndrome,disease,C12;C13;C16;C19,Disease or Syndrome,0.3,,,,0,0,ORPHANET
48920,6657,SOX2,0.45899999999999996,0.759,C0205944,"Sarcoma, Epithelioid",disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
48921,6657,SOX2,0.45899999999999996,0.759,C0205945,"Sarcoma, Spindle Cell",disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
48922,6657,SOX2,0.45899999999999996,0.759,C0242379,Malignant neoplasm of lung,disease,C04;C08,Neoplastic Process,0.4,1.0,2009.0,2016.0,1,0,CTD_human
48923,6657,SOX2,0.45899999999999996,0.759,C0279626,Squamous cell carcinoma of esophagus,disease,C04;C06,Neoplastic Process,0.4,1.0,2009.0,2017.0,1,0,CTD_human
48924,6657,SOX2,0.45899999999999996,0.759,C0338503,Septo-Optic Dysplasia,disease,C10;C16,Disease or Syndrome,0.42,1.0,2008.0,2011.0,0,0,ORPHANET
48925,6657,SOX2,0.45899999999999996,0.759,C0342384,Idiopathic hypogonadotropic hypogonadism,disease,C19,Disease or Syndrome,0.3,,2003.0,2011.0,3,0,GENOMICS_ENGLAND
48926,6657,SOX2,0.45899999999999996,0.759,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.39,1.0,2010.0,2017.0,1,0,CTD_human
48927,6657,SOX2,0.45899999999999996,0.759,C0496899,"Benign neoplasm of brain, unspecified",disease,C04;C10,Neoplastic Process,0.3,,2017.0,2017.0,1,0,CTD_human
48928,6657,SOX2,0.45899999999999996,0.759,C0750974,"Brain Tumor, Primary",disease,C04;C10,Neoplastic Process,0.31,1.0,2012.0,2017.0,1,0,CTD_human
48929,6657,SOX2,0.45899999999999996,0.759,C0750977,Recurrent Brain Neoplasm,disease,C04;C10,Neoplastic Process,0.3,,2017.0,2017.0,1,0,CTD_human
48930,6657,SOX2,0.45899999999999996,0.759,C0750979,Primary malignant neoplasm of brain,disease,C04;C10,Neoplastic Process,0.3,,2017.0,2017.0,1,0,CTD_human
48931,6657,SOX2,0.45899999999999996,0.759,C1261473,Sarcoma,group,C04,Neoplastic Process,0.31,1.0,2015.0,2015.0,1,0,CTD_human
48932,6657,SOX2,0.45899999999999996,0.759,C1527390,"Neoplasms, Intracranial",group,C04;C10,Neoplastic Process,0.3,,2017.0,2017.0,1,0,CTD_human
48933,6657,SOX2,0.45899999999999996,0.759,C1855052,"MICROPHTHALMIA, ISOLATED 1",disease,C11;C16,Disease or Syndrome,0.3,,,,0,0,ORPHANET
48934,6657,SOX2,0.45899999999999996,0.759,C1859773,"Microphthalmia, Syndromic 3",disease,C06;C10;C11;C16,Disease or Syndrome,0.74,1.0,2003.0,2017.0,2,17,CTD_human;ORPHANET;UNIPROT
48935,6657,SOX2,0.45899999999999996,0.759,C1859774,Optic Nerve Hypoplasia and Abnormalities of the Central Nervous System,disease,C10;C11,Disease or Syndrome,0.4,,2003.0,2015.0,2,2,UNIPROT
48936,6657,SOX2,0.45899999999999996,0.759,C1861028,Esophageal atresia with or without tracheoesophageal fistula,disease,C06;C08;C16;C23,Disease or Syndrome,0.3,,,,0,0,CTD_human
48937,6657,SOX2,0.45899999999999996,0.759,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
11729,1427,CRYGS,0.799,0.172,C0086543,Cataract,disease,C11,Acquired Abnormality,0.56,1.0,2006.0,2016.0,1,0,CTD_human;GENOMICS_ENGLAND
11730,1427,CRYGS,0.799,0.172,C0524524,Pseudoaphakia,disease,C11,Disease or Syndrome,0.4,,2006.0,2006.0,1,1,CTD_human
11731,1427,CRYGS,0.799,0.172,C1510497,Lens Opacities,phenotype,C11,Finding,0.3,,2006.0,2006.0,1,0,CTD_human
11732,1427,CRYGS,0.799,0.172,C1854021,"Cataract, Central Saccular, With Sutural Opacities",disease,C11,Disease or Syndrome,0.3,,,,0,0,ORPHANET
11733,1427,CRYGS,0.799,0.172,C3805410,"CATARACT 20, MULTIPLE TYPES",disease,,Disease or Syndrome,0.7,,1983.0,2006.0,1,1,CTD_human;UNIPROT
51887,7096,TLR1,0.529,0.7929999999999999,C0013221,Drug toxicity,group,C25,Injury or Poisoning,0.3,,2008.0,2008.0,1,0,CTD_human
51888,7096,TLR1,0.529,0.7929999999999999,C0023343,Leprosy,disease,C01,Disease or Syndrome,0.36,1.0,2007.0,2017.0,0,0,CTD_human
51889,7096,TLR1,0.529,0.7929999999999999,C0041755,Adverse reaction to drug,group,C25,Pathologic Function,0.3,,2008.0,2008.0,1,0,CTD_human
51890,7096,TLR1,0.529,0.7929999999999999,C0085742,"Injuries, Acute Brain",group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51891,7096,TLR1,0.529,0.7929999999999999,C0270611,Brain Injuries,group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51892,7096,TLR1,0.529,0.7929999999999999,C0272945,Brain Lacerations,disease,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51893,7096,TLR1,0.529,0.7929999999999999,C0452047,"Brain Injuries, Focal",group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
69679,55212,BBS7,0.713,0.379,C0020796,Profound Mental Retardation,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
69680,55212,BBS7,0.713,0.379,C0025363,"Mental Retardation, Psychosocial",disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
69681,55212,BBS7,0.713,0.379,C0152427,Polydactyly,disease,C05;C16,Congenital Abnormality,0.4,,,,0,0,GENOMICS_ENGLAND
69682,55212,BBS7,0.713,0.379,C0752166,Bardet-Biedl Syndrome,disease,C10;C16,Disease or Syndrome,0.47,1.0,2003.0,2017.0,0,4,ORPHANET
69683,55212,BBS7,0.713,0.379,C0917816,Mental deficiency,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2012.0,2012.0,1,0,CTD_human
69684,55212,BBS7,0.713,0.379,C1859565,BARDET-BIEDL SYNDROME 7,disease,C10;C16,Disease or Syndrome,0.6,,2003.0,2016.0,4,12,CTD_human;UNIPROT
69685,55212,BBS7,0.713,0.379,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.6,,2012.0,2012.0,1,0,CTD_human;GENOMICS_ENGLAND
69686,55212,BBS7,0.713,0.379,C4277690,Ciliopathies,group,C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
78154,256471,MFSD8,0.672,0.172,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
78155,256471,MFSD8,0.672,0.172,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
78156,256471,MFSD8,0.672,0.172,C1838571,"Ceroid Lipofuscinosis, Neuronal, 7",disease,C10;C16;C18,Disease or Syndrome,0.95,1.0,1993.0,2018.0,7,15,CTD_human;ORPHANET;UNIPROT
78157,256471,MFSD8,0.672,0.172,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
78158,256471,MFSD8,0.672,0.172,C4015371,MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT,disease,,Disease or Syndrome,0.61,1.0,2015.0,2015.0,1,3,CTD_human;UNIPROT
58740,9227,LRAT,0.602,0.621,C0015398,"Eye Diseases, Hereditary",group,C11;C16,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
58741,9227,LRAT,0.602,0.621,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2015.0,2015.0,1,0,CTD_human
58742,9227,LRAT,0.602,0.621,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
58743,9227,LRAT,0.602,0.621,C0035334,Retinitis Pigmentosa,disease,C11;C16,Disease or Syndrome,0.6,,,,0,1,CTD_human;ORPHANET
58744,9227,LRAT,0.602,0.621,C0042842,Vitamin A Deficiency,disease,C18,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
58745,9227,LRAT,0.602,0.621,C0339527,Leber Congenital Amaurosis,disease,C11,Disease or Syndrome,0.55,1.0,2006.0,2014.0,1,0,CTD_human;ORPHANET
58746,9227,LRAT,0.602,0.621,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
58747,9227,LRAT,0.602,0.621,C0917796,"Optic Atrophy, Hereditary, Leber",disease,C10;C11;C16;C18,Disease or Syndrome,0.3,,2006.0,2006.0,2,0,CTD_human
58748,9227,LRAT,0.602,0.621,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
58749,9227,LRAT,0.602,0.621,C1858080,"Retinal Dystrophy, Early Onset Severe",disease,C11;C16,Disease or Syndrome,0.32,1.0,2001.0,2008.0,0,0,ORPHANET
58750,9227,LRAT,0.602,0.621,C2750063,Leber Congenital Amaurosis 14,disease,C11;C16,Disease or Syndrome,0.7,,2001.0,2011.0,3,1,CTD_human;UNIPROT
58751,9227,LRAT,0.602,0.621,C2750064,"Retinal Dystrophy, Early-Onset Severe, Lrat-Related",disease,C11;C16,Disease or Syndrome,0.8,,2001.0,2011.0,3,1,CTD_human;UNIPROT
58752,9227,LRAT,0.602,0.621,C2750065,"RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED",disease,C11;C16,Disease or Syndrome,0.7,,2001.0,2011.0,3,1,CTD_human;UNIPROT
58753,9227,LRAT,0.602,0.621,C3540662,Congenital Amaurosis of Retinal Origin,disease,C11,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
58754,9227,LRAT,0.602,0.621,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
58755,9227,LRAT,0.602,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
58756,9227,LRAT,0.602,0.621,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
58757,9227,LRAT,0.602,0.621,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
47179,6507,SLC1A3,0.619,0.552,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
47180,6507,SLC1A3,0.619,0.552,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2001.0,2017.0,1,0,CTD_human
47181,6507,SLC1A3,0.619,0.552,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2002.0,2002.0,1,0,PSYGENET
47182,6507,SLC1A3,0.619,0.552,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
47183,6507,SLC1A3,0.619,0.552,C0014544,Epilepsy,disease,C10,Disease or Syndrome,0.41,0.0,1995.0,2010.0,1,0,CTD_human
47184,6507,SLC1A3,0.619,0.552,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.36,1.0,2002.0,2016.0,4,0,PSYGENET
47185,6507,SLC1A3,0.619,0.552,C0086237,"Epilepsy, Cryptogenic",disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
47186,6507,SLC1A3,0.619,0.552,C0178417,Anhedonia,disease,C10;C23;F01,Mental or Behavioral Dysfunction,0.3,1.0,2009.0,2009.0,1,0,PSYGENET
47187,6507,SLC1A3,0.619,0.552,C0236018,Aura,phenotype,C10,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
47188,6507,SLC1A3,0.619,0.552,C0338488,Alternating hemiplegia of childhood,disease,C10;C23,Disease or Syndrome,0.33,1.0,2006.0,2009.0,0,0,ORPHANET
47189,6507,SLC1A3,0.619,0.552,C0751111,Awakening Epilepsy,disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
47190,6507,SLC1A3,0.619,0.552,C2675211,"EPISODIC ATAXIA, TYPE 6 (disorder)",disease,C10;C23,Disease or Syndrome,0.72,1.0,2006.0,2017.0,1,2,CTD_human;ORPHANET;UNIPROT
38636,5144,PDE4D,0.5720000000000001,0.69,C0004096,Asthma,disease,C08;C20,Disease or Syndrome,0.48,0.75,2001.0,2016.0,2,4,CTD_human
38637,5144,PDE4D,0.5720000000000001,0.69,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.5,1.0,2002.0,2012.0,2,0,PSYGENET
38638,5144,PDE4D,0.5720000000000001,0.69,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2002.0,2013.0,3,0,PSYGENET
38639,5144,PDE4D,0.5720000000000001,0.69,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2006.0,2018.0,2,0,CTD_human
38640,5144,PDE4D,0.5720000000000001,0.69,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2009.0,2011.0,1,1,PSYGENET
38641,5144,PDE4D,0.5720000000000001,0.69,C0038454,Cerebrovascular accident,group,C10;C14,Disease or Syndrome,0.4,0.9375,2002.0,2017.0,0,0,CTD_human
38642,5144,PDE4D,0.5720000000000001,0.69,C0220659,Acrodysostosis,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.59,0.8888889000000001,2012.0,2018.0,0,0,CTD_human;ORPHANET
38643,5144,PDE4D,0.5720000000000001,0.69,C0236733,Amphetamine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38644,5144,PDE4D,0.5720000000000001,0.69,C0236804,Amphetamine Addiction,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38645,5144,PDE4D,0.5720000000000001,0.69,C0236807,Amphetamine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38646,5144,PDE4D,0.5720000000000001,0.69,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.31,1.0,2006.0,2018.0,2,0,CTD_human
38647,5144,PDE4D,0.5720000000000001,0.69,C0751956,Acute Cerebrovascular Accidents,disease,C10;C14,Disease or Syndrome,0.3,,,,0,0,CTD_human
38648,5144,PDE4D,0.5720000000000001,0.69,C3276228,ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.3,,,,0,0,CTD_human
38649,5144,PDE4D,0.5720000000000001,0.69,C3553250,ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.61,1.0,2001.0,2018.0,4,9,CTD_human;UNIPROT
38650,5144,PDE4D,0.5720000000000001,0.69,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.41,1.0,2014.0,2014.0,0,0,GENOMICS_ENGLAND
32511,4208,MEF2C,0.57,0.483,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.3,,2009.0,2009.0,1,0,CTD_human
32512,4208,MEF2C,0.57,0.483,C0005899,Body Rocking,phenotype,F03,Individual Behavior,0.3,,2011.0,2011.0,1,0,CTD_human
32513,4208,MEF2C,0.57,0.483,C0007820,Cerebrovascular Disorders,group,C10;C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
32514,4208,MEF2C,0.57,0.483,C0014544,Epilepsy,disease,C10,Disease or Syndrome,0.43,1.0,2011.0,2017.0,1,0,CTD_human
32515,4208,MEF2C,0.57,0.483,C0018672,Head Banging,phenotype,F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
32516,4208,MEF2C,0.57,0.483,C0020796,Profound Mental Retardation,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
32517,4208,MEF2C,0.57,0.483,C0025363,"Mental Retardation, Psychosocial",disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
32518,4208,MEF2C,0.57,0.483,C0038220,Status Epilepticus,disease,C10;C23,Disease or Syndrome,0.5,,2009.0,2009.0,1,0,CTD_human
32519,4208,MEF2C,0.57,0.483,C0038273,Stereotypic Movement Disorder,phenotype,F03,Mental or Behavioral Dysfunction,0.4,,2011.0,2011.0,1,0,CTD_human
32520,4208,MEF2C,0.57,0.483,C0086237,"Epilepsy, Cryptogenic",disease,C10,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
32521,4208,MEF2C,0.57,0.483,C0236018,Aura,phenotype,C10,Finding,0.3,,2011.0,2011.0,1,0,CTD_human
32522,4208,MEF2C,0.57,0.483,C0270823,Petit mal status,disease,C10;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
32523,4208,MEF2C,0.57,0.483,C0311335,Grand Mal Status Epilepticus,disease,C10;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
32524,4208,MEF2C,0.57,0.483,C0393734,Complex Partial Status Epilepticus,disease,C10;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
32525,4208,MEF2C,0.57,0.483,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
32526,4208,MEF2C,0.57,0.483,C0751111,Awakening Epilepsy,disease,C10,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
32527,4208,MEF2C,0.57,0.483,C0751522,"Status Epilepticus, Subclinical",disease,C10;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
32528,4208,MEF2C,0.57,0.483,C0751523,Non-Convulsive Status Epilepticus,disease,C10;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
32529,4208,MEF2C,0.57,0.483,C0751524,Simple Partial Status Epilepticus,disease,C10;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
32530,4208,MEF2C,0.57,0.483,C0917816,Mental deficiency,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
32531,4208,MEF2C,0.57,0.483,C1510586,Autism Spectrum Disorders,disease,F03,Mental or Behavioral Dysfunction,0.4,,2011.0,2011.0,1,0,CTD_human
32532,4208,MEF2C,0.57,0.483,C3150700,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 20",disease,,Disease or Syndrome,0.4,,2008.0,2017.0,0,10,CTD_human
32533,4208,MEF2C,0.57,0.483,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.53,1.0,2010.0,2015.0,6,0,CTD_human;GENOMICS_ENGLAND
32534,4208,MEF2C,0.57,0.483,C4225434,"CHROMOSOME 5q14.3 DELETION SYNDROME, PROXIMAL",disease,,Disease or Syndrome,0.3,,,,0,0,CTD_human
32535,4208,MEF2C,0.57,0.483,C4304529,5q14.3 microdeletion syndrome,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
49134,6695,SPOCK1,0.701,0.172,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.31,1.0,2008.0,2016.0,1,0,CTD_human
49135,6695,SPOCK1,0.701,0.172,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.31,1.0,2008.0,2016.0,1,0,CTD_human
43782,5813,PURA,0.713,0.276,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,GENOMICS_ENGLAND
43783,5813,PURA,0.713,0.276,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2015.0,2015.0,1,0,GENOMICS_ENGLAND
43784,5813,PURA,0.713,0.276,C4015357,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 31",disease,,Disease or Syndrome,0.7,,1993.0,2017.0,2,16,CTD_human;ORPHANET;UNIPROT
21256,2741,GLRA1,0.642,0.379,C0393593,Dystonia Disorders,group,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21257,2741,GLRA1,0.642,0.379,C0393598,Idiopathic familial dystonia,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21258,2741,GLRA1,0.642,0.379,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
21259,2741,GLRA1,0.642,0.379,C0743332,Focal Dystonia,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21260,2741,GLRA1,0.642,0.379,C0752197,Adult-Onset Dystonias,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21261,2741,GLRA1,0.642,0.379,C0752198,Adult-Onset Idiopathic Focal Dystonias,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21262,2741,GLRA1,0.642,0.379,C0752199,Adult-Onset Idiopathic Torsion Dystonias,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21263,2741,GLRA1,0.642,0.379,C0752200,Autosomal Dominant Familial Dystonia,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21264,2741,GLRA1,0.642,0.379,C0752201,Autosomal Recessive Familial Dystonia,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21265,2741,GLRA1,0.642,0.379,C0752202,Childhood Onset Dystonias,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21266,2741,GLRA1,0.642,0.379,C0752203,"Dystonia, Primary",disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21267,2741,GLRA1,0.642,0.379,C0752205,"Dystonia, Secondary",disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21268,2741,GLRA1,0.642,0.379,C0752206,"Dystonias, Sporadic",disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21269,2741,GLRA1,0.642,0.379,C0752207,Familial Dystonia,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
21270,2741,GLRA1,0.642,0.379,C0752208,Pseudodystonia,disease,C10,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
21271,2741,GLRA1,0.642,0.379,C1835614,Hereditary Hyperexplexia,disease,C05;C10;C23,Disease or Syndrome,0.72,1.0,1993.0,2017.0,12,25,CTD_human;ORPHANET;UNIPROT
21272,2741,GLRA1,0.642,0.379,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2017.0,2018.0,2,0,GENOMICS_ENGLAND
21273,2741,GLRA1,0.642,0.379,C4316810,Writer's Cramp,disease,C10,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
18811,2296,FOXC1,0.517,0.7240000000000001,C0003076,Aniridia,disease,C11;C16,Congenital Abnormality,0.42,1.0,2008.0,2009.0,0,0,ORPHANET
18812,2296,FOXC1,0.517,0.7240000000000001,C0010964,Dandy-Walker Syndrome,disease,C10;C16,Disease or Syndrome,0.32,1.0,2009.0,2013.0,1,0,CTD_human
18813,2296,FOXC1,0.517,0.7240000000000001,C0017612,"Glaucoma, Open-Angle",disease,C11,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CTD_human
18814,2296,FOXC1,0.517,0.7240000000000001,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
18815,2296,FOXC1,0.517,0.7240000000000001,C0039685,Tetralogy of Fallot,disease,C14;C16,Congenital Abnormality,0.3,,2015.0,2015.0,1,0,CTD_human
18816,2296,FOXC1,0.517,0.7240000000000001,C0086543,Cataract,disease,C11,Acquired Abnormality,0.4,,,,0,0,GENOMICS_ENGLAND
18817,2296,FOXC1,0.517,0.7240000000000001,C0087012,"Ataxia, Spinocerebellar",disease,C10;C16,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
18818,2296,FOXC1,0.517,0.7240000000000001,C0265341,Rieger syndrome,disease,C11;C16,Disease or Syndrome,0.44,1.0,2002.0,2004.0,0,0,ORPHANET
18819,2296,FOXC1,0.517,0.7240000000000001,C0266548,Axenfeld anomaly (disorder),disease,C11;C16,Congenital Abnormality,0.48,1.0,1998.0,2013.0,0,0,ORPHANET
18820,2296,FOXC1,0.517,0.7240000000000001,C0271148,Secondary Open Angle Glaucoma,disease,C11,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CTD_human
18821,2296,FOXC1,0.517,0.7240000000000001,C0339573,"Glaucoma, Primary Open Angle",disease,C11,Disease or Syndrome,0.32,0.5,2012.0,2016.0,1,0,CTD_human
18822,2296,FOXC1,0.517,0.7240000000000001,C0344559,Irido-corneo-trabecular dysgenesis (disorder),disease,C11;C16,Congenital Abnormality,0.42,1.0,2003.0,2008.0,0,0,ORPHANET
18823,2296,FOXC1,0.517,0.7240000000000001,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.32,1.0,2007.0,2011.0,1,0,CTD_human
18824,2296,FOXC1,0.517,0.7240000000000001,C0752120,Spinocerebellar Ataxia Type 1,disease,C10;C16,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
18825,2296,FOXC1,0.517,0.7240000000000001,C0752121,Spinocerebellar Ataxia Type 2,disease,C10;C16,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
18826,2296,FOXC1,0.517,0.7240000000000001,C0752122,Spinocerebellar Ataxia Type 4,disease,C10;C16,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
18827,2296,FOXC1,0.517,0.7240000000000001,C0752123,Spinocerebellar Ataxia Type 5,disease,C10;C16,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
18828,2296,FOXC1,0.517,0.7240000000000001,C0752124,Spinocerebellar Ataxia Type 6 (disorder),disease,C10;C16,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
18829,2296,FOXC1,0.517,0.7240000000000001,C0752125,Spinocerebellar Ataxia Type 7,disease,C10;C16,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
18830,2296,FOXC1,0.517,0.7240000000000001,C1839928,IRIS HYPOPLASIA WITH GLAUCOMA,disease,C11,Disease or Syndrome,0.31,1.0,1998.0,2011.0,6,5,UNIPROT
18831,2296,FOXC1,0.517,0.7240000000000001,C1866560,"IRIDOGONIODYSGENESIS, TYPE 1 (disorder)",disease,C11;C16,Disease or Syndrome,0.6,,1998.0,2011.0,6,6,CTD_human;UNIPROT
18832,2296,FOXC1,0.517,0.7240000000000001,C1866561,"Glaucoma Iridogoniodysplasia, Familial",disease,C11,Disease or Syndrome,0.3,,1998.0,2011.0,6,5,UNIPROT
18833,2296,FOXC1,0.517,0.7240000000000001,C1968949,Cakut,disease,C12;C13;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
18834,2296,FOXC1,0.517,0.7240000000000001,C2678503,"AXENFELD-RIEGER SYNDROME, TYPE 3",disease,C11;C16,Disease or Syndrome,0.6,,1997.0,2017.0,20,23,CTD_human;UNIPROT
18835,2296,FOXC1,0.517,0.7240000000000001,C3495488,Axenfeld-Rieger syndrome,disease,C11;C16,Disease or Syndrome,0.4,1.0,2000.0,2017.0,0,0,ORPHANET
18836,2296,FOXC1,0.517,0.7240000000000001,C3495489,Rieger eye malformation sequence,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
18837,2296,FOXC1,0.517,0.7240000000000001,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.31,1.0,2011.0,2011.0,0,0,GENOMICS_ENGLAND
18838,2296,FOXC1,0.517,0.7240000000000001,C3714873,"Axenfeld-Rieger Syndrome, Type 1",disease,C11;C16,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
18839,2296,FOXC1,0.517,0.7240000000000001,C3887633,"Dandy-Walker Syndrome, Familial",disease,C10;C16,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
79004,378884,NHLRC1,0.701,0.172,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,2003.0,2006.0,2,0,GENOMICS_ENGLAND
79005,378884,NHLRC1,0.701,0.172,C0271713,Ketotic hypoglycemia,phenotype,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
79006,378884,NHLRC1,0.701,0.172,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
79007,378884,NHLRC1,0.701,0.172,C0751776,Atypical Inclusion-Body Disease,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
79008,378884,NHLRC1,0.701,0.172,C0751777,Familial Progressive Myoclonic Epilepsy,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
79009,378884,NHLRC1,0.701,0.172,C0751778,"Myoclonic Epilepsies, Progressive",disease,C10,Disease or Syndrome,0.44,1.0,2003.0,2015.0,1,0,CTD_human
79010,378884,NHLRC1,0.701,0.172,C0751779,Action Myoclonus-Renal Failure Syndrome,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
79011,378884,NHLRC1,0.701,0.172,C0751780,Biotin-Responsive Encephalopathy,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
79012,378884,NHLRC1,0.701,0.172,C0751781,Dentatorubral-Pallidoluysian Atrophy,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
79013,378884,NHLRC1,0.701,0.172,C0751782,May-White Syndrome,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
79014,378884,NHLRC1,0.701,0.172,C0751783,Lafora Disease,disease,C10;C16,Disease or Syndrome,1.0,0.9629629999999999,1993.0,2018.0,6,13,CTD_human;ORPHANET;UNIPROT
79015,378884,NHLRC1,0.701,0.172,C0751784,"Lafora Body Disease, Late Onset",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
79016,378884,NHLRC1,0.701,0.172,C1850764,"EPILEPSY, PROGRESSIVE MYOCLONIC 2B",disease,C10,Disease or Syndrome,0.4,,2003.0,2011.0,6,14,UNIPROT
79017,378884,NHLRC1,0.701,0.172,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
57320,8724,SNX3,0.773,0.24100000000000002,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2003.0,2003.0,1,0,GENOMICS_ENGLAND
64432,23345,SYNE1,0.594,0.621,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.31,1.0,2009.0,2009.0,0,0,GENOMICS_ENGLAND
64433,23345,SYNE1,0.594,0.621,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
64434,23345,SYNE1,0.594,0.621,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.42,0.6666667,2011.0,2018.0,3,3,PSYGENET
64435,23345,SYNE1,0.594,0.621,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
64436,23345,SYNE1,0.594,0.621,C0007193,"Cardiomyopathy, Dilated",group,C14,Disease or Syndrome,0.31,1.0,2017.0,2017.0,0,0,GENOMICS_ENGLAND
64437,23345,SYNE1,0.594,0.621,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.32,1.0,2007.0,2015.0,2,0,CTD_human
64438,23345,SYNE1,0.594,0.621,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2008.0,2011.0,2,0,CTD_human
64439,23345,SYNE1,0.594,0.621,C0013146,Drug abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64440,23345,SYNE1,0.594,0.621,C0013170,Drug habituation,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64441,23345,SYNE1,0.594,0.621,C0013222,Drug Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64442,23345,SYNE1,0.594,0.621,C0029231,"Organic Mental Disorders, Substance-Induced",disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64443,23345,SYNE1,0.594,0.621,C0038580,Substance Dependence,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64444,23345,SYNE1,0.594,0.621,C0038586,Substance Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64445,23345,SYNE1,0.594,0.621,C0154409,Recurrent major depressive episodes,disease,,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
64446,23345,SYNE1,0.594,0.621,C0236969,Substance-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64447,23345,SYNE1,0.594,0.621,C0264886,Conduction disorder of the heart,group,C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
64448,23345,SYNE1,0.594,0.621,C0410189,"Muscular Dystrophy, Emery-Dreifuss",disease,C05;C10;C16,Disease or Syndrome,0.56,1.0,2008.0,2017.0,0,0,CTD_human
64449,23345,SYNE1,0.594,0.621,C0410190,Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder),disease,C05;C10;C16,Disease or Syndrome,0.5,,,,0,0,CTD_human;ORPHANET
64450,23345,SYNE1,0.594,0.621,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.33,1.0,1998.0,2008.0,1,0,CTD_human
64451,23345,SYNE1,0.594,0.621,C0686353,"Muscular Dystrophies, Limb-Girdle",group,C05;C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
64452,23345,SYNE1,0.594,0.621,C0699743,Congenital muscular dystrophy (disorder),disease,,Disease or Syndrome,0.31,1.0,2009.0,2018.0,2,0,GENOMICS_ENGLAND
64453,23345,SYNE1,0.594,0.621,C0740858,Substance abuse problem,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64454,23345,SYNE1,0.594,0.621,C0751337,X-Linked Emery-Dreifuss Muscular Dystrophy,disease,C05;C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
64455,23345,SYNE1,0.594,0.621,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
64456,23345,SYNE1,0.594,0.621,C1450051,Autosomal Recessive Emery-Dreifuss Muscular Dystrophy,disease,C05;C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
64457,23345,SYNE1,0.594,0.621,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
64458,23345,SYNE1,0.594,0.621,C1510472,Drug Dependence,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64459,23345,SYNE1,0.594,0.621,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.52,1.0,2006.0,2015.0,3,3,CTD_human;UNIPROT
64460,23345,SYNE1,0.594,0.621,C1853116,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8 (disorder)",disease,C10;C16,Disease or Syndrome,0.6,,2007.0,2017.0,0,27,CTD_human;ORPHANET
64461,23345,SYNE1,0.594,0.621,C2751807,Emery-Dreifuss Muscular Dystrophy 4,disease,C05;C10;C16,Disease or Syndrome,0.4,,2008.0,2008.0,1,10,UNIPROT
64462,23345,SYNE1,0.594,0.621,C2931822,Nasopharyngeal carcinoma,disease,C04;C07;C09,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
64463,23345,SYNE1,0.594,0.621,C3683483,Autosomal Recessive Cerebellar Ataxia Type 1,disease,C10;C23,Disease or Syndrome,0.3,,,,0,0,ORPHANET
64464,23345,SYNE1,0.594,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2014.0,2016.0,2,0,GENOMICS_ENGLAND
64465,23345,SYNE1,0.594,0.621,C4316881,Prescription Drug Abuse,phenotype,C25;F03,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
78006,221895,JAZF1,0.616,0.44799999999999995,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",disease,C18;C19,Disease or Syndrome,0.5,0.9375,2008.0,2018.0,1,4,CTD_human
78007,221895,JAZF1,0.616,0.44799999999999995,C0014170,Endometrial Neoplasms,group,C04;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
78008,221895,JAZF1,0.616,0.44799999999999995,C0024141,"Lupus Erythematosus, Systemic",disease,C17;C20,Disease or Syndrome,0.43,0.6666667,2009.0,2016.0,1,3,CTD_human
78009,221895,JAZF1,0.616,0.44799999999999995,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
78010,221895,JAZF1,0.616,0.44799999999999995,C0206630,Endometrial Stromal Sarcoma,disease,C04;C13,Neoplastic Process,0.4,0.9,2006.0,2016.0,0,0,ORPHANET
78011,221895,JAZF1,0.616,0.44799999999999995,C0242380,Libman-Sacks Disease,disease,C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
78012,221895,JAZF1,0.616,0.44799999999999995,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.37,0.8571429,2008.0,2015.0,1,0,CTD_human
78013,221895,JAZF1,0.616,0.44799999999999995,C0476089,Endometrial Carcinoma,disease,C04;C13,Neoplastic Process,0.31,1.0,2008.0,2008.0,1,0,CTD_human
55222,7532,YWHAG,0.727,0.31,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
55223,7532,YWHAG,0.727,0.31,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,2014.0,2017.0,4,0,GENOMICS_ENGLAND
55224,7532,YWHAG,0.727,0.31,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.31,1.0,2011.0,2017.0,5,0,GENOMICS_ENGLAND
55225,7532,YWHAG,0.727,0.31,C4540034,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56",disease,,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,UNIPROT
64480,23362,PSD3,0.685,0.379,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,GENOMICS_ENGLAND
64481,23362,PSD3,0.685,0.379,C0017638,Glioma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64482,23362,PSD3,0.685,0.379,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2013.0,2016.0,1,1,PSYGENET
64483,23362,PSD3,0.685,0.379,C0236733,Amphetamine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64484,23362,PSD3,0.685,0.379,C0236804,Amphetamine Addiction,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64485,23362,PSD3,0.685,0.379,C0236807,Amphetamine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64486,23362,PSD3,0.685,0.379,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64487,23362,PSD3,0.685,0.379,C0555198,Malignant Glioma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64488,23362,PSD3,0.685,0.379,C1867439,"Pterygium, Antecubital",disease,C05;C16,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CLINGEN
65328,25792,CIZ1,0.685,0.379,C0013421,Dystonia,phenotype,C10;C23,Sign or Symptom,0.32,1.0,2013.0,2014.0,1,0,CTD_human
65329,25792,CIZ1,0.685,0.379,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
65330,25792,CIZ1,0.685,0.379,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
65331,25792,CIZ1,0.685,0.379,C0393588,"Dystonia, Paroxysmal",phenotype,C10;C23,Sign or Symptom,0.3,,2013.0,2013.0,1,0,CTD_human
65332,25792,CIZ1,0.685,0.379,C0393610,"Dystonia, Diurnal",phenotype,C10;C23,Sign or Symptom,0.3,,2013.0,2013.0,1,0,CTD_human
65333,25792,CIZ1,0.685,0.379,C0553580,Ewings sarcoma,disease,C04,Neoplastic Process,0.31,1.0,2007.0,2007.0,1,0,CTD_human
65334,25792,CIZ1,0.685,0.379,C0751093,"Dystonia, Limb",phenotype,C10;C23,Sign or Symptom,0.3,,2013.0,2013.0,1,0,CTD_human
65335,25792,CIZ1,0.685,0.379,C1865818,"DYSTONIA 7, TORSION (disorder)",disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
65336,25792,CIZ1,0.685,0.379,C1865819,"CERVICAL DYSTONIA, PRIMARY",disease,C10;C23,Disease or Syndrome,0.31,1.0,2012.0,2012.0,1,0,CTD_human
65337,25792,CIZ1,0.685,0.379,C3538999,DYSTONIA 23,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
72709,65217,PCDH15,0.627,0.44799999999999995,C0009197,Cochlear Diseases,group,C09,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72710,65217,PCDH15,0.627,0.44799999999999995,C0011052,Prelingual Deafness,disease,C09;C10;C23,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72711,65217,PCDH15,0.627,0.44799999999999995,C0011053,Deafness,phenotype,C09;C10;C23,Finding,0.41,,2000.0,2008.0,1,0,CTD_human
72712,65217,PCDH15,0.627,0.44799999999999995,C0013146,Drug abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72713,65217,PCDH15,0.627,0.44799999999999995,C0013170,Drug habituation,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72714,65217,PCDH15,0.627,0.44799999999999995,C0013222,Drug Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72715,65217,PCDH15,0.627,0.44799999999999995,C0029231,"Organic Mental Disorders, Substance-Induced",disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72716,65217,PCDH15,0.627,0.44799999999999995,C0038580,Substance Dependence,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72717,65217,PCDH15,0.627,0.44799999999999995,C0038586,Substance Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72718,65217,PCDH15,0.627,0.44799999999999995,C0086395,"Hearing Loss, Extreme",phenotype,C09;C10;C23,Sign or Symptom,0.3,,2000.0,2000.0,1,0,CTD_human
72719,65217,PCDH15,0.627,0.44799999999999995,C0236969,Substance-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72720,65217,PCDH15,0.627,0.44799999999999995,C0271097,Usher Syndrome,disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.47,1.0,2001.0,2015.0,1,1,CTD_human
72721,65217,PCDH15,0.627,0.44799999999999995,C0581883,Complete Hearing Loss,phenotype,C09;C10;C23,Finding,0.3,,2000.0,2000.0,1,0,CTD_human
72722,65217,PCDH15,0.627,0.44799999999999995,C0740858,Substance abuse problem,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72723,65217,PCDH15,0.627,0.44799999999999995,C0751068,"Deafness, Acquired",disease,C09;C10;C23,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72724,65217,PCDH15,0.627,0.44799999999999995,C1510472,Drug Dependence,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72725,65217,PCDH15,0.627,0.44799999999999995,C1568247,"Usher Syndrome, Type I",disease,,Disease or Syndrome,0.49,0.8888889000000001,1993.0,2015.0,0,3,ORPHANET
72726,65217,PCDH15,0.627,0.44799999999999995,C1568248,"Usher Syndrome, Type III",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
72727,65217,PCDH15,0.627,0.44799999999999995,C1568249,"Usher Syndrome, Type II",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
72728,65217,PCDH15,0.627,0.44799999999999995,C1832845,"USHER SYNDROME, TYPE ID",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.4,,2003.0,2017.0,2,3,UNIPROT
72729,65217,PCDH15,0.627,0.44799999999999995,C1836027,"Deafness, Autosomal Recessive 23",disease,C09;C10;C23,Disease or Syndrome,0.82,1.0,2003.0,2017.0,3,6,CTD_human;UNIPROT
72730,65217,PCDH15,0.627,0.44799999999999995,C1865885,"Usher Syndrome, Type IF",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.87,1.0,2001.0,2017.0,9,49,CLINGEN;UNIPROT
72731,65217,PCDH15,0.627,0.44799999999999995,C2931205,"Usher syndrome, type 1A",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.34,1.0,2008.0,2012.0,1,0,CTD_human
72732,65217,PCDH15,0.627,0.44799999999999995,C2931208,"Usher syndrome, type 1D",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.3,,,,0,0,CTD_human
72733,65217,PCDH15,0.627,0.44799999999999995,C2931210,"Usher syndrome, type 1F",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.38,0.875,2001.0,2016.0,0,0,CTD_human
72734,65217,PCDH15,0.627,0.44799999999999995,C3152102,"USH1D/F, CDH23/PCDH15, DIGENIC",disease,,Disease or Syndrome,0.3,,2005.0,2008.0,2,0,UNIPROT
72735,65217,PCDH15,0.627,0.44799999999999995,C3275872,"USHER SYNDROME, TYPE ID/F, CDH23/PCDH15, DIGENIC",disease,,Disease or Syndrome,0.3,,2005.0,2008.0,2,0,UNIPROT
72736,65217,PCDH15,0.627,0.44799999999999995,C3665473,Bilateral Deafness,phenotype,C09;C10;C23,Finding,0.3,,2000.0,2000.0,1,0,CTD_human
72737,65217,PCDH15,0.627,0.44799999999999995,C4082305,Deaf Mutism,disease,C09;C10;C23,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72738,65217,PCDH15,0.627,0.44799999999999995,C4316881,Prescription Drug Abuse,phenotype,C25;F03,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
62922,10984,KCNQ1OT1,0.604,0.586,C0004903,Beckwith-Wiedemann Syndrome,disease,C16,Disease or Syndrome,0.4,0.9782609,1999.0,2016.0,0,0,CTD_human
62923,10984,KCNQ1OT1,0.604,0.586,C0332890,Congenital hemihypertrophy,disease,,Congenital Abnormality,0.4,,,,0,0,ORPHANET
62924,10984,KCNQ1OT1,0.604,0.586,C1856184,"HEMIHYPERPLASIA, ISOLATED",disease,C23,Disease or Syndrome,0.31,1.0,2008.0,2008.0,0,0,ORPHANET
59228,9415,FADS2,0.627,0.552,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2011.0,2018.0,1,2,PSYGENET
59229,9415,FADS2,0.627,0.552,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
59230,9415,FADS2,0.627,0.552,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
59231,9415,FADS2,0.627,0.552,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2015.0,2015.0,1,0,CTD_human
59232,9415,FADS2,0.627,0.552,C0023794,Lipoidosis,disease,C16;C18,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
59233,9415,FADS2,0.627,0.552,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2009.0,2009.0,1,0,PSYGENET
59234,9415,FADS2,0.627,0.552,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59235,9415,FADS2,0.627,0.552,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59236,9415,FADS2,0.627,0.552,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.4,,2014.0,2018.0,1,1,CTD_human
59237,9415,FADS2,0.627,0.552,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59238,9415,FADS2,0.627,0.552,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59239,9415,FADS2,0.627,0.552,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
65218,23705,CADM1,0.537,0.655,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.31,,2008.0,2008.0,1,0,CTD_human
65219,23705,CADM1,0.537,0.655,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.33,1.0,2002.0,2013.0,1,0,CTD_human
65220,23705,CADM1,0.537,0.655,C0011573,Endogenous depression,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65221,23705,CADM1,0.537,0.655,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65222,23705,CADM1,0.537,0.655,C0025193,Melancholia,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65223,23705,CADM1,0.537,0.655,C0041696,Unipolar Depression,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65224,23705,CADM1,0.537,0.655,C0086133,Depressive Syndrome,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65225,23705,CADM1,0.537,0.655,C0282126,"Depression, Neurotic",disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65226,23705,CADM1,0.537,0.655,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.32,1.0,2002.0,2007.0,1,0,CTD_human
65227,23705,CADM1,0.537,0.655,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
65228,23705,CADM1,0.537,0.655,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.32,,2002.0,2007.0,1,0,CTD_human
68104,51535,PPHLN1,0.9279999999999999,0.069,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,2006.0,2006.0,1,1,UNIPROT
62571,10804,GJB6,0.5589999999999999,0.655,C0013575,Ectodermal Dysplasia,disease,C16;C17,Disease or Syndrome,0.42,1.0,2002.0,2014.0,0,0,CTD_human
62572,10804,GJB6,0.5589999999999999,0.655,C0022596,Palmoplantar Keratosis,disease,C16;C17,Disease or Syndrome,0.42,1.0,1996.0,2010.0,2,0,GENOMICS_ENGLAND
62573,10804,GJB6,0.5589999999999999,0.655,C0162361,Hidrotic Ectodermal Dysplasia,disease,C16;C17,Disease or Syndrome,1.0,1.0,2000.0,2017.0,2,3,CTD_human;ORPHANET;UNIPROT
62574,10804,GJB6,0.5589999999999999,0.655,C0265336,Senter syndrome,disease,C09;C10;C11;C16;C17;C23,Disease or Syndrome,0.32,1.0,2004.0,2015.0,0,0,ORPHANET
62575,10804,GJB6,0.5589999999999999,0.655,C0282160,Aplasia Cutis Congenita,disease,C16;C17,Congenital Abnormality,0.3,,,,0,0,CTD_human
62576,10804,GJB6,0.5589999999999999,0.655,C0432330,Erythrokeratoderma,disease,,Congenital Abnormality,0.3,,1996.0,2002.0,2,0,GENOMICS_ENGLAND
62577,10804,GJB6,0.5589999999999999,0.655,C1706004,Anhydrotic Ectodermal Dysplasias,disease,C16;C17,Congenital Abnormality,0.3,,,,0,0,CTD_human
62578,10804,GJB6,0.5589999999999999,0.655,C1844678,Progressive hearing loss stapes fixation,disease,C09;C10;C16;C23,Disease or Syndrome,0.3,,,,0,0,CTD_human
62579,10804,GJB6,0.5589999999999999,0.655,C2673759,"DEAFNESS, AUTOSOMAL RECESSIVE 1A (disorder)",disease,C09;C10;C23,Disease or Syndrome,0.6,,2000.0,2017.0,0,1,CTD_human
62580,10804,GJB6,0.5589999999999999,0.655,C2673760,"DEAFNESS, DIGENIC, GJB2/GJB6 (disorder)",disease,C09;C10;C23,Disease or Syndrome,0.5,,2003.0,2011.0,0,0,CTD_human
62581,10804,GJB6,0.5589999999999999,0.655,C2673761,"DEAFNESS, DIGENIC, GJB2/GJB3 (disorder)",disease,C09;C10;C23,Disease or Syndrome,0.5,,2003.0,2011.0,0,0,CTD_human
62582,10804,GJB6,0.5589999999999999,0.655,C2675235,"Deafness, Autosomal Recessive 1b",disease,C09;C10;C23,Disease or Syndrome,0.4,,2000.0,2017.0,0,1,CTD_human
62583,10804,GJB6,0.5589999999999999,0.655,C2675237,"Deafness, Autosomal Dominant 3B",disease,C09;C10;C23,Disease or Syndrome,0.6,,1993.0,2017.0,1,3,CTD_human;UNIPROT
62584,10804,GJB6,0.5589999999999999,0.655,C3665333,Keratitis-Ichthyosis-Deafness Syndrome,disease,C11,Disease or Syndrome,0.32,1.0,2004.0,2015.0,0,0,ORPHANET
62585,10804,GJB6,0.5589999999999999,0.655,C4302111,Familial Ménière disease,disease,,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,GENOMICS_ENGLAND
18758,2290,FOXG1,0.561,0.517,C0020796,Profound Mental Retardation,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
18759,2290,FOXG1,0.561,0.517,C0022333,Jacksonian Seizure,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18760,2290,FOXG1,0.561,0.517,C0025363,"Mental Retardation, Psychosocial",disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
18761,2290,FOXG1,0.561,0.517,C0025958,Microcephaly,disease,C05;C10;C16,Congenital Abnormality,0.59,1.0,2005.0,2016.0,1,0,CTD_human;GENOMICS_ENGLAND
18762,2290,FOXG1,0.561,0.517,C0027765,nervous system disorder,group,C10,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
18763,2290,FOXG1,0.561,0.517,C0036572,Seizures,phenotype,C10;C23,Sign or Symptom,0.43,1.0,2008.0,2014.0,1,0,CTD_human
18764,2290,FOXG1,0.561,0.517,C0149958,Complex partial seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18765,2290,FOXG1,0.561,0.517,C0234533,Generalized seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18766,2290,FOXG1,0.561,0.517,C0234535,"Seizures, Clonic",disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18767,2290,FOXG1,0.561,0.517,C0270824,Visual seizure,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18768,2290,FOXG1,0.561,0.517,C0270844,Tonic Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
18769,2290,FOXG1,0.561,0.517,C0270846,Epileptic drop attack,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18770,2290,FOXG1,0.561,0.517,C0422850,"Seizures, Somatosensory",phenotype,C10;C23,Pathologic Function,0.3,,2008.0,2008.0,1,0,CTD_human
18771,2290,FOXG1,0.561,0.517,C0422852,"Seizures, Auditory",phenotype,C10;C23,Pathologic Function,0.3,,2008.0,2008.0,1,0,CTD_human
18772,2290,FOXG1,0.561,0.517,C0422853,Olfactory seizure,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18773,2290,FOXG1,0.561,0.517,C0422854,Gustatory seizure,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
18774,2290,FOXG1,0.561,0.517,C0422855,Vertiginous seizure,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18775,2290,FOXG1,0.561,0.517,C0494475,Tonic - clonic seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18776,2290,FOXG1,0.561,0.517,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,GENOMICS_ENGLAND
18777,2290,FOXG1,0.561,0.517,C0751056,Non-epileptic convulsion,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
18778,2290,FOXG1,0.561,0.517,C0751110,Single Seizure,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18779,2290,FOXG1,0.561,0.517,C0751123,Atonic Absence Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18780,2290,FOXG1,0.561,0.517,C0751494,Convulsive Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
18781,2290,FOXG1,0.561,0.517,C0751495,"Seizures, Focal",phenotype,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18782,2290,FOXG1,0.561,0.517,C0751496,"Seizures, Sensory",phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
18783,2290,FOXG1,0.561,0.517,C0796147,Acrocallosal Syndrome,disease,C10;C16,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18784,2290,FOXG1,0.561,0.517,C0917816,Mental deficiency,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2008.0,2008.0,1,0,CTD_human
18785,2290,FOXG1,0.561,0.517,C1956147,Microlissencephaly,disease,C05;C10;C16,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18786,2290,FOXG1,0.561,0.517,C2748910,"Rett Syndrome, Atypical",disease,C10;C16,Disease or Syndrome,0.32,1.0,2010.0,2013.0,0,0,ORPHANET
18787,2290,FOXG1,0.561,0.517,C3150705,FOXG1 syndrome,disease,,Disease or Syndrome,0.63,1.0,2008.0,2017.0,3,35,CTD_human;UNIPROT
18788,2290,FOXG1,0.561,0.517,C3495874,Nonepileptic Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18789,2290,FOXG1,0.561,0.517,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.61,1.0,2008.0,2017.0,1,0,CTD_human;GENOMICS_ENGLAND
18790,2290,FOXG1,0.561,0.517,C3853041,Severe Congenital Microcephaly,disease,C05;C10;C16,Congenital Abnormality; Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18791,2290,FOXG1,0.561,0.517,C4048158,Convulsions,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
18792,2290,FOXG1,0.561,0.517,C4305240,14q12 microdeletion syndrome,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
18793,2290,FOXG1,0.561,0.517,C4316903,Absence Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
18794,2290,FOXG1,0.561,0.517,C4317109,Epileptic Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
18795,2290,FOXG1,0.561,0.517,C4317123,Myoclonic Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
18796,2290,FOXG1,0.561,0.517,C4505436,Generalized Absence Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
53961,7337,UBE3A,0.59,0.483,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.5,1.0,1999.0,2017.0,3,0,CTD_human
53962,7337,UBE3A,0.59,0.483,C0014544,Epilepsy,disease,C10,Disease or Syndrome,0.45,1.0,2003.0,2015.0,1,0,CTD_human
53963,7337,UBE3A,0.59,0.483,C0025958,Microcephaly,disease,C05;C10;C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
53964,7337,UBE3A,0.59,0.483,C0086237,"Epilepsy, Cryptogenic",disease,C10,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
53965,7337,UBE3A,0.59,0.483,C0162635,Angelman Syndrome,disease,C10;C16,Disease or Syndrome,1.0,0.9734513000000001,1997.0,2017.0,11,120,CLINGEN;CTD_human;ORPHANET;UNIPROT
53966,7337,UBE3A,0.59,0.483,C0236018,Aura,phenotype,C10,Finding,0.3,,2005.0,2005.0,1,0,CTD_human
53967,7337,UBE3A,0.59,0.483,C0376634,Craniofacial Abnormalities,group,C05;C16,Congenital Abnormality,0.3,,2005.0,2005.0,1,0,CTD_human
53968,7337,UBE3A,0.59,0.483,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,1990.0,2011.0,8,0,GENOMICS_ENGLAND
53969,7337,UBE3A,0.59,0.483,C0751111,Awakening Epilepsy,disease,C10,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
53970,7337,UBE3A,0.59,0.483,C2675336,Duplication 15q11-q13 Syndrome,disease,C10;C23;F01;F03,Disease or Syndrome,0.3,,,,0,0,ORPHANET
53971,7337,UBE3A,0.59,0.483,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.41,1.0,2007.0,2007.0,0,0,GENOMICS_ENGLAND
70964,57099,AVEN,0.785,0.207,C0007131,Non-Small Cell Lung Carcinoma,disease,C04;C08,Neoplastic Process,0.3,,2005.0,2005.0,1,0,CTD_human
12834,1544,CYP1A2,0.509,0.828,C0007137,Squamous cell carcinoma,disease,C04,Neoplastic Process,0.33,0.666666666666667,2007.0,2012.0,1,0,CTD_human
12835,1544,CYP1A2,0.509,0.828,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12836,1544,CYP1A2,0.509,0.828,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.4,1.0,1993.0,2015.0,1,0,CTD_human
12837,1544,CYP1A2,0.509,0.828,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.32,,2007.0,2011.0,1,0,CTD_human
12838,1544,CYP1A2,0.509,0.828,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",disease,C18;C19,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
12839,1544,CYP1A2,0.509,0.828,C0011999,Diastematomyelia,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12840,1544,CYP1A2,0.509,0.828,C0013221,Drug toxicity,group,C25,Injury or Poisoning,0.3,,1999.0,1999.0,1,0,CTD_human
12841,1544,CYP1A2,0.509,0.828,C0018273,Growth Disorders,group,C23,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
12842,1544,CYP1A2,0.509,0.828,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2018.0,2018.0,1,0,CTD_human
12843,1544,CYP1A2,0.509,0.828,C0019207,"Hepatoma, Morris",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12844,1544,CYP1A2,0.509,0.828,C0019208,"Hepatoma, Novikoff",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12845,1544,CYP1A2,0.509,0.828,C0019209,Hepatomegaly,phenotype,C06;C23,Finding,0.3,,1999.0,1999.0,1,0,CTD_human
12846,1544,CYP1A2,0.509,0.828,C0023452,Childhood Acute Lymphoblastic Leukemia,disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12847,1544,CYP1A2,0.509,0.828,C0023453,"Leukemia, Lymphocytic, Acute, L2",disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12848,1544,CYP1A2,0.509,0.828,C0023890,Liver Cirrhosis,disease,C06,Disease or Syndrome,0.31,1.0,1995.0,2017.0,1,0,CTD_human
12849,1544,CYP1A2,0.509,0.828,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2007.0,2007.0,1,0,CTD_human
12850,1544,CYP1A2,0.509,0.828,C0023895,Liver diseases,group,C06,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
12851,1544,CYP1A2,0.509,0.828,C0023904,"Liver Neoplasms, Experimental",group,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12852,1544,CYP1A2,0.509,0.828,C0024117,Chronic Obstructive Airway Disease,disease,C08,Disease or Syndrome,0.33,1.0,2008.0,2010.0,1,0,CTD_human
12853,1544,CYP1A2,0.509,0.828,C0024121,Lung Neoplasms,group,C04;C08,Neoplastic Process,0.31,,2007.0,2012.0,1,0,CTD_human
12854,1544,CYP1A2,0.509,0.828,C0025637,Methemoglobinemia,disease,C15,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
12855,1544,CYP1A2,0.509,0.828,C0027794,Neural Tube Defects,group,C10;C16,Congenital Abnormality,0.31,1.0,2010.0,2010.0,1,0,CTD_human
12856,1544,CYP1A2,0.509,0.828,C0027806,Neurenteric Cyst,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12857,1544,CYP1A2,0.509,0.828,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.4,1.0,2000.0,2014.0,1,0,PSYGENET
12858,1544,CYP1A2,0.509,0.828,C0037997,Splenic Diseases,group,C15,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
12859,1544,CYP1A2,0.509,0.828,C0038002,Splenomegaly,phenotype,C23,Finding,0.3,,1999.0,1999.0,1,0,CTD_human
12860,1544,CYP1A2,0.509,0.828,C0041755,Adverse reaction to drug,group,C25,Pathologic Function,0.3,,1999.0,1999.0,1,0,CTD_human
12861,1544,CYP1A2,0.509,0.828,C0080218,Tethered Cord Syndrome,disease,C10;C16,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
12862,1544,CYP1A2,0.509,0.828,C0086404,Experimental Hepatoma,disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12863,1544,CYP1A2,0.509,0.828,C0086565,Liver Dysfunction,phenotype,C06,Finding,0.3,,2004.0,2004.0,1,0,CTD_human
12864,1544,CYP1A2,0.509,0.828,C0152234,Iniencephaly,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12865,1544,CYP1A2,0.509,0.828,C0152426,Craniorachischisis,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12866,1544,CYP1A2,0.509,0.828,C0162566,Porphyria Cutanea Tarda,disease,C06;C16;C17;C18,Disease or Syndrome,0.36,0.666666666666667,2001.0,2012.0,1,0,CTD_human
12867,1544,CYP1A2,0.509,0.828,C0239946,"Fibrosis, Liver",disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12868,1544,CYP1A2,0.509,0.828,C0242379,Malignant neoplasm of lung,disease,C04;C08,Neoplastic Process,0.39,0.8888888888888891,2001.0,2016.0,1,0,CTD_human
12869,1544,CYP1A2,0.509,0.828,C0266453,Exencephaly,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12870,1544,CYP1A2,0.509,0.828,C0273115,Lung Injury,disease,C08;C26,Injury or Poisoning,0.3,,2015.0,2015.0,1,0,CTD_human
12871,1544,CYP1A2,0.509,0.828,C0333641,Atrophic,phenotype,C23,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
12872,1544,CYP1A2,0.509,0.828,C0344479,Spinal Cord Myelodysplasia,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12873,1544,CYP1A2,0.509,0.828,C0400966,Non-alcoholic Fatty Liver Disease,disease,C06,Disease or Syndrome,0.31,1.0,2010.0,2017.0,1,0,CTD_human
12874,1544,CYP1A2,0.509,0.828,C0702169,Acrania,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12875,1544,CYP1A2,0.509,0.828,C0809983,Schizophrenia and related disorders,group,,Disease or Syndrome,0.31,1.0,2011.0,2011.0,1,0,PSYGENET
12876,1544,CYP1A2,0.509,0.828,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12877,1544,CYP1A2,0.509,0.828,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12878,1544,CYP1A2,0.509,0.828,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.4,1.0,1993.0,2015.0,1,0,CTD_human
12879,1544,CYP1A2,0.509,0.828,C1527303,Chronic Airflow Obstruction,disease,C08,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
12880,1544,CYP1A2,0.509,0.828,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12881,1544,CYP1A2,0.509,0.828,C2350344,Chronic Lung Injury,disease,C08;C26,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
12882,1544,CYP1A2,0.509,0.828,C3241937,Nonalcoholic Steatohepatitis,disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12883,1544,CYP1A2,0.509,0.828,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12884,1544,CYP1A2,0.509,0.828,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12885,1544,CYP1A2,0.509,0.828,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
75788,112476,PRRT2,0.491,0.7929999999999999,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
75789,112476,PRRT2,0.491,0.7929999999999999,C0020796,Profound Mental Retardation,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
75790,112476,PRRT2,0.491,0.7929999999999999,C0025363,"Mental Retardation, Psychosocial",disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
75791,112476,PRRT2,0.491,0.7929999999999999,C0220669,Familial benign neonatal epilepsy,disease,C10;C16,Disease or Syndrome,0.38,0.875,2012.0,2015.0,0,0,ORPHANET
75792,112476,PRRT2,0.491,0.7929999999999999,C0270862,Hemiplegic migraine,disease,,Disease or Syndrome,0.39,1.0,2012.0,2016.0,0,0,ORPHANET
75793,112476,PRRT2,0.491,0.7929999999999999,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
75794,112476,PRRT2,0.491,0.7929999999999999,C0917816,Mental deficiency,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
75795,112476,PRRT2,0.491,0.7929999999999999,C1842534,DYSTONIA 18 (disorder),disease,C10,Disease or Syndrome,0.31,1.0,2000.0,2000.0,0,0,ORPHANET
75796,112476,PRRT2,0.491,0.7929999999999999,C1853995,"SEIZURES, BENIGN FAMILIAL INFANTILE, 2",disease,C10,Disease or Syndrome,0.4,,1993.0,2016.0,3,7,UNIPROT
75797,112476,PRRT2,0.491,0.7929999999999999,C1865926,"Infantile convulsions and paroxysmal choreoathetosis, familial (disorder)",disease,C10;C16;C23,Disease or Syndrome,0.7,0.9333333,1993.0,2017.0,2,9,ORPHANET;UNIPROT
75798,112476,PRRT2,0.491,0.7929999999999999,C1868682,Paroxysmal kinesigenic choreoathetosis,disease,C10;C23,Disease or Syndrome,0.8,0.9636364,1993.0,2018.0,6,14,CTD_human;ORPHANET;UNIPROT
75799,112476,PRRT2,0.491,0.7929999999999999,C1869117,Paroxysmal nonkinesigenic dyskinesia,disease,C10;C23,Disease or Syndrome,0.31,1.0,2014.0,2014.0,0,0,ORPHANET
75800,112476,PRRT2,0.491,0.7929999999999999,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.55,1.0,2012.0,2016.0,4,0,CTD_human;GENOMICS_ENGLAND
25132,3299,HSF4,0.69,0.31,C0086543,Cataract,disease,C11,Acquired Abnormality,0.4,0.8888889000000001,2002.0,2013.0,0,0,GENOMICS_ENGLAND
25133,3299,HSF4,0.69,0.31,C0266539,Congenital total cataract,disease,,Congenital Abnormality,0.3,,,,0,0,ORPHANET
25134,3299,HSF4,0.69,0.31,C1861821,"CATARACT, MARNER TYPE",disease,C11,Disease or Syndrome,0.73,1.0,2006.0,2015.0,1,4,CTD_human;UNIPROT
25135,3299,HSF4,0.69,0.31,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
25136,3299,HSF4,0.69,0.31,C3888417,"CATARACT 5, MULTIPLE TYPES",disease,,Disease or Syndrome,0.5,,2006.0,2012.0,1,4,UNIPROT
48967,6662,SOX9,0.45899999999999996,0.7240000000000001,C0007097,Carcinoma,group,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
48968,6662,SOX9,0.45899999999999996,0.7240000000000001,C0018054,"Gonadal Dysgenesis, 46,XY",disease,C12;C13;C16;C19,Disease or Syndrome,0.31,0.0,1997.0,1997.0,0,0,ORPHANET
48969,6662,SOX9,0.45899999999999996,0.7240000000000001,C0018566,Congenital Hand Deformities,group,C05;C16,Congenital Abnormality,0.3,,2009.0,2009.0,1,0,CTD_human
48970,6662,SOX9,0.45899999999999996,0.7240000000000001,C0024121,Lung Neoplasms,group,C04;C08,Neoplastic Process,0.3,,2017.0,2017.0,1,0,CTD_human
48971,6662,SOX9,0.45899999999999996,0.7240000000000001,C0024667,Animal Mammary Neoplasms,group,C04;C22,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
48972,6662,SOX9,0.45899999999999996,0.7240000000000001,C0024668,"Mammary Neoplasms, Experimental",group,C04,Experimental Model of Disease; Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
48973,6662,SOX9,0.45899999999999996,0.7240000000000001,C0029434,Osteogenesis Imperfecta,disease,C05;C16;C17,Congenital Abnormality; Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
48974,6662,SOX9,0.45899999999999996,0.7240000000000001,C0031900,Pierre Robin Syndrome,disease,C05;C07;C16,Congenital Abnormality,0.6,0.8181818000000001,2007.0,2016.0,1,0,CTD_human;ORPHANET
48975,6662,SOX9,0.45899999999999996,0.7240000000000001,C0036875,Disorders of Sex Development,group,C12;C13;C16;C19,Congenital Abnormality,0.35,0.8,2011.0,2014.0,0,0,GENOMICS_ENGLAND
48976,6662,SOX9,0.45899999999999996,0.7240000000000001,C0041696,Unipolar Depression,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2015.0,2015.0,1,0,PSYGENET
48977,6662,SOX9,0.45899999999999996,0.7240000000000001,C0205696,Anaplastic carcinoma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
48978,6662,SOX9,0.45899999999999996,0.7240000000000001,C0205697,"Carcinoma, Spindle-Cell",disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
48979,6662,SOX9,0.45899999999999996,0.7240000000000001,C0205698,Undifferentiated carcinoma,phenotype,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
48980,6662,SOX9,0.45899999999999996,0.7240000000000001,C0205699,Carcinomatosis,phenotype,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
48981,6662,SOX9,0.45899999999999996,0.7240000000000001,C0242379,Malignant neoplasm of lung,disease,C04;C08,Neoplastic Process,0.34,1.0,2011.0,2018.0,1,0,CTD_human
48982,6662,SOX9,0.45899999999999996,0.7240000000000001,C0265998,ANONYCHIA,disease,C23,Congenital Abnormality,0.3,,2009.0,2009.0,1,0,CTD_human
48983,6662,SOX9,0.45899999999999996,0.7240000000000001,C0266361,True Hermaphroditism (disorder),disease,C12;C13;C16;C19,Congenital Abnormality,0.4,,,,0,0,ORPHANET
48984,6662,SOX9,0.45899999999999996,0.7240000000000001,C0376634,Craniofacial Abnormalities,group,C05;C16,Congenital Abnormality,0.31,1.0,2002.0,2012.0,1,0,CTD_human
48985,6662,SOX9,0.45899999999999996,0.7240000000000001,C0432475,XX males,disease,,Disease or Syndrome,0.32,1.0,2009.0,2012.0,0,0,ORPHANET
48986,6662,SOX9,0.45899999999999996,0.7240000000000001,C1257925,"Mammary Carcinoma, Animal",disease,C04;C22,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
48987,6662,SOX9,0.45899999999999996,0.7240000000000001,C1269683,Major Depressive Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2015.0,2015.0,1,0,PSYGENET
48988,6662,SOX9,0.45899999999999996,0.7240000000000001,C1510586,Autism Spectrum Disorders,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
48989,6662,SOX9,0.45899999999999996,0.7240000000000001,C1842462,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL,disease,C05;C12;C13;C16;C19,Disease or Syndrome,0.4,,1992.0,2014.0,12,8,UNIPROT
48990,6662,SOX9,0.45899999999999996,0.7240000000000001,C1861922,CAMPOMELIC DYSPLASIA,disease,C05;C16,Disease or Syndrome,1.0,0.9615385000000001,1992.0,2017.0,12,11,CTD_human;ORPHANET;UNIPROT
48991,6662,SOX9,0.45899999999999996,0.7240000000000001,C1861923,Acampomelic Campomelic Dysplasia,disease,C05;C16,Disease or Syndrome,0.82,1.0,1995.0,2017.0,12,6,CTD_human;UNIPROT
48992,6662,SOX9,0.45899999999999996,0.7240000000000001,C2748895,Ovotesticular Disorders of Sex Development,disease,C12;C13;C16;C19,Congenital Abnormality,0.33,0.6666667,2010.0,2016.0,0,0,ORPHANET
48993,6662,SOX9,0.45899999999999996,0.7240000000000001,C2936419,"46, XX Testicular Disorders of Sex Development",disease,C12;C13;C16;C19,Congenital Abnormality,0.37,0.8571429,1999.0,2016.0,0,0,ORPHANET
48994,6662,SOX9,0.45899999999999996,0.7240000000000001,C2936694,Swyer Syndrome,disease,C12;C13;C16;C19,Disease or Syndrome,0.31,0.0,1997.0,1997.0,0,0,ORPHANET
48995,6662,SOX9,0.45899999999999996,0.7240000000000001,C3549544,ACAMPOMELIC CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL,disease,,Disease or Syndrome,0.3,,1995.0,2014.0,12,6,UNIPROT
48996,6662,SOX9,0.45899999999999996,0.7240000000000001,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2015.0,3,0,GENOMICS_ENGLAND
48997,6662,SOX9,0.45899999999999996,0.7240000000000001,C4225331,"46,XY SEX REVERSAL 10",disease,,Disease or Syndrome,0.3,,,,0,0,CTD_human
48998,6662,SOX9,0.45899999999999996,0.7240000000000001,C4510744,"46,XY partial gonadal dysgenesis",phenotype,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
67126,30062,RAX,0.785,0.24100000000000002,C0003119,Anophthalmos,disease,C11;C16,Congenital Abnormality,0.46,1.0,2004.0,2012.0,1,0,CTD_human
67127,30062,RAX,0.785,0.24100000000000002,C0025202,melanoma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
67128,30062,RAX,0.785,0.24100000000000002,C0376634,Craniofacial Abnormalities,group,C05;C16,Congenital Abnormality,0.3,,2005.0,2005.0,1,0,CTD_human
67129,30062,RAX,0.785,0.24100000000000002,C1855052,"MICROPHTHALMIA, ISOLATED 1",disease,C11;C16,Disease or Syndrome,0.3,,,,0,0,ORPHANET
67130,30062,RAX,0.785,0.24100000000000002,C1970237,"Microphthalmia, Isolated 3",disease,C11;C16,Disease or Syndrome,0.6,,2004.0,2015.0,2,3,CTD_human;UNIPROT
67131,30062,RAX,0.785,0.24100000000000002,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2015.0,2,0,GENOMICS_ENGLAND
74274,83636,C19orf12,0.667,0.379,C0030567,Parkinson Disease,disease,C10,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
74275,83636,C19orf12,0.667,0.379,C0037773,"Spastic Paraplegia, Hereditary",disease,C10;C16,Disease or Syndrome,0.4,,2018.0,2018.0,0,1,GENOMICS_ENGLAND
74276,83636,C19orf12,0.667,0.379,C0751651,Mitochondrial Diseases,group,C18,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
74277,83636,C19orf12,0.667,0.379,C0919267,ovarian neoplasm,disease,C04;C13;C19,Neoplastic Process,0.3,,2011.0,2011.0,1,0,CTD_human
74278,83636,C19orf12,0.667,0.379,C1140680,Malignant neoplasm of ovary,disease,C04;C13;C19,Neoplastic Process,0.3,,2011.0,2011.0,1,0,CTD_human
74279,83636,C19orf12,0.667,0.379,C2680446,"SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE",disease,,Disease or Syndrome,0.71,1.0,2010.0,2017.0,1,2,CTD_human;ORPHANET;UNIPROT
74280,83636,C19orf12,0.667,0.379,C3280371,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4,disease,,Disease or Syndrome,0.7,,1993.0,2016.0,10,11,CTD_human;ORPHANET;UNIPROT
74281,83636,C19orf12,0.667,0.379,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2016.0,3,0,GENOMICS_ENGLAND
63078,11133,KPTN,0.752,0.24100000000000002,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.41,1.0,2014.0,2016.0,1,0,GENOMICS_ENGLAND
63079,11133,KPTN,0.752,0.24100000000000002,C3810225,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41",disease,,Disease or Syndrome,0.6,,2014.0,2017.0,0,3,CTD_human;ORPHANET
63431,11284,PNKP,0.616,0.379,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
63432,11284,PNKP,0.616,0.379,C0008073,Developmental Disabilities,group,F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
63433,11284,PNKP,0.616,0.379,C0022333,Jacksonian Seizure,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63434,11284,PNKP,0.616,0.379,C0025958,Microcephaly,disease,C05;C10;C16,Congenital Abnormality,0.51,1.0,2010.0,2010.0,1,0,CTD_human;GENOMICS_ENGLAND
63435,11284,PNKP,0.616,0.379,C0036572,Seizures,phenotype,C10;C23,Sign or Symptom,0.41,1.0,2010.0,2010.0,1,0,CTD_human
63436,11284,PNKP,0.616,0.379,C0085996,Child Development Deviations,phenotype,F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
63437,11284,PNKP,0.616,0.379,C0085997,"Child Development Disorders, Specific",group,F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
63438,11284,PNKP,0.616,0.379,C0149958,Complex partial seizures,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63439,11284,PNKP,0.616,0.379,C0234533,Generalized seizures,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63440,11284,PNKP,0.616,0.379,C0234535,"Seizures, Clonic",disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63441,11284,PNKP,0.616,0.379,C0268134,DNA Repair-Deficiency,phenotype,C18,Pathologic Function,0.3,,2010.0,2010.0,1,0,CTD_human
63442,11284,PNKP,0.616,0.379,C0270824,Visual seizure,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63443,11284,PNKP,0.616,0.379,C0270844,Tonic Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
63444,11284,PNKP,0.616,0.379,C0270846,Epileptic drop attack,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63445,11284,PNKP,0.616,0.379,C0393706,Early infantile epileptic encephalopathy with suppression bursts,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
63446,11284,PNKP,0.616,0.379,C0422850,"Seizures, Somatosensory",phenotype,C10;C23,Pathologic Function,0.3,,2010.0,2010.0,1,0,CTD_human
63447,11284,PNKP,0.616,0.379,C0422852,"Seizures, Auditory",phenotype,C10;C23,Pathologic Function,0.3,,2010.0,2010.0,1,0,CTD_human
63448,11284,PNKP,0.616,0.379,C0422853,Olfactory seizure,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63449,11284,PNKP,0.616,0.379,C0422854,Gustatory seizure,phenotype,C10;C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
63450,11284,PNKP,0.616,0.379,C0422855,Vertiginous seizure,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63451,11284,PNKP,0.616,0.379,C0431350,Primary microcephaly,disease,,Congenital Abnormality,0.41,1.0,2010.0,2015.0,1,1,GENOMICS_ENGLAND
63452,11284,PNKP,0.616,0.379,C0494475,Tonic - clonic seizures,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63453,11284,PNKP,0.616,0.379,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.4,,,,0,0,GENOMICS_ENGLAND
63454,11284,PNKP,0.616,0.379,C0751056,Non-epileptic convulsion,phenotype,C10;C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
63455,11284,PNKP,0.616,0.379,C0751110,Single Seizure,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63456,11284,PNKP,0.616,0.379,C0751123,Atonic Absence Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63457,11284,PNKP,0.616,0.379,C0751494,Convulsive Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
63458,11284,PNKP,0.616,0.379,C0751495,"Seizures, Focal",phenotype,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63459,11284,PNKP,0.616,0.379,C0751496,"Seizures, Sensory",phenotype,C10;C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
63460,11284,PNKP,0.616,0.379,C1563696,DNA Repair-Deficiency Disorders,group,C18,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63461,11284,PNKP,0.616,0.379,C1563697,Chromosome Instability Syndromes,disease,C18,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63462,11284,PNKP,0.616,0.379,C1956147,Microlissencephaly,disease,C05;C10;C16,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63463,11284,PNKP,0.616,0.379,C3150667,"MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY",disease,,Disease or Syndrome,0.61,1.0,2008.0,2016.0,2,7,CTD_human;UNIPROT
63464,11284,PNKP,0.616,0.379,C3495874,Nonepileptic Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63465,11284,PNKP,0.616,0.379,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
63466,11284,PNKP,0.616,0.379,C3853041,Severe Congenital Microcephaly,disease,C05;C10;C16,Congenital Abnormality; Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63467,11284,PNKP,0.616,0.379,C4048158,Convulsions,phenotype,C10;C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
63468,11284,PNKP,0.616,0.379,C4225397,ATAXIA-OCULOMOTOR APRAXIA 4,disease,,Disease or Syndrome,0.7,,2010.0,2015.0,1,5,CTD_human;ORPHANET;UNIPROT
63469,11284,PNKP,0.616,0.379,C4316903,Absence Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
63470,11284,PNKP,0.616,0.379,C4317109,Epileptic Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
63471,11284,PNKP,0.616,0.379,C4317123,Myoclonic Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
63472,11284,PNKP,0.616,0.379,C4505436,Generalized Absence Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
73874,80331,DNAJC5,0.735,0.207,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,2011.0,2016.0,2,0,GENOMICS_ENGLAND
73875,80331,DNAJC5,0.735,0.207,C1834207,"Ceroid Lipofuscinosis, Neuronal, Parry Type",disease,C10;C16;C18,Disease or Syndrome,0.62,1.0,1971.0,2013.0,5,2,ORPHANET;UNIPROT
7616,861,RUNX1,0.467,0.69,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.38,0.875,2004.0,2013.0,1,0,CTD_human
7617,861,RUNX1,0.467,0.69,C0006413,Burkitt Lymphoma,disease,C02;C04;C15;C20,Neoplastic Process,0.3,,,,0,0,ORPHANET
7618,861,RUNX1,0.467,0.69,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,2008.0,2012.0,3,0,GENOMICS_ENGLAND
7619,861,RUNX1,0.467,0.69,C0017636,Glioblastoma,disease,C04,Neoplastic Process,0.32,1.0,2012.0,2017.0,1,0,CTD_human
7620,861,RUNX1,0.467,0.69,C0023452,Childhood Acute Lymphoblastic Leukemia,disease,C04;C15;C20,Neoplastic Process,0.4,0.97979797979798,1996.0,2018.0,1,0,CTD_human
7621,861,RUNX1,0.467,0.69,C0023453,"Leukemia, Lymphocytic, Acute, L2",disease,C04;C15;C20,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
7622,861,RUNX1,0.467,0.69,C0023467,"Leukemia, Myelocytic, Acute",disease,C04,Neoplastic Process,0.7,0.9829059829059829,1990.0,2018.0,2,4,CGI;CTD_human
7623,861,RUNX1,0.467,0.69,C0023473,"Myeloid Leukemia, Chronic",disease,C04;C15,Neoplastic Process,0.4,1.0,1993.0,2014.0,0,0,ORPHANET
7624,861,RUNX1,0.467,0.69,C0023485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.38,1.0,1999.0,2016.0,2,0,CTD_human
7625,861,RUNX1,0.467,0.69,C0026998,"Acute Myeloid Leukemia, M1",disease,C04,Neoplastic Process,0.3,,2008.0,2016.0,2,0,CTD_human
7626,861,RUNX1,0.467,0.69,C0032197,Platelet Storage Pool Deficiency,disease,C15,Disease or Syndrome,0.32,1.0,2004.0,2018.0,0,0,ORPHANET
7627,861,RUNX1,0.467,0.69,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
7628,861,RUNX1,0.467,0.69,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,2008.0,2012.0,3,0,GENOMICS_ENGLAND
7629,861,RUNX1,0.467,0.69,C0334588,Giant Cell Glioblastoma,disease,C04,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
7630,861,RUNX1,0.467,0.69,C0349639,Juvenile Myelomonocytic Leukemia,disease,C04;C15,Neoplastic Process,0.33,1.0,1998.0,2016.0,1,0,CTD_human
7631,861,RUNX1,0.467,0.69,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.32,1.0,2007.0,2016.0,1,0,CTD_human
7632,861,RUNX1,0.467,0.69,C0376545,Hematologic Neoplasms,group,C04;C15,Neoplastic Process,0.4,1.0,1998.0,2017.0,2,0,GENOMICS_ENGLAND
7633,861,RUNX1,0.467,0.69,C1292769,Precursor B-cell lymphoblastic leukemia,disease,,Neoplastic Process,0.4,0.95,1997.0,2016.0,0,0,ORPHANET
7634,861,RUNX1,0.467,0.69,C1621958,Glioblastoma Multiforme,disease,C04,Neoplastic Process,0.31,1.0,2013.0,2017.0,1,0,CTD_human
7635,861,RUNX1,0.467,0.69,C1832388,"Platelet Disorder, Familial, with Associated Myeloid Malignancy",disease,C04;C15;C16,Disease or Syndrome,0.72,1.0,1999.0,2017.0,7,11,CLINGEN;CTD_human;ORPHANET;UNIPROT
7636,861,RUNX1,0.467,0.69,C1879321,Acute Myeloid Leukemia (AML-M2),disease,C04,Neoplastic Process,0.34,1.0,1994.0,2016.0,2,0,CTD_human
7637,861,RUNX1,0.467,0.69,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.4,1.0,1994.0,2017.0,1,0,CTD_human
7638,861,RUNX1,0.467,0.69,C2713368,Hematopoetic Myelodysplasia,disease,C15,Pathologic Function,0.3,,2017.0,2017.0,1,0,CTD_human
7639,861,RUNX1,0.467,0.69,C2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,disease,C11;C15;C16;C17;C18,Disease or Syndrome,0.3,,,,0,0,ORPHANET
7640,861,RUNX1,0.467,0.69,C3463824,MYELODYSPLASTIC SYNDROME,group,C15,Neoplastic Process,0.5,0.9859154929577459,1993.0,2017.0,1,0,CTD_human
31178,3976,LIF,0.528,0.655,C0000786,Spontaneous abortion,phenotype,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
31179,3976,LIF,0.528,0.655,C0000822,"Abortion, Tubal",disease,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
31180,3976,LIF,0.528,0.655,C0011206,Delirium,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,0.6666667,2007.0,2011.0,3,0,PSYGENET
31181,3976,LIF,0.528,0.655,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.3,1.0,2004.0,2004.0,1,0,PSYGENET
31182,3976,LIF,0.528,0.655,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2004.0,2004.0,1,0,PSYGENET
31183,3976,LIF,0.528,0.655,C0012684,Blastocyst Disintegration,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31184,3976,LIF,0.528,0.655,C0018800,Cardiomegaly,phenotype,C14;C23,Finding,0.3,,2004.0,2004.0,1,0,CTD_human
31185,3976,LIF,0.528,0.655,C0021361,Female infertility,phenotype,C13,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31186,3976,LIF,0.528,0.655,C0032460,Polycystic Ovary Syndrome,disease,C04;C13;C19,Disease or Syndrome,0.31,1.0,2011.0,2011.0,1,0,CTD_human
31187,3976,LIF,0.528,0.655,C0038279,"Sterility, Postpartum",phenotype,C13,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31188,3976,LIF,0.528,0.655,C0341869,"Subfertility, Female",disease,C13,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
31189,3976,LIF,0.528,0.655,C0400966,Non-alcoholic Fatty Liver Disease,disease,C06,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
31190,3976,LIF,0.528,0.655,C0752351,Embryo Loss,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31191,3976,LIF,0.528,0.655,C0917730,Female sterility,phenotype,C13,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
31192,3976,LIF,0.528,0.655,C1136082,Embryo Disintegration,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31193,3976,LIF,0.528,0.655,C1136382,Sclerocystic Ovaries,disease,C04;C13;C19,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
31194,3976,LIF,0.528,0.655,C1262477,Weight decreased,phenotype,C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
31195,3976,LIF,0.528,0.655,C1383860,Cardiac Hypertrophy,phenotype,C14;C23,Pathologic Function,0.3,,2004.0,2004.0,1,0,CTD_human
31196,3976,LIF,0.528,0.655,C1720887,Female Urogenital Diseases,group,C13,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
31197,3976,LIF,0.528,0.655,C3241937,Nonalcoholic Steatohepatitis,disease,C06,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
59421,9463,PICK1,0.713,0.345,C0033937,"Psychoses, Drug",disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
59422,9463,PICK1,0.713,0.345,C0033941,"Psychoses, Substance-Induced",disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
59423,9463,PICK1,0.713,0.345,C0033975,Psychotic Disorders,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2007.0,2007.0,1,0,PSYGENET
59424,9463,PICK1,0.713,0.345,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.35,0.75,2004.0,2007.0,4,0,PSYGENET
59425,9463,PICK1,0.713,0.345,C0236733,Amphetamine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
59426,9463,PICK1,0.713,0.345,C0236804,Amphetamine Addiction,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
59427,9463,PICK1,0.713,0.345,C0236807,Amphetamine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
59428,9463,PICK1,0.713,0.345,C0349204,Nonorganic psychosis,disease,,Mental or Behavioral Dysfunction,0.31,1.0,2007.0,2007.0,1,0,PSYGENET
56443,8398,PLA2G6,0.494,0.7240000000000001,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
56444,8398,PLA2G6,0.494,0.7240000000000001,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
56445,8398,PLA2G6,0.494,0.7240000000000001,C0027960,Nevus,disease,C04,Neoplastic Process,0.41,1.0,2009.0,2016.0,1,2,CTD_human
56446,8398,PLA2G6,0.494,0.7240000000000001,C0030567,Parkinson Disease,disease,C10,Disease or Syndrome,0.36,1.0,2012.0,2017.0,0,0,GENOMICS_ENGLAND
56447,8398,PLA2G6,0.494,0.7240000000000001,C0033975,Psychotic Disorders,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
56448,8398,PLA2G6,0.494,0.7240000000000001,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.36,1.0,2003.0,2016.0,1,0,PSYGENET
56449,8398,PLA2G6,0.494,0.7240000000000001,C0270724,Infantile Neuroaxonal Dystrophy,disease,C10,Disease or Syndrome,1.0,1.0,2004.0,2018.0,3,11,CTD_human;ORPHANET;UNIPROT
56450,8398,PLA2G6,0.494,0.7240000000000001,C0349204,Nonorganic psychosis,disease,,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
56451,8398,PLA2G6,0.494,0.7240000000000001,C1857747,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2 (disorder),disease,C10;C18,Disease or Syndrome,0.62,1.0,2006.0,2017.0,1,6,CTD_human;UNIPROT
56452,8398,PLA2G6,0.494,0.7240000000000001,C2750220,Karak Syndrome,disease,C10,Disease or Syndrome,0.43,1.0,2006.0,2015.0,1,2,UNIPROT
56453,8398,PLA2G6,0.494,0.7240000000000001,C2751842,"PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE",disease,C10,Disease or Syndrome,0.74,1.0,2009.0,2017.0,1,5,CTD_human;ORPHANET;UNIPROT
56454,8398,PLA2G6,0.494,0.7240000000000001,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
60867,10084,PQBP1,0.5770000000000001,0.621,C0018273,Growth Disorders,group,C23,Pathologic Function,0.3,,2004.0,2006.0,2,0,CTD_human
60868,10084,PQBP1,0.5770000000000001,0.621,C0018817,Atrial Septal Defects,group,C14;C16,Congenital Abnormality,0.4,,2006.0,2006.0,1,0,CTD_human
60869,10084,PQBP1,0.5770000000000001,0.621,C0025958,Microcephaly,disease,C05;C10;C16,Congenital Abnormality,0.55,1.0,2004.0,2015.0,3,0,CTD_human;GENOMICS_ENGLAND
60870,10084,PQBP1,0.5770000000000001,0.621,C0031192,Persistent Ostium Primum,disease,C14;C16,Congenital Abnormality,0.3,,2006.0,2006.0,1,0,CTD_human
60871,10084,PQBP1,0.5770000000000001,0.621,C0037773,"Spastic Paraplegia, Hereditary",disease,C10;C16,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
60872,10084,PQBP1,0.5770000000000001,0.621,C0344724,Ostium secundum atrial septal defect,disease,C14;C16,Congenital Abnormality,0.3,,2006.0,2006.0,1,0,CTD_human
60873,10084,PQBP1,0.5770000000000001,0.621,C0431350,Primary microcephaly,disease,,Congenital Abnormality,0.3,,2004.0,2004.0,1,0,GENOMICS_ENGLAND
60874,10084,PQBP1,0.5770000000000001,0.621,C0751602,Hereditary Autosomal Dominant Spastic Paraplegia,disease,C10;C16,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
60875,10084,PQBP1,0.5770000000000001,0.621,C0751603,Autosomal Recessive Hereditary Spastic Paraplegia,disease,C10;C16,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
60876,10084,PQBP1,0.5770000000000001,0.621,C0751604,Hereditary X-Linked Recessive Spastic Paraplegia,disease,C10;C16,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
60877,10084,PQBP1,0.5770000000000001,0.621,C0751605,"X-Linked, Spastic Paraplegia, Hereditary",disease,C10;C16,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
60878,10084,PQBP1,0.5770000000000001,0.621,C0796135,Renpenning syndrome 1,disease,C10;C16,Disease or Syndrome,0.7,1.0,1962.0,2017.0,8,7,CTD_human;UNIPROT
60879,10084,PQBP1,0.5770000000000001,0.621,C1136249,"Mental Retardation, X-Linked",disease,C10;C16,Disease or Syndrome,0.4,1.0,1994.0,2013.0,2,0,CTD_human
60880,10084,PQBP1,0.5770000000000001,0.621,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.3,,,,0,0,UNIPROT
60881,10084,PQBP1,0.5770000000000001,0.621,C1956147,Microlissencephaly,disease,C05;C10;C16,Disease or Syndrome,0.3,,2004.0,2006.0,3,0,CTD_human
60882,10084,PQBP1,0.5770000000000001,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.5,1.0,1998.0,2015.0,0,0,GENOMICS_ENGLAND
60883,10084,PQBP1,0.5770000000000001,0.621,C3853041,Severe Congenital Microcephaly,disease,C05;C10;C16,Congenital Abnormality; Disease or Syndrome,0.3,,2004.0,2006.0,3,0,CTD_human
70423,55869,HDAC8,0.546,0.828,C0270972,Cornelia De Lange Syndrome,disease,C10;C16,Disease or Syndrome,0.4,1.0,2012.0,2016.0,0,0,ORPHANET
70424,55869,HDAC8,0.546,0.828,C0431350,Primary microcephaly,disease,,Congenital Abnormality,0.3,,2015.0,2015.0,1,0,GENOMICS_ENGLAND
70425,55869,HDAC8,0.546,0.828,C1839736,WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME,disease,C10;C16;C17;C18;C23,Disease or Syndrome,0.3,,,,0,0,ORPHANET
70426,55869,HDAC8,0.546,0.828,C3550903,CORNELIA DE LANGE SYNDROME 5,disease,,Disease or Syndrome,0.4,,2008.0,2017.0,1,17,UNIPROT
70427,55869,HDAC8,0.546,0.828,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.42,1.0,2012.0,2016.0,0,0,GENOMICS_ENGLAND
70428,55869,HDAC8,0.546,0.828,C4025414,Radial club hand,disease,,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
74623,84295,PHF6,0.639,0.586,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,2010.0,2010.0,1,0,GENOMICS_ENGLAND
74624,84295,PHF6,0.639,0.586,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,GENOMICS_ENGLAND
74625,84295,PHF6,0.639,0.586,C0265339,Borjeson-Forssman-Lehmann syndrome,disease,C10;C16;C18;C19;C23,Disease or Syndrome,0.8,1.0,1962.0,2017.0,8,11,CLINGEN;CTD_human;ORPHANET;UNIPROT
74626,84295,PHF6,0.639,0.586,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.57,0.8571429,2010.0,2015.0,1,0,CGI;CTD_human
74627,84295,PHF6,0.639,0.586,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.42,1.0,2014.0,2015.0,0,0,GENOMICS_ENGLAND
67337,50814,NSDHL,0.667,0.483,C0265267,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,disease,C05;C16;C17,Disease or Syndrome,0.76,0.8333333,1993.0,2015.0,2,13,CTD_human;ORPHANET;UNIPROT
67338,50814,NSDHL,0.667,0.483,C0282528,Peroxisomal Disorders,group,C16;C18,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
67339,50814,NSDHL,0.667,0.483,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
67340,50814,NSDHL,0.667,0.483,C1168401,Squamous cell carcinoma of the head and neck,disease,C04,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
67341,50814,NSDHL,0.667,0.483,C3151781,CK SYNDROME,disease,,Disease or Syndrome,0.62,1.0,1993.0,2016.0,0,2,CTD_human;ORPHANET
67342,50814,NSDHL,0.667,0.483,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.41,1.0,2011.0,2011.0,0,0,GENOMICS_ENGLAND
18943,2316,FLNA,0.456,0.7929999999999999,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
18944,2316,FLNA,0.456,0.7929999999999999,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.33,1.0,2009.0,2016.0,1,0,CTD_human
18945,2316,FLNA,0.456,0.7929999999999999,C0010701,Phyllodes Tumor,disease,C04,Neoplastic Process,0.3,,2016.0,2016.0,1,0,CTD_human
18946,2316,FLNA,0.456,0.7929999999999999,C0013366,Dyschondroplasias,disease,C05;C16,Congenital Abnormality,0.3,,2003.0,2003.0,1,0,CTD_human
18947,2316,FLNA,0.456,0.7929999999999999,C0014544,Epilepsy,disease,C10,Disease or Syndrome,0.43,1.0,2002.0,2016.0,1,0,CTD_human
18948,2316,FLNA,0.456,0.7929999999999999,C0020255,Hydrocephalus,disease,C10,Disease or Syndrome,0.41,1.0,2004.0,2004.0,0,0,GENOMICS_ENGLAND
18949,2316,FLNA,0.456,0.7929999999999999,C0021847,Intestinal Pseudo-Obstruction,disease,C06,Disease or Syndrome,0.43,1.0,2007.0,2013.0,0,0,ORPHANET
18950,2316,FLNA,0.456,0.7929999999999999,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
18951,2316,FLNA,0.456,0.7929999999999999,C0024796,Marfan Syndrome,disease,C05;C14;C16;C17,Disease or Syndrome,0.3,,2006.0,2016.0,7,0,CLINGEN
18952,2316,FLNA,0.456,0.7929999999999999,C0025237,Melnick-Needles Syndrome,disease,C05;C16,Disease or Syndrome,0.75,1.0,1993.0,2017.0,2,5,CTD_human;ORPHANET;UNIPROT
18953,2316,FLNA,0.456,0.7929999999999999,C0026760,Multiple Epiphyseal Dysplasia,disease,C05;C16,Congenital Abnormality,0.3,,2003.0,2003.0,1,0,CTD_human
18954,2316,FLNA,0.456,0.7929999999999999,C0029422,Osteochondrodysplasias,group,C05;C16,Disease or Syndrome,0.42,1.0,1983.0,2011.0,1,0,CTD_human
18955,2316,FLNA,0.456,0.7929999999999999,C0036391,Schwartz-Jampel Syndrome,disease,C05;C16,Disease or Syndrome,0.3,,2003.0,2003.0,1,0,CTD_human
18956,2316,FLNA,0.456,0.7929999999999999,C0038015,Spondyloepiphyseal Dysplasia,disease,C05;C16,Disease or Syndrome,0.3,,2003.0,2003.0,1,0,CTD_human
18957,2316,FLNA,0.456,0.7929999999999999,C0086237,"Epilepsy, Cryptogenic",disease,C10,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
18958,2316,FLNA,0.456,0.7929999999999999,C0220769,FG syndrome,disease,C06;C10;C16;C23,Disease or Syndrome,0.31,1.0,2007.0,2007.0,1,0,CTD_human
18959,2316,FLNA,0.456,0.7929999999999999,C0236018,Aura,phenotype,C10,Finding,0.3,,2002.0,2002.0,1,0,CTD_human
18960,2316,FLNA,0.456,0.7929999999999999,C0262436,"Cardiac valvular dysplasia, X-linked",disease,C04;C14;C16,Congenital Abnormality,0.61,1.0,1993.0,2017.0,1,5,CTD_human;UNIPROT
18961,2316,FLNA,0.456,0.7929999999999999,C0265251,Oto-Palato-digital syndrome type 1,disease,C05;C16,Disease or Syndrome,0.72,1.0,2003.0,2017.0,4,16,CTD_human;ORPHANET;UNIPROT
18962,2316,FLNA,0.456,0.7929999999999999,C0265293,Frontometaphyseal dysplasia,disease,C05;C16,Congenital Abnormality,0.7,0.9090909090909091,1997.0,2017.0,2,4,CTD_human;ORPHANET
18963,2316,FLNA,0.456,0.7929999999999999,C0432272,Van Buchem disease,disease,C05;C16,Disease or Syndrome,0.3,,2003.0,2003.0,1,0,CTD_human
18964,2316,FLNA,0.456,0.7929999999999999,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
18965,2316,FLNA,0.456,0.7929999999999999,C0600066,Malignant Cystosarcoma Phyllodes,disease,C04,Neoplastic Process,0.3,,2016.0,2016.0,1,0,CTD_human
18966,2316,FLNA,0.456,0.7929999999999999,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.32,1.0,2009.0,2016.0,1,0,CTD_human
18967,2316,FLNA,0.456,0.7929999999999999,C0751111,Awakening Epilepsy,disease,C10,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
18968,2316,FLNA,0.456,0.7929999999999999,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2016.0,2016.0,1,0,CTD_human
18969,2316,FLNA,0.456,0.7929999999999999,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.3,,2016.0,2016.0,1,0,CTD_human
18970,2316,FLNA,0.456,0.7929999999999999,C1844696,"OTOPALATODIGITAL SYNDROME, TYPE II",disease,C05;C16,Congenital Abnormality,0.8,0.9,2003.0,2017.0,4,7,CTD_human;ORPHANET;UNIPROT
18971,2316,FLNA,0.456,0.7929999999999999,C1845235,"Heterotopia, Periventricular, Ehlers-Danlos Variant",disease,C10;C16,Congenital Abnormality,0.6,,2002.0,2006.0,6,4,CTD_human;ORPHANET;UNIPROT
18972,2316,FLNA,0.456,0.7929999999999999,C1845546,FG SYNDROME 4 (disorder),disease,C06;C10;C16;C23,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
18973,2316,FLNA,0.456,0.7929999999999999,C1845567,FG SYNDROME 3,disease,C06;C10;C16;C23,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
18974,2316,FLNA,0.456,0.7929999999999999,C1845902,FG SYNDROME 2,disease,C06;C10;C16;C23,Disease or Syndrome,0.6,,2007.0,2007.0,1,2,CTD_human;UNIPROT
18975,2316,FLNA,0.456,0.7929999999999999,C1846129,Terminal Osseous Dysplasia and Pigmentary Defects,disease,C05;C16;C17;C23,Disease or Syndrome,0.61,1.0,1993.0,2010.0,0,1,CTD_human;ORPHANET
18976,2316,FLNA,0.456,0.7929999999999999,C1848213,"Periventricular Heterotopia, X-Linked",disease,C10;C16,Congenital Abnormality; Disease or Syndrome,0.9,1.0,1987.0,2017.0,7,54,CTD_human;UNIPROT
18977,2316,FLNA,0.456,0.7929999999999999,C1848214,"Heterotopia, Periventricular Nodular, with Frontometaphyseal Dysplasia",disease,C05;C10;C16,Disease or Syndrome,0.3,,2002.0,2006.0,6,4,UNIPROT
18978,2316,FLNA,0.456,0.7929999999999999,C1855733,Neuronal intestinal pseudoobstruction,disease,C06;C10,Disease or Syndrome,0.3,,,,0,0,ORPHANET
18979,2316,FLNA,0.456,0.7929999999999999,C1857034,"Ehlers-Danlos syndrome, cardiac valvular form",disease,C14;C15;C16;C17,Disease or Syndrome,0.3,,,,0,0,ORPHANET
18980,2316,FLNA,0.456,0.7929999999999999,C1868720,Periventricular Nodular Heterotopia,disease,C10;C16,Disease or Syndrome,0.8,1.0,1999.0,2017.0,2,0,CTD_human;ORPHANET
18981,2316,FLNA,0.456,0.7929999999999999,C1955869,Malformations of Cortical Development,group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
18982,2316,FLNA,0.456,0.7929999999999999,C2746068,Congenital idiopathic intestinal pseudoobstruction,disease,C06;C16,Disease or Syndrome,0.41,1.0,1993.0,2018.0,0,4,CTD_human
18983,2316,FLNA,0.456,0.7929999999999999,C2748918,Otopalatodigital Spectrum Disorder,disease,C05;C16,Disease or Syndrome,0.4,,2003.0,2017.0,3,6,UNIPROT
18984,2316,FLNA,0.456,0.7929999999999999,C2748919,Frontootopalatodigital Osteodysplasia,disease,C05;C16,Disease or Syndrome,0.3,,2003.0,2017.0,3,4,UNIPROT
18985,2316,FLNA,0.456,0.7929999999999999,C3541456,"Spondyloepiphyseal Dysplasia Tarda, X-Linked",disease,C05;C16,Congenital Abnormality,0.3,,2003.0,2003.0,1,0,CTD_human
18986,2316,FLNA,0.456,0.7929999999999999,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.41,1.0,2006.0,2006.0,0,0,GENOMICS_ENGLAND
18987,2316,FLNA,0.456,0.7929999999999999,C4273726,Congenital dysplasia of cardiac valve,disease,,Congenital Abnormality,0.3,,,,0,0,ORPHANET
18988,2316,FLNA,0.456,0.7929999999999999,C4281559,FRONTOMETAPHYSEAL DYSPLASIA 1,disease,,Congenital Abnormality,0.3,,2003.0,2017.0,3,3,UNIPROT
76815,140032,RPS4Y2,0.9279999999999999,0.069,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",disease,C12;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
75931,114034,TOE1,0.701,0.414,C0036875,Disorders of Sex Development,group,C12;C13;C16;C19,Congenital Abnormality,0.3,,2017.0,2017.0,1,0,GENOMICS_ENGLAND
75932,114034,TOE1,0.701,0.414,C0266468,Congenital pontocerebellar hypoplasia,disease,C10,Congenital Abnormality,0.31,1.0,2017.0,2017.0,1,0,CTD_human
75933,114034,TOE1,0.701,0.414,C0266470,Cerebellar Hypoplasia,disease,C10;C16;F03,Congenital Abnormality,0.4,,2017.0,2017.0,1,0,GENOMICS_ENGLAND
75934,114034,TOE1,0.701,0.414,C3554226,Congenital pontocerebellar hypoplasia type 7,disease,,Disease or Syndrome,0.7,,2017.0,2017.0,1,8,CTD_human;ORPHANET;UNIPROT
75935,114034,TOE1,0.701,0.414,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2017.0,2017.0,1,0,GENOMICS_ENGLAND
44983,6121,RPE65,0.479,0.759,C0015398,"Eye Diseases, Hereditary",group,C11;C16,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
44984,6121,RPE65,0.479,0.759,C0035304,Retinal Degeneration,phenotype,C11,Pathologic Function,0.4,,2014.0,2015.0,1,1,CTD_human
44985,6121,RPE65,0.479,0.759,C0035334,Retinitis Pigmentosa,disease,C11;C16,Disease or Syndrome,0.69,1.0,1998.0,2016.0,3,2,CTD_human;ORPHANET
44986,6121,RPE65,0.479,0.759,C0155003,"Blindness, Transient",phenotype,C10;C11;C23,Pathologic Function,0.3,,2005.0,2006.0,2,0,CTD_human
44987,6121,RPE65,0.479,0.759,C0221473,"Blindness, Hysterical",disease,C10;C11;C23,Mental or Behavioral Dysfunction,0.3,,2005.0,2006.0,2,0,CTD_human
44988,6121,RPE65,0.479,0.759,C0271215,"Blindness, Legal",disease,C10;C11;C23,Disease or Syndrome,0.4,,2005.0,2006.0,2,0,CTD_human
44989,6121,RPE65,0.479,0.759,C0339527,Leber Congenital Amaurosis,disease,C11,Disease or Syndrome,0.6,0.9833333000000001,1997.0,2018.0,3,0,CTD_human;ORPHANET
44990,6121,RPE65,0.479,0.759,C0339730,"Blindness, Acquired",disease,C10;C11;C23,Disease or Syndrome,0.3,,2005.0,2006.0,2,0,CTD_human
44991,6121,RPE65,0.479,0.759,C0376288,Amaurosis,disease,C10;C11;C23,Disease or Syndrome,0.3,,2005.0,2006.0,2,0,CTD_human
44992,6121,RPE65,0.479,0.759,C0456909,Blindness,phenotype,C10;C11;C23,Finding,0.45,,2001.0,2008.0,2,0,CTD_human
44993,6121,RPE65,0.479,0.759,C0750958,"Blindness, Monocular",disease,C10;C11;C23,Disease or Syndrome,0.3,,2005.0,2006.0,2,0,CTD_human
44994,6121,RPE65,0.479,0.759,C0854723,Retinal Dystrophies,group,C11,Disease or Syndrome,0.5,1.0,1997.0,2017.0,1,2,CTD_human
44995,6121,RPE65,0.479,0.759,C0917796,"Optic Atrophy, Hereditary, Leber",disease,C10;C11;C16;C18,Disease or Syndrome,0.31,1.0,2006.0,2014.0,2,0,CTD_human
44996,6121,RPE65,0.479,0.759,C1858080,"Retinal Dystrophy, Early Onset Severe",disease,C11;C16,Disease or Syndrome,0.33,1.0,2004.0,2015.0,0,0,ORPHANET
44997,6121,RPE65,0.479,0.759,C1859844,"LEBER CONGENITAL AMAUROSIS, TYPE II (disorder)",disease,C11,Disease or Syndrome,0.94,0.75,1959.0,2017.0,27,28,CLINGEN;CTD_human;UNIPROT
44998,6121,RPE65,0.479,0.759,C1879328,Blindness both eyes NOS (disorder),phenotype,C10;C11;C23,Finding,0.3,,2005.0,2006.0,2,0,CTD_human
44999,6121,RPE65,0.479,0.759,C3151086,Retinitis Pigmentosa 20,disease,C11;C16,Disease or Syndrome,0.9,,1959.0,2017.0,11,19,CLINGEN;CTD_human;UNIPROT
45000,6121,RPE65,0.479,0.759,C3540662,Congenital Amaurosis of Retinal Origin,disease,C11,Disease or Syndrome,0.3,,1997.0,2009.0,3,0,CTD_human
45001,6121,RPE65,0.479,0.759,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
67323,50717,DCAF8,0.799,0.10300000000000001,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
67324,50717,DCAF8,0.799,0.10300000000000001,C1864695,"Giant Axonal Neuropathy, Autosomal Dominant",disease,C10;C16,Disease or Syndrome,0.4,,1985.0,2014.0,0,1,CTD_human
67325,50717,DCAF8,0.799,0.10300000000000001,C4013360,"GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT",disease,,Disease or Syndrome,0.5,,2014.0,2014.0,1,1,ORPHANET;UNIPROT
43848,5824,PEX19,0.5770000000000001,0.655,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,1993.0,1993.0,1,0,GENOMICS_ENGLAND
43849,5824,PEX19,0.5770000000000001,0.655,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
43850,5824,PEX19,0.5770000000000001,0.655,C0020305,Hydrops Fetalis,disease,C13;C15;C16;C20;C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
43851,5824,PEX19,0.5770000000000001,0.655,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.01,1.0,2009.0,2009.0,1,0,PSYGENET
43852,5824,PEX19,0.5770000000000001,0.655,C0043459,Zellweger Syndrome,disease,C06;C10;C12;C13;C16;C18,Disease or Syndrome,0.5,,1999.0,1999.0,1,0,CTD_human;ORPHANET
43853,5824,PEX19,0.5770000000000001,0.655,C0086543,Cataract,disease,C11,Acquired Abnormality,0.4,,,,0,0,GENOMICS_ENGLAND
43854,5824,PEX19,0.5770000000000001,0.655,C0282525,"Adrenoleukodystrophy, Neonatal",disease,C16;C18,Disease or Syndrome,0.3,,,,0,0,ORPHANET
43855,5824,PEX19,0.5770000000000001,0.655,C0282527,Infantile Refsum Disease (disorder),disease,C10;C16;C18,Disease or Syndrome,0.3,,,,0,0,ORPHANET
43856,5824,PEX19,0.5770000000000001,0.655,C0282528,Peroxisomal Disorders,group,C16;C18,Disease or Syndrome,0.3,,1999.0,2010.0,2,0,GENOMICS_ENGLAND
43857,5824,PEX19,0.5770000000000001,0.655,C0751594,Zellweger-Like Syndrome,disease,C06;C10;C12;C13;C16;C18,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
43858,5824,PEX19,0.5770000000000001,0.655,C1112213,Cholestasis in newborn,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
43859,5824,PEX19,0.5770000000000001,0.655,C1269683,Major Depressive Disorder,disease,F03,Mental or Behavioral Dysfunction,0.01,0.0,2011.0,2011.0,1,0,PSYGENET
43860,5824,PEX19,0.5770000000000001,0.655,C1832200,Peroxisome biogenesis disorders,group,C16;C18,Disease or Syndrome,0.31,1.0,1999.0,2010.0,1,0,CTD_human
43861,5824,PEX19,0.5770000000000001,0.655,C1838299,"Peroxisome Biogenesis Disorder, Complementation Group 14",disease,C16;C18,Disease or Syndrome,0.3,,,,0,0,CTD_human
43862,5824,PEX19,0.5770000000000001,0.655,C1838300,"Peroxisome Biogenesis Disorder, Complementation Group J",disease,C16;C18,Disease or Syndrome,0.3,,,,0,0,CTD_human
43863,5824,PEX19,0.5770000000000001,0.655,C1955869,Malformations of Cortical Development,group,C10;C16,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,GENOMICS_ENGLAND
43864,5824,PEX19,0.5770000000000001,0.655,C3554002,PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER),disease,,Disease or Syndrome,0.3,,,,0,0,CTD_human
43865,5824,PEX19,0.5770000000000001,0.655,C3658299,Zellweger Spectrum,disease,C06;C10;C12;C13;C16;C18,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
43866,5824,PEX19,0.5770000000000001,0.655,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
4091,462,SERPINC1,0.5539999999999999,0.621,C0005779,Blood Coagulation Disorders,group,C15,Disease or Syndrome,0.31,1.0,1977.0,1983.0,1,0,CTD_human
4092,462,SERPINC1,0.5539999999999999,0.621,C0012739,Disseminated Intravascular Coagulation,disease,C15,Disease or Syndrome,0.32,1.0,1984.0,2014.0,3,0,CTD_human
4093,462,SERPINC1,0.5539999999999999,0.621,C0018674,Craniocerebral Trauma,group,C10;C26,Injury or Poisoning,0.3,,1996.0,1996.0,1,0,CTD_human
4094,462,SERPINC1,0.5539999999999999,0.621,C0027726,Nephrotic Syndrome,group,C12;C13,Disease or Syndrome,0.5,,1995.0,2001.0,1,0,CTD_human
4095,462,SERPINC1,0.5539999999999999,0.621,C0035222,"Respiratory Distress Syndrome, Adult",disease,C08,Disease or Syndrome,0.3,,1996.0,1996.0,1,0,CTD_human
4096,462,SERPINC1,0.5539999999999999,0.621,C0040053,Thrombosis,phenotype,C14,Pathologic Function,0.51,,1983.0,2007.0,4,0,CTD_human
4097,462,SERPINC1,0.5539999999999999,0.621,C0042487,Venous Thrombosis,phenotype,C14,Pathologic Function,0.34,,1976.0,2007.0,3,0,CTD_human
4098,462,SERPINC1,0.5539999999999999,0.621,C0079102,Cerebral Thrombosis,disease,C10;C14,Disease or Syndrome,0.31,1.0,1980.0,1983.0,1,0,CTD_human
4099,462,SERPINC1,0.5539999999999999,0.621,C0085742,"Injuries, Acute Brain",group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
4100,462,SERPINC1,0.5539999999999999,0.621,C0087086,Thrombus,phenotype,C14,Pathologic Function,0.3,,1983.0,2001.0,4,0,CTD_human
4101,462,SERPINC1,0.5539999999999999,0.621,C0149871,Deep Vein Thrombosis,disease,C14,Disease or Syndrome,0.5,1.0,1976.0,2018.0,3,0,CTD_human
4102,462,SERPINC1,0.5539999999999999,0.621,C0162557,"Liver Failure, Acute",disease,C06,Disease or Syndrome,0.3,,1986.0,1986.0,1,0,CTD_human
4103,462,SERPINC1,0.5539999999999999,0.621,C0270611,Brain Injuries,group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
4104,462,SERPINC1,0.5539999999999999,0.621,C0272375,Antithrombin III Deficiency,disease,C15;C16,Disease or Syndrome,1.0,0.941176470588235,1965.0,2018.0,37,35,CTD_human;ORPHANET;UNIPROT
4105,462,SERPINC1,0.5539999999999999,0.621,C0272945,Brain Lacerations,disease,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
4106,462,SERPINC1,0.5539999999999999,0.621,C0347536,"Head Injury, Superficial",disease,C10;C26,Injury or Poisoning,0.3,,1996.0,1996.0,1,0,CTD_human
4107,462,SERPINC1,0.5539999999999999,0.621,C0451948,"Head Injuries, Multiple",disease,C10;C26,Injury or Poisoning,0.3,,1996.0,1996.0,1,0,CTD_human
4108,462,SERPINC1,0.5539999999999999,0.621,C0451981,Crushing Skull Injury,disease,C10;C26,Injury or Poisoning,0.3,,1996.0,1996.0,1,0,CTD_human
4109,462,SERPINC1,0.5539999999999999,0.621,C0452047,"Brain Injuries, Focal",group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
4110,462,SERPINC1,0.5539999999999999,0.621,C0518454,"Head Injury, Open",disease,C10;C26,Injury or Poisoning,0.3,,1996.0,1996.0,1,0,CTD_human
4111,462,SERPINC1,0.5539999999999999,0.621,C0555305,"Head Injury, Minor",disease,C10;C26,Injury or Poisoning,0.3,,1996.0,1996.0,1,0,CTD_human
4112,462,SERPINC1,0.5539999999999999,0.621,C0751181,Frontal Region Trauma,disease,C10;C26,Injury or Poisoning,0.3,,1996.0,1996.0,1,0,CTD_human
4113,462,SERPINC1,0.5539999999999999,0.621,C0751182,Occipital Region Trauma,disease,C10;C26,Injury or Poisoning,0.3,,1996.0,1996.0,1,0,CTD_human
4114,462,SERPINC1,0.5539999999999999,0.621,C0751183,Parietal Region Trauma,disease,C10;C26,Injury or Poisoning,0.3,,1996.0,1996.0,1,0,CTD_human
4115,462,SERPINC1,0.5539999999999999,0.621,C0751184,Temporal Region Trauma,disease,C10;C26,Injury or Poisoning,0.3,,1996.0,1996.0,1,0,CTD_human
4116,462,SERPINC1,0.5539999999999999,0.621,C0752143,Intracranial Thrombosis,disease,C10;C14,Disease or Syndrome,0.3,,1983.0,1983.0,1,0,CTD_human
4117,462,SERPINC1,0.5539999999999999,0.621,C0752144,Brain Thrombosis,disease,C10;C14,Disease or Syndrome,0.3,,1983.0,1983.0,1,0,CTD_human
4118,462,SERPINC1,0.5539999999999999,0.621,C0936261,Brain Thrombus,disease,C10;C14,Disease or Syndrome,0.3,,1983.0,1983.0,1,0,CTD_human
4119,462,SERPINC1,0.5539999999999999,0.621,C0936263,Cerebral Thrombus,disease,C10;C14,Disease or Syndrome,0.3,,1983.0,1983.0,1,0,CTD_human
4120,462,SERPINC1,0.5539999999999999,0.621,C0948089,Acute Coronary Syndrome,disease,C14,Disease or Syndrome,0.3,,1994.0,1994.0,1,0,CTD_human
4121,462,SERPINC1,0.5539999999999999,0.621,C1861172,Venous Thromboembolism,phenotype,C14,Disease or Syndrome,0.31,1.0,1979.0,2018.0,1,0,CTD_human
4122,462,SERPINC1,0.5539999999999999,0.621,C2937358,Cerebral Hemorrhage,phenotype,C10;C14;C23,Pathologic Function,0.3,,1983.0,1983.0,1,0,CTD_human
4123,462,SERPINC1,0.5539999999999999,0.621,C3658294,Hereditary Antithrombin Deficiency,disease,C15;C16,Disease or Syndrome,0.32,1.0,1984.0,2014.0,1,0,CTD_human
77725,200150,PLD5,,,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
32170,4148,MATN3,0.685,0.172,C0026760,Multiple Epiphyseal Dysplasia,disease,C05;C16,Congenital Abnormality,0.7,1.0,1993.0,2016.0,3,0,GENOMICS_ENGLAND
32171,4148,MATN3,0.685,0.172,C0029408,Degenerative polyarthritis,disease,C05,Disease or Syndrome,0.49,1.0,2002.0,2012.0,0,0,CTD_human
32172,4148,MATN3,0.685,0.172,C0029434,Osteogenesis Imperfecta,disease,C05;C16;C17,Congenital Abnormality; Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
32173,4148,MATN3,0.685,0.172,C0086743,Osteoarthrosis Deformans,disease,C05,Disease or Syndrome,0.3,,,,0,0,CTD_human
32174,4148,MATN3,0.685,0.172,C1837481,"Spondyloepimetaphyseal Dysplasia, Matrilin-3 Related",disease,C05;C16,Disease or Syndrome,0.7,,1993.0,2004.0,1,1,CTD_human;ORPHANET;UNIPROT
32175,4148,MATN3,0.685,0.172,C1846843,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 5",disease,C05;C16,Disease or Syndrome,0.7,,1959.0,2012.0,7,10,CTD_human;ORPHANET;UNIPROT
33683,4358,MPV17,0.611,0.483,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
33684,4358,MPV17,0.611,0.483,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.31,1.0,2014.0,2014.0,0,0,GENOMICS_ENGLAND
33685,4358,MPV17,0.611,0.483,C0009197,Cochlear Diseases,group,C09,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
33686,4358,MPV17,0.611,0.483,C0017668,Focal glomerulosclerosis,disease,C12;C13,Disease or Syndrome,0.32,1.0,2003.0,2009.0,1,0,CTD_human
33687,4358,MPV17,0.611,0.483,C0022283,Incontinentia Pigmenti Achromians,disease,C17;C23,Congenital Abnormality,0.3,,2009.0,2009.0,1,0,CTD_human
33688,4358,MPV17,0.611,0.483,C0033687,Proteinuria,phenotype,C12;C13;C23,Finding,0.3,,2009.0,2009.0,1,0,CTD_human
33689,4358,MPV17,0.611,0.483,C0036305,Schamberg Disease,disease,C17;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
33690,4358,MPV17,0.611,0.483,C0086432,"Hyalinosis, Segmental Glomerular",disease,C12;C13,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
33691,4358,MPV17,0.611,0.483,C0391976,Pain Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,1976.0,2015.0,6,0,GENOMICS_ENGLAND
33692,4358,MPV17,0.611,0.483,C0549567,Pigmentation Disorders,group,C17;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
33693,4358,MPV17,0.611,0.483,C0751651,Mitochondrial Diseases,group,C18,Disease or Syndrome,0.5,,2009.0,2009.0,1,0,CTD_human;GENOMICS_ENGLAND
33694,4358,MPV17,0.611,0.483,C0949855,"Electron Transport Chain Deficiencies, Mitochondrial",disease,C18,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
33695,4358,MPV17,0.611,0.483,C0949856,Oxidative Phosphorylation Deficiencies,disease,C18,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
33696,4358,MPV17,0.611,0.483,C0949857,Mitochondrial Respiratory Chain Deficiencies,disease,C18,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
33697,4358,MPV17,0.611,0.483,C1112213,Cholestasis in newborn,disease,,Disease or Syndrome,0.3,,2006.0,2008.0,3,0,GENOMICS_ENGLAND
33698,4358,MPV17,0.611,0.483,C1850406,NAVAJO NEUROHEPATOPATHY,disease,C06;C10;C16;C18,Disease or Syndrome,0.74,1.0,1993.0,2016.0,4,24,CTD_human;ORPHANET;UNIPROT
33699,4358,MPV17,0.611,0.483,C1850407,Navajo Familial Neurogenic Arthropathy,disease,C06;C10;C16;C18,Disease or Syndrome,0.5,,2006.0,2016.0,4,7,CTD_human;UNIPROT
33700,4358,MPV17,0.611,0.483,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
31737,4072,EPCAM,0.499,0.69,C0007097,Carcinoma,group,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
31738,4072,EPCAM,0.499,0.69,C0009405,Hereditary Nonpolyposis Colorectal Neoplasms,group,C04;C06;C16;C18,Neoplastic Process,0.31,,2009.0,2016.0,1,0,CTD_human
31739,4072,EPCAM,0.499,0.69,C0017185,Gastrointestinal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,,,0,0,GENOMICS_ENGLAND
31740,4072,EPCAM,0.499,0.69,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
31741,4072,EPCAM,0.499,0.69,C0024667,Animal Mammary Neoplasms,group,C04;C22,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
31742,4072,EPCAM,0.499,0.69,C0024668,"Mammary Neoplasms, Experimental",group,C04,Experimental Model of Disease; Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
31743,4072,EPCAM,0.499,0.69,C0030297,Pancreatic Neoplasm,disease,C04;C06;C19,Neoplastic Process,0.31,1.0,2007.0,2009.0,1,0,CTD_human
31744,4072,EPCAM,0.499,0.69,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
31745,4072,EPCAM,0.499,0.69,C0205696,Anaplastic carcinoma,disease,C04,Neoplastic Process,0.31,1.0,2006.0,2015.0,1,0,CTD_human
31746,4072,EPCAM,0.499,0.69,C0205697,"Carcinoma, Spindle-Cell",disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
31747,4072,EPCAM,0.499,0.69,C0205698,Undifferentiated carcinoma,phenotype,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
31748,4072,EPCAM,0.499,0.69,C0205699,Carcinomatosis,phenotype,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
31749,4072,EPCAM,0.499,0.69,C0346153,"Breast Cancer, Familial",disease,C04;C17,Neoplastic Process,0.5,,,,0,0,CLINGEN;GENOMICS_ENGLAND
31750,4072,EPCAM,0.499,0.69,C0346647,Malignant neoplasm of pancreas,disease,C04;C06;C19,Neoplastic Process,0.36,1.0,1987.0,2016.0,1,0,CTD_human
31751,4072,EPCAM,0.499,0.69,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.4,1.0,2005.0,2016.0,1,0,CTD_human
31752,4072,EPCAM,0.499,0.69,C0919267,ovarian neoplasm,disease,C04;C13;C19,Neoplastic Process,0.31,,2004.0,2011.0,1,0,CTD_human
31753,4072,EPCAM,0.499,0.69,C1112155,Hereditary non-polyposis colorectal cancer syndrome,disease,,Congenital Abnormality,0.3,,,,0,0,ORPHANET
31754,4072,EPCAM,0.499,0.69,C1140680,Malignant neoplasm of ovary,disease,C04;C13;C19,Neoplastic Process,0.38,1.0,1994.0,2015.0,1,0,CTD_human
31755,4072,EPCAM,0.499,0.69,C1257925,"Mammary Carcinoma, Animal",disease,C04;C22,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
31756,4072,EPCAM,0.499,0.69,C1333990,Hereditary Nonpolyposis Colorectal Cancer,disease,C04;C06;C16;C18,Neoplastic Process,0.7,1.0,2009.0,2018.0,1,7,CTD_human;ORPHANET
31757,4072,EPCAM,0.499,0.69,C2750471,"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8",disease,C04;C06;C16;C18,Neoplastic Process,0.5,,2006.0,2015.0,6,0,CLINGEN;CTD_human
31758,4072,EPCAM,0.499,0.69,C2750737,"DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL",disease,C06;C18;C23,Disease or Syndrome,0.96,1.0,2008.0,2018.0,1,6,CTD_human;ORPHANET;UNIPROT
31759,4072,EPCAM,0.499,0.69,C2931459,Lynch syndrome I (site-specific colonic cancer),disease,C04;C06;C16;C18,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
57930,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C0282577,Congenital Disorders of Glycosylation,group,C16;C18,Disease or Syndrome,0.3,,2004.0,2014.0,2,0,GENOMICS_ENGLAND
57931,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
57932,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C1836824,Amish Infantile Epilepsy Syndrome,disease,C10,Disease or Syndrome,0.6,,2004.0,2017.0,0,5,CTD_human;ORPHANET
57933,8869,ST3GAL5,0.6759999999999999,0.44799999999999995,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2014.0,2017.0,4,0,GENOMICS_ENGLAND
13574,1615,DARS,0.8340000000000001,0.207,C3809008,HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY,disease,,Disease or Syndrome,0.71,1.0,2013.0,2015.0,1,10,CTD_human;ORPHANET;UNIPROT
700,90,ACVR1,0.573,0.552,C0004114,Astrocytoma,disease,C04,Neoplastic Process,0.32,1.0,2014.0,2015.0,1,0,CTD_human
701,90,ACVR1,0.573,0.552,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
702,90,ACVR1,0.573,0.552,C0013720,Ehlers-Danlos Syndrome,disease,C14;C15;C16;C17,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
703,90,ACVR1,0.573,0.552,C0016037,Fibrodysplasia Ossificans Progressiva,disease,C05,Disease or Syndrome,1.0,1.0,1972.0,2018.0,3,9,CTD_human;ORPHANET;UNIPROT
704,90,ACVR1,0.573,0.552,C0017638,Glioma,disease,C04,Neoplastic Process,0.51,1.0,2014.0,2014.0,3,0,CGI;CTD_human
705,90,ACVR1,0.573,0.552,C0025202,melanoma,disease,C04,Neoplastic Process,0.3,,,,0,0,UNIPROT
706,90,ACVR1,0.573,0.552,C0027122,Myositis Ossificans,disease,C05,Disease or Syndrome,0.31,,2007.0,2007.0,0,0,CTD_human
707,90,ACVR1,0.573,0.552,C0205768,Subependymal Giant Cell Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
708,90,ACVR1,0.573,0.552,C0242488,Acute Lung Injury,disease,C08,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
709,90,ACVR1,0.573,0.552,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,3,0,CTD_human
710,90,ACVR1,0.573,0.552,C0280783,Juvenile Pilocytic Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
711,90,ACVR1,0.573,0.552,C0280785,Diffuse Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
712,90,ACVR1,0.573,0.552,C0334579,Anaplastic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
713,90,ACVR1,0.573,0.552,C0334580,Protoplasmic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
714,90,ACVR1,0.573,0.552,C0334581,Gemistocytic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
715,90,ACVR1,0.573,0.552,C0334582,Fibrillary Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
716,90,ACVR1,0.573,0.552,C0334583,Pilocytic Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
717,90,ACVR1,0.573,0.552,C0338070,Childhood Cerebral Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
718,90,ACVR1,0.573,0.552,C0345050,Congenital aneurysm of ascending aorta,disease,C14,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
719,90,ACVR1,0.573,0.552,C0547065,Mixed oligoastrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
720,90,ACVR1,0.573,0.552,C0555198,Malignant Glioma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,3,0,CTD_human
721,90,ACVR1,0.573,0.552,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
722,90,ACVR1,0.573,0.552,C0750935,Cerebral Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
723,90,ACVR1,0.573,0.552,C0750936,Intracranial Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
724,90,ACVR1,0.573,0.552,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
725,90,ACVR1,0.573,0.552,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
726,90,ACVR1,0.573,0.552,C1704230,Grade I Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
727,90,ACVR1,0.573,0.552,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
70812,57007,ACKR3,0.494,0.759,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.32,1.0,1999.0,2010.0,1,0,CTD_human
70813,57007,ACKR3,0.494,0.759,C0007097,Carcinoma,group,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70814,57007,ACKR3,0.494,0.759,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.31,1.0,2012.0,2015.0,1,0,CTD_human
70815,57007,ACKR3,0.494,0.759,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70816,57007,ACKR3,0.494,0.759,C0022658,Kidney Diseases,group,C12;C13,Disease or Syndrome,0.31,1.0,2013.0,2017.0,1,0,CTD_human
70817,57007,ACKR3,0.494,0.759,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
70818,57007,ACKR3,0.494,0.759,C0027627,Neoplasm Metastasis,phenotype,C04;C23,Neoplastic Process,0.4,0.9629629999999999,2005.0,2017.0,1,0,CTD_human
70819,57007,ACKR3,0.494,0.759,C0205696,Anaplastic carcinoma,disease,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70820,57007,ACKR3,0.494,0.759,C0205697,"Carcinoma, Spindle-Cell",disease,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70821,57007,ACKR3,0.494,0.759,C0205698,Undifferentiated carcinoma,phenotype,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70822,57007,ACKR3,0.494,0.759,C0205699,Carcinomatosis,phenotype,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70823,57007,ACKR3,0.494,0.759,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.31,1.0,2012.0,2015.0,1,0,CTD_human
7569,859,CAV3,0.5920000000000001,0.414,C0002152,Alloxan Diabetes,disease,C18;C19,Experimental Model of Disease,0.3,,2009.0,2009.0,1,0,CTD_human
7570,859,CAV3,0.5920000000000001,0.414,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
7571,859,CAV3,0.5920000000000001,0.414,C0007194,Hypertrophic Cardiomyopathy,disease,C14,Disease or Syndrome,0.52,1.0,2004.0,2010.0,0,0,GENOMICS_ENGLAND
7572,859,CAV3,0.5920000000000001,0.414,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
7573,859,CAV3,0.5920000000000001,0.414,C0011853,"Diabetes Mellitus, Experimental",disease,C18;C19,Experimental Model of Disease,0.3,,2009.0,2009.0,1,0,CTD_human
7574,859,CAV3,0.5920000000000001,0.414,C0018798,Congenital Heart Defects,group,C14;C16,Congenital Abnormality,0.3,,2011.0,2011.0,1,0,CTD_human
7575,859,CAV3,0.5920000000000001,0.414,C0018800,Cardiomegaly,phenotype,C14;C23,Finding,0.3,,2009.0,2009.0,1,0,CTD_human
7576,859,CAV3,0.5920000000000001,0.414,C0023976,Long QT Syndrome,disease,C14;C16;C23,Disease or Syndrome,0.48,1.0,2000.0,2017.0,0,3,GENOMICS_ENGLAND
7577,859,CAV3,0.5920000000000001,0.414,C0035410,Rhabdomyolysis,phenotype,C05,Pathologic Function,0.3,,,,0,0,GENOMICS_ENGLAND
7578,859,CAV3,0.5920000000000001,0.414,C0035828,Romano-Ward Syndrome,disease,C14;C16;C23,Disease or Syndrome,0.3,,,,0,0,ORPHANET
7579,859,CAV3,0.5920000000000001,0.414,C0038433,Streptozotocin Diabetes,disease,C18;C19,Experimental Model of Disease,0.3,,2009.0,2009.0,1,0,CTD_human
7580,859,CAV3,0.5920000000000001,0.414,C0038644,Sudden infant death syndrome,disease,C23,Disease or Syndrome,0.35,1.0,2007.0,2014.0,1,3,UNIPROT
7581,859,CAV3,0.5920000000000001,0.414,C0205700,Asymmetric Septal Hypertrophy,disease,,Disease or Syndrome,0.4,,2004.0,2004.0,1,1,UNIPROT
7582,859,CAV3,0.5920000000000001,0.414,C0241005,Creatine phosphokinase serum increased,phenotype,,Finding,0.6,,1975.0,2009.0,4,4,CTD_human;UNIPROT
7583,859,CAV3,0.5920000000000001,0.414,C0270960,Congenital myopathy (disorder),group,,Congenital Abnormality,0.31,1.0,2007.0,2007.0,0,0,GENOMICS_ENGLAND
7584,859,CAV3,0.5920000000000001,0.414,C0686353,"Muscular Dystrophies, Limb-Girdle",group,C05;C10;C16,Disease or Syndrome,0.8,1.0,1998.0,2017.0,1,0,CTD_human;GENOMICS_ENGLAND
7585,859,CAV3,0.5920000000000001,0.414,C0700053,Idiopathic hypertrophic subaortic stenosis,disease,C14;C16,Congenital Abnormality,0.3,,2004.0,2004.0,1,1,UNIPROT
7586,859,CAV3,0.5920000000000001,0.414,C0949658,"Cardiomyopathy, Hypertrophic, Familial",disease,C14;C16,Disease or Syndrome,0.6,,2004.0,2006.0,1,1,UNIPROT
7587,859,CAV3,0.5920000000000001,0.414,C1142166,Brugada Syndrome (disorder),disease,C14;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
7588,859,CAV3,0.5920000000000001,0.414,C1383860,Cardiac Hypertrophy,phenotype,C14;C23,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
7589,859,CAV3,0.5920000000000001,0.414,C1832560,RIPPLING MUSCLE DISEASE 2 (disorder),disease,C05;C10,Disease or Syndrome,0.6,,1975.0,2012.0,7,9,CTD_human;UNIPROT
7590,859,CAV3,0.5920000000000001,0.414,C1832567,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C",disease,C05;C10;C16,Disease or Syndrome,0.92,1.0,1975.0,2016.0,7,11,CTD_human;ORPHANET;UNIPROT
7591,859,CAV3,0.5920000000000001,0.414,C1838254,RIPPLING MUSCLE DISEASE 1,disease,C05;C10,Disease or Syndrome,0.4,1.0,2001.0,2017.0,1,0,CTD_human
7592,859,CAV3,0.5920000000000001,0.414,C1853698,Rippling muscle disease,disease,C05;C10,Disease or Syndrome,0.8,1.0,2001.0,2017.0,7,8,CTD_human;ORPHANET;UNIPROT
7593,859,CAV3,0.5920000000000001,0.414,C2678485,LONG QT SYNDROME 9 (disorder),disease,C14;C16;C23,Disease or Syndrome,0.63,1.0,2006.0,2014.0,2,6,CTD_human;UNIPROT
7594,859,CAV3,0.5920000000000001,0.414,C2931337,"Chromosome 3, monosomy 3p25",disease,C23,Cell or Molecular Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
7595,859,CAV3,0.5920000000000001,0.414,C3280443,"MYOPATHY, DISTAL, TATEYAMA TYPE",disease,,Disease or Syndrome,0.7,,1999.0,2009.0,2,3,CTD_human;ORPHANET;UNIPROT
7596,859,CAV3,0.5920000000000001,0.414,C3495498,"Cardiomyopathy, Familial Hypertrophic, 1 (disorder)",disease,C14;C16,Disease or Syndrome,0.5,,2004.0,2004.0,1,1,CTD_human;UNIPROT
63380,11277,TREX1,0.58,0.621,C0006111,Brain Diseases,group,C10,Disease or Syndrome,0.31,1.0,2006.0,2007.0,1,0,CTD_human
63381,11277,TREX1,0.58,0.621,C0021368,Inflammation,phenotype,C23,Pathologic Function,0.3,,2006.0,2006.0,1,0,CTD_human
63382,11277,TREX1,0.58,0.621,C0021400,Influenza,disease,C02;C08,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
63383,11277,TREX1,0.58,0.621,C0023520,Leukodystrophy,disease,,Disease or Syndrome,0.44,1.0,2007.0,2015.0,0,0,GENOMICS_ENGLAND
63384,11277,TREX1,0.58,0.621,C0024141,"Lupus Erythematosus, Systemic",disease,C17;C20,Disease or Syndrome,0.6,0.9375,2007.0,2017.0,3,8,CTD_human;UNIPROT
63385,11277,TREX1,0.58,0.621,C0024145,Chilblain lupus 1,disease,C17;C26,Disease or Syndrome,0.68,1.0,2007.0,2016.0,3,1,CTD_human;ORPHANET;UNIPROT
63386,11277,TREX1,0.58,0.621,C0085584,Encephalopathies,group,C10,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
63387,11277,TREX1,0.58,0.621,C0242380,Libman-Sacks Disease,disease,C17;C20,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
63388,11277,TREX1,0.58,0.621,C0263666,"Dermatomyositis, Childhood Type",disease,C05;C10;C17,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
63389,11277,TREX1,0.58,0.621,C0393591,AICARDI-GOUTIERES SYNDROME,disease,,Disease or Syndrome,0.4,1.0,2000.0,2017.0,0,0,ORPHANET
63390,11277,TREX1,0.58,0.621,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
63391,11277,TREX1,0.58,0.621,C0796126,AICARDI-GOUTIERES SYNDROME 1,disease,C10;C16;C20,Disease or Syndrome,0.9,1.0,1993.0,2017.0,8,24,CTD_human;UNIPROT
63392,11277,TREX1,0.58,0.621,C1835308,EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA,phenotype,,Finding,0.3,,2007.0,2013.0,3,8,UNIPROT
63393,11277,TREX1,0.58,0.621,C1835309,EXCESS LMW-DNA,phenotype,,Finding,0.3,,2007.0,2013.0,3,8,UNIPROT
63394,11277,TREX1,0.58,0.621,C1860518,"Vasculopathy, Retinal, With Cerebral Leukodystrophy",disease,C10;C11;C14;C16;C18,Disease or Syndrome,0.51,1.0,2011.0,2011.0,0,0,CTD_human;ORPHANET
63395,11277,TREX1,0.58,0.621,C3150315,"AICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT",disease,,Disease or Syndrome,0.6,,2004.0,2017.0,8,6,UNIPROT
63396,11277,TREX1,0.58,0.621,C3489724,Aicardi-Goutieres Syndrome 2,disease,C10;C16;C20,Disease or Syndrome,0.5,,2004.0,2017.0,1,0,CTD_human
63397,11277,TREX1,0.58,0.621,C3489725,Pseudo-TORCH syndrome,disease,C10;C16;C20,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
63398,11277,TREX1,0.58,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
6816,788,SLC25A20,0.619,0.586,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.4,,,,0,0,GENOMICS_ENGLAND
6817,788,SLC25A20,0.619,0.586,C0342791,Carnitine-Acylcarnitine Translocase Deficiency,disease,C16;C18,Disease or Syndrome,0.75,1.0,1992.0,2017.0,2,10,CTD_human;ORPHANET;UNIPROT
6818,788,SLC25A20,0.619,0.586,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,1998.0,2003.0,5,0,GENOMICS_ENGLAND
30634,3913,LAMB2,0.639,0.483,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
30635,3913,LAMB2,0.639,0.483,C0268747,Diffuse mesangial sclerosis (disorder),disease,C12;C13;C23,Disease or Syndrome,0.43,1.0,2005.0,2008.0,1,0,CTD_human
30636,3913,LAMB2,0.639,0.483,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
30637,3913,LAMB2,0.639,0.483,C0751882,"Myasthenic Syndromes, Congenital",disease,C10;C16,Disease or Syndrome,0.32,1.0,2009.0,2016.0,2,0,GENOMICS_ENGLAND
30638,3913,LAMB2,0.639,0.483,C1836876,Pierson syndrome,disease,C10;C11;C12;C13;C16;C23,Disease or Syndrome,1.0,1.0,1963.0,2017.0,2,9,CTD_human;ORPHANET;UNIPROT
30639,3913,LAMB2,0.639,0.483,C1855670,Abnormality of the cornea,group,,Finding,0.3,,1963.0,2005.0,3,0,GENOMICS_ENGLAND
30640,3913,LAMB2,0.639,0.483,C3280113,"NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES",disease,,Disease or Syndrome,0.7,,2006.0,2011.0,2,6,CTD_human;ORPHANET;UNIPROT
30641,3913,LAMB2,0.639,0.483,C3489732,Familial mesangial sclerosis,disease,C12;C13;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
30642,3913,LAMB2,0.639,0.483,C3501249,"Nephrotic Syndrome, Congenital, With Ocular Abnormalities And Congenital Myasthenic Syndrome",disease,C10;C11;C12;C13;C16;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
25744,3373,HYAL1,0.648,0.483,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
25745,3373,HYAL1,0.648,0.483,C1291490,Hyaluronidase Deficiency,disease,C16;C17;C18,Disease or Syndrome,0.9,,1996.0,2008.0,1,1,CTD_human;ORPHANET;UNIPROT
25746,3373,HYAL1,0.648,0.483,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
56229,8314,BAP1,0.488,0.586,C0005684,Malignant neoplasm of urinary bladder,disease,C04;C12;C13,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56230,8314,BAP1,0.488,0.586,C0005695,Bladder Neoplasm,group,C04;C12;C13,Neoplastic Process,0.31,1.0,2015.0,2017.0,1,0,CTD_human
56231,8314,BAP1,0.488,0.586,C0005967,Bone neoplasms,group,C04;C05,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56232,8314,BAP1,0.488,0.586,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.56,1.0,1998.0,2018.0,2,0,CGI;CTD_human
56233,8314,BAP1,0.488,0.586,C0006826,Malignant Neoplasms,group,C04,Neoplastic Process,0.34,1.0,2017.0,2017.0,0,0,CGI
56234,8314,BAP1,0.488,0.586,C0007102,Malignant tumor of colon,disease,C04;C06,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56235,8314,BAP1,0.488,0.586,C0007117,Basal cell carcinoma,disease,C04,Neoplastic Process,0.3,,2016.0,2016.0,1,0,CTD_human
56236,8314,BAP1,0.488,0.586,C0007131,Non-Small Cell Lung Carcinoma,disease,C04;C08,Neoplastic Process,0.3,,,,0,0,CGI
56237,8314,BAP1,0.488,0.586,C0007134,Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.4,0.9166667,2012.0,2016.0,4,0,CTD_human
56238,8314,BAP1,0.488,0.586,C0009375,Colonic Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56239,8314,BAP1,0.488,0.586,C0018671,Head and Neck Neoplasms,group,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56240,8314,BAP1,0.488,0.586,C0018675,Head Neoplasms,group,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56241,8314,BAP1,0.488,0.586,C0022665,Kidney Neoplasm,disease,C04;C12;C13,Neoplastic Process,0.5,,2016.0,2016.0,1,0,CGI;CTD_human
56242,8314,BAP1,0.488,0.586,C0023418,leukemia,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56243,8314,BAP1,0.488,0.586,C0023798,Lipoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56244,8314,BAP1,0.488,0.586,C0023903,Liver neoplasms,group,C04;C06,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56245,8314,BAP1,0.488,0.586,C0024121,Lung Neoplasms,group,C04;C08,Neoplastic Process,0.3,,2016.0,2016.0,1,0,CTD_human
56246,8314,BAP1,0.488,0.586,C0024623,Malignant neoplasm of stomach,disease,C04;C06,Neoplastic Process,0.31,1.0,2014.0,2016.0,2,0,CTD_human
56247,8314,BAP1,0.488,0.586,C0025202,melanoma,disease,C04,Neoplastic Process,0.7,0.9130434999999999,2010.0,2017.0,0,0,CGI;GENOMICS_ENGLAND
56248,8314,BAP1,0.488,0.586,C0025286,Meningioma,disease,C04;C10,Neoplastic Process,0.45,1.0,2012.0,2018.0,1,0,CTD_human
56249,8314,BAP1,0.488,0.586,C0025500,Mesothelioma,disease,C04,Neoplastic Process,0.6,0.9259259,2011.0,2018.0,4,0,CGI;CTD_human
56250,8314,BAP1,0.488,0.586,C0027533,Neck Neoplasms,group,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56251,8314,BAP1,0.488,0.586,C0030297,Pancreatic Neoplasm,disease,C04;C06;C19,Neoplastic Process,0.31,1.0,2014.0,2015.0,1,0,CTD_human
56252,8314,BAP1,0.488,0.586,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.31,1.0,2013.0,2015.0,1,0,CTD_human
56253,8314,BAP1,0.488,0.586,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56254,8314,BAP1,0.488,0.586,C0038356,Stomach Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2015.0,2016.0,2,0,CTD_human
56255,8314,BAP1,0.488,0.586,C0039590,Testicular Neoplasms,group,C04;C12;C19,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56256,8314,BAP1,0.488,0.586,C0040100,Thymoma,disease,C04;C15,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56257,8314,BAP1,0.488,0.586,C0042138,Uterine Neoplasms,group,C04;C13,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56258,8314,BAP1,0.488,0.586,C0085136,Central Nervous System Neoplasms,group,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56259,8314,BAP1,0.488,0.586,C0151779,Cutaneous Melanoma,disease,C04;C17,Neoplastic Process,0.7,0.9,2012.0,2017.0,2,0,CGI;CTD_human
56260,8314,BAP1,0.488,0.586,C0152013,Adenocarcinoma of lung (disorder),disease,C04;C08,Neoplastic Process,0.4,,2015.0,2015.0,1,0,CTD_human
56261,8314,BAP1,0.488,0.586,C0153567,Uterine Cancer,disease,C04;C13,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56262,8314,BAP1,0.488,0.586,C0153594,Malignant neoplasm of testis,disease,C04;C12;C19,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56263,8314,BAP1,0.488,0.586,C0154040,Benign neoplasm of adrenal gland,disease,,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CLINGEN
56264,8314,BAP1,0.488,0.586,C0154045,Benign neoplasm of aortic body and other paraganglia,disease,,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CLINGEN
56265,8314,BAP1,0.488,0.586,C0205822,Hibernoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56266,8314,BAP1,0.488,0.586,C0205823,Pleomorphic Lipoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56267,8314,BAP1,0.488,0.586,C0205834,"Meningiomas, Multiple",disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56268,8314,BAP1,0.488,0.586,C0205969,Thymic Carcinoma,disease,C04;C15,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56269,8314,BAP1,0.488,0.586,C0206686,Adrenocortical carcinoma,disease,C04;C19,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56270,8314,BAP1,0.488,0.586,C0206694,Mucoepidermoid Carcinoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56271,8314,BAP1,0.488,0.586,C0206698,Cholangiocarcinoma,disease,C04,Neoplastic Process,0.31,1.0,2014.0,2015.0,2,0,CTD_human
56272,8314,BAP1,0.488,0.586,C0206739,Epithelioid and spindle cell nevus,disease,C04,Neoplastic Process,0.31,1.0,2012.0,2015.0,1,0,CTD_human
56273,8314,BAP1,0.488,0.586,C0206754,Neuroendocrine Tumors,group,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56274,8314,BAP1,0.488,0.586,C0206769,Nevi and Melanomas,group,C04,Neoplastic Process,0.3,,2011.0,2011.0,1,0,CTD_human
56275,8314,BAP1,0.488,0.586,C0220633,Uveal melanoma,disease,C04;C11,Neoplastic Process,0.8,0.9428571,2010.0,2018.0,3,0,CGI;CTD_human;ORPHANET
56276,8314,BAP1,0.488,0.586,C0242379,Malignant neoplasm of lung,disease,C04;C08,Neoplastic Process,0.51,1.0,2016.0,2016.0,1,0,CTD_human;UNIPROT
56277,8314,BAP1,0.488,0.586,C0259785,Malignant Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56278,8314,BAP1,0.488,0.586,C0278996,Malignant Head and Neck Neoplasm,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56279,8314,BAP1,0.488,0.586,C0279530,Malignant Bone Neoplasm,disease,C04;C05,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56280,8314,BAP1,0.488,0.586,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.6,1.0,2012.0,2018.0,4,0,CGI;CTD_human
56281,8314,BAP1,0.488,0.586,C0281784,Benign Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56282,8314,BAP1,0.488,0.586,C0334605,Meningothelial meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56283,8314,BAP1,0.488,0.586,C0334606,Fibrous Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56284,8314,BAP1,0.488,0.586,C0334607,Psammomatous Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56285,8314,BAP1,0.488,0.586,C0334608,Angiomatous Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56286,8314,BAP1,0.488,0.586,C0334609,Hemangioblastic Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56287,8314,BAP1,0.488,0.586,C0334610,Hemangiopericytic Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56288,8314,BAP1,0.488,0.586,C0334611,Transitional Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56289,8314,BAP1,0.488,0.586,C0344456,Malignant Adrenal Medulla Neoplasm,disease,,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CLINGEN
56290,8314,BAP1,0.488,0.586,C0345904,Malignant neoplasm of liver,disease,C04;C06,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56291,8314,BAP1,0.488,0.586,C0345905,Intrahepatic Cholangiocarcinoma,disease,C04,Neoplastic Process,0.32,1.0,2014.0,2015.0,2,0,CTD_human
56292,8314,BAP1,0.488,0.586,C0345967,Malignant mesothelioma,disease,C04;C08,Neoplastic Process,0.4,1.0,2011.0,2017.0,5,0,CTD_human
56293,8314,BAP1,0.488,0.586,C0346373,Malignant melanoma of iris,disease,,Neoplastic Process,0.4,,,,0,0,ORPHANET
56294,8314,BAP1,0.488,0.586,C0346388,Malignant melanoma of choroid,disease,,Neoplastic Process,0.4,,,,0,0,ORPHANET
56295,8314,BAP1,0.488,0.586,C0346647,Malignant neoplasm of pancreas,disease,C04;C06;C19,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56296,8314,BAP1,0.488,0.586,C0347515,Spinal Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56297,8314,BAP1,0.488,0.586,C0349604,Intracranial Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56298,8314,BAP1,0.488,0.586,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56299,8314,BAP1,0.488,0.586,C0431121,Clear Cell Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56300,8314,BAP1,0.488,0.586,C0438413,Malignant neoplasm of aortic body and other paraganglia,disease,,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CLINGEN
56301,8314,BAP1,0.488,0.586,C0457190,Xanthomatous Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56302,8314,BAP1,0.488,0.586,C0496956,Neoplasm of uncertain or unknown behavior of breast,disease,,Neoplastic Process,0.3,,,,0,0,CGI
56303,8314,BAP1,0.488,0.586,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.57,1.0,1998.0,2018.0,2,0,CGI;CTD_human
56304,8314,BAP1,0.488,0.586,C0740457,Malignant neoplasm of kidney,disease,C04;C12;C13,Neoplastic Process,0.52,0.5,2014.0,2016.0,1,0,CGI;CTD_human
56305,8314,BAP1,0.488,0.586,C0746787,Cancer of Neck,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56306,8314,BAP1,0.488,0.586,C0751177,Cancer of Head,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56307,8314,BAP1,0.488,0.586,C0751303,Cerebral Convexity Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56308,8314,BAP1,0.488,0.586,C0751304,Parasagittal Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56309,8314,BAP1,0.488,0.586,C0751620,"Central Nervous System Neoplasms, Primary",group,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56310,8314,BAP1,0.488,0.586,C0858252,Breast adenocarcinoma,disease,,Neoplastic Process,0.3,,,,0,0,CGI
56311,8314,BAP1,0.488,0.586,C0887900,Upper Aerodigestive Tract Neoplasms,group,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56312,8314,BAP1,0.488,0.586,C0919267,ovarian neoplasm,disease,C04;C13;C19,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56313,8314,BAP1,0.488,0.586,C1140680,Malignant neoplasm of ovary,disease,C04;C13;C19,Neoplastic Process,0.31,1.0,1998.0,2015.0,1,0,CTD_human
56314,8314,BAP1,0.488,0.586,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2015.0,2016.0,2,0,CTD_human
56315,8314,BAP1,0.488,0.586,C1266042,Chromophobe Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2012.0,2015.0,4,0,CTD_human
56316,8314,BAP1,0.488,0.586,C1266043,Sarcomatoid Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2012.0,2015.0,4,0,CTD_human
56317,8314,BAP1,0.488,0.586,C1266044,Collecting Duct Carcinoma of the Kidney,disease,C04;C12;C13,Neoplastic Process,0.3,,2012.0,2015.0,4,0,CTD_human
56318,8314,BAP1,0.488,0.586,C1306837,Papillary Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2012.0,2015.0,4,0,CTD_human
56319,8314,BAP1,0.488,0.586,C1334261,Intraorbital Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56320,8314,BAP1,0.488,0.586,C1334271,Intraventricular Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56321,8314,BAP1,0.488,0.586,C1335107,Olfactory Groove Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56322,8314,BAP1,0.488,0.586,C1368275,Pigmented Basal Cell Carcinoma,disease,C04,Neoplastic Process,0.3,,2016.0,2016.0,1,0,CTD_human
56323,8314,BAP1,0.488,0.586,C1378703,Renal carcinoma,disease,,Neoplastic Process,0.32,0.5,2014.0,2016.0,0,0,CGI
56324,8314,BAP1,0.488,0.586,C1384406,Secretory meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56325,8314,BAP1,0.488,0.586,C1384408,Microcystic meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56326,8314,BAP1,0.488,0.586,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.3,,2015.0,2016.0,2,0,CTD_human
56327,8314,BAP1,0.488,0.586,C1527197,Angioblastic Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56328,8314,BAP1,0.488,0.586,C1565950,Posterior Fossa Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56329,8314,BAP1,0.488,0.586,C1565951,Sphenoid Wing Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56330,8314,BAP1,0.488,0.586,C1708349,Hereditary Diffuse Gastric Cancer,disease,C04;C06,Neoplastic Process,0.3,,2015.0,2016.0,2,0,CTD_human
56331,8314,BAP1,0.488,0.586,C1720811,Tumor of Rete Testis,disease,C04;C12;C19,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56332,8314,BAP1,0.488,0.586,C2314896,Familial Atypical Mole Melanoma Syndrome,disease,,Neoplastic Process,0.3,,,,0,0,ORPHANET
56333,8314,BAP1,0.488,0.586,C2931822,Nasopharyngeal carcinoma,disease,C04;C07;C09,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56334,8314,BAP1,0.488,0.586,C3163622,Papillary Meningioma,disease,C04;C10,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56335,8314,BAP1,0.488,0.586,C3280492,TUMOR PREDISPOSITION SYNDROME,disease,,Disease or Syndrome,0.67,1.0,2008.0,2017.0,0,21,CTD_human;ORPHANET
56336,8314,BAP1,0.488,0.586,C3489413,"Lipomatosis, Multiple",disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
56337,8314,BAP1,0.488,0.586,C3805278,Extrahepatic Cholangiocarcinoma,disease,C04,Neoplastic Process,0.31,1.0,2014.0,2015.0,2,0,CTD_human
66280,27086,FOXP1,0.528,0.69,C0006413,Burkitt Lymphoma,disease,C02;C04;C15;C20,Neoplastic Process,0.3,,,,0,0,ORPHANET
66281,27086,FOXP1,0.528,0.69,C0024232,Lymphatic Metastasis,disease,C04;C23,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
66282,27086,FOXP1,0.528,0.69,C0027626,Neoplasm Invasiveness,phenotype,C04;C23,Pathologic Function,0.3,,2015.0,2015.0,1,0,CTD_human
66283,27086,FOXP1,0.528,0.69,C0030297,Pancreatic Neoplasm,disease,C04;C06;C19,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
66284,27086,FOXP1,0.528,0.69,C0042900,Vitiligo,disease,C17,Disease or Syndrome,0.4,,2010.0,2017.0,1,2,CTD_human
66285,27086,FOXP1,0.528,0.69,C0087031,Juvenile-Onset Still Disease,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66286,27086,FOXP1,0.528,0.69,C0242647,Mucosa-Associated Lymphoid Tissue Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.4,1.0,2005.0,2015.0,0,0,ORPHANET
66287,27086,FOXP1,0.528,0.69,C0279628,Adenocarcinoma Of Esophagus,disease,C04;C06,Neoplastic Process,0.31,1.0,2014.0,2016.0,1,0,CTD_human
66288,27086,FOXP1,0.528,0.69,C0346647,Malignant neoplasm of pancreas,disease,C04;C06;C19,Neoplastic Process,0.31,1.0,2015.0,2015.0,1,0,CTD_human
66289,27086,FOXP1,0.528,0.69,C1292769,Precursor B-cell lymphoblastic leukemia,disease,,Neoplastic Process,0.3,,,,0,0,ORPHANET
66290,27086,FOXP1,0.528,0.69,C1510586,Autism Spectrum Disorders,disease,F03,Mental or Behavioral Dysfunction,0.42,1.0,2011.0,2018.0,1,1,CTD_human
66291,27086,FOXP1,0.528,0.69,C1535926,Neurodevelopmental Disorders,group,F03,Mental or Behavioral Dysfunction,0.35,1.0,2016.0,2018.0,1,0,CTD_human
66292,27086,FOXP1,0.528,0.69,C3495559,Juvenile arthritis,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66293,27086,FOXP1,0.528,0.69,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.46,1.0,2010.0,2018.0,0,0,GENOMICS_ENGLAND
66294,27086,FOXP1,0.528,0.69,C3714758,Juvenile psoriatic arthritis,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66295,27086,FOXP1,0.528,0.69,C4013764,MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES,disease,,Disease or Syndrome,0.6,,2011.0,2016.0,2,3,CTD_human;ORPHANET;UNIPROT
58003,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
58004,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C0023520,Leukodystrophy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
58005,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C0152013,Adenocarcinoma of lung (disorder),disease,C04;C08,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
58006,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
58007,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C1847967,OVARIOLEUKODYSTROPHY,disease,C10;C13;C19,Disease or Syndrome,0.9,,2001.0,2016.0,6,24,CTD_human;ORPHANET;UNIPROT
58008,8893,EIF2B5,0.7070000000000001,0.44799999999999995,C1858991,Childhood Ataxia with Central Nervous System Hypomyelinization,disease,C10,Disease or Syndrome,0.87,1.0,2001.0,2016.0,6,29,ORPHANET;UNIPROT
51887,7096,TLR1,0.529,0.7929999999999999,C0013221,Drug toxicity,group,C25,Injury or Poisoning,0.3,,2008.0,2008.0,1,0,CTD_human
51888,7096,TLR1,0.529,0.7929999999999999,C0023343,Leprosy,disease,C01,Disease or Syndrome,0.36,1.0,2007.0,2017.0,0,0,CTD_human
51889,7096,TLR1,0.529,0.7929999999999999,C0041755,Adverse reaction to drug,group,C25,Pathologic Function,0.3,,2008.0,2008.0,1,0,CTD_human
51890,7096,TLR1,0.529,0.7929999999999999,C0085742,"Injuries, Acute Brain",group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51891,7096,TLR1,0.529,0.7929999999999999,C0270611,Brain Injuries,group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51892,7096,TLR1,0.529,0.7929999999999999,C0272945,Brain Lacerations,disease,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51893,7096,TLR1,0.529,0.7929999999999999,C0452047,"Brain Injuries, Focal",group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
69679,55212,BBS7,0.713,0.379,C0020796,Profound Mental Retardation,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
69680,55212,BBS7,0.713,0.379,C0025363,"Mental Retardation, Psychosocial",disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
69681,55212,BBS7,0.713,0.379,C0152427,Polydactyly,disease,C05;C16,Congenital Abnormality,0.4,,,,0,0,GENOMICS_ENGLAND
69682,55212,BBS7,0.713,0.379,C0752166,Bardet-Biedl Syndrome,disease,C10;C16,Disease or Syndrome,0.47,1.0,2003.0,2017.0,0,4,ORPHANET
69683,55212,BBS7,0.713,0.379,C0917816,Mental deficiency,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2012.0,2012.0,1,0,CTD_human
69684,55212,BBS7,0.713,0.379,C1859565,BARDET-BIEDL SYNDROME 7,disease,C10;C16,Disease or Syndrome,0.6,,2003.0,2016.0,4,12,CTD_human;UNIPROT
69685,55212,BBS7,0.713,0.379,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.6,,2012.0,2012.0,1,0,CTD_human;GENOMICS_ENGLAND
69686,55212,BBS7,0.713,0.379,C4277690,Ciliopathies,group,C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
78154,256471,MFSD8,0.672,0.172,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
78155,256471,MFSD8,0.672,0.172,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
78156,256471,MFSD8,0.672,0.172,C1838571,"Ceroid Lipofuscinosis, Neuronal, 7",disease,C10;C16;C18,Disease or Syndrome,0.95,1.0,1993.0,2018.0,7,15,CTD_human;ORPHANET;UNIPROT
78157,256471,MFSD8,0.672,0.172,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
78158,256471,MFSD8,0.672,0.172,C4015371,MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT,disease,,Disease or Syndrome,0.61,1.0,2015.0,2015.0,1,3,CTD_human;UNIPROT
47179,6507,SLC1A3,0.619,0.552,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
47180,6507,SLC1A3,0.619,0.552,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2001.0,2017.0,1,0,CTD_human
47181,6507,SLC1A3,0.619,0.552,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2002.0,2002.0,1,0,PSYGENET
47182,6507,SLC1A3,0.619,0.552,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
47183,6507,SLC1A3,0.619,0.552,C0014544,Epilepsy,disease,C10,Disease or Syndrome,0.41,0.0,1995.0,2010.0,1,0,CTD_human
47184,6507,SLC1A3,0.619,0.552,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.36,1.0,2002.0,2016.0,4,0,PSYGENET
47185,6507,SLC1A3,0.619,0.552,C0086237,"Epilepsy, Cryptogenic",disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
47186,6507,SLC1A3,0.619,0.552,C0178417,Anhedonia,disease,C10;C23;F01,Mental or Behavioral Dysfunction,0.3,1.0,2009.0,2009.0,1,0,PSYGENET
47187,6507,SLC1A3,0.619,0.552,C0236018,Aura,phenotype,C10,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
47188,6507,SLC1A3,0.619,0.552,C0338488,Alternating hemiplegia of childhood,disease,C10;C23,Disease or Syndrome,0.33,1.0,2006.0,2009.0,0,0,ORPHANET
47189,6507,SLC1A3,0.619,0.552,C0751111,Awakening Epilepsy,disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
47190,6507,SLC1A3,0.619,0.552,C2675211,"EPISODIC ATAXIA, TYPE 6 (disorder)",disease,C10;C23,Disease or Syndrome,0.72,1.0,2006.0,2017.0,1,2,CTD_human;ORPHANET;UNIPROT
38636,5144,PDE4D,0.5720000000000001,0.69,C0004096,Asthma,disease,C08;C20,Disease or Syndrome,0.48,0.75,2001.0,2016.0,2,4,CTD_human
38637,5144,PDE4D,0.5720000000000001,0.69,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.5,1.0,2002.0,2012.0,2,0,PSYGENET
38638,5144,PDE4D,0.5720000000000001,0.69,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2002.0,2013.0,3,0,PSYGENET
38639,5144,PDE4D,0.5720000000000001,0.69,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2006.0,2018.0,2,0,CTD_human
38640,5144,PDE4D,0.5720000000000001,0.69,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2009.0,2011.0,1,1,PSYGENET
38641,5144,PDE4D,0.5720000000000001,0.69,C0038454,Cerebrovascular accident,group,C10;C14,Disease or Syndrome,0.4,0.9375,2002.0,2017.0,0,0,CTD_human
38642,5144,PDE4D,0.5720000000000001,0.69,C0220659,Acrodysostosis,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.59,0.8888889000000001,2012.0,2018.0,0,0,CTD_human;ORPHANET
38643,5144,PDE4D,0.5720000000000001,0.69,C0236733,Amphetamine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38644,5144,PDE4D,0.5720000000000001,0.69,C0236804,Amphetamine Addiction,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38645,5144,PDE4D,0.5720000000000001,0.69,C0236807,Amphetamine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38646,5144,PDE4D,0.5720000000000001,0.69,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.31,1.0,2006.0,2018.0,2,0,CTD_human
38647,5144,PDE4D,0.5720000000000001,0.69,C0751956,Acute Cerebrovascular Accidents,disease,C10;C14,Disease or Syndrome,0.3,,,,0,0,CTD_human
38648,5144,PDE4D,0.5720000000000001,0.69,C3276228,ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.3,,,,0,0,CTD_human
38649,5144,PDE4D,0.5720000000000001,0.69,C3553250,ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.61,1.0,2001.0,2018.0,4,9,CTD_human;UNIPROT
38650,5144,PDE4D,0.5720000000000001,0.69,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.41,1.0,2014.0,2014.0,0,0,GENOMICS_ENGLAND
49134,6695,SPOCK1,0.701,0.172,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.31,1.0,2008.0,2016.0,1,0,CTD_human
49135,6695,SPOCK1,0.701,0.172,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.31,1.0,2008.0,2016.0,1,0,CTD_human
15183,1836,SLC26A2,0.6,0.552,C0005941,"Bone Diseases, Developmental",group,C05,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
15184,1836,SLC26A2,0.6,0.552,C0013447,Ear Diseases,group,C09,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
15185,1836,SLC26A2,0.6,0.552,C0022821,Kyphosis deformity of spine,phenotype,C05,Anatomical Abnormality,0.4,,2008.0,2008.0,1,0,CTD_human
15186,1836,SLC26A2,0.6,0.552,C0026760,Multiple Epiphyseal Dysplasia,disease,C05;C16,Congenital Abnormality,0.49,0.8888888888888891,2001.0,2016.0,1,0,GENOMICS_ENGLAND
15187,1836,SLC26A2,0.6,0.552,C0029434,Osteogenesis Imperfecta,disease,C05;C16;C17,Congenital Abnormality; Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
15188,1836,SLC26A2,0.6,0.552,C0220726,Diastrophic dysplasia,disease,C05;C16;C19,Congenital Abnormality,0.9,1.0,1972.0,2017.0,0,48,CTD_human;ORPHANET
15189,1836,SLC26A2,0.6,0.552,C0265274,"Achondrogenesis, type IB (disorder)",disease,C05;C16,Congenital Abnormality,0.79,1.0,1994.0,2017.0,1,30,CTD_human;ORPHANET;UNIPROT
15190,1836,SLC26A2,0.6,0.552,C0376634,Craniofacial Abnormalities,group,C05;C16,Congenital Abnormality,0.3,,2008.0,2008.0,1,0,CTD_human
15191,1836,SLC26A2,0.6,0.552,C1847593,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 4",disease,C05;C16,Disease or Syndrome,0.73,1.0,1994.0,2017.0,2,32,CTD_human;ORPHANET;UNIPROT
15192,1836,SLC26A2,0.6,0.552,C1850554,Atelosteogenesis type 2,disease,C05;C16,Disease or Syndrome,0.77,1.0,1994.0,2017.0,1,30,CTD_human;ORPHANET;UNIPROT
15193,1836,SLC26A2,0.6,0.552,C1850555,De La Chapelle Dysplasia,disease,C05;C16,Disease or Syndrome,0.71,1.0,1972.0,2009.0,1,4,CTD_human;ORPHANET;UNIPROT
15194,1836,SLC26A2,0.6,0.552,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
52623,7148,TNXB,0.598,0.621,C0013720,Ehlers-Danlos Syndrome,disease,C14;C15;C16;C17,Disease or Syndrome,0.4,1.0,1997.0,2017.0,6,0,GENOMICS_ENGLAND
52624,7148,TNXB,0.598,0.621,C0029434,Osteogenesis Imperfecta,disease,C05;C16;C17,Congenital Abnormality; Disease or Syndrome,0.3,,2016.0,2016.0,1,0,GENOMICS_ENGLAND
52625,7148,TNXB,0.598,0.621,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.43,0.6666667,2004.0,2018.0,3,1,PSYGENET
52626,7148,TNXB,0.598,0.621,C0042580,Vesico-Ureteral Reflux,disease,C12;C13,Disease or Syndrome,0.61,1.0,2013.0,2013.0,0,0,CTD_human;ORPHANET
52627,7148,TNXB,0.598,0.621,C0268337,"Ehlers-Danlos syndrome, type 3 (disorder)",disease,C14;C15;C16;C17,Disease or Syndrome,0.42,1.0,2014.0,2015.0,0,1,ORPHANET
52628,7148,TNXB,0.598,0.621,C0279626,Squamous cell carcinoma of esophagus,disease,C04;C06,Neoplastic Process,0.3,,2018.0,2018.0,1,0,CTD_human
52629,7148,TNXB,0.598,0.621,C0345050,Congenital aneurysm of ascending aorta,disease,C14,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
52630,7148,TNXB,0.598,0.621,C1848029,Ehlers-Danlos syndrome caused by tenascin-X deficiency,disease,C14;C15;C16;C17,Disease or Syndrome,0.61,1.0,1997.0,2014.0,3,0,CTD_human;ORPHANET;UNIPROT
52631,7148,TNXB,0.598,0.621,C1968949,Cakut,disease,C12;C13;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
52632,7148,TNXB,0.598,0.621,C4014831,VESICOURETERAL REFLUX 8,disease,,Disease or Syndrome,0.4,,2013.0,2013.0,1,2,UNIPROT
40926,5429,POLH,0.667,0.414,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,2006.0,2006.0,1,1,UNIPROT
40927,5429,POLH,0.667,0.414,C0043346,Xeroderma Pigmentosum,disease,C04;C16;C17;C18,Congenital Abnormality,0.6,0.9583333,1999.0,2017.0,1,0,CTD_human
40928,5429,POLH,0.667,0.414,C0432328,"Xeroderma pigmentosum, variant form",disease,,Congenital Abnormality; Disease or Syndrome,0.3,,,,0,0,ORPHANET
40929,5429,POLH,0.667,0.414,C1848410,"Xeroderma pigmentosum, variant type",disease,C04;C16;C17;C18,Disease or Syndrome,0.94,1.0,1993.0,2016.0,6,13,CTD_human;ORPHANET;UNIPROT
68919,54676,GTPBP2,1.0,0.034,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CTD_human
3848,383,ARG1,0.551,0.7240000000000001,C0002514,"Amino Acid Metabolism, Inborn Errors",group,C16;C18,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3849,383,ARG1,0.551,0.7240000000000001,C0003949,Asbestosis,disease,C08;C24,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
3850,383,ARG1,0.551,0.7240000000000001,C0004096,Asthma,disease,C08;C20,Disease or Syndrome,0.4,0.9,2003.0,2014.0,2,0,CTD_human
3851,383,ARG1,0.551,0.7240000000000001,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.5,,2005.0,2005.0,0,0,GENOMICS_ENGLAND
3852,383,ARG1,0.551,0.7240000000000001,C0018500,Hair Diseases,group,C17,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3853,383,ARG1,0.551,0.7240000000000001,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2013.0,2013.0,1,0,CTD_human
3854,383,ARG1,0.551,0.7240000000000001,C0021053,Immune System Diseases,group,C20,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3855,383,ARG1,0.551,0.7240000000000001,C0023281,Leishmaniasis,disease,C03;C17,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3856,383,ARG1,0.551,0.7240000000000001,C0026848,Myopathy,group,C05;C10,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3857,383,ARG1,0.551,0.7240000000000001,C0032927,Precancerous Conditions,group,C04,Neoplastic Process,0.31,1.0,2012.0,2016.0,1,0,CTD_human
3858,383,ARG1,0.551,0.7240000000000001,C0037116,Silicosis,disease,C08;C24,Disease or Syndrome,0.5,,2004.0,2007.0,1,0,CTD_human
3859,383,ARG1,0.551,0.7240000000000001,C0152013,Adenocarcinoma of lung (disorder),disease,C04;C08,Neoplastic Process,0.3,,2016.0,2016.0,1,0,CTD_human
3860,383,ARG1,0.551,0.7240000000000001,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.44,0.75,2013.0,2016.0,0,0,GENOMICS_ENGLAND
3861,383,ARG1,0.551,0.7240000000000001,C0268548,Hyperargininemia,phenotype,C10;C16;C18,Disease or Syndrome,1.0,1.0,1979.0,2018.0,4,9,CTD_human;ORPHANET;UNIPROT
3862,383,ARG1,0.551,0.7240000000000001,C0282313,"Condition, Preneoplastic",phenotype,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
3863,383,ARG1,0.551,0.7240000000000001,C0750905,"Amino Acid Metabolism, Inherited Disorders",disease,C16;C18,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
3864,383,ARG1,0.551,0.7240000000000001,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
3865,383,ARG1,0.551,0.7240000000000001,C1112213,Cholestasis in newborn,disease,,Disease or Syndrome,0.31,1.0,2016.0,2016.0,0,0,GENOMICS_ENGLAND
3866,383,ARG1,0.551,0.7240000000000001,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
3867,383,ARG1,0.551,0.7240000000000001,C2930617,Pulmonary Fibrosis - from Asbestos Exposure,disease,C08;C24,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
3868,383,ARG1,0.551,0.7240000000000001,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
3869,383,ARG1,0.551,0.7240000000000001,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
3870,383,ARG1,0.551,0.7240000000000001,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
3871,383,ARG1,0.551,0.7240000000000001,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
59304,9439,MED23,0.69,0.379,C3280265,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18",disease,,Disease or Syndrome,0.6,,2011.0,2011.0,1,3,CTD_human;UNIPROT
59305,9439,MED23,0.69,0.379,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.43,1.0,2011.0,2016.0,4,0,GENOMICS_ENGLAND
64432,23345,SYNE1,0.594,0.621,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.31,1.0,2009.0,2009.0,0,0,GENOMICS_ENGLAND
64433,23345,SYNE1,0.594,0.621,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
64434,23345,SYNE1,0.594,0.621,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.42,0.6666667,2011.0,2018.0,3,3,PSYGENET
64435,23345,SYNE1,0.594,0.621,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
64436,23345,SYNE1,0.594,0.621,C0007193,"Cardiomyopathy, Dilated",group,C14,Disease or Syndrome,0.31,1.0,2017.0,2017.0,0,0,GENOMICS_ENGLAND
64437,23345,SYNE1,0.594,0.621,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.32,1.0,2007.0,2015.0,2,0,CTD_human
64438,23345,SYNE1,0.594,0.621,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2008.0,2011.0,2,0,CTD_human
64439,23345,SYNE1,0.594,0.621,C0013146,Drug abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64440,23345,SYNE1,0.594,0.621,C0013170,Drug habituation,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64441,23345,SYNE1,0.594,0.621,C0013222,Drug Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64442,23345,SYNE1,0.594,0.621,C0029231,"Organic Mental Disorders, Substance-Induced",disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64443,23345,SYNE1,0.594,0.621,C0038580,Substance Dependence,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64444,23345,SYNE1,0.594,0.621,C0038586,Substance Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64445,23345,SYNE1,0.594,0.621,C0154409,Recurrent major depressive episodes,disease,,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
64446,23345,SYNE1,0.594,0.621,C0236969,Substance-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64447,23345,SYNE1,0.594,0.621,C0264886,Conduction disorder of the heart,group,C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
64448,23345,SYNE1,0.594,0.621,C0410189,"Muscular Dystrophy, Emery-Dreifuss",disease,C05;C10;C16,Disease or Syndrome,0.56,1.0,2008.0,2017.0,0,0,CTD_human
64449,23345,SYNE1,0.594,0.621,C0410190,Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder),disease,C05;C10;C16,Disease or Syndrome,0.5,,,,0,0,CTD_human;ORPHANET
64450,23345,SYNE1,0.594,0.621,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.33,1.0,1998.0,2008.0,1,0,CTD_human
64451,23345,SYNE1,0.594,0.621,C0686353,"Muscular Dystrophies, Limb-Girdle",group,C05;C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
64452,23345,SYNE1,0.594,0.621,C0699743,Congenital muscular dystrophy (disorder),disease,,Disease or Syndrome,0.31,1.0,2009.0,2018.0,2,0,GENOMICS_ENGLAND
64453,23345,SYNE1,0.594,0.621,C0740858,Substance abuse problem,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64454,23345,SYNE1,0.594,0.621,C0751337,X-Linked Emery-Dreifuss Muscular Dystrophy,disease,C05;C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
64455,23345,SYNE1,0.594,0.621,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
64456,23345,SYNE1,0.594,0.621,C1450051,Autosomal Recessive Emery-Dreifuss Muscular Dystrophy,disease,C05;C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
64457,23345,SYNE1,0.594,0.621,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
64458,23345,SYNE1,0.594,0.621,C1510472,Drug Dependence,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
64459,23345,SYNE1,0.594,0.621,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.52,1.0,2006.0,2015.0,3,3,CTD_human;UNIPROT
64460,23345,SYNE1,0.594,0.621,C1853116,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8 (disorder)",disease,C10;C16,Disease or Syndrome,0.6,,2007.0,2017.0,0,27,CTD_human;ORPHANET
64461,23345,SYNE1,0.594,0.621,C2751807,Emery-Dreifuss Muscular Dystrophy 4,disease,C05;C10;C16,Disease or Syndrome,0.4,,2008.0,2008.0,1,10,UNIPROT
64462,23345,SYNE1,0.594,0.621,C2931822,Nasopharyngeal carcinoma,disease,C04;C07;C09,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
64463,23345,SYNE1,0.594,0.621,C3683483,Autosomal Recessive Cerebellar Ataxia Type 1,disease,C10;C23,Disease or Syndrome,0.3,,,,0,0,ORPHANET
64464,23345,SYNE1,0.594,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2014.0,2016.0,2,0,GENOMICS_ENGLAND
64465,23345,SYNE1,0.594,0.621,C4316881,Prescription Drug Abuse,phenotype,C25;F03,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
78006,221895,JAZF1,0.616,0.44799999999999995,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",disease,C18;C19,Disease or Syndrome,0.5,0.9375,2008.0,2018.0,1,4,CTD_human
78007,221895,JAZF1,0.616,0.44799999999999995,C0014170,Endometrial Neoplasms,group,C04;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
78008,221895,JAZF1,0.616,0.44799999999999995,C0024141,"Lupus Erythematosus, Systemic",disease,C17;C20,Disease or Syndrome,0.43,0.6666667,2009.0,2016.0,1,3,CTD_human
78009,221895,JAZF1,0.616,0.44799999999999995,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
78010,221895,JAZF1,0.616,0.44799999999999995,C0206630,Endometrial Stromal Sarcoma,disease,C04;C13,Neoplastic Process,0.4,0.9,2006.0,2016.0,0,0,ORPHANET
78011,221895,JAZF1,0.616,0.44799999999999995,C0242380,Libman-Sacks Disease,disease,C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
78012,221895,JAZF1,0.616,0.44799999999999995,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.37,0.8571429,2008.0,2015.0,1,0,CTD_human
78013,221895,JAZF1,0.616,0.44799999999999995,C0476089,Endometrial Carcinoma,disease,C04;C13,Neoplastic Process,0.31,1.0,2008.0,2008.0,1,0,CTD_human
51054,7036,TFR2,0.594,0.517,C0002875,Cooley's anemia,disease,C15;C16,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
51055,7036,TFR2,0.594,0.517,C0005283,beta Thalassemia,disease,C15;C16,Disease or Syndrome,0.31,1.0,2006.0,2006.0,1,0,CTD_human
51056,7036,TFR2,0.594,0.517,C0007193,"Cardiomyopathy, Dilated",group,C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
51057,7036,TFR2,0.594,0.517,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
51058,7036,TFR2,0.594,0.517,C0018995,Hemochromatosis,disease,C16;C18,Disease or Syndrome,0.4,1.0,2000.0,2017.0,4,0,CTD_human
51059,7036,TFR2,0.594,0.517,C0019025,Hemoglobin F Disease,disease,C15;C16,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
51060,7036,TFR2,0.594,0.517,C0085578,Thalassemia Minor,disease,C15;C16,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
51061,7036,TFR2,0.594,0.517,C0264886,Conduction disorder of the heart,group,C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
51062,7036,TFR2,0.594,0.517,C0271979,Thalassemia Intermedia,disease,C15;C16,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
51063,7036,TFR2,0.594,0.517,C0342384,Idiopathic hypogonadotropic hypogonadism,disease,C19,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
51064,7036,TFR2,0.594,0.517,C0392514,Hereditary hemochromatosis,disease,C16;C18,Disease or Syndrome,0.5,1.0,2000.0,2017.0,4,1,CTD_human
51065,7036,TFR2,0.594,0.517,C1112213,Cholestasis in newborn,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
51066,7036,TFR2,0.594,0.517,C1858664,"HEMOCHROMATOSIS, TYPE 3",disease,C16;C18,Disease or Syndrome,0.99,1.0,1993.0,2014.0,2,15,CTD_human;ORPHANET;UNIPROT
16453,2055,CLN8,0.667,0.345,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
16454,2055,CLN8,0.667,0.345,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
16455,2055,CLN8,0.667,0.345,C1838570,"CEROID LIPOFUSCINOSIS, NEURONAL, 8",disease,C10;C16;C18,Disease or Syndrome,0.93,1.0,1986.0,2016.0,7,30,CTD_human;ORPHANET;UNIPROT
16456,2055,CLN8,0.667,0.345,C1864923,Northern epilepsy syndrome,disease,C10;C16;C18,Disease or Syndrome,0.75,1.0,1993.0,2017.0,2,1,CTD_human;ORPHANET;UNIPROT
16457,2055,CLN8,0.667,0.345,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.41,1.0,2010.0,2010.0,0,0,GENOMICS_ENGLAND
64480,23362,PSD3,0.685,0.379,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,GENOMICS_ENGLAND
64481,23362,PSD3,0.685,0.379,C0017638,Glioma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64482,23362,PSD3,0.685,0.379,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2013.0,2016.0,1,1,PSYGENET
64483,23362,PSD3,0.685,0.379,C0236733,Amphetamine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64484,23362,PSD3,0.685,0.379,C0236804,Amphetamine Addiction,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64485,23362,PSD3,0.685,0.379,C0236807,Amphetamine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64486,23362,PSD3,0.685,0.379,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64487,23362,PSD3,0.685,0.379,C0555198,Malignant Glioma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64488,23362,PSD3,0.685,0.379,C1867439,"Pterygium, Antecubital",disease,C05;C16,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CLINGEN
62922,10984,KCNQ1OT1,0.604,0.586,C0004903,Beckwith-Wiedemann Syndrome,disease,C16,Disease or Syndrome,0.4,0.9782609,1999.0,2016.0,0,0,CTD_human
62923,10984,KCNQ1OT1,0.604,0.586,C0332890,Congenital hemihypertrophy,disease,,Congenital Abnormality,0.4,,,,0,0,ORPHANET
62924,10984,KCNQ1OT1,0.604,0.586,C1856184,"HEMIHYPERPLASIA, ISOLATED",disease,C23,Disease or Syndrome,0.31,1.0,2008.0,2008.0,0,0,ORPHANET
23382,3047,HBG1,0.639,0.44799999999999995,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,,,0,0,GENOMICS_ENGLAND
23383,3047,HBG1,0.639,0.44799999999999995,C0019025,Hemoglobin F Disease,disease,C15;C16,Disease or Syndrome,0.4,1.0,1982.0,2010.0,0,0,ORPHANET
23384,3047,HBG1,0.639,0.44799999999999995,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2010.0,2010.0,1,0,CTD_human
23385,3047,HBG1,0.639,0.44799999999999995,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
23386,3047,HBG1,0.639,0.44799999999999995,C0263454,Chloracne,disease,C17,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
23387,3047,HBG1,0.639,0.44799999999999995,C0271985,Delta-Beta Thalassemia,disease,C15;C16,Disease or Syndrome,0.35,0.8,1982.0,1988.0,0,0,ORPHANET
23388,3047,HBG1,0.639,0.44799999999999995,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2010.0,2010.0,1,0,CTD_human
75150,85363,TRIM5,0.799,0.24100000000000002,C0019693,HIV Infections,group,C02;C20,Disease or Syndrome,0.36,1.0,2004.0,2015.0,1,0,CTD_human
75151,85363,TRIM5,0.799,0.24100000000000002,C4505456,HIV Coinfection,disease,C02;C20,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
76243,120227,CYP2R1,0.607,0.586,C0005944,Metabolic Bone Disorder,group,C05;C18,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CTD_human
76244,120227,CYP2R1,0.607,0.586,C0023890,Liver Cirrhosis,disease,C06,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CTD_human
76245,120227,CYP2R1,0.607,0.586,C0029453,Osteopenia,disease,C05;C18,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CTD_human
76246,120227,CYP2R1,0.607,0.586,C0239946,"Fibrosis, Liver",disease,C06,Disease or Syndrome,0.31,1.0,2013.0,2016.0,1,0,CTD_human
76247,120227,CYP2R1,0.607,0.586,C0268689,"Vitamin D-dependent rickets, type 1",disease,C05;C12;C13;C16;C18,Disease or Syndrome,0.3,,,,0,0,ORPHANET
76248,120227,CYP2R1,0.607,0.586,C1838657,"Vitamin D Hydroxylation-Deficient Rickets, Type 1B",disease,C05;C12;C13;C16;C18,Disease or Syndrome,0.61,1.0,1994.0,2018.0,2,1,CTD_human;UNIPROT
44161,5896,RAG1,0.528,0.69,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2018.0,2018.0,1,0,CTD_human
44162,5896,RAG1,0.528,0.69,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2018.0,2018.0,1,0,CTD_human
44163,5896,RAG1,0.528,0.69,C1832322,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive",disease,C20,Disease or Syndrome,0.7,,1996.0,2017.0,2,10,CTD_human;ORPHANET;UNIPROT
44164,5896,RAG1,0.528,0.69,C1835931,"ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY",disease,C02;C15;C20,Disease or Syndrome,0.7,,2001.0,2006.0,1,2,CTD_human;ORPHANET;UNIPROT
44165,5896,RAG1,0.528,0.69,C2673536,Combined Cellular And Humoral Immune Defects With Granulomas,disease,C15;C16;C18;C20,Disease or Syndrome,0.7,,2001.0,2017.0,1,7,CTD_human;ORPHANET;UNIPROT
44166,5896,RAG1,0.528,0.69,C2700553,Omenn Syndrome,disease,C16;C18;C20,Disease or Syndrome,0.6,0.9642857,1998.0,2016.0,6,24,ORPHANET;UNIPROT
44167,5896,RAG1,0.528,0.69,C2931884,"Reticuloendotheliosis, familial, with eosinophilia",disease,C15;C16;C18;C20,Disease or Syndrome,0.5,,1998.0,2011.0,6,24,CTD_human;UNIPROT
59228,9415,FADS2,0.627,0.552,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2011.0,2018.0,1,2,PSYGENET
59229,9415,FADS2,0.627,0.552,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
59230,9415,FADS2,0.627,0.552,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
59231,9415,FADS2,0.627,0.552,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2015.0,2015.0,1,0,CTD_human
59232,9415,FADS2,0.627,0.552,C0023794,Lipoidosis,disease,C16;C18,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
59233,9415,FADS2,0.627,0.552,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2009.0,2009.0,1,0,PSYGENET
59234,9415,FADS2,0.627,0.552,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59235,9415,FADS2,0.627,0.552,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59236,9415,FADS2,0.627,0.552,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.4,,2014.0,2018.0,1,1,CTD_human
59237,9415,FADS2,0.627,0.552,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59238,9415,FADS2,0.627,0.552,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59239,9415,FADS2,0.627,0.552,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
57318,8722,CTSF,0.735,0.31,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
57319,8722,CTSF,0.735,0.31,C3715049,"CEROID LIPOFUSCINOSIS, NEURONAL, 13",disease,,Disease or Syndrome,0.7,,2013.0,2015.0,1,6,CTD_human;ORPHANET;UNIPROT
38426,5091,PC,0.565,0.7240000000000001,C0006413,Burkitt Lymphoma,disease,C02;C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
38427,5091,PC,0.565,0.7240000000000001,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2007.0,2007.0,1,0,CTD_human
38428,5091,PC,0.565,0.7240000000000001,C0034341,Pyruvate Carboxylase Deficiency Disease,disease,C10;C16;C18,Disease or Syndrome,0.7,0.8888889000000001,1983.0,2016.0,3,15,CTD_human;UNIPROT
38429,5091,PC,0.565,0.7240000000000001,C0343640,African Burkitt's lymphoma,disease,C02;C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
38430,5091,PC,0.565,0.7240000000000001,C2931141,Leigh necrotizing encephalopathy due to pyruvate carboxylase deficiency,disease,C10;C16;C18,Disease or Syndrome,0.3,,1998.0,2009.0,3,7,UNIPROT
65218,23705,CADM1,0.537,0.655,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.31,,2008.0,2008.0,1,0,CTD_human
65219,23705,CADM1,0.537,0.655,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.33,1.0,2002.0,2013.0,1,0,CTD_human
65220,23705,CADM1,0.537,0.655,C0011573,Endogenous depression,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65221,23705,CADM1,0.537,0.655,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65222,23705,CADM1,0.537,0.655,C0025193,Melancholia,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65223,23705,CADM1,0.537,0.655,C0041696,Unipolar Depression,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65224,23705,CADM1,0.537,0.655,C0086133,Depressive Syndrome,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65225,23705,CADM1,0.537,0.655,C0282126,"Depression, Neurotic",disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65226,23705,CADM1,0.537,0.655,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.32,1.0,2002.0,2007.0,1,0,CTD_human
65227,23705,CADM1,0.537,0.655,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
65228,23705,CADM1,0.537,0.655,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.32,,2002.0,2007.0,1,0,CTD_human
77917,219844,HYLS1,0.645,0.552,C0020255,Hydrocephalus,disease,C10,Disease or Syndrome,0.4,,,,0,0,GENOMICS_ENGLAND
77918,219844,HYLS1,0.645,0.552,C0152427,Polydactyly,disease,C05;C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
77919,219844,HYLS1,0.645,0.552,C0431399,Familial aplasia of the vermis,disease,C11;C12;C13;C16,Disease or Syndrome,0.3,,,,0,0,ORPHANET
77920,219844,HYLS1,0.645,0.552,C1856016,HYDROLETHALUS SYNDROME 1,disease,C05;C10;C16,Disease or Syndrome,0.6,,2005.0,2015.0,1,1,CTD_human;UNIPROT
77921,219844,HYLS1,0.645,0.552,C2931104,Hydrolethalus syndrome,disease,C05;C10;C14;C16,Disease or Syndrome,0.42,1.0,2005.0,2009.0,0,1,ORPHANET
77922,219844,HYLS1,0.645,0.552,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2005.0,2005.0,1,0,GENOMICS_ENGLAND
77923,219844,HYLS1,0.645,0.552,C4277690,Ciliopathies,group,C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
74227,83480,PUS3,0.762,0.31,C4310745,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55",disease,,Disease or Syndrome,0.6,,2017.0,2017.0,0,1,CTD_human;ORPHANET
2641,269,AMHR2,0.639,0.44799999999999995,C1720887,Female Urogenital Diseases,group,C13,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
2642,269,AMHR2,0.639,0.44799999999999995,C1849930,Persistent Mullerian duct syndrome,phenotype,C12;C13;C16;C19,Anatomical Abnormality,0.85,1.0,1996.0,2016.0,2,6,CTD_human;ORPHANET;UNIPROT
13474,1594,CYP27B1,0.542,0.69,C0020437,Hypercalcemia,disease,C18,Disease or Syndrome,0.33,1.0,1999.0,2018.0,1,0,CTD_human
13475,1594,CYP27B1,0.542,0.69,C0026141,Milk-Alkali Syndrome,disease,C18,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
13476,1594,CYP27B1,0.542,0.69,C0033975,Psychotic Disorders,group,F03,Mental or Behavioral Dysfunction,0.01,1.0,2004.0,2004.0,1,0,PSYGENET
13477,1594,CYP27B1,0.542,0.69,C0035579,Rickets,disease,C05;C18,Disease or Syndrome,0.69,1.0,1998.0,2018.0,1,0,CTD_human
13478,1594,CYP27B1,0.542,0.69,C0085655,Polymyositis,disease,C05;C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
13479,1594,CYP27B1,0.542,0.69,C0263984,Polymyositis Ossificans,disease,C05;C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
13480,1594,CYP27B1,0.542,0.69,C0268689,"Vitamin D-dependent rickets, type 1",disease,C05;C12;C13;C16;C18,Disease or Syndrome,0.8,1.0,1998.0,2016.0,4,18,CTD_human;ORPHANET;UNIPROT
13481,1594,CYP27B1,0.542,0.69,C0349204,Nonorganic psychosis,disease,,Mental or Behavioral Dysfunction,0.01,1.0,2004.0,2004.0,1,0,PSYGENET
13482,1594,CYP27B1,0.542,0.69,C0554591,"Polymyositis, Idiopathic",disease,C05;C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
62092,10577,NPC2,0.607,0.655,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
62093,10577,NPC2,0.607,0.655,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
62094,10577,NPC2,0.607,0.655,C0023520,Leukodystrophy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
62095,10577,NPC2,0.607,0.655,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
62096,10577,NPC2,0.607,0.655,C1112213,Cholestasis in newborn,disease,,Disease or Syndrome,0.3,,2001.0,2007.0,4,0,GENOMICS_ENGLAND
62097,10577,NPC2,0.607,0.655,C1843366,"NIEMANN-PICK DISEASE, TYPE C2",disease,C10;C15;C16;C18,Disease or Syndrome,0.67,1.0,1993.0,2017.0,6,15,CTD_human;UNIPROT
62098,10577,NPC2,0.607,0.655,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2001.0,2007.0,4,0,GENOMICS_ENGLAND
12834,1544,CYP1A2,0.509,0.828,C0007137,Squamous cell carcinoma,disease,C04,Neoplastic Process,0.33,0.666666666666667,2007.0,2012.0,1,0,CTD_human
12835,1544,CYP1A2,0.509,0.828,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12836,1544,CYP1A2,0.509,0.828,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.4,1.0,1993.0,2015.0,1,0,CTD_human
12837,1544,CYP1A2,0.509,0.828,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.32,,2007.0,2011.0,1,0,CTD_human
12838,1544,CYP1A2,0.509,0.828,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",disease,C18;C19,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
12839,1544,CYP1A2,0.509,0.828,C0011999,Diastematomyelia,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12840,1544,CYP1A2,0.509,0.828,C0013221,Drug toxicity,group,C25,Injury or Poisoning,0.3,,1999.0,1999.0,1,0,CTD_human
12841,1544,CYP1A2,0.509,0.828,C0018273,Growth Disorders,group,C23,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
12842,1544,CYP1A2,0.509,0.828,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2018.0,2018.0,1,0,CTD_human
12843,1544,CYP1A2,0.509,0.828,C0019207,"Hepatoma, Morris",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12844,1544,CYP1A2,0.509,0.828,C0019208,"Hepatoma, Novikoff",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12845,1544,CYP1A2,0.509,0.828,C0019209,Hepatomegaly,phenotype,C06;C23,Finding,0.3,,1999.0,1999.0,1,0,CTD_human
12846,1544,CYP1A2,0.509,0.828,C0023452,Childhood Acute Lymphoblastic Leukemia,disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12847,1544,CYP1A2,0.509,0.828,C0023453,"Leukemia, Lymphocytic, Acute, L2",disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12848,1544,CYP1A2,0.509,0.828,C0023890,Liver Cirrhosis,disease,C06,Disease or Syndrome,0.31,1.0,1995.0,2017.0,1,0,CTD_human
12849,1544,CYP1A2,0.509,0.828,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2007.0,2007.0,1,0,CTD_human
12850,1544,CYP1A2,0.509,0.828,C0023895,Liver diseases,group,C06,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
12851,1544,CYP1A2,0.509,0.828,C0023904,"Liver Neoplasms, Experimental",group,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12852,1544,CYP1A2,0.509,0.828,C0024117,Chronic Obstructive Airway Disease,disease,C08,Disease or Syndrome,0.33,1.0,2008.0,2010.0,1,0,CTD_human
12853,1544,CYP1A2,0.509,0.828,C0024121,Lung Neoplasms,group,C04;C08,Neoplastic Process,0.31,,2007.0,2012.0,1,0,CTD_human
12854,1544,CYP1A2,0.509,0.828,C0025637,Methemoglobinemia,disease,C15,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
12855,1544,CYP1A2,0.509,0.828,C0027794,Neural Tube Defects,group,C10;C16,Congenital Abnormality,0.31,1.0,2010.0,2010.0,1,0,CTD_human
12856,1544,CYP1A2,0.509,0.828,C0027806,Neurenteric Cyst,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12857,1544,CYP1A2,0.509,0.828,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.4,1.0,2000.0,2014.0,1,0,PSYGENET
12858,1544,CYP1A2,0.509,0.828,C0037997,Splenic Diseases,group,C15,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
12859,1544,CYP1A2,0.509,0.828,C0038002,Splenomegaly,phenotype,C23,Finding,0.3,,1999.0,1999.0,1,0,CTD_human
12860,1544,CYP1A2,0.509,0.828,C0041755,Adverse reaction to drug,group,C25,Pathologic Function,0.3,,1999.0,1999.0,1,0,CTD_human
12861,1544,CYP1A2,0.509,0.828,C0080218,Tethered Cord Syndrome,disease,C10;C16,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
12862,1544,CYP1A2,0.509,0.828,C0086404,Experimental Hepatoma,disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12863,1544,CYP1A2,0.509,0.828,C0086565,Liver Dysfunction,phenotype,C06,Finding,0.3,,2004.0,2004.0,1,0,CTD_human
12864,1544,CYP1A2,0.509,0.828,C0152234,Iniencephaly,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12865,1544,CYP1A2,0.509,0.828,C0152426,Craniorachischisis,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12866,1544,CYP1A2,0.509,0.828,C0162566,Porphyria Cutanea Tarda,disease,C06;C16;C17;C18,Disease or Syndrome,0.36,0.666666666666667,2001.0,2012.0,1,0,CTD_human
12867,1544,CYP1A2,0.509,0.828,C0239946,"Fibrosis, Liver",disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12868,1544,CYP1A2,0.509,0.828,C0242379,Malignant neoplasm of lung,disease,C04;C08,Neoplastic Process,0.39,0.8888888888888891,2001.0,2016.0,1,0,CTD_human
12869,1544,CYP1A2,0.509,0.828,C0266453,Exencephaly,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12870,1544,CYP1A2,0.509,0.828,C0273115,Lung Injury,disease,C08;C26,Injury or Poisoning,0.3,,2015.0,2015.0,1,0,CTD_human
12871,1544,CYP1A2,0.509,0.828,C0333641,Atrophic,phenotype,C23,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
12872,1544,CYP1A2,0.509,0.828,C0344479,Spinal Cord Myelodysplasia,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12873,1544,CYP1A2,0.509,0.828,C0400966,Non-alcoholic Fatty Liver Disease,disease,C06,Disease or Syndrome,0.31,1.0,2010.0,2017.0,1,0,CTD_human
12874,1544,CYP1A2,0.509,0.828,C0702169,Acrania,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12875,1544,CYP1A2,0.509,0.828,C0809983,Schizophrenia and related disorders,group,,Disease or Syndrome,0.31,1.0,2011.0,2011.0,1,0,PSYGENET
12876,1544,CYP1A2,0.509,0.828,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12877,1544,CYP1A2,0.509,0.828,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12878,1544,CYP1A2,0.509,0.828,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.4,1.0,1993.0,2015.0,1,0,CTD_human
12879,1544,CYP1A2,0.509,0.828,C1527303,Chronic Airflow Obstruction,disease,C08,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
12880,1544,CYP1A2,0.509,0.828,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12881,1544,CYP1A2,0.509,0.828,C2350344,Chronic Lung Injury,disease,C08;C26,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
12882,1544,CYP1A2,0.509,0.828,C3241937,Nonalcoholic Steatohepatitis,disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12883,1544,CYP1A2,0.509,0.828,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12884,1544,CYP1A2,0.509,0.828,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12885,1544,CYP1A2,0.509,0.828,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
37172,4913,NTHL1,0.6759999999999999,0.276,C0017185,Gastrointestinal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2015.0,2015.0,1,0,GENOMICS_ENGLAND
37173,4913,NTHL1,0.6759999999999999,0.276,C0032580,Adenomatous Polyposis Coli,disease,C04;C06;C16,Neoplastic Process,0.31,1.0,2015.0,2015.0,1,0,CTD_human
37174,4913,NTHL1,0.6759999999999999,0.276,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.32,1.0,2006.0,2015.0,1,0,GENOMICS_ENGLAND
37175,4913,NTHL1,0.6759999999999999,0.276,C2713442,"Polyposis, Adenomatous Intestinal",disease,C04;C06;C16,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
37176,4913,NTHL1,0.6759999999999999,0.276,C2713443,Familial Intestinal Polyposis,disease,C04;C06;C16,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
37177,4913,NTHL1,0.6759999999999999,0.276,C4225157,FAMILIAL ADENOMATOUS POLYPOSIS 3,disease,,Disease or Syndrome,0.6,,2015.0,2017.0,4,1,CLINGEN;ORPHANET
73355,79759,ZNF668,0.773,0.069,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.31,1.0,2011.0,2011.0,0,0,UNIPROT
73356,79759,ZNF668,0.773,0.069,C0014474,Ependymoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
73357,79759,ZNF668,0.773,0.069,C0205769,Myxopapillary ependymoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
73358,79759,ZNF668,0.773,0.069,C0280788,Anaplastic Ependymoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
73359,79759,ZNF668,0.773,0.069,C0334578,Papillary ependymoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
73360,79759,ZNF668,0.773,0.069,C1384403,Cellular Ependymoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
34585,4597,MVD,0.642,0.44799999999999995,C0265970,"Porokeratosis, Disseminated Superficial Actinic",disease,C16;C17,Disease or Syndrome,0.4,,2011.0,2016.0,0,2,ORPHANET
34586,4597,MVD,0.642,0.44799999999999995,C3553549,"POROKERATOSIS 7, MULTIPLE TYPES",disease,,Disease or Syndrome,0.5,,2008.0,2016.0,2,8,CTD_human;UNIPROT
76445,124583,CANT1,0.645,0.621,C0029434,Osteogenesis Imperfecta,disease,C05;C16;C17,Congenital Abnormality; Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
76446,124583,CANT1,0.645,0.621,C0432242,Desbuquois syndrome,disease,C05;C16;C19;C23,Disease or Syndrome,0.68,1.0,2009.0,2015.0,6,8,CTD_human;ORPHANET;UNIPROT
76447,124583,CANT1,0.645,0.621,C3278482,"DESBUQUOIS DYSPLASIA, KIM VARIANT",disease,,Disease or Syndrome,0.3,,2009.0,2012.0,6,8,UNIPROT
76448,124583,CANT1,0.645,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
76449,124583,CANT1,0.645,0.621,C4012146,DESBUQUOIS DYSPLASIA 1,disease,,Disease or Syndrome,0.4,,2009.0,2015.0,6,18,UNIPROT
76450,124583,CANT1,0.645,0.621,C4540251,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 7",disease,,Congenital Abnormality,0.4,,2017.0,2017.0,1,2,UNIPROT
18112,2235,FECH,0.636,0.414,C0005395,Bile Duct Diseases,group,C06,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
18113,2235,FECH,0.636,0.414,C0016059,Fibrosis,phenotype,C23,Pathologic Function,0.3,,1999.0,1999.0,1,0,CTD_human
18114,2235,FECH,0.636,0.414,C0162568,Erythropoietic Protoporphyria,disease,C06;C16;C17;C18,Disease or Syndrome,1.0,0.956043956043956,1982.0,2018.0,17,18,CTD_human;ORPHANET;UNIPROT
18115,2235,FECH,0.636,0.414,C0349426,Ferrochelatase deficiency,disease,C06;C16;C17;C18,Disease or Syndrome,0.5,,1992.0,2007.0,17,8,CTD_human;UNIPROT
18116,2235,FECH,0.636,0.414,C1623038,Cirrhosis,disease,C23,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
20106,2593,GAMT,0.667,0.24100000000000002,C0002514,"Amino Acid Metabolism, Inborn Errors",group,C16;C18,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20107,2593,GAMT,0.667,0.24100000000000002,C0020796,Profound Mental Retardation,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2005.0,2005.0,1,0,CTD_human
20108,2593,GAMT,0.667,0.24100000000000002,C0022333,Jacksonian Seizure,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20109,2593,GAMT,0.667,0.24100000000000002,C0025363,"Mental Retardation, Psychosocial",disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2005.0,2005.0,1,0,CTD_human
20110,2593,GAMT,0.667,0.24100000000000002,C0036572,Seizures,phenotype,C10;C23,Sign or Symptom,0.4,,2005.0,2005.0,1,0,CTD_human
20111,2593,GAMT,0.667,0.24100000000000002,C0149958,Complex partial seizures,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20112,2593,GAMT,0.667,0.24100000000000002,C0234533,Generalized seizures,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20113,2593,GAMT,0.667,0.24100000000000002,C0234535,"Seizures, Clonic",disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20114,2593,GAMT,0.667,0.24100000000000002,C0270824,Visual seizure,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20115,2593,GAMT,0.667,0.24100000000000002,C0270844,Tonic Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2005.0,2005.0,1,0,CTD_human
20116,2593,GAMT,0.667,0.24100000000000002,C0270846,Epileptic drop attack,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20117,2593,GAMT,0.667,0.24100000000000002,C0422850,"Seizures, Somatosensory",phenotype,C10;C23,Pathologic Function,0.3,,2005.0,2005.0,1,0,CTD_human
20118,2593,GAMT,0.667,0.24100000000000002,C0422852,"Seizures, Auditory",phenotype,C10;C23,Pathologic Function,0.3,,2005.0,2005.0,1,0,CTD_human
20119,2593,GAMT,0.667,0.24100000000000002,C0422853,Olfactory seizure,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20120,2593,GAMT,0.667,0.24100000000000002,C0422854,Gustatory seizure,phenotype,C10;C23,Sign or Symptom,0.3,,2005.0,2005.0,1,0,CTD_human
20121,2593,GAMT,0.667,0.24100000000000002,C0422855,Vertiginous seizure,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20122,2593,GAMT,0.667,0.24100000000000002,C0494475,Tonic - clonic seizures,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20123,2593,GAMT,0.667,0.24100000000000002,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
20124,2593,GAMT,0.667,0.24100000000000002,C0574080,Guanidinoacetate methyltransferase deficiency,disease,C10;C23,Disease or Syndrome,0.94,1.0,1993.0,2016.0,11,13,CTD_human;ORPHANET;UNIPROT
20125,2593,GAMT,0.667,0.24100000000000002,C0750905,"Amino Acid Metabolism, Inherited Disorders",disease,C16;C18,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20126,2593,GAMT,0.667,0.24100000000000002,C0751056,Non-epileptic convulsion,phenotype,C10;C23,Sign or Symptom,0.3,,2005.0,2005.0,1,0,CTD_human
20127,2593,GAMT,0.667,0.24100000000000002,C0751110,Single Seizure,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20128,2593,GAMT,0.667,0.24100000000000002,C0751123,Atonic Absence Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20129,2593,GAMT,0.667,0.24100000000000002,C0751494,Convulsive Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2005.0,2005.0,1,0,CTD_human
20130,2593,GAMT,0.667,0.24100000000000002,C0751495,"Seizures, Focal",phenotype,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20131,2593,GAMT,0.667,0.24100000000000002,C0751496,"Seizures, Sensory",phenotype,C10;C23,Sign or Symptom,0.3,,2005.0,2005.0,1,0,CTD_human
20132,2593,GAMT,0.667,0.24100000000000002,C0917816,Mental deficiency,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2005.0,2005.0,1,0,CTD_human
20133,2593,GAMT,0.667,0.24100000000000002,C3495874,Nonepileptic Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20134,2593,GAMT,0.667,0.24100000000000002,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.6,,2005.0,2005.0,1,0,CTD_human;GENOMICS_ENGLAND
20135,2593,GAMT,0.667,0.24100000000000002,C4048158,Convulsions,phenotype,C10;C23,Sign or Symptom,0.3,,2005.0,2005.0,1,0,CTD_human
20136,2593,GAMT,0.667,0.24100000000000002,C4316903,Absence Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2005.0,2005.0,1,0,CTD_human
20137,2593,GAMT,0.667,0.24100000000000002,C4317109,Epileptic Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
20138,2593,GAMT,0.667,0.24100000000000002,C4317123,Myoclonic Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2005.0,2005.0,1,0,CTD_human
20139,2593,GAMT,0.667,0.24100000000000002,C4505436,Generalized Absence Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
42017,5589,PRKCSH,0.735,0.517,C0022680,Polycystic Kidney Diseases,group,C12;C13;C16,Disease or Syndrome,0.33,1.0,2003.0,2014.0,1,0,CTD_human
42018,5589,PRKCSH,0.735,0.517,C0158683,Polycystic liver disease,disease,C04;C06;C23,Disease or Syndrome,0.7,0.9375,2003.0,2014.0,2,0,CTD_human;ORPHANET
42019,5589,PRKCSH,0.735,0.517,C1567435,Polycystic Kidney - body part,phenotype,C12;C13;C16,Anatomical Abnormality,0.3,,2011.0,2011.0,1,0,CTD_human
42020,5589,PRKCSH,0.735,0.517,C1691228,Cystic Kidney Diseases,group,C12;C13,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
42021,5589,PRKCSH,0.735,0.517,C4277690,Ciliopathies,group,C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
71707,57787,MARK4,0.773,0.24100000000000002,C1319315,Adenocarcinoma of large intestine,disease,,Neoplastic Process,0.3,,2007.0,2007.0,1,1,UNIPROT
79076,388552,BLOC1S3,0.773,0.379,C0032460,Polycystic Ovary Syndrome,disease,C04;C13;C19,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
79077,388552,BLOC1S3,0.773,0.379,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.32,1.0,2008.0,2014.0,1,0,PSYGENET
79078,388552,BLOC1S3,0.773,0.379,C0079504,Hermanski-Pudlak Syndrome,disease,C11;C15;C16;C17;C18,Disease or Syndrome,0.32,1.0,2006.0,2013.0,0,0,CTD_human
79079,388552,BLOC1S3,0.773,0.379,C1136382,Sclerocystic Ovaries,disease,C04;C13;C19,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
79080,388552,BLOC1S3,0.773,0.379,C3888026,HERMANSKY-PUDLAK SYNDROME 8,disease,,Disease or Syndrome,0.61,1.0,1981.0,2013.0,0,2,ORPHANET
42473,5621,PRNP,0.474,0.897,C0002395,Alzheimer's Disease,disease,C10;F03,Disease or Syndrome,0.4,0.9104478000000001,1986.0,2016.0,1,0,CTD_human
42474,5621,PRNP,0.474,0.897,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
42475,5621,PRNP,0.474,0.897,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
42476,5621,PRNP,0.474,0.897,C0011265,Presenile dementia,disease,C10;F03,Mental or Behavioral Dysfunction,0.4,0.9032258,1990.0,2015.0,1,0,CTD_human
42477,5621,PRNP,0.474,0.897,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.4,1.0,2012.0,2012.0,1,0,PSYGENET
42478,5621,PRNP,0.474,0.897,C0013364,"Dysautonomia, Familial",disease,C10;C16,Congenital Abnormality; Disease or Syndrome,0.3,,1992.0,2005.0,2,0,GENOMICS_ENGLAND
42479,5621,PRNP,0.474,0.897,C0017495,Gerstmann-Straussler-Scheinker Disease,disease,C10;C16,Disease or Syndrome,1.0,0.9826087,1989.0,2017.0,12,13,CTD_human;ORPHANET;UNIPROT
42480,5621,PRNP,0.474,0.897,C0019202,Hepatolenticular Degeneration,disease,C06;C10;C16;C18,Disease or Syndrome,0.32,1.0,2006.0,2006.0,1,0,CTD_human
42481,5621,PRNP,0.474,0.897,C0022336,Creutzfeldt-Jakob disease,disease,C10;F03,Disease or Syndrome,1.0,0.9463601999999999,1988.0,2018.0,12,10,CTD_human;ORPHANET;UNIPROT
42482,5621,PRNP,0.474,0.897,C0022802,Kuru,disease,C10,Disease or Syndrome,0.5,,,,0,0,CTD_human;ORPHANET
42483,5621,PRNP,0.474,0.897,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
42484,5621,PRNP,0.474,0.897,C0024623,Malignant neoplasm of stomach,disease,C04;C06,Neoplastic Process,0.36,1.0,2005.0,2015.0,1,0,CTD_human
42485,5621,PRNP,0.474,0.897,C0027540,Necrosis,phenotype,C23,Organ or Tissue Function,0.3,,2008.0,2008.0,1,0,CTD_human
42486,5621,PRNP,0.474,0.897,C0027627,Neoplasm Metastasis,phenotype,C04;C23,Neoplastic Process,0.34,1.0,2008.0,2017.0,1,0,CTD_human
42487,5621,PRNP,0.474,0.897,C0027659,"Neoplasms, Experimental",group,C04,Experimental Model of Disease; Neoplastic Process,0.3,,2011.0,2011.0,1,0,CTD_human
42488,5621,PRNP,0.474,0.897,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.31,1.0,2000.0,2007.0,1,0,CTD_human
42489,5621,PRNP,0.474,0.897,C0036457,Scrapie,disease,C10;C22,Disease or Syndrome,0.35,1.0,1994.0,2011.0,4,0,CTD_human
42490,5621,PRNP,0.474,0.897,C0038356,Stomach Neoplasms,group,C04;C06,Neoplastic Process,0.33,,2006.0,2008.0,1,0,CTD_human
42491,5621,PRNP,0.474,0.897,C0162534,Prion Diseases,group,C10,Disease or Syndrome,0.5,0.9562363000000002,1988.0,2018.0,4,15,CTD_human
42492,5621,PRNP,0.474,0.897,C0206042,Fatal Familial Insomnia,disease,C10,Disease or Syndrome,1.0,0.9577465000000001,1989.0,2017.0,3,2,CTD_human;ORPHANET;UNIPROT
42493,5621,PRNP,0.474,0.897,C0276496,Familial Alzheimer Disease (FAD),disease,C10;F03,Disease or Syndrome,0.32,0.5,2000.0,2012.0,1,0,CTD_human
42494,5621,PRNP,0.474,0.897,C0376329,New Variant Creutzfeldt-Jakob Disease,disease,C10;F03,Disease or Syndrome,0.7,0.875,1990.0,2016.0,12,8,CTD_human;ORPHANET;UNIPROT
42495,5621,PRNP,0.474,0.897,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
42496,5621,PRNP,0.474,0.897,C0391976,Pain Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,2013.0,2017.0,4,0,GENOMICS_ENGLAND
42497,5621,PRNP,0.474,0.897,C0494463,"Alzheimer Disease, Late Onset",disease,C10;F03,Mental or Behavioral Dysfunction,0.31,1.0,2007.0,2015.0,1,0,CTD_human
42498,5621,PRNP,0.474,0.897,C0525045,Mood Disorders,group,F03,Mental or Behavioral Dysfunction,0.3,1.0,2012.0,2012.0,1,0,PSYGENET
42499,5621,PRNP,0.474,0.897,C0546126,Acute Confusional Senile Dementia,disease,C10;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
42500,5621,PRNP,0.474,0.897,C0750900,"Alzheimer's Disease, Focal Onset",disease,C10;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
42501,5621,PRNP,0.474,0.897,C0750901,"Alzheimer Disease, Early Onset",disease,C10;F03,Disease or Syndrome,0.32,1.0,2000.0,2007.0,1,0,CTD_human
42502,5621,PRNP,0.474,0.897,C0751254,"Creutzfeldt-Jakob Disease, Familial",disease,C10;F03,Disease or Syndrome,0.7,1.0,1990.0,2018.0,12,8,CTD_human;ORPHANET;UNIPROT
42503,5621,PRNP,0.474,0.897,C0751645,"Human Transmissible Spongiform Encephalopathies, Inherited",disease,C10,Disease or Syndrome,0.31,1.0,1998.0,2007.0,4,0,CTD_human
42504,5621,PRNP,0.474,0.897,C0751776,Atypical Inclusion-Body Disease,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42505,5621,PRNP,0.474,0.897,C0751777,Familial Progressive Myoclonic Epilepsy,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42506,5621,PRNP,0.474,0.897,C0751778,"Myoclonic Epilepsies, Progressive",disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42507,5621,PRNP,0.474,0.897,C0751779,Action Myoclonus-Renal Failure Syndrome,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42508,5621,PRNP,0.474,0.897,C0751780,Biotin-Responsive Encephalopathy,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42509,5621,PRNP,0.474,0.897,C0751781,Dentatorubral-Pallidoluysian Atrophy,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42510,5621,PRNP,0.474,0.897,C0751782,May-White Syndrome,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42511,5621,PRNP,0.474,0.897,C1527352,Hepatic Form of Wilson Disease,disease,C06;C10;C16;C18,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
42512,5621,PRNP,0.474,0.897,C1708349,Hereditary Diffuse Gastric Cancer,disease,C04;C06,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
42513,5621,PRNP,0.474,0.897,C1847650,SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES,disease,C10;C16;F03,Disease or Syndrome,0.6,,1997.0,2006.0,2,3,CTD_human;UNIPROT
42514,5621,PRNP,0.474,0.897,C1852467,"Creutzfeldt-Jakob Disease, Sporadic",disease,C10;F03,Disease or Syndrome,0.6,0.9722221999999999,1990.0,2016.0,10,8,ORPHANET;UNIPROT
42515,5621,PRNP,0.474,0.897,C1864112,HUNTINGTON DISEASE-LIKE 1,disease,C10;C16;F03,Disease or Syndrome,0.6,,1989.0,2017.0,0,3,CTD_human;ORPHANET
42516,5621,PRNP,0.474,0.897,C1969957,"Creutzfeldt-Jakob Disease, Heidenhain Variant",disease,C10;C11;C23;F03,Disease or Syndrome,0.5,,1990.0,2010.0,10,8,ORPHANET;UNIPROT
42517,5621,PRNP,0.474,0.897,C2362914,clinical depression,disease,,Mental or Behavioral Dysfunction,0.3,1.0,2015.0,2015.0,1,0,PSYGENET
42518,5621,PRNP,0.474,0.897,C2931022,"Amyloidosis, Cerebral, with Spongiform Encephalopathy",disease,C10;F03,Disease or Syndrome,0.33,0.6666667,1989.0,2010.0,11,8,UNIPROT
42519,5621,PRNP,0.474,0.897,C3805618,"CEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED",disease,,Disease or Syndrome,0.4,,1989.0,2011.0,11,11,UNIPROT
42520,5621,PRNP,0.474,0.897,C4303482,Familial Alzheimer-like prion disease,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
41549,5476,CTSA,0.696,0.552,C0020305,Hydrops Fetalis,disease,C13;C15;C16;C20;C23,Disease or Syndrome,0.3,,1995.0,2009.0,3,0,GENOMICS_ENGLAND
41550,5476,CTSA,0.696,0.552,C0268233,GALACTOSIALIDOSIS,disease,C16;C18,Disease or Syndrome,0.8,1.0,1992.0,2018.0,4,14,CTD_human;ORPHANET;UNIPROT
41551,5476,CTSA,0.696,0.552,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
73874,80331,DNAJC5,0.735,0.207,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,2011.0,2016.0,2,0,GENOMICS_ENGLAND
73875,80331,DNAJC5,0.735,0.207,C1834207,"Ceroid Lipofuscinosis, Neuronal, Parry Type",disease,C10;C16;C18,Disease or Syndrome,0.62,1.0,1971.0,2013.0,5,2,ORPHANET;UNIPROT
7616,861,RUNX1,0.467,0.69,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.38,0.875,2004.0,2013.0,1,0,CTD_human
7617,861,RUNX1,0.467,0.69,C0006413,Burkitt Lymphoma,disease,C02;C04;C15;C20,Neoplastic Process,0.3,,,,0,0,ORPHANET
7618,861,RUNX1,0.467,0.69,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,2008.0,2012.0,3,0,GENOMICS_ENGLAND
7619,861,RUNX1,0.467,0.69,C0017636,Glioblastoma,disease,C04,Neoplastic Process,0.32,1.0,2012.0,2017.0,1,0,CTD_human
7620,861,RUNX1,0.467,0.69,C0023452,Childhood Acute Lymphoblastic Leukemia,disease,C04;C15;C20,Neoplastic Process,0.4,0.97979797979798,1996.0,2018.0,1,0,CTD_human
7621,861,RUNX1,0.467,0.69,C0023453,"Leukemia, Lymphocytic, Acute, L2",disease,C04;C15;C20,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
7622,861,RUNX1,0.467,0.69,C0023467,"Leukemia, Myelocytic, Acute",disease,C04,Neoplastic Process,0.7,0.9829059829059829,1990.0,2018.0,2,4,CGI;CTD_human
7623,861,RUNX1,0.467,0.69,C0023473,"Myeloid Leukemia, Chronic",disease,C04;C15,Neoplastic Process,0.4,1.0,1993.0,2014.0,0,0,ORPHANET
7624,861,RUNX1,0.467,0.69,C0023485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.38,1.0,1999.0,2016.0,2,0,CTD_human
7625,861,RUNX1,0.467,0.69,C0026998,"Acute Myeloid Leukemia, M1",disease,C04,Neoplastic Process,0.3,,2008.0,2016.0,2,0,CTD_human
7626,861,RUNX1,0.467,0.69,C0032197,Platelet Storage Pool Deficiency,disease,C15,Disease or Syndrome,0.32,1.0,2004.0,2018.0,0,0,ORPHANET
7627,861,RUNX1,0.467,0.69,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
7628,861,RUNX1,0.467,0.69,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,2008.0,2012.0,3,0,GENOMICS_ENGLAND
7629,861,RUNX1,0.467,0.69,C0334588,Giant Cell Glioblastoma,disease,C04,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
7630,861,RUNX1,0.467,0.69,C0349639,Juvenile Myelomonocytic Leukemia,disease,C04;C15,Neoplastic Process,0.33,1.0,1998.0,2016.0,1,0,CTD_human
7631,861,RUNX1,0.467,0.69,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.32,1.0,2007.0,2016.0,1,0,CTD_human
7632,861,RUNX1,0.467,0.69,C0376545,Hematologic Neoplasms,group,C04;C15,Neoplastic Process,0.4,1.0,1998.0,2017.0,2,0,GENOMICS_ENGLAND
7633,861,RUNX1,0.467,0.69,C1292769,Precursor B-cell lymphoblastic leukemia,disease,,Neoplastic Process,0.4,0.95,1997.0,2016.0,0,0,ORPHANET
7634,861,RUNX1,0.467,0.69,C1621958,Glioblastoma Multiforme,disease,C04,Neoplastic Process,0.31,1.0,2013.0,2017.0,1,0,CTD_human
7635,861,RUNX1,0.467,0.69,C1832388,"Platelet Disorder, Familial, with Associated Myeloid Malignancy",disease,C04;C15;C16,Disease or Syndrome,0.72,1.0,1999.0,2017.0,7,11,CLINGEN;CTD_human;ORPHANET;UNIPROT
7636,861,RUNX1,0.467,0.69,C1879321,Acute Myeloid Leukemia (AML-M2),disease,C04,Neoplastic Process,0.34,1.0,1994.0,2016.0,2,0,CTD_human
7637,861,RUNX1,0.467,0.69,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.4,1.0,1994.0,2017.0,1,0,CTD_human
7638,861,RUNX1,0.467,0.69,C2713368,Hematopoetic Myelodysplasia,disease,C15,Pathologic Function,0.3,,2017.0,2017.0,1,0,CTD_human
7639,861,RUNX1,0.467,0.69,C2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,disease,C11;C15;C16;C17;C18,Disease or Syndrome,0.3,,,,0,0,ORPHANET
7640,861,RUNX1,0.467,0.69,C3463824,MYELODYSPLASTIC SYNDROME,group,C15,Neoplastic Process,0.5,0.9859154929577459,1993.0,2017.0,1,0,CTD_human
31178,3976,LIF,0.528,0.655,C0000786,Spontaneous abortion,phenotype,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
31179,3976,LIF,0.528,0.655,C0000822,"Abortion, Tubal",disease,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
31180,3976,LIF,0.528,0.655,C0011206,Delirium,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,0.6666667,2007.0,2011.0,3,0,PSYGENET
31181,3976,LIF,0.528,0.655,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.3,1.0,2004.0,2004.0,1,0,PSYGENET
31182,3976,LIF,0.528,0.655,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2004.0,2004.0,1,0,PSYGENET
31183,3976,LIF,0.528,0.655,C0012684,Blastocyst Disintegration,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31184,3976,LIF,0.528,0.655,C0018800,Cardiomegaly,phenotype,C14;C23,Finding,0.3,,2004.0,2004.0,1,0,CTD_human
31185,3976,LIF,0.528,0.655,C0021361,Female infertility,phenotype,C13,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31186,3976,LIF,0.528,0.655,C0032460,Polycystic Ovary Syndrome,disease,C04;C13;C19,Disease or Syndrome,0.31,1.0,2011.0,2011.0,1,0,CTD_human
31187,3976,LIF,0.528,0.655,C0038279,"Sterility, Postpartum",phenotype,C13,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31188,3976,LIF,0.528,0.655,C0341869,"Subfertility, Female",disease,C13,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
31189,3976,LIF,0.528,0.655,C0400966,Non-alcoholic Fatty Liver Disease,disease,C06,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
31190,3976,LIF,0.528,0.655,C0752351,Embryo Loss,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31191,3976,LIF,0.528,0.655,C0917730,Female sterility,phenotype,C13,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
31192,3976,LIF,0.528,0.655,C1136082,Embryo Disintegration,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31193,3976,LIF,0.528,0.655,C1136382,Sclerocystic Ovaries,disease,C04;C13;C19,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
31194,3976,LIF,0.528,0.655,C1262477,Weight decreased,phenotype,C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
31195,3976,LIF,0.528,0.655,C1383860,Cardiac Hypertrophy,phenotype,C14;C23,Pathologic Function,0.3,,2004.0,2004.0,1,0,CTD_human
31196,3976,LIF,0.528,0.655,C1720887,Female Urogenital Diseases,group,C13,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
31197,3976,LIF,0.528,0.655,C3241937,Nonalcoholic Steatohepatitis,disease,C06,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
56443,8398,PLA2G6,0.494,0.7240000000000001,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
56444,8398,PLA2G6,0.494,0.7240000000000001,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
56445,8398,PLA2G6,0.494,0.7240000000000001,C0027960,Nevus,disease,C04,Neoplastic Process,0.41,1.0,2009.0,2016.0,1,2,CTD_human
56446,8398,PLA2G6,0.494,0.7240000000000001,C0030567,Parkinson Disease,disease,C10,Disease or Syndrome,0.36,1.0,2012.0,2017.0,0,0,GENOMICS_ENGLAND
56447,8398,PLA2G6,0.494,0.7240000000000001,C0033975,Psychotic Disorders,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
56448,8398,PLA2G6,0.494,0.7240000000000001,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.36,1.0,2003.0,2016.0,1,0,PSYGENET
56449,8398,PLA2G6,0.494,0.7240000000000001,C0270724,Infantile Neuroaxonal Dystrophy,disease,C10,Disease or Syndrome,1.0,1.0,2004.0,2018.0,3,11,CTD_human;ORPHANET;UNIPROT
56450,8398,PLA2G6,0.494,0.7240000000000001,C0349204,Nonorganic psychosis,disease,,Mental or Behavioral Dysfunction,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
56451,8398,PLA2G6,0.494,0.7240000000000001,C1857747,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2 (disorder),disease,C10;C18,Disease or Syndrome,0.62,1.0,2006.0,2017.0,1,6,CTD_human;UNIPROT
56452,8398,PLA2G6,0.494,0.7240000000000001,C2750220,Karak Syndrome,disease,C10,Disease or Syndrome,0.43,1.0,2006.0,2015.0,1,2,UNIPROT
56453,8398,PLA2G6,0.494,0.7240000000000001,C2751842,"PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE",disease,C10,Disease or Syndrome,0.74,1.0,2009.0,2017.0,1,5,CTD_human;ORPHANET;UNIPROT
56454,8398,PLA2G6,0.494,0.7240000000000001,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,,,0,0,GENOMICS_ENGLAND
49865,6792,CDKL5,0.551,0.44799999999999995,C0022333,Jacksonian Seizure,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49866,6792,CDKL5,0.551,0.44799999999999995,C0025958,Microcephaly,disease,C05;C10;C16,Congenital Abnormality,0.31,1.0,2010.0,2010.0,0,0,GENOMICS_ENGLAND
49867,6792,CDKL5,0.551,0.44799999999999995,C0035372,Rett Syndrome,disease,C10;C16,Disease or Syndrome,0.5,0.9692308000000001,2005.0,2017.0,1,2,CTD_human
49868,6792,CDKL5,0.551,0.44799999999999995,C0036572,Seizures,phenotype,C10;C23,Sign or Symptom,0.5,1.0,2005.0,2017.0,1,1,CTD_human
49869,6792,CDKL5,0.551,0.44799999999999995,C0037769,West Syndrome,disease,C10,Disease or Syndrome,0.5,0.9642857,2003.0,2018.0,0,1,ORPHANET
49870,6792,CDKL5,0.551,0.44799999999999995,C0149958,Complex partial seizures,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49871,6792,CDKL5,0.551,0.44799999999999995,C0162635,Angelman Syndrome,disease,C10;C16,Disease or Syndrome,0.41,1.0,2005.0,2009.0,1,1,CTD_human
49872,6792,CDKL5,0.551,0.44799999999999995,C0234533,Generalized seizures,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49873,6792,CDKL5,0.551,0.44799999999999995,C0234535,"Seizures, Clonic",disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49874,6792,CDKL5,0.551,0.44799999999999995,C0270824,Visual seizure,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49875,6792,CDKL5,0.551,0.44799999999999995,C0270844,Tonic Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2012.0,2012.0,1,0,CTD_human
49876,6792,CDKL5,0.551,0.44799999999999995,C0270846,Epileptic drop attack,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49877,6792,CDKL5,0.551,0.44799999999999995,C0278883,Metastatic melanoma,disease,,Neoplastic Process,0.3,,,,0,0,UNIPROT
49878,6792,CDKL5,0.551,0.44799999999999995,C0393706,Early infantile epileptic encephalopathy with suppression bursts,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
49879,6792,CDKL5,0.551,0.44799999999999995,C0422850,"Seizures, Somatosensory",phenotype,C10;C23,Pathologic Function,0.3,,2012.0,2012.0,1,0,CTD_human
49880,6792,CDKL5,0.551,0.44799999999999995,C0422852,"Seizures, Auditory",phenotype,C10;C23,Pathologic Function,0.3,,2012.0,2012.0,1,0,CTD_human
49881,6792,CDKL5,0.551,0.44799999999999995,C0422853,Olfactory seizure,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49882,6792,CDKL5,0.551,0.44799999999999995,C0422854,Gustatory seizure,phenotype,C10;C23,Sign or Symptom,0.3,,2012.0,2012.0,1,0,CTD_human
49883,6792,CDKL5,0.551,0.44799999999999995,C0422855,Vertiginous seizure,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49884,6792,CDKL5,0.551,0.44799999999999995,C0494475,Tonic - clonic seizures,disease,C10;C23,Disease or Syndrome,0.31,1.0,2011.0,2012.0,1,0,CTD_human
49885,6792,CDKL5,0.551,0.44799999999999995,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.5,0.9583333,2007.0,2018.0,0,4,GENOMICS_ENGLAND
49886,6792,CDKL5,0.551,0.44799999999999995,C0751056,Non-epileptic convulsion,phenotype,C10;C23,Sign or Symptom,0.3,,2012.0,2012.0,1,0,CTD_human
49887,6792,CDKL5,0.551,0.44799999999999995,C0751110,Single Seizure,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49888,6792,CDKL5,0.551,0.44799999999999995,C0751123,Atonic Absence Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49889,6792,CDKL5,0.551,0.44799999999999995,C0751494,Convulsive Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2012.0,2012.0,1,0,CTD_human
49890,6792,CDKL5,0.551,0.44799999999999995,C0751495,"Seizures, Focal",phenotype,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49891,6792,CDKL5,0.551,0.44799999999999995,C0751496,"Seizures, Sensory",phenotype,C10;C23,Sign or Symptom,0.3,,2012.0,2012.0,1,0,CTD_human
49892,6792,CDKL5,0.551,0.44799999999999995,C1335177,Ovarian Serous Adenocarcinoma,disease,,Neoplastic Process,0.3,,2007.0,2007.0,1,1,UNIPROT
49893,6792,CDKL5,0.551,0.44799999999999995,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.3,,,,0,0,UNIPROT
49894,6792,CDKL5,0.551,0.44799999999999995,C1839333,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2",disease,C10;C16,Disease or Syndrome,0.81,1.0,2003.0,2017.0,18,98,CTD_human;UNIPROT
49895,6792,CDKL5,0.551,0.44799999999999995,C2748910,"Rett Syndrome, Atypical",disease,C10;C16,Disease or Syndrome,0.5,0.9,2008.0,2017.0,0,42,ORPHANET
49896,6792,CDKL5,0.551,0.44799999999999995,C3495874,Nonepileptic Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49897,6792,CDKL5,0.551,0.44799999999999995,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.5,1.0,2003.0,2015.0,0,0,GENOMICS_ENGLAND
49898,6792,CDKL5,0.551,0.44799999999999995,C4048158,Convulsions,phenotype,C10;C23,Sign or Symptom,0.31,1.0,2006.0,2012.0,1,0,CTD_human
49899,6792,CDKL5,0.551,0.44799999999999995,C4316903,Absence Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2012.0,2012.0,1,0,CTD_human
49900,6792,CDKL5,0.551,0.44799999999999995,C4317109,Epileptic Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
49901,6792,CDKL5,0.551,0.44799999999999995,C4317123,Myoclonic Seizures,phenotype,C10;C23,Sign or Symptom,0.4,,2012.0,2012.0,1,0,CTD_human
49902,6792,CDKL5,0.551,0.44799999999999995,C4505436,Generalized Absence Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
45341,6247,RS1,0.7070000000000001,0.276,C0152439,Retinoschisis,disease,C11,Disease or Syndrome,0.5,1.0,1998.0,2015.0,2,0,CTD_human
45342,6247,RS1,0.7070000000000001,0.276,C0271091,"Retinoschisis, Juvenile, X-Linked",disease,C11,Disease or Syndrome,0.7,1.0,1997.0,2016.0,2,18,CTD_human;ORPHANET
45343,6247,RS1,0.7070000000000001,0.276,C1137478,"Retinoschisis, Degenerative",disease,C11,Disease or Syndrome,0.3,,2006.0,2011.0,2,0,CTD_human
45344,6247,RS1,0.7070000000000001,0.276,C3714753,"RETINOSCHISIS 1, X-LINKED, JUVENILE",disease,,Disease or Syndrome,0.51,1.0,1997.0,2017.0,13,56,UNIPROT
77620,170302,ARX,0.541,0.44799999999999995,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
77621,170302,ARX,0.541,0.44799999999999995,C0007820,Cerebrovascular Disorders,group,C10;C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
77622,170302,ARX,0.541,0.44799999999999995,C0020255,Hydrocephalus,disease,C10,Disease or Syndrome,0.31,,2004.0,2008.0,1,0,GENOMICS_ENGLAND
77623,170302,ARX,0.541,0.44799999999999995,C0036875,Disorders of Sex Development,group,C12;C13;C16;C19,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
77624,170302,ARX,0.541,0.44799999999999995,C0037769,West Syndrome,disease,C10,Disease or Syndrome,0.4,1.0,2002.0,2016.0,0,0,ORPHANET
77625,170302,ARX,0.541,0.44799999999999995,C0393706,Early infantile epileptic encephalopathy with suppression bursts,disease,,Disease or Syndrome,0.37,1.0,2007.0,2012.0,0,0,ORPHANET
77626,170302,ARX,0.541,0.44799999999999995,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.41,1.0,2013.0,2013.0,0,0,GENOMICS_ENGLAND
77627,170302,ARX,0.541,0.44799999999999995,C0796124,Proud Syndrome,disease,C10;C12;C13;C16;C23;F01;F03,Disease or Syndrome,0.7,,1992.0,2012.0,1,1,CTD_human;ORPHANET;UNIPROT
77628,170302,ARX,0.541,0.44799999999999995,C0796244,"MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED (disorder)",disease,C10;C16,Disease or Syndrome,0.6,,2002.0,2017.0,1,4,CTD_human;UNIPROT
77629,170302,ARX,0.541,0.44799999999999995,C0796250,PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME,disease,C10;C16;C23,Disease or Syndrome,0.54,1.0,1996.0,2015.0,0,0,CTD_human;ORPHANET
77630,170302,ARX,0.541,0.44799999999999995,C1846171,"Lissencephaly, X-Linked, 2",disease,C10;C12;C13;C16,Disease or Syndrome,0.73,1.0,2002.0,2016.0,2,24,CTD_human;ORPHANET;UNIPROT
77631,170302,ARX,0.541,0.44799999999999995,C1846172,Hydranencephaly and Abnormal Genitalia,disease,C10;C12;C13;C16,Disease or Syndrome,0.6,,2002.0,2004.0,2,4,CTD_human;UNIPROT
77632,170302,ARX,0.541,0.44799999999999995,C1955869,Malformations of Cortical Development,group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
77633,170302,ARX,0.541,0.44799999999999995,C2931498,"Mental Retardation, X-Linked 1",disease,C10;C16,Disease or Syndrome,0.31,0.0,2007.0,2007.0,0,0,ORPHANET
77634,170302,ARX,0.541,0.44799999999999995,C3463992,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1",disease,C10,Disease or Syndrome,0.9,,1997.0,2017.0,3,8,CTD_human;ORPHANET;UNIPROT
77635,170302,ARX,0.541,0.44799999999999995,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.5,1.0,2002.0,2016.0,0,0,GENOMICS_ENGLAND
20969,2705,GJB1,0.527,0.621,C0001430,Adenoma,group,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20970,2705,GJB1,0.527,0.621,C0007134,Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.4,1.0,2003.0,2010.0,1,0,CTD_human
20971,2705,GJB1,0.527,0.621,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.6,0.9702970297029699,1994.0,2018.0,0,0,GENOMICS_ENGLAND
20972,2705,GJB1,0.527,0.621,C0011195,Dejerine-Sottas Disease (disorder),disease,C10;C16,Disease or Syndrome,0.62,1.0,1996.0,2006.0,1,1,UNIPROT
20973,2705,GJB1,0.527,0.621,C0019207,"Hepatoma, Morris",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20974,2705,GJB1,0.527,0.621,C0019208,"Hepatoma, Novikoff",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20975,2705,GJB1,0.527,0.621,C0023903,Liver neoplasms,group,C04;C06,Neoplastic Process,0.38,0.875,1990.0,2016.0,1,0,CTD_human
20976,2705,GJB1,0.527,0.621,C0023904,"Liver Neoplasms, Experimental",group,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20977,2705,GJB1,0.527,0.621,C0024121,Lung Neoplasms,group,C04;C08,Neoplastic Process,0.31,,2004.0,2007.0,2,0,CTD_human
20978,2705,GJB1,0.527,0.621,C0027627,Neoplasm Metastasis,phenotype,C04;C23,Neoplastic Process,0.34,1.0,2007.0,2016.0,1,0,CTD_human
20979,2705,GJB1,0.527,0.621,C0032927,Precancerous Conditions,group,C04,Neoplastic Process,0.3,,1990.0,1990.0,1,0,CTD_human
20980,2705,GJB1,0.527,0.621,C0035126,Reperfusion Injury,disease,C14;C23,Injury or Poisoning,0.3,,2016.0,2016.0,1,0,CTD_human
20981,2705,GJB1,0.527,0.621,C0086404,Experimental Hepatoma,disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20982,2705,GJB1,0.527,0.621,C0205646,"Adenoma, Basal Cell",disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20983,2705,GJB1,0.527,0.621,C0205647,Follicular adenoma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20984,2705,GJB1,0.527,0.621,C0205648,"Adenoma, Microcystic",disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20985,2705,GJB1,0.527,0.621,C0205649,"Adenoma, Monomorphic",disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20986,2705,GJB1,0.527,0.621,C0205650,Papillary adenoma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20987,2705,GJB1,0.527,0.621,C0205651,"Adenoma, Trabecular",disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20988,2705,GJB1,0.527,0.621,C0242379,Malignant neoplasm of lung,disease,C04;C08,Neoplastic Process,0.31,1.0,2004.0,2007.0,2,0,CTD_human
20989,2705,GJB1,0.527,0.621,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20990,2705,GJB1,0.527,0.621,C0282313,"Condition, Preneoplastic",phenotype,C04,Neoplastic Process,0.3,,1990.0,1990.0,1,0,CTD_human
20991,2705,GJB1,0.527,0.621,C0345904,Malignant neoplasm of liver,disease,C04;C06,Neoplastic Process,0.3,,1990.0,1990.0,1,0,CTD_human
20992,2705,GJB1,0.527,0.621,C0393808,"Charcot-Marie-Tooth disease, X-linked, 1",disease,C10;C16,Disease or Syndrome,1.0,1.0,1979.0,2018.0,58,58,CTD_human;ORPHANET;UNIPROT
20993,2705,GJB1,0.527,0.621,C0796205,"SPINOCEREBELLAR ATAXIA, X-LINKED 1",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,ORPHANET
20994,2705,GJB1,0.527,0.621,C1266042,Chromophobe Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20995,2705,GJB1,0.527,0.621,C1266043,Sarcomatoid Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20996,2705,GJB1,0.527,0.621,C1266044,Collecting Duct Carcinoma of the Kidney,disease,C04;C12;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20997,2705,GJB1,0.527,0.621,C1306837,Papillary Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20998,2705,GJB1,0.527,0.621,C2239176,Liver carcinoma,disease,C04;C06,Neoplastic Process,0.4,1.0,1990.0,2017.0,1,0,CTD_human
20999,2705,GJB1,0.527,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2013.0,2016.0,3,0,GENOMICS_ENGLAND
21068,2717,GLA,0.588,0.621,C0002985,Angiokeratoma,disease,C04,Neoplastic Process,0.41,1.0,2010.0,2014.0,1,0,CTD_human
21069,2717,GLA,0.588,0.621,C0002986,Fabry Disease,disease,C10;C14;C16;C18,Disease or Syndrome,1.0,0.9783393501805051,1967.0,2018.0,51,192,CLINGEN;CTD_human;ORPHANET;UNIPROT
21070,2717,GLA,0.588,0.621,C0007193,"Cardiomyopathy, Dilated",group,C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
21071,2717,GLA,0.588,0.621,C0007194,Hypertrophic Cardiomyopathy,disease,C14,Disease or Syndrome,0.36,1.0,1991.0,2018.0,0,0,GENOMICS_ENGLAND
21072,2717,GLA,0.588,0.621,C0007820,Cerebrovascular Disorders,group,C10;C14,Disease or Syndrome,0.32,1.0,2005.0,2015.0,0,0,GENOMICS_ENGLAND
21073,2717,GLA,0.588,0.621,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
21074,2717,GLA,0.588,0.621,C0020305,Hydrops Fetalis,disease,C13;C15;C16;C20;C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
21075,2717,GLA,0.588,0.621,C0023520,Leukodystrophy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
21076,2717,GLA,0.588,0.621,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
21077,2717,GLA,0.588,0.621,C0264886,Conduction disorder of the heart,group,C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
21078,2717,GLA,0.588,0.621,C0391976,Pain Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
21079,2717,GLA,0.588,0.621,C1691228,Cystic Kidney Diseases,group,C12;C13,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
21080,2717,GLA,0.588,0.621,C1970820,"Fabry Disease, Cardiac Variant",disease,C10;C14;C16;C18,Disease or Syndrome,0.6,,1967.0,2018.0,48,113,CLINGEN;UNIPROT
42581,5631,PRPS1,0.614,0.655,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,,,0,0,UNIPROT
42582,5631,PRPS1,0.614,0.655,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.35,1.0,2010.0,2016.0,0,0,GENOMICS_ENGLAND
42583,5631,PRPS1,0.614,0.655,C0043094,Weight Gain,phenotype,C23,Finding,0.3,,2008.0,2008.0,1,0,CTD_human
42584,5631,PRPS1,0.614,0.655,C0796028,"ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.77,1.0,1993.0,2017.0,1,4,CTD_human;ORPHANET;UNIPROT
42585,5631,PRPS1,0.614,0.655,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.3,,,,0,0,UNIPROT
42586,5631,PRPS1,0.614,0.655,C1839566,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5",disease,C05;C09;C10;C11;C16;C23,Disease or Syndrome,0.72,1.0,1993.0,2016.0,1,6,CTD_human;ORPHANET;UNIPROT
42587,5631,PRPS1,0.614,0.655,C1844677,"DEAFNESS, X-LINKED 1 (disorder)",disease,C09;C10;C16;C23,Disease or Syndrome,0.44,1.0,1997.0,2016.0,1,7,UNIPROT
42588,5631,PRPS1,0.614,0.655,C1970827,Phosphoribosylpyrophosphate Synthetase Superactivity,disease,C16;C18,Disease or Syndrome,0.71,1.0,1975.0,2012.0,1,6,CTD_human;ORPHANET;UNIPROT
42589,5631,PRPS1,0.614,0.655,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2014.0,2015.0,2,0,GENOMICS_ENGLAND
8207,959,CD40LG,0.447,0.828,C0002736,Amyotrophic Lateral Sclerosis,disease,C10;C18,Disease or Syndrome,0.31,1.0,2010.0,2010.0,1,0,CTD_human
8208,959,CD40LG,0.447,0.828,C0004364,Autoimmune Diseases,group,C20,Disease or Syndrome,0.4,1.0,1996.0,2017.0,1,0,CTD_human
8209,959,CD40LG,0.447,0.828,C0010054,Coronary Arteriosclerosis,disease,C14,Disease or Syndrome,0.51,1.0,2006.0,2013.0,1,0,CTD_human
8210,959,CD40LG,0.447,0.828,C0020517,Hypersensitivity,group,C20,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
8211,959,CD40LG,0.447,0.828,C0020542,Pulmonary Hypertension,phenotype,C08,Pathologic Function,0.5,,2005.0,2015.0,1,0,CTD_human
8212,959,CD40LG,0.447,0.828,C0027540,Necrosis,phenotype,C23,Organ or Tissue Function,0.3,,2012.0,2012.0,1,0,CTD_human
8213,959,CD40LG,0.447,0.828,C0032285,Pneumonia,disease,C08,Disease or Syndrome,0.32,1.0,2011.0,2014.0,1,0,CTD_human
8214,959,CD40LG,0.447,0.828,C0032300,Lobar Pneumonia,disease,C08,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
8215,959,CD40LG,0.447,0.828,C0333704,Chromosome Breaks,phenotype,C23,Cell or Molecular Dysfunction,0.3,,2016.0,2016.0,1,0,CTD_human
8216,959,CD40LG,0.447,0.828,C0376628,Chromosome Breakage,phenotype,C23,Cell or Molecular Dysfunction,0.3,,2016.0,2016.0,1,0,CTD_human
8217,959,CD40LG,0.447,0.828,C0393554,Amyotrophic Lateral Sclerosis With Dementia,disease,C10;C18,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
8218,959,CD40LG,0.447,0.828,C0398689,"Hyper-IgM Immunodeficiency Syndrome, Type 1",disease,C15;C16;C20,Disease or Syndrome,0.8,0.967032967032967,1992.0,2017.0,8,12,CTD_human;ORPHANET;UNIPROT
8219,959,CD40LG,0.447,0.828,C0543859,"Amyotrophic Lateral Sclerosis, Guam Form",disease,C10;C18,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
8220,959,CD40LG,0.447,0.828,C0887898,Experimental Lung Inflammation,disease,C08,Experimental Model of Disease,0.3,,2011.0,2011.0,1,0,CTD_human
8221,959,CD40LG,0.447,0.828,C1527304,Allergic Reaction,phenotype,C20,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
8222,959,CD40LG,0.447,0.828,C1956346,Coronary Artery Disease,disease,C14,Disease or Syndrome,0.34,1.0,2004.0,2011.0,1,0,CTD_human
8223,959,CD40LG,0.447,0.828,C3714636,Pneumonitis,disease,C08,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
24581,3208,HPCA,0.735,0.345,C1857093,"DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)",disease,C10;C16,Disease or Syndrome,0.7,,1981.0,2017.0,2,3,CTD_human;ORPHANET;UNIPROT
35781,4803,NGF,0.426,0.862,C0002622,Amnesia,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.31,1.0,1995.0,2009.0,2,0,CTD_human
35782,4803,NGF,0.426,0.862,C0002768,Congenital Pain Insensitivity,disease,C10;C16,Disease or Syndrome,0.32,1.0,2009.0,2013.0,0,0,ORPHANET
35783,4803,NGF,0.426,0.862,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
35784,4803,NGF,0.426,0.862,C0009171,Cocaine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
35785,4803,NGF,0.426,0.862,C0010043,Corneal Ulcer,disease,C01;C11,Disease or Syndrome,0.3,,2014.0,2014.0,1,0,CTD_human
35786,4803,NGF,0.426,0.862,C0010692,Cystitis,disease,C12;C13,Disease or Syndrome,0.52,1.0,2006.0,2010.0,1,0,CTD_human
35787,4803,NGF,0.426,0.862,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.52,1.0,2004.0,2013.0,1,0,PSYGENET
35788,4803,NGF,0.426,0.862,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.32,1.0,2004.0,2013.0,1,0,PSYGENET
35789,4803,NGF,0.426,0.862,C0013364,"Dysautonomia, Familial",disease,C10;C16,Congenital Abnormality; Disease or Syndrome,0.32,0.5,1984.0,2013.0,4,0,GENOMICS_ENGLAND
35790,4803,NGF,0.426,0.862,C0014549,Tonic-Clonic Epilepsy,disease,C10,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
35791,4803,NGF,0.426,0.862,C0017658,Glomerulonephritis,disease,C12;C13,Disease or Syndrome,0.31,1.0,2009.0,2014.0,1,0,CTD_human
35792,4803,NGF,0.426,0.862,C0019337,Heroin Dependence,disease,C25,Mental or Behavioral Dysfunction,0.31,1.0,2008.0,2012.0,1,0,CTD_human
35793,4803,NGF,0.426,0.862,C0020071,"Hereditary Sensory Autonomic Neuropathy, Type 1",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
35794,4803,NGF,0.426,0.862,C0020072,"Hereditary Sensory Autonomic Neuropathy, Type 2",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
35795,4803,NGF,0.426,0.862,C0020074,HSAN Type IV,disease,C10;C16,Disease or Syndrome,0.4,1.0,1999.0,2014.0,0,0,CTD_human
35796,4803,NGF,0.426,0.862,C0020075,"Hereditary Sensory Autonomic Neuropathy, Type 5",disease,C10;C16,Disease or Syndrome,0.77,1.0,2002.0,2014.0,3,1,CTD_human;ORPHANET;UNIPROT
35797,4803,NGF,0.426,0.862,C0020429,Hyperalgesia,phenotype,C10;C23,Sign or Symptom,0.32,1.0,1999.0,2013.0,1,0,CTD_human
35798,4803,NGF,0.426,0.862,C0021368,Inflammation,phenotype,C23,Pathologic Function,0.31,,2000.0,2003.0,1,0,CTD_human
35799,4803,NGF,0.426,0.862,C0022333,Jacksonian Seizure,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35800,4803,NGF,0.426,0.862,C0022661,"Kidney Failure, Chronic",disease,C12;C13,Disease or Syndrome,0.31,1.0,2009.0,2014.0,1,0,CTD_human
35801,4803,NGF,0.426,0.862,C0027707,"Nephritis, Interstitial",disease,C12;C13,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
35802,4803,NGF,0.426,0.862,C0027746,Nerve Degeneration,phenotype,C23,Cell or Molecular Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
35803,4803,NGF,0.426,0.862,C0027765,nervous system disorder,group,C10,Disease or Syndrome,0.31,1.0,2001.0,2004.0,1,0,CTD_human
35804,4803,NGF,0.426,0.862,C0027889,Hereditary Sensory and Autonomic Neuropathies,group,C10;C16,Disease or Syndrome,0.33,1.0,2009.0,2016.0,0,0,CTD_human
35805,4803,NGF,0.426,0.862,C0030567,Parkinson Disease,disease,C10,Disease or Syndrome,0.33,0.6666667,2009.0,2014.0,1,0,CTD_human
35806,4803,NGF,0.426,0.862,C0031117,Peripheral Neuropathy,group,C10,Disease or Syndrome,0.32,1.0,1998.0,2005.0,1,0,CTD_human
35807,4803,NGF,0.426,0.862,C0036572,Seizures,phenotype,C10;C23,Sign or Symptom,0.33,1.0,1992.0,2008.0,1,0,CTD_human
35808,4803,NGF,0.426,0.862,C0037299,Skin Ulcer,phenotype,C17,Disease or Syndrome,0.3,,2014.0,2014.0,1,0,CTD_human
35809,4803,NGF,0.426,0.862,C0038220,Status Epilepticus,disease,C10;C23,Disease or Syndrome,0.3,,1996.0,1996.0,2,0,CTD_human
35810,4803,NGF,0.426,0.862,C0041349,"Nephritis, Tubulointerstitial",disease,C12;C13,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
35811,4803,NGF,0.426,0.862,C0085129,Bronchial Hyperreactivity,disease,C08,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
35812,4803,NGF,0.426,0.862,C0086405,Hereditary Sensory Radicular Neuropathy,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
35813,4803,NGF,0.426,0.862,C0149958,Complex partial seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35814,4803,NGF,0.426,0.862,C0233750,Hysterical amnesia,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2006.0,2009.0,2,0,CTD_human
35815,4803,NGF,0.426,0.862,C0233796,Temporary Amnesia,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2006.0,2009.0,2,0,CTD_human
35816,4803,NGF,0.426,0.862,C0234533,Generalized seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35817,4803,NGF,0.426,0.862,C0234535,"Seizures, Clonic",disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35818,4803,NGF,0.426,0.862,C0236663,Alcohol withdrawal syndrome,disease,,Disease or Syndrome,0.31,1.0,2013.0,2013.0,1,0,PSYGENET
35819,4803,NGF,0.426,0.862,C0236736,Cocaine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
35820,4803,NGF,0.426,0.862,C0236795,Dissociative Amnesia,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2006.0,2009.0,2,0,CTD_human
35821,4803,NGF,0.426,0.862,C0238281,Middle Cerebral Artery Syndrome,disease,C10;C14,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
35822,4803,NGF,0.426,0.862,C0242422,Parkinsonian Disorders,group,C10,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
35823,4803,NGF,0.426,0.862,C0242423,Ramsay Hunt Paralysis Syndrome,disease,C10,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
35824,4803,NGF,0.426,0.862,C0262497,Global Amnesia,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2006.0,2009.0,2,0,CTD_human
35825,4803,NGF,0.426,0.862,C0268849,Overactive Detrusor,disease,C12;C13;C23,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
35826,4803,NGF,0.426,0.862,C0270715,"Degenerative Diseases, Central Nervous System",group,C10,Disease or Syndrome,0.3,,2014.0,2014.0,1,0,CTD_human
35827,4803,NGF,0.426,0.862,C0270823,Petit mal status,disease,C10;C23,Disease or Syndrome,0.3,,1996.0,1996.0,2,0,CTD_human
35828,4803,NGF,0.426,0.862,C0270824,Visual seizure,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35829,4803,NGF,0.426,0.862,C0270844,Tonic Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
35830,4803,NGF,0.426,0.862,C0270846,Epileptic drop attack,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35831,4803,NGF,0.426,0.862,C0273115,Lung Injury,disease,C08;C26,Injury or Poisoning,0.3,,2010.0,2010.0,1,0,CTD_human
35832,4803,NGF,0.426,0.862,C0311335,Grand Mal Status Epilepticus,disease,C10;C23,Disease or Syndrome,0.3,,1996.0,1996.0,2,0,CTD_human
35833,4803,NGF,0.426,0.862,C0345967,Malignant mesothelioma,disease,C04;C08,Neoplastic Process,0.31,1.0,2004.0,2015.0,1,0,CTD_human
35834,4803,NGF,0.426,0.862,C0391976,Pain Disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2000.0,2016.0,4,0,GENOMICS_ENGLAND
35835,4803,NGF,0.426,0.862,C0393734,Complex Partial Status Epilepticus,disease,C10;C23,Disease or Syndrome,0.3,,1996.0,1996.0,2,0,CTD_human
35836,4803,NGF,0.426,0.862,C0403447,Chronic Kidney Insufficiency,disease,C12;C13,Disease or Syndrome,0.3,,2014.0,2014.0,1,0,CTD_human
35837,4803,NGF,0.426,0.862,C0422850,"Seizures, Somatosensory",phenotype,C10;C23,Pathologic Function,0.3,,2008.0,2008.0,1,0,CTD_human
35838,4803,NGF,0.426,0.862,C0422852,"Seizures, Auditory",phenotype,C10;C23,Pathologic Function,0.3,,2008.0,2008.0,1,0,CTD_human
35839,4803,NGF,0.426,0.862,C0422853,Olfactory seizure,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35840,4803,NGF,0.426,0.862,C0422854,Gustatory seizure,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
35841,4803,NGF,0.426,0.862,C0422855,Vertiginous seizure,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35842,4803,NGF,0.426,0.862,C0424295,Hyperactive behavior,phenotype,C10;C23,Mental or Behavioral Dysfunction,0.32,1.0,1992.0,2014.0,1,0,CTD_human
35843,4803,NGF,0.426,0.862,C0458247,Allodynia,phenotype,C10;C23,Finding,0.3,,2011.0,2011.0,1,0,CTD_human
35844,4803,NGF,0.426,0.862,C0494475,Tonic - clonic seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35845,4803,NGF,0.426,0.862,C0524851,Neurodegenerative Disorders,group,C10,Disease or Syndrome,0.35,1.0,2000.0,2016.0,1,0,CTD_human
35846,4803,NGF,0.426,0.862,C0525041,Neurobehavioral Manifestations,group,C10;C23;F01,Sign or Symptom,0.3,,2012.0,2012.0,1,0,CTD_human
35847,4803,NGF,0.426,0.862,C0600427,Cocaine Dependence,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
35848,4803,NGF,0.426,0.862,C0600467,Neurogenic Inflammation,disease,C10;C23,Injury or Poisoning,0.3,,2012.0,2012.0,1,0,CTD_human
35849,4803,NGF,0.426,0.862,C0699739,"Sensory Neuropathy, Hereditary",disease,C10;C16,Disease or Syndrome,0.32,1.0,1999.0,2007.0,0,0,CTD_human
35850,4803,NGF,0.426,0.862,C0740376,Middle Cerebral Artery Thrombosis,disease,C10;C14,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
35851,4803,NGF,0.426,0.862,C0740391,Middle Cerebral Artery Occlusion,phenotype,C10;C14,Acquired Abnormality,0.3,,1999.0,1999.0,1,0,CTD_human
35852,4803,NGF,0.426,0.862,C0740392,"Infarction, Middle Cerebral Artery",disease,C10;C14,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
35853,4803,NGF,0.426,0.862,C0750906,Tactile Amnesia,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2006.0,2009.0,2,0,CTD_human
35854,4803,NGF,0.426,0.862,C0750907,Amnestic State,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2006.0,2009.0,2,0,CTD_human
35855,4803,NGF,0.426,0.862,C0751056,Non-epileptic convulsion,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
35856,4803,NGF,0.426,0.862,C0751110,Single Seizure,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35857,4803,NGF,0.426,0.862,C0751117,Cryptogenic Tonic-Clonic Epilepsy,disease,C10,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
35858,4803,NGF,0.426,0.862,C0751118,"Epilepsy, Tonic-Clonic, Familial",disease,C10,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
35859,4803,NGF,0.426,0.862,C0751119,"Epilepsy, Tonic-Clonic, Symptomatic",disease,C10,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
35860,4803,NGF,0.426,0.862,C0751123,Atonic Absence Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35861,4803,NGF,0.426,0.862,C0751211,"Hyperalgesia, Primary",phenotype,C10;C23,Sign or Symptom,0.3,,2011.0,2011.0,1,0,CTD_human
35862,4803,NGF,0.426,0.862,C0751212,"Hyperalgesia, Secondary",phenotype,C10;C23,Sign or Symptom,0.3,,2011.0,2011.0,1,0,CTD_human
35863,4803,NGF,0.426,0.862,C0751213,Tactile Allodynia,phenotype,C10;C23,Sign or Symptom,0.3,,2011.0,2011.0,1,0,CTD_human
35864,4803,NGF,0.426,0.862,C0751214,"Hyperalgesia, Thermal",phenotype,C10;C23,Sign or Symptom,0.3,,2011.0,2011.0,1,0,CTD_human
35865,4803,NGF,0.426,0.862,C0751217,"Hyperkinesia, Generalized",phenotype,C10;C23,Sign or Symptom,0.3,,1992.0,1992.0,1,0,CTD_human
35866,4803,NGF,0.426,0.862,C0751494,Convulsive Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
35867,4803,NGF,0.426,0.862,C0751495,"Seizures, Focal",phenotype,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35868,4803,NGF,0.426,0.862,C0751496,"Seizures, Sensory",phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
35869,4803,NGF,0.426,0.862,C0751522,"Status Epilepticus, Subclinical",disease,C10;C23,Disease or Syndrome,0.3,,1996.0,1996.0,2,0,CTD_human
35870,4803,NGF,0.426,0.862,C0751523,Non-Convulsive Status Epilepticus,disease,C10;C23,Disease or Syndrome,0.3,,1996.0,1996.0,2,0,CTD_human
35871,4803,NGF,0.426,0.862,C0751524,Simple Partial Status Epilepticus,disease,C10;C23,Disease or Syndrome,0.3,,1996.0,1996.0,2,0,CTD_human
35872,4803,NGF,0.426,0.862,C0751733,"Degenerative Diseases, Spinal Cord",disease,C10,Disease or Syndrome,0.3,,2014.0,2014.0,1,0,CTD_human
35873,4803,NGF,0.426,0.862,C0751845,Middle Cerebral Artery Embolus,disease,C10;C14,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
35874,4803,NGF,0.426,0.862,C0751846,Left Middle Cerebral Artery Infarction,disease,C10;C14,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
35875,4803,NGF,0.426,0.862,C0751847,"Embolic Infarction, Middle Cerebral Artery",disease,C10;C14,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
35876,4803,NGF,0.426,0.862,C0751848,"Thrombotic Infarction, Middle Cerebral Artery",disease,C10;C14,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
35877,4803,NGF,0.426,0.862,C0751849,Right Middle Cerebral Artery Infarction,disease,C10;C14,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
35878,4803,NGF,0.426,0.862,C0752097,Autosomal Dominant Juvenile Parkinson Disease,disease,C10,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
35879,4803,NGF,0.426,0.862,C0752098,Autosomal Dominant Parkinsonism,disease,C10,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
35880,4803,NGF,0.426,0.862,C0752100,Autosomal Recessive Parkinsonism,disease,C10,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
35881,4803,NGF,0.426,0.862,C0752101,"Parkinsonism, Experimental",disease,C10,Experimental Model of Disease,0.3,,2009.0,2009.0,1,0,CTD_human
35882,4803,NGF,0.426,0.862,C0752104,Familial Juvenile Parkinsonism,disease,C10,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
35883,4803,NGF,0.426,0.862,C0752105,"Parkinsonism, Juvenile",disease,C10,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
35884,4803,NGF,0.426,0.862,C0752347,Lewy Body Disease,disease,C10;F03,Disease or Syndrome,0.31,1.0,2009.0,2009.0,1,0,CTD_human
35885,4803,NGF,0.426,0.862,C0878773,Overactive Bladder,disease,C12;C13;C23,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
35886,4803,NGF,0.426,0.862,C1561643,Chronic Kidney Diseases,group,C12;C13,Disease or Syndrome,0.3,,2014.0,2014.0,1,0,CTD_human
35887,4803,NGF,0.426,0.862,C1704377,Bright Disease,disease,C12;C13,Disease or Syndrome,0.3,,2014.0,2014.0,1,0,CTD_human
35888,4803,NGF,0.426,0.862,C1868675,"PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE",disease,C10,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
35889,4803,NGF,0.426,0.862,C2350344,Chronic Lung Injury,disease,C08;C26,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
35890,4803,NGF,0.426,0.862,C2936719,Mechanical Allodynia,phenotype,C10;C23,Sign or Symptom,0.3,,2011.0,2011.0,1,0,CTD_human
35891,4803,NGF,0.426,0.862,C3495874,Nonepileptic Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35892,4803,NGF,0.426,0.862,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
35893,4803,NGF,0.426,0.862,C4048158,Convulsions,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
35894,4803,NGF,0.426,0.862,C4316903,Absence Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
35895,4803,NGF,0.426,0.862,C4317109,Epileptic Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
35896,4803,NGF,0.426,0.862,C4317123,Myoclonic Seizures,phenotype,C10;C23,Sign or Symptom,0.3,,2008.0,2008.0,1,0,CTD_human
35897,4803,NGF,0.426,0.862,C4505390,Heroin Smoking,disease,C25,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
35898,4803,NGF,0.426,0.862,C4505436,Generalized Absence Seizures,disease,C10;C23,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
33701,4359,MPZ,0.535,0.7929999999999999,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,1996.0,2016.0,2,0,GENOMICS_ENGLAND
33702,4359,MPZ,0.535,0.7929999999999999,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,1.0,0.9917355,1988.0,2018.0,39,24,CTD_human;GENOMICS_ENGLAND;UNIPROT
33703,4359,MPZ,0.535,0.7929999999999999,C0011195,Dejerine-Sottas Disease (disorder),disease,C10;C16,Disease or Syndrome,1.0,1.0,1992.0,2016.0,12,9,CTD_human;ORPHANET;UNIPROT
33704,4359,MPZ,0.535,0.7929999999999999,C0019816,"Hereditary, Type VII, Motor and Sensory Neuropathy",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
33705,4359,MPZ,0.535,0.7929999999999999,C0020429,Hyperalgesia,phenotype,C10;C23,Sign or Symptom,0.3,,2006.0,2006.0,1,0,CTD_human
33706,4359,MPZ,0.535,0.7929999999999999,C0027746,Nerve Degeneration,phenotype,C23,Cell or Molecular Dysfunction,0.3,,2006.0,2006.0,1,0,CTD_human
33707,4359,MPZ,0.535,0.7929999999999999,C0027888,Hereditary Motor and Sensory Neuropathies,group,C10;C16,Disease or Syndrome,0.6,0.9333333,1992.0,2017.0,0,0,CTD_human
33708,4359,MPZ,0.535,0.7929999999999999,C0205713,Roussy-Levy Syndrome (disorder),disease,C10;C16,Disease or Syndrome,0.9,,1992.0,2014.0,1,3,CTD_human;ORPHANET;UNIPROT
33709,4359,MPZ,0.535,0.7929999999999999,C0270911,"Charcot-Marie-Tooth Disease, Type Ia (disorder)",disease,C10;C16,Disease or Syndrome,0.33,1.0,1994.0,2001.0,0,0,CTD_human
33710,4359,MPZ,0.535,0.7929999999999999,C0270912,"Charcot-Marie-Tooth Disease, Type Ib",disease,C10;C16,Disease or Syndrome,1.0,1.0,1992.0,2018.0,39,43,CTD_human;ORPHANET;UNIPROT
33711,4359,MPZ,0.535,0.7929999999999999,C0270914,Hereditary Motor and Sensory-Neuropathy Type II,disease,C10;C16,Disease or Syndrome,0.34,0.5,1998.0,2007.0,0,0,CTD_human
33712,4359,MPZ,0.535,0.7929999999999999,C0393818,Congenital hypomyelinating neuropathy,disease,C10;C16,Disease or Syndrome,0.9,1.0,1998.0,2014.0,1,3,CTD_human;UNIPROT
33713,4359,MPZ,0.535,0.7929999999999999,C0458247,Allodynia,phenotype,C10;C23,Finding,0.3,,2006.0,2006.0,1,0,CTD_human
33714,4359,MPZ,0.535,0.7929999999999999,C0751036,Hereditary Motor and Sensory Neuropathy Type I,disease,C10;C16,Disease or Syndrome,0.9,1.0,1992.0,2017.0,39,28,CTD_human;UNIPROT
33715,4359,MPZ,0.535,0.7929999999999999,C0751211,"Hyperalgesia, Primary",phenotype,C10;C23,Sign or Symptom,0.3,,2006.0,2006.0,1,0,CTD_human
33716,4359,MPZ,0.535,0.7929999999999999,C0751212,"Hyperalgesia, Secondary",phenotype,C10;C23,Sign or Symptom,0.3,,2006.0,2006.0,1,0,CTD_human
33717,4359,MPZ,0.535,0.7929999999999999,C0751213,Tactile Allodynia,phenotype,C10;C23,Sign or Symptom,0.3,,2006.0,2006.0,1,0,CTD_human
33718,4359,MPZ,0.535,0.7929999999999999,C0751214,"Hyperalgesia, Thermal",phenotype,C10;C23,Sign or Symptom,0.3,,2006.0,2006.0,1,0,CTD_human
33719,4359,MPZ,0.535,0.7929999999999999,C1843075,"Charcot-Marie-Tooth Disease, Dominant Intermediate D",disease,C10;C16,Disease or Syndrome,0.7,,1999.0,2014.0,1,3,CTD_human;ORPHANET;UNIPROT
33720,4359,MPZ,0.535,0.7929999999999999,C1843153,"Charcot-Marie-Tooth disease, Type 2J",disease,C09;C10;C16;C23,Disease or Syndrome,0.71,1.0,1999.0,2014.0,4,6,CTD_human;ORPHANET;UNIPROT
33721,4359,MPZ,0.535,0.7929999999999999,C2936719,Mechanical Allodynia,phenotype,C10;C23,Sign or Symptom,0.3,,2006.0,2006.0,1,0,CTD_human
33722,4359,MPZ,0.535,0.7929999999999999,C3551756,"NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT",disease,,Disease or Syndrome,0.6,,1996.0,2004.0,1,2,UNIPROT
33723,4359,MPZ,0.535,0.7929999999999999,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
33724,4359,MPZ,0.535,0.7929999999999999,C3888087,"Charcot-Marie-Tooth disease, Type 2I",disease,C10;C16,Disease or Syndrome,0.7,,1998.0,2014.0,5,12,CTD_human;ORPHANET;UNIPROT
51377,7044,LEFTY2,0.752,0.172,C0000772,Multiple congenital anomalies,group,C16,Congenital Abnormality,0.3,,1999.0,1999.0,1,0,CTD_human
51378,7044,LEFTY2,0.752,0.172,C0175707,Asplenia Syndrome,disease,C14;C15;C16,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
51379,7044,LEFTY2,0.752,0.172,C0265357,Polysplenia Syndrome,disease,C14;C15;C16,Congenital Abnormality,0.3,,1999.0,1999.0,1,0,CTD_human
51380,7044,LEFTY2,0.752,0.172,C0266642,Situs ambiguus,disease,C14;C15;C16,Congenital Abnormality,0.5,,1999.0,1999.0,1,0,CTD_human;ORPHANET
51381,7044,LEFTY2,0.752,0.172,C1167664,Situs ambiguous,disease,,Congenital Abnormality,0.3,,,,0,0,ORPHANET
51382,7044,LEFTY2,0.752,0.172,C1866091,Left-Right Axis Malformations,disease,C14;C15;C16,Disease or Syndrome,0.3,,1999.0,1999.0,1,1,UNIPROT
51383,7044,LEFTY2,0.752,0.172,C3178805,Heterotaxy Syndrome,disease,C14;C15;C16,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
51384,7044,LEFTY2,0.752,0.172,C3178806,Right Atrial Isomerism,disease,C14;C15;C16,Congenital Abnormality,0.3,,1999.0,1999.0,1,0,CTD_human
51385,7044,LEFTY2,0.752,0.172,C3178807,Left Atrial Isomerism,disease,C14;C15;C16,Congenital Abnormality,0.3,,1999.0,1999.0,1,0,CTD_human
519,58,ACTA1,0.59,0.586,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.4,,1999.0,1999.0,1,0,GENOMICS_ENGLAND
520,58,ACTA1,0.59,0.586,C0007194,Hypertrophic Cardiomyopathy,disease,C14,Disease or Syndrome,0.32,1.0,2001.0,2012.0,3,0,CLINGEN
521,58,ACTA1,0.59,0.586,C0149721,Left Ventricular Hypertrophy,disease,C14;C23,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
522,58,ACTA1,0.59,0.586,C0175709,Centronuclear myopathy,disease,C05;C10,Disease or Syndrome,0.3,,,,0,0,CTD_human
523,58,ACTA1,0.59,0.586,C0206157,"Myopathies, Nemaline",disease,C05;C10,Disease or Syndrome,0.4,0.967741935483871,1999.0,2018.0,0,0,ORPHANET
524,58,ACTA1,0.59,0.586,C0270960,Congenital myopathy (disorder),group,,Congenital Abnormality,0.5,0.916666666666667,1999.0,2016.0,2,1,GENOMICS_ENGLAND
525,58,ACTA1,0.59,0.586,C0270969,Zebra body myopathy,disease,,Disease or Syndrome,0.31,1.0,2016.0,2016.0,0,0,ORPHANET
526,58,ACTA1,0.59,0.586,C0410180,Eichsfeld type congenital muscular dystrophy,disease,C05;C10;C16,Disease or Syndrome,0.3,,,,0,0,ORPHANET
527,58,ACTA1,0.59,0.586,C0410203,X-linked centronuclear myopathy,disease,C05;C10,Congenital Abnormality,0.3,,,,0,0,CTD_human
528,58,ACTA1,0.59,0.586,C0410207,Tubular Aggregate Myopathy,disease,C05;C10,Disease or Syndrome,0.3,,,,0,0,CTD_human
529,58,ACTA1,0.59,0.586,C0546125,"Nemaline Myopathy, Childhood Onset",disease,C05;C10,Disease or Syndrome,0.3,,,,0,0,ORPHANET
530,58,ACTA1,0.59,0.586,C0546264,Congenital Fiber Type Disproportion,disease,C05;C10,Congenital Abnormality,0.74,0.75,1993.0,2011.0,2,7,CTD_human;ORPHANET;UNIPROT
531,58,ACTA1,0.59,0.586,C0699743,Congenital muscular dystrophy (disorder),disease,,Disease or Syndrome,0.31,1.0,2010.0,2016.0,5,0,GENOMICS_ENGLAND
532,58,ACTA1,0.59,0.586,C0751336,Distal Muscular Dystrophies,group,C05;C10;C16,Disease or Syndrome,0.31,1.0,2018.0,2018.0,0,0,GENOMICS_ENGLAND
533,58,ACTA1,0.59,0.586,C0752282,Congenital Structural Myopathy,disease,C05;C10,Disease or Syndrome,0.3,,,,0,0,CTD_human
534,58,ACTA1,0.59,0.586,C0949658,"Cardiomyopathy, Hypertrophic, Familial",disease,C14;C16,Disease or Syndrome,0.3,,2005.0,2012.0,3,0,CLINGEN
535,58,ACTA1,0.59,0.586,C1834339,"Myopathy, Actin, Congenital, with Excess of Thin Myofilaments",disease,C05;C10,Disease or Syndrome,0.8,,1997.0,2015.0,13,15,CTD_human;UNIPROT
536,58,ACTA1,0.59,0.586,C1834558,"Myopathy, Centronuclear, Autosomal Dominant",disease,C05;C10,Disease or Syndrome,0.3,,,,0,0,CTD_human
537,58,ACTA1,0.59,0.586,C2750536,"Nemaline Myopathy 3, With Intranuclear Rods",disease,C05;C10,Disease or Syndrome,0.7,,1999.0,2015.0,13,15,CTD_human;UNIPROT
538,58,ACTA1,0.59,0.586,C2750537,"Myopathy, Actin, Congenital, With Cores",disease,C05;C10,Disease or Syndrome,0.8,,1999.0,2015.0,13,15,CTD_human;UNIPROT
539,58,ACTA1,0.59,0.586,C3645536,Autosomal Recessive Centronuclear Myopathy,disease,C05;C10,Disease or Syndrome,0.3,,,,0,0,CTD_human
540,58,ACTA1,0.59,0.586,C3661489,Autosomal Dominant Myotubular Myopathy,disease,C05;C10,Disease or Syndrome,0.3,,,,0,0,CTD_human
541,58,ACTA1,0.59,0.586,C3711389,Actin-Accumulation Myopathy,disease,C05;C10,Disease or Syndrome,0.92,1.0,1997.0,2017.0,13,24,CTD_human;ORPHANET;UNIPROT
542,58,ACTA1,0.59,0.586,C4225181,"MYOPATHY, SCAPULOHUMEROPERONEAL",disease,,Disease or Syndrome,0.7,,1966.0,2015.0,1,1,CTD_human;ORPHANET;UNIPROT
77725,200150,PLD5,,,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
49215,6697,SPR,0.667,0.379,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2009.0,2009.0,1,0,PSYGENET
49216,6697,SPR,0.667,0.379,C0268468,"Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency",disease,C10;C16;C18;C23;F01,Disease or Syndrome,0.71,0.0,1993.0,2015.0,4,7,CTD_human;ORPHANET;UNIPROT
49217,6697,SPR,0.667,0.379,C0525045,Mood Disorders,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2009.0,2009.0,1,0,PSYGENET
32166,4144,MAT2A,0.713,0.44799999999999995,C0024796,Marfan Syndrome,disease,C05;C14;C16;C17,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CLINGEN
32167,4144,MAT2A,0.713,0.44799999999999995,C0162872,"Aortic Aneurysm, Thoracic",disease,C14,Disease or Syndrome,0.31,1.0,2015.0,2015.0,0,0,GENOMICS_ENGLAND
13574,1615,DARS,0.8340000000000001,0.207,C3809008,HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY,disease,,Disease or Syndrome,0.71,1.0,2013.0,2015.0,1,10,CTD_human;ORPHANET;UNIPROT
700,90,ACVR1,0.573,0.552,C0004114,Astrocytoma,disease,C04,Neoplastic Process,0.32,1.0,2014.0,2015.0,1,0,CTD_human
701,90,ACVR1,0.573,0.552,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
702,90,ACVR1,0.573,0.552,C0013720,Ehlers-Danlos Syndrome,disease,C14;C15;C16;C17,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
703,90,ACVR1,0.573,0.552,C0016037,Fibrodysplasia Ossificans Progressiva,disease,C05,Disease or Syndrome,1.0,1.0,1972.0,2018.0,3,9,CTD_human;ORPHANET;UNIPROT
704,90,ACVR1,0.573,0.552,C0017638,Glioma,disease,C04,Neoplastic Process,0.51,1.0,2014.0,2014.0,3,0,CGI;CTD_human
705,90,ACVR1,0.573,0.552,C0025202,melanoma,disease,C04,Neoplastic Process,0.3,,,,0,0,UNIPROT
706,90,ACVR1,0.573,0.552,C0027122,Myositis Ossificans,disease,C05,Disease or Syndrome,0.31,,2007.0,2007.0,0,0,CTD_human
707,90,ACVR1,0.573,0.552,C0205768,Subependymal Giant Cell Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
708,90,ACVR1,0.573,0.552,C0242488,Acute Lung Injury,disease,C08,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
709,90,ACVR1,0.573,0.552,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,3,0,CTD_human
710,90,ACVR1,0.573,0.552,C0280783,Juvenile Pilocytic Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
711,90,ACVR1,0.573,0.552,C0280785,Diffuse Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
712,90,ACVR1,0.573,0.552,C0334579,Anaplastic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
713,90,ACVR1,0.573,0.552,C0334580,Protoplasmic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
714,90,ACVR1,0.573,0.552,C0334581,Gemistocytic astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
715,90,ACVR1,0.573,0.552,C0334582,Fibrillary Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
716,90,ACVR1,0.573,0.552,C0334583,Pilocytic Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
717,90,ACVR1,0.573,0.552,C0338070,Childhood Cerebral Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
718,90,ACVR1,0.573,0.552,C0345050,Congenital aneurysm of ascending aorta,disease,C14,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
719,90,ACVR1,0.573,0.552,C0547065,Mixed oligoastrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
720,90,ACVR1,0.573,0.552,C0555198,Malignant Glioma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,3,0,CTD_human
721,90,ACVR1,0.573,0.552,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
722,90,ACVR1,0.573,0.552,C0750935,Cerebral Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
723,90,ACVR1,0.573,0.552,C0750936,Intracranial Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
724,90,ACVR1,0.573,0.552,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
725,90,ACVR1,0.573,0.552,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
726,90,ACVR1,0.573,0.552,C1704230,Grade I Astrocytoma,disease,C04,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
727,90,ACVR1,0.573,0.552,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
70812,57007,ACKR3,0.494,0.759,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.32,1.0,1999.0,2010.0,1,0,CTD_human
70813,57007,ACKR3,0.494,0.759,C0007097,Carcinoma,group,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70814,57007,ACKR3,0.494,0.759,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.31,1.0,2012.0,2015.0,1,0,CTD_human
70815,57007,ACKR3,0.494,0.759,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70816,57007,ACKR3,0.494,0.759,C0022658,Kidney Diseases,group,C12;C13,Disease or Syndrome,0.31,1.0,2013.0,2017.0,1,0,CTD_human
70817,57007,ACKR3,0.494,0.759,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
70818,57007,ACKR3,0.494,0.759,C0027627,Neoplasm Metastasis,phenotype,C04;C23,Neoplastic Process,0.4,0.9629629999999999,2005.0,2017.0,1,0,CTD_human
70819,57007,ACKR3,0.494,0.759,C0205696,Anaplastic carcinoma,disease,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70820,57007,ACKR3,0.494,0.759,C0205697,"Carcinoma, Spindle-Cell",disease,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70821,57007,ACKR3,0.494,0.759,C0205698,Undifferentiated carcinoma,phenotype,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70822,57007,ACKR3,0.494,0.759,C0205699,Carcinomatosis,phenotype,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
70823,57007,ACKR3,0.494,0.759,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.31,1.0,2012.0,2015.0,1,0,CTD_human
7569,859,CAV3,0.5920000000000001,0.414,C0002152,Alloxan Diabetes,disease,C18;C19,Experimental Model of Disease,0.3,,2009.0,2009.0,1,0,CTD_human
7570,859,CAV3,0.5920000000000001,0.414,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
7571,859,CAV3,0.5920000000000001,0.414,C0007194,Hypertrophic Cardiomyopathy,disease,C14,Disease or Syndrome,0.52,1.0,2004.0,2010.0,0,0,GENOMICS_ENGLAND
7572,859,CAV3,0.5920000000000001,0.414,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
7573,859,CAV3,0.5920000000000001,0.414,C0011853,"Diabetes Mellitus, Experimental",disease,C18;C19,Experimental Model of Disease,0.3,,2009.0,2009.0,1,0,CTD_human
7574,859,CAV3,0.5920000000000001,0.414,C0018798,Congenital Heart Defects,group,C14;C16,Congenital Abnormality,0.3,,2011.0,2011.0,1,0,CTD_human
7575,859,CAV3,0.5920000000000001,0.414,C0018800,Cardiomegaly,phenotype,C14;C23,Finding,0.3,,2009.0,2009.0,1,0,CTD_human
7576,859,CAV3,0.5920000000000001,0.414,C0023976,Long QT Syndrome,disease,C14;C16;C23,Disease or Syndrome,0.48,1.0,2000.0,2017.0,0,3,GENOMICS_ENGLAND
7577,859,CAV3,0.5920000000000001,0.414,C0035410,Rhabdomyolysis,phenotype,C05,Pathologic Function,0.3,,,,0,0,GENOMICS_ENGLAND
7578,859,CAV3,0.5920000000000001,0.414,C0035828,Romano-Ward Syndrome,disease,C14;C16;C23,Disease or Syndrome,0.3,,,,0,0,ORPHANET
7579,859,CAV3,0.5920000000000001,0.414,C0038433,Streptozotocin Diabetes,disease,C18;C19,Experimental Model of Disease,0.3,,2009.0,2009.0,1,0,CTD_human
7580,859,CAV3,0.5920000000000001,0.414,C0038644,Sudden infant death syndrome,disease,C23,Disease or Syndrome,0.35,1.0,2007.0,2014.0,1,3,UNIPROT
7581,859,CAV3,0.5920000000000001,0.414,C0205700,Asymmetric Septal Hypertrophy,disease,,Disease or Syndrome,0.4,,2004.0,2004.0,1,1,UNIPROT
7582,859,CAV3,0.5920000000000001,0.414,C0241005,Creatine phosphokinase serum increased,phenotype,,Finding,0.6,,1975.0,2009.0,4,4,CTD_human;UNIPROT
7583,859,CAV3,0.5920000000000001,0.414,C0270960,Congenital myopathy (disorder),group,,Congenital Abnormality,0.31,1.0,2007.0,2007.0,0,0,GENOMICS_ENGLAND
7584,859,CAV3,0.5920000000000001,0.414,C0686353,"Muscular Dystrophies, Limb-Girdle",group,C05;C10;C16,Disease or Syndrome,0.8,1.0,1998.0,2017.0,1,0,CTD_human;GENOMICS_ENGLAND
7585,859,CAV3,0.5920000000000001,0.414,C0700053,Idiopathic hypertrophic subaortic stenosis,disease,C14;C16,Congenital Abnormality,0.3,,2004.0,2004.0,1,1,UNIPROT
7586,859,CAV3,0.5920000000000001,0.414,C0949658,"Cardiomyopathy, Hypertrophic, Familial",disease,C14;C16,Disease or Syndrome,0.6,,2004.0,2006.0,1,1,UNIPROT
7587,859,CAV3,0.5920000000000001,0.414,C1142166,Brugada Syndrome (disorder),disease,C14;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
7588,859,CAV3,0.5920000000000001,0.414,C1383860,Cardiac Hypertrophy,phenotype,C14;C23,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
7589,859,CAV3,0.5920000000000001,0.414,C1832560,RIPPLING MUSCLE DISEASE 2 (disorder),disease,C05;C10,Disease or Syndrome,0.6,,1975.0,2012.0,7,9,CTD_human;UNIPROT
7590,859,CAV3,0.5920000000000001,0.414,C1832567,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C",disease,C05;C10;C16,Disease or Syndrome,0.92,1.0,1975.0,2016.0,7,11,CTD_human;ORPHANET;UNIPROT
7591,859,CAV3,0.5920000000000001,0.414,C1838254,RIPPLING MUSCLE DISEASE 1,disease,C05;C10,Disease or Syndrome,0.4,1.0,2001.0,2017.0,1,0,CTD_human
7592,859,CAV3,0.5920000000000001,0.414,C1853698,Rippling muscle disease,disease,C05;C10,Disease or Syndrome,0.8,1.0,2001.0,2017.0,7,8,CTD_human;ORPHANET;UNIPROT
7593,859,CAV3,0.5920000000000001,0.414,C2678485,LONG QT SYNDROME 9 (disorder),disease,C14;C16;C23,Disease or Syndrome,0.63,1.0,2006.0,2014.0,2,6,CTD_human;UNIPROT
7594,859,CAV3,0.5920000000000001,0.414,C2931337,"Chromosome 3, monosomy 3p25",disease,C23,Cell or Molecular Dysfunction,0.3,,2011.0,2011.0,1,0,CTD_human
7595,859,CAV3,0.5920000000000001,0.414,C3280443,"MYOPATHY, DISTAL, TATEYAMA TYPE",disease,,Disease or Syndrome,0.7,,1999.0,2009.0,2,3,CTD_human;ORPHANET;UNIPROT
7596,859,CAV3,0.5920000000000001,0.414,C3495498,"Cardiomyopathy, Familial Hypertrophic, 1 (disorder)",disease,C14;C16,Disease or Syndrome,0.5,,2004.0,2004.0,1,1,CTD_human;UNIPROT
72770,78987,CRELD1,0.743,0.207,C0344735,Partial atrioventricular canal,disease,C14;C16,Congenital Abnormality,0.3,,,,0,0,ORPHANET
72771,78987,CRELD1,0.743,0.207,C1853508,"ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2",phenotype,,Finding,0.4,,2003.0,2013.0,2,5,UNIPROT
72772,78987,CRELD1,0.743,0.207,C1853509,"Atrioventricular Septal Defect, Partial, with Heterotaxy Syndrome",disease,C14;C15;C16,Disease or Syndrome,0.5,,2003.0,2005.0,2,4,CTD_human;UNIPROT
72773,78987,CRELD1,0.743,0.207,C4277690,Ciliopathies,group,C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
30634,3913,LAMB2,0.639,0.483,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
30635,3913,LAMB2,0.639,0.483,C0268747,Diffuse mesangial sclerosis (disorder),disease,C12;C13;C23,Disease or Syndrome,0.43,1.0,2005.0,2008.0,1,0,CTD_human
30636,3913,LAMB2,0.639,0.483,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
30637,3913,LAMB2,0.639,0.483,C0751882,"Myasthenic Syndromes, Congenital",disease,C10;C16,Disease or Syndrome,0.32,1.0,2009.0,2016.0,2,0,GENOMICS_ENGLAND
30638,3913,LAMB2,0.639,0.483,C1836876,Pierson syndrome,disease,C10;C11;C12;C13;C16;C23,Disease or Syndrome,1.0,1.0,1963.0,2017.0,2,9,CTD_human;ORPHANET;UNIPROT
30639,3913,LAMB2,0.639,0.483,C1855670,Abnormality of the cornea,group,,Finding,0.3,,1963.0,2005.0,3,0,GENOMICS_ENGLAND
30640,3913,LAMB2,0.639,0.483,C3280113,"NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES",disease,,Disease or Syndrome,0.7,,2006.0,2011.0,2,6,CTD_human;ORPHANET;UNIPROT
30641,3913,LAMB2,0.639,0.483,C3489732,Familial mesangial sclerosis,disease,C12;C13;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
30642,3913,LAMB2,0.639,0.483,C3501249,"Nephrotic Syndrome, Congenital, With Ocular Abnormalities And Congenital Myasthenic Syndrome",disease,C10;C11;C12;C13;C16;C23,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
66978,29925,GMPPB,0.645,0.345,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
66979,29925,GMPPB,0.645,0.345,C0020255,Hydrocephalus,disease,C10,Disease or Syndrome,0.4,,,,0,0,GENOMICS_ENGLAND
66980,29925,GMPPB,0.645,0.345,C0086543,Cataract,disease,C11,Acquired Abnormality,0.4,,,,0,0,GENOMICS_ENGLAND
66981,29925,GMPPB,0.645,0.345,C0265221,Walker-Warburg congenital muscular dystrophy,disease,C10;C11;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
66982,29925,GMPPB,0.645,0.345,C0266470,Cerebellar Hypoplasia,disease,C10;C16;F03,Congenital Abnormality,0.4,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
66983,29925,GMPPB,0.645,0.345,C0282577,Congenital Disorders of Glycosylation,group,C16;C18,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
66984,29925,GMPPB,0.645,0.345,C0410174,Fukuyama Type Congenital Muscular Dystrophy,disease,C10;C11;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
66985,29925,GMPPB,0.645,0.345,C0457133,Muscle eye brain disease,disease,C10;C11;C16,Disease or Syndrome,0.5,,,,0,0,CTD_human;ORPHANET
66986,29925,GMPPB,0.645,0.345,C0686353,"Muscular Dystrophies, Limb-Girdle",group,C05;C10;C16,Disease or Syndrome,0.35,1.0,2013.0,2018.0,0,0,GENOMICS_ENGLAND
66987,29925,GMPPB,0.645,0.345,C0699743,Congenital muscular dystrophy (disorder),disease,,Disease or Syndrome,0.4,,2013.0,2015.0,2,0,GENOMICS_ENGLAND
66988,29925,GMPPB,0.645,0.345,C0751882,"Myasthenic Syndromes, Congenital",disease,C10;C16,Disease or Syndrome,0.32,1.0,2015.0,2018.0,2,0,GENOMICS_ENGLAND
66989,29925,GMPPB,0.645,0.345,C1836373,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K",disease,C10;C11;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
66990,29925,GMPPB,0.645,0.345,C1955869,Malformations of Cortical Development,group,C10;C16,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
66991,29925,GMPPB,0.645,0.345,C2936406,alpha-Dystroglycanopathies,disease,C10;C11;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
66992,29925,GMPPB,0.645,0.345,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.42,1.0,2013.0,2018.0,4,0,GENOMICS_ENGLAND
66993,29925,GMPPB,0.645,0.345,C3714932,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14",disease,,Disease or Syndrome,0.7,,2013.0,2018.0,4,16,CTD_human;ORPHANET;UNIPROT
66994,29925,GMPPB,0.645,0.345,C3809216,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14",disease,,Disease or Syndrome,0.4,,2013.0,2017.0,1,4,UNIPROT
66995,29925,GMPPB,0.645,0.345,C3809221,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14",disease,,Disease or Syndrome,0.6,,2009.0,2017.0,1,5,CTD_human;UNIPROT
66280,27086,FOXP1,0.528,0.69,C0006413,Burkitt Lymphoma,disease,C02;C04;C15;C20,Neoplastic Process,0.3,,,,0,0,ORPHANET
66281,27086,FOXP1,0.528,0.69,C0024232,Lymphatic Metastasis,disease,C04;C23,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
66282,27086,FOXP1,0.528,0.69,C0027626,Neoplasm Invasiveness,phenotype,C04;C23,Pathologic Function,0.3,,2015.0,2015.0,1,0,CTD_human
66283,27086,FOXP1,0.528,0.69,C0030297,Pancreatic Neoplasm,disease,C04;C06;C19,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
66284,27086,FOXP1,0.528,0.69,C0042900,Vitiligo,disease,C17,Disease or Syndrome,0.4,,2010.0,2017.0,1,2,CTD_human
66285,27086,FOXP1,0.528,0.69,C0087031,Juvenile-Onset Still Disease,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66286,27086,FOXP1,0.528,0.69,C0242647,Mucosa-Associated Lymphoid Tissue Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.4,1.0,2005.0,2015.0,0,0,ORPHANET
66287,27086,FOXP1,0.528,0.69,C0279628,Adenocarcinoma Of Esophagus,disease,C04;C06,Neoplastic Process,0.31,1.0,2014.0,2016.0,1,0,CTD_human
66288,27086,FOXP1,0.528,0.69,C0346647,Malignant neoplasm of pancreas,disease,C04;C06;C19,Neoplastic Process,0.31,1.0,2015.0,2015.0,1,0,CTD_human
66289,27086,FOXP1,0.528,0.69,C1292769,Precursor B-cell lymphoblastic leukemia,disease,,Neoplastic Process,0.3,,,,0,0,ORPHANET
66290,27086,FOXP1,0.528,0.69,C1510586,Autism Spectrum Disorders,disease,F03,Mental or Behavioral Dysfunction,0.42,1.0,2011.0,2018.0,1,1,CTD_human
66291,27086,FOXP1,0.528,0.69,C1535926,Neurodevelopmental Disorders,group,F03,Mental or Behavioral Dysfunction,0.35,1.0,2016.0,2018.0,1,0,CTD_human
66292,27086,FOXP1,0.528,0.69,C3495559,Juvenile arthritis,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66293,27086,FOXP1,0.528,0.69,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.46,1.0,2010.0,2018.0,0,0,GENOMICS_ENGLAND
66294,27086,FOXP1,0.528,0.69,C3714758,Juvenile psoriatic arthritis,disease,C05;C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
66295,27086,FOXP1,0.528,0.69,C4013764,MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES,disease,,Disease or Syndrome,0.6,,2011.0,2016.0,2,3,CTD_human;ORPHANET;UNIPROT
51887,7096,TLR1,0.529,0.7929999999999999,C0013221,Drug toxicity,group,C25,Injury or Poisoning,0.3,,2008.0,2008.0,1,0,CTD_human
51888,7096,TLR1,0.529,0.7929999999999999,C0023343,Leprosy,disease,C01,Disease or Syndrome,0.36,1.0,2007.0,2017.0,0,0,CTD_human
51889,7096,TLR1,0.529,0.7929999999999999,C0041755,Adverse reaction to drug,group,C25,Pathologic Function,0.3,,2008.0,2008.0,1,0,CTD_human
51890,7096,TLR1,0.529,0.7929999999999999,C0085742,"Injuries, Acute Brain",group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51891,7096,TLR1,0.529,0.7929999999999999,C0270611,Brain Injuries,group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51892,7096,TLR1,0.529,0.7929999999999999,C0272945,Brain Lacerations,disease,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
51893,7096,TLR1,0.529,0.7929999999999999,C0452047,"Brain Injuries, Focal",group,C10;C26,Injury or Poisoning,0.3,,2011.0,2011.0,1,0,CTD_human
47179,6507,SLC1A3,0.619,0.552,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
47180,6507,SLC1A3,0.619,0.552,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2001.0,2017.0,1,0,CTD_human
47181,6507,SLC1A3,0.619,0.552,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2002.0,2002.0,1,0,PSYGENET
47182,6507,SLC1A3,0.619,0.552,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
47183,6507,SLC1A3,0.619,0.552,C0014544,Epilepsy,disease,C10,Disease or Syndrome,0.41,0.0,1995.0,2010.0,1,0,CTD_human
47184,6507,SLC1A3,0.619,0.552,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.36,1.0,2002.0,2016.0,4,0,PSYGENET
47185,6507,SLC1A3,0.619,0.552,C0086237,"Epilepsy, Cryptogenic",disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
47186,6507,SLC1A3,0.619,0.552,C0178417,Anhedonia,disease,C10;C23;F01,Mental or Behavioral Dysfunction,0.3,1.0,2009.0,2009.0,1,0,PSYGENET
47187,6507,SLC1A3,0.619,0.552,C0236018,Aura,phenotype,C10,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
47188,6507,SLC1A3,0.619,0.552,C0338488,Alternating hemiplegia of childhood,disease,C10;C23,Disease or Syndrome,0.33,1.0,2006.0,2009.0,0,0,ORPHANET
47189,6507,SLC1A3,0.619,0.552,C0751111,Awakening Epilepsy,disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
47190,6507,SLC1A3,0.619,0.552,C2675211,"EPISODIC ATAXIA, TYPE 6 (disorder)",disease,C10;C23,Disease or Syndrome,0.72,1.0,2006.0,2017.0,1,2,CTD_human;ORPHANET;UNIPROT
38636,5144,PDE4D,0.5720000000000001,0.69,C0004096,Asthma,disease,C08;C20,Disease or Syndrome,0.48,0.75,2001.0,2016.0,2,4,CTD_human
38637,5144,PDE4D,0.5720000000000001,0.69,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.5,1.0,2002.0,2012.0,2,0,PSYGENET
38638,5144,PDE4D,0.5720000000000001,0.69,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2002.0,2013.0,3,0,PSYGENET
38639,5144,PDE4D,0.5720000000000001,0.69,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2006.0,2018.0,2,0,CTD_human
38640,5144,PDE4D,0.5720000000000001,0.69,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2009.0,2011.0,1,1,PSYGENET
38641,5144,PDE4D,0.5720000000000001,0.69,C0038454,Cerebrovascular accident,group,C10;C14,Disease or Syndrome,0.4,0.9375,2002.0,2017.0,0,0,CTD_human
38642,5144,PDE4D,0.5720000000000001,0.69,C0220659,Acrodysostosis,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.59,0.8888889000000001,2012.0,2018.0,0,0,CTD_human;ORPHANET
38643,5144,PDE4D,0.5720000000000001,0.69,C0236733,Amphetamine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38644,5144,PDE4D,0.5720000000000001,0.69,C0236804,Amphetamine Addiction,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38645,5144,PDE4D,0.5720000000000001,0.69,C0236807,Amphetamine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
38646,5144,PDE4D,0.5720000000000001,0.69,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.31,1.0,2006.0,2018.0,2,0,CTD_human
38647,5144,PDE4D,0.5720000000000001,0.69,C0751956,Acute Cerebrovascular Accidents,disease,C10;C14,Disease or Syndrome,0.3,,,,0,0,CTD_human
38648,5144,PDE4D,0.5720000000000001,0.69,C3276228,ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.3,,,,0,0,CTD_human
38649,5144,PDE4D,0.5720000000000001,0.69,C3553250,ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE,disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.61,1.0,2001.0,2018.0,4,9,CTD_human;UNIPROT
38650,5144,PDE4D,0.5720000000000001,0.69,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.41,1.0,2014.0,2014.0,0,0,GENOMICS_ENGLAND
23845,3094,HINT1,0.667,0.345,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2009.0,2009.0,1,0,PSYGENET
23846,3094,HINT1,0.667,0.345,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.32,1.0,2015.0,2017.0,0,0,GENOMICS_ENGLAND
23847,3094,HINT1,0.667,0.345,C0026848,Myopathy,group,C05;C10,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
23848,3094,HINT1,0.667,0.345,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.33,1.0,2004.0,2011.0,2,0,CTD_human
23849,3094,HINT1,0.667,0.345,C0242287,Isaacs syndrome,disease,C05;C10,Disease or Syndrome,0.67,1.0,2006.0,2017.0,2,6,CTD_human;ORPHANET;UNIPROT
23850,3094,HINT1,0.667,0.345,C0751919,Acquired Neuromyotonia,disease,C05;C10,Disease or Syndrome,0.3,,,,0,0,CTD_human
23851,3094,HINT1,0.667,0.345,C1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)",phenotype,,Finding,0.3,,2011.0,2011.0,1,0,CTD_human
23852,3094,HINT1,0.667,0.345,C2932678,Inherited Peripheral Neuropathy,disease,C10,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
23853,3094,HINT1,0.667,0.345,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
49134,6695,SPOCK1,0.701,0.172,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.31,1.0,2008.0,2016.0,1,0,CTD_human
49135,6695,SPOCK1,0.701,0.172,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.31,1.0,2008.0,2016.0,1,0,CTD_human
57964,8878,SQSTM1,0.49,0.828,C0002736,Amyotrophic Lateral Sclerosis,disease,C10;C18,Disease or Syndrome,0.7,1.0,2009.0,2017.0,1,0,CTD_human;ORPHANET
57965,8878,SQSTM1,0.49,0.828,C0029401,Osteitis Deformans,disease,C05,Disease or Syndrome,0.6,0.9259259,2002.0,2017.0,0,0,CTD_human
57966,8878,SQSTM1,0.49,0.828,C0242383,Age related macular degeneration,disease,C11,Disease or Syndrome,0.3,,2014.0,2014.0,1,0,CTD_human
57967,8878,SQSTM1,0.49,0.828,C0393554,Amyotrophic Lateral Sclerosis With Dementia,disease,C10;C18,Disease or Syndrome,0.31,1.0,2009.0,2013.0,1,0,CTD_human
57968,8878,SQSTM1,0.49,0.828,C0543859,"Amyotrophic Lateral Sclerosis, Guam Form",disease,C10;C18,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
57969,8878,SQSTM1,0.49,0.828,C0751336,Distal Muscular Dystrophies,group,C05;C10;C16,Disease or Syndrome,0.31,1.0,2015.0,2015.0,1,0,GENOMICS_ENGLAND
57970,8878,SQSTM1,0.49,0.828,C1261473,Sarcoma,group,C04,Neoplastic Process,0.3,,1997.0,2011.0,4,0,GENOMICS_ENGLAND
57971,8878,SQSTM1,0.49,0.828,C1833373,"Inclusion Body Myopathy, Autosomal Recessive",disease,C05;C10,Disease or Syndrome,0.3,,,,0,0,ORPHANET
57972,8878,SQSTM1,0.49,0.828,C1853926,NONAKA MYOPATHY,disease,C05;C10;C16,Disease or Syndrome,0.61,1.0,2015.0,2015.0,0,1,CTD_human;ORPHANET
57973,8878,SQSTM1,0.49,0.828,C3888102,Frontotemporal Dementia With Motor Neuron Disease,disease,C10;C18;F03,Disease or Syndrome,0.3,,,,0,0,ORPHANET
57974,8878,SQSTM1,0.49,0.828,C4011788,Behavioral variant of frontotemporal dementia,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
57975,8878,SQSTM1,0.49,0.828,C4085252,PAGET DISEASE OF BONE 3,disease,,Disease or Syndrome,0.4,,2002.0,2010.0,8,8,UNIPROT
57976,8878,SQSTM1,0.49,0.828,C4225326,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3,disease,,Disease or Syndrome,0.6,,2012.0,2015.0,4,21,CTD_human;UNIPROT
57977,8878,SQSTM1,0.49,0.828,C4310693,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET",disease,,Disease or Syndrome,0.4,,2017.0,2017.0,0,3,CTD_human
16981,2099,ESR1,0.355,0.897,C0001418,Adenocarcinoma,group,C04,Neoplastic Process,0.4,0.8846153846153849,1991.0,2017.0,2,0,CTD_human
16982,2099,ESR1,0.355,0.897,C0002395,Alzheimer's Disease,disease,C10;F03,Disease or Syndrome,0.4,1.0,1999.0,2016.0,1,0,CTD_human
16983,2099,ESR1,0.355,0.897,C0004114,Astrocytoma,disease,C04,Neoplastic Process,0.34,1.0,2001.0,2015.0,1,0,CTD_human
16984,2099,ESR1,0.355,0.897,C0004153,Atherosclerosis,disease,C14,Disease or Syndrome,0.38,0.875,2002.0,2016.0,1,0,CTD_human
16985,2099,ESR1,0.355,0.897,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.35,1.0,2000.0,2012.0,5,0,PSYGENET
16986,2099,ESR1,0.355,0.897,C0005684,Malignant neoplasm of urinary bladder,disease,C04;C12;C13,Neoplastic Process,0.32,1.0,2006.0,2015.0,1,0,CTD_human
16987,2099,ESR1,0.355,0.897,C0005695,Bladder Neoplasm,group,C04;C12;C13,Neoplastic Process,0.32,1.0,2006.0,2015.0,1,0,CTD_human
16988,2099,ESR1,0.355,0.897,C0005940,Bone Diseases,group,C05,Disease or Syndrome,0.31,1.0,2007.0,2017.0,1,0,CTD_human
16989,2099,ESR1,0.355,0.897,C0005944,Metabolic Bone Disorder,group,C05;C18,Disease or Syndrome,0.3,,2008.0,2008.0,1,0,CTD_human
16990,2099,ESR1,0.355,0.897,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.9,0.9704449496589799,1983.0,2018.0,15,1,CGI;CTD_human;UNIPROT
16991,2099,ESR1,0.355,0.897,C0006826,Malignant Neoplasms,group,C04,Neoplastic Process,0.33,1.0,2017.0,2018.0,0,0,CGI
16992,2099,ESR1,0.355,0.897,C0007097,Carcinoma,group,C04,Neoplastic Process,0.31,1.0,2005.0,2018.0,2,0,CTD_human
16993,2099,ESR1,0.355,0.897,C0007621,Neoplastic Cell Transformation,phenotype,C04;C23,Neoplastic Process,0.3,,2013.0,2016.0,2,0,CTD_human
16994,2099,ESR1,0.355,0.897,C0007852,Cervical Migraine Syndrome,disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
16995,2099,ESR1,0.355,0.897,C0010054,Coronary Arteriosclerosis,disease,C14,Disease or Syndrome,0.4,0.96,1998.0,2018.0,2,0,CTD_human
16996,2099,ESR1,0.355,0.897,C0011265,Presenile dementia,disease,C10;F03,Mental or Behavioral Dysfunction,0.37,0.857142857142857,2000.0,2014.0,1,0,CTD_human
16997,2099,ESR1,0.355,0.897,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.37,0.8,2011.0,2018.0,5,0,PSYGENET
16998,2099,ESR1,0.355,0.897,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.37,0.8,2011.0,2018.0,5,0,PSYGENET
16999,2099,ESR1,0.355,0.897,C0014170,Endometrial Neoplasms,group,C04;C13,Neoplastic Process,0.4,1.0,1998.0,2014.0,1,0,CTD_human
17000,2099,ESR1,0.355,0.897,C0015799,Feminization,phenotype,C23,Pathologic Function,0.3,,2012.0,2012.0,1,0,CTD_human
17001,2099,ESR1,0.355,0.897,C0017658,Glomerulonephritis,disease,C12;C13,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
17002,2099,ESR1,0.355,0.897,C0018984,Hemicrania migraine,disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
17003,2099,ESR1,0.355,0.897,C0020445,"Hypercholesterolemia, Familial",disease,C16;C18,Disease or Syndrome,0.31,1.0,2002.0,2002.0,0,0,GENOMICS_ENGLAND
17004,2099,ESR1,0.355,0.897,C0021361,Female infertility,phenotype,C13,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
17005,2099,ESR1,0.355,0.897,C0021364,Male infertility,disease,C12,Disease or Syndrome,0.37,0.857142857142857,2006.0,2015.0,2,0,CTD_human
17006,2099,ESR1,0.355,0.897,C0023267,Fibroid Tumor,group,C04,Neoplastic Process,0.4,0.9393939393939391,1995.0,2016.0,1,0,CTD_human
17007,2099,ESR1,0.355,0.897,C0023418,leukemia,disease,C04,Neoplastic Process,0.35,1.0,1991.0,2016.0,1,0,CTD_human
17008,2099,ESR1,0.355,0.897,C0023903,Liver neoplasms,group,C04;C06,Neoplastic Process,0.38,1.0,1996.0,2016.0,1,0,CTD_human
17009,2099,ESR1,0.355,0.897,C0024121,Lung Neoplasms,group,C04;C08,Neoplastic Process,0.36,1.0,2002.0,2016.0,2,0,CTD_human
17010,2099,ESR1,0.355,0.897,C0024667,Animal Mammary Neoplasms,group,C04;C22,Neoplastic Process,0.3,,2005.0,2007.0,2,0,CTD_human
17011,2099,ESR1,0.355,0.897,C0024668,"Mammary Neoplasms, Experimental",group,C04,Experimental Model of Disease; Neoplastic Process,0.3,,2005.0,2005.0,1,0,CTD_human
17012,2099,ESR1,0.355,0.897,C0024809,Marijuana Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.31,1.0,2006.0,2006.0,1,0,PSYGENET
17013,2099,ESR1,0.355,0.897,C0025500,Mesothelioma,disease,C04,Neoplastic Process,0.3,,2005.0,2008.0,2,0,CTD_human
17014,2099,ESR1,0.355,0.897,C0026858,Musculoskeletal Pain,phenotype,C05;C23,Finding,0.3,,2015.0,2015.0,1,0,CTD_human
17015,2099,ESR1,0.355,0.897,C0027051,Myocardial Infarction,disease,C14,Disease or Syndrome,0.4,0.916666666666667,2003.0,2016.0,1,0,CTD_human
17016,2099,ESR1,0.355,0.897,C0027626,Neoplasm Invasiveness,phenotype,C04;C23,Pathologic Function,0.3,,2016.0,2017.0,2,0,CTD_human
17017,2099,ESR1,0.355,0.897,C0027627,Neoplasm Metastasis,phenotype,C04;C23,Neoplastic Process,0.4,0.9527559055118109,1992.0,2018.0,1,0,CTD_human
17018,2099,ESR1,0.355,0.897,C0027643,"Neoplasm Recurrence, Local",phenotype,C04;C23,Neoplastic Process,0.3,,2011.0,2011.0,1,0,CTD_human
17019,2099,ESR1,0.355,0.897,C0027819,Neuroblastoma,group,C04,Neoplastic Process,0.4,1.0,1993.0,2016.0,1,0,CTD_human
17020,2099,ESR1,0.355,0.897,C0028754,Obesity,disease,C18;C23,Disease or Syndrome,0.6,1.0,2001.0,2017.0,1,0,CTD_human
17021,2099,ESR1,0.355,0.897,C0028960,Oligospermia,disease,C12,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
17022,2099,ESR1,0.355,0.897,C0029434,Osteogenesis Imperfecta,disease,C05;C16;C17,Congenital Abnormality; Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
17023,2099,ESR1,0.355,0.897,C0029453,Osteopenia,disease,C05;C18,Disease or Syndrome,0.5,0.941176470588235,1997.0,2016.0,1,0,CTD_human
17024,2099,ESR1,0.355,0.897,C0029925,Ovarian Carcinoma,disease,,Neoplastic Process,0.4,0.926470588235294,1990.0,2018.0,0,0,CGI
17025,2099,ESR1,0.355,0.897,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.39,1.0,2001.0,2009.0,2,0,CTD_human
17026,2099,ESR1,0.355,0.897,C0033937,"Psychoses, Drug",disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
17027,2099,ESR1,0.355,0.897,C0033941,"Psychoses, Substance-Induced",disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
17028,2099,ESR1,0.355,0.897,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.38,1.0,2002.0,2013.0,5,0,PSYGENET
17029,2099,ESR1,0.355,0.897,C0036939,Shared Paranoid Disorder,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2010.0,2010.0,1,0,PSYGENET
17030,2099,ESR1,0.355,0.897,C0038279,"Sterility, Postpartum",phenotype,C13,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
17031,2099,ESR1,0.355,0.897,C0042133,Uterine Fibroids,group,C04,Neoplastic Process,0.4,0.931034482758621,1995.0,2014.0,1,0,CTD_human
17032,2099,ESR1,0.355,0.897,C0042331,Migraine Variant,disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
17033,2099,ESR1,0.355,0.897,C0149931,Migraine Disorders,group,C10,Disease or Syndrome,0.4,0.8,2004.0,2016.0,1,0,CTD_human
17034,2099,ESR1,0.355,0.897,C0205641,"Adenocarcinoma, Basal Cell",disease,C04,Neoplastic Process,0.3,,2005.0,2012.0,2,0,CTD_human
17035,2099,ESR1,0.355,0.897,C0205642,"Adenocarcinoma, Oxyphilic",disease,C04,Neoplastic Process,0.3,,2005.0,2012.0,2,0,CTD_human
17036,2099,ESR1,0.355,0.897,C0205643,"Carcinoma, Cribriform",disease,C04,Neoplastic Process,0.3,,2005.0,2012.0,2,0,CTD_human
17037,2099,ESR1,0.355,0.897,C0205644,"Carcinoma, Granular Cell",disease,C04,Neoplastic Process,0.3,,2005.0,2012.0,2,0,CTD_human
17038,2099,ESR1,0.355,0.897,C0205645,"Adenocarcinoma, Tubular",disease,C04,Neoplastic Process,0.31,1.0,2005.0,2015.0,2,0,CTD_human
17039,2099,ESR1,0.355,0.897,C0205696,Anaplastic carcinoma,disease,C04,Neoplastic Process,0.3,,2005.0,2007.0,2,0,CTD_human
17040,2099,ESR1,0.355,0.897,C0205697,"Carcinoma, Spindle-Cell",disease,C04,Neoplastic Process,0.3,,2005.0,2007.0,2,0,CTD_human
17041,2099,ESR1,0.355,0.897,C0205698,Undifferentiated carcinoma,phenotype,C04,Neoplastic Process,0.3,,2005.0,2007.0,2,0,CTD_human
17042,2099,ESR1,0.355,0.897,C0205699,Carcinomatosis,phenotype,C04,Neoplastic Process,0.3,,2005.0,2007.0,2,0,CTD_human
17043,2099,ESR1,0.355,0.897,C0205768,Subependymal Giant Cell Astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17044,2099,ESR1,0.355,0.897,C0235874,Disease Exacerbation,phenotype,C23,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
17045,2099,ESR1,0.355,0.897,C0242379,Malignant neoplasm of lung,disease,C04;C08,Neoplastic Process,0.4,0.923076923076923,1999.0,2017.0,2,0,CTD_human
17046,2099,ESR1,0.355,0.897,C0270858,Abdominal Migraine,disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
17047,2099,ESR1,0.355,0.897,C0276496,Familial Alzheimer Disease (FAD),disease,C10;F03,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
17048,2099,ESR1,0.355,0.897,C0280783,Juvenile Pilocytic Astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17049,2099,ESR1,0.355,0.897,C0280785,Diffuse Astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17050,2099,ESR1,0.355,0.897,C0282612,Prostatic Intraepithelial Neoplasias,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
17051,2099,ESR1,0.355,0.897,C0334579,Anaplastic astrocytoma,disease,C04,Neoplastic Process,0.31,1.0,2001.0,2015.0,1,0,CTD_human
17052,2099,ESR1,0.355,0.897,C0334580,Protoplasmic astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17053,2099,ESR1,0.355,0.897,C0334581,Gemistocytic astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17054,2099,ESR1,0.355,0.897,C0334582,Fibrillary Astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17055,2099,ESR1,0.355,0.897,C0334583,Pilocytic Astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17056,2099,ESR1,0.355,0.897,C0338070,Childhood Cerebral Astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17057,2099,ESR1,0.355,0.897,C0338489,Status Migrainosus,disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
17058,2099,ESR1,0.355,0.897,C0341869,"Subfertility, Female",disease,C13,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
17059,2099,ESR1,0.355,0.897,C0345904,Malignant neoplasm of liver,disease,C04;C06,Neoplastic Process,0.32,1.0,2003.0,2017.0,1,0,CTD_human
17060,2099,ESR1,0.355,0.897,C0346153,"Breast Cancer, Familial",disease,C04;C17,Neoplastic Process,0.47,0.857142857142857,1995.0,2013.0,0,1,GENOMICS_ENGLAND
17061,2099,ESR1,0.355,0.897,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.4,0.970588235294118,1996.0,2017.0,2,0,CTD_human
17062,2099,ESR1,0.355,0.897,C0476089,Endometrial Carcinoma,disease,C04;C13,Neoplastic Process,0.6,0.9540229885057471,1991.0,2018.0,1,0,CGI;CTD_human
17063,2099,ESR1,0.355,0.897,C0494463,"Alzheimer Disease, Late Onset",disease,C10;F03,Mental or Behavioral Dysfunction,0.32,1.0,2007.0,2016.0,1,0,CTD_human
17064,2099,ESR1,0.355,0.897,C0496920,Neoplasm of uncertain or unknown behavior of ovary,disease,,Neoplastic Process,0.3,,,,0,0,CGI
17065,2099,ESR1,0.355,0.897,C0496956,Neoplasm of uncertain or unknown behavior of breast,disease,,Neoplastic Process,0.3,,,,0,0,CGI
17066,2099,ESR1,0.355,0.897,C0521664,Acute Confusional Migraine,disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
17067,2099,ESR1,0.355,0.897,C0525045,Mood Disorders,group,F03,Mental or Behavioral Dysfunction,0.33,1.0,2008.0,2014.0,4,0,PSYGENET
17068,2099,ESR1,0.355,0.897,C0546126,Acute Confusional Senile Dementia,disease,C10;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
17069,2099,ESR1,0.355,0.897,C0547065,Mixed oligoastrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17070,2099,ESR1,0.355,0.897,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.7,0.9721054642720669,1981.0,2018.0,14,4,CGI;CTD_human
17071,2099,ESR1,0.355,0.897,C0700438,Sick Headaches,disease,C10,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
17072,2099,ESR1,0.355,0.897,C0750900,"Alzheimer's Disease, Focal Onset",disease,C10;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
17073,2099,ESR1,0.355,0.897,C0750901,"Alzheimer Disease, Early Onset",disease,C10;F03,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
17074,2099,ESR1,0.355,0.897,C0750935,Cerebral Astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17075,2099,ESR1,0.355,0.897,C0750936,Intracranial Astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17076,2099,ESR1,0.355,0.897,C0848676,"Subfertility, Male",phenotype,C12,Sign or Symptom,0.3,,2010.0,2013.0,2,0,CTD_human
17077,2099,ESR1,0.355,0.897,C0858252,Breast adenocarcinoma,disease,,Neoplastic Process,0.34,0.75,2003.0,2015.0,0,0,CGI
17078,2099,ESR1,0.355,0.897,C0917730,Female sterility,phenotype,C13,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
17079,2099,ESR1,0.355,0.897,C0917731,Male sterility,phenotype,C12,Finding,0.3,,2010.0,2013.0,2,0,CTD_human
17080,2099,ESR1,0.355,0.897,C0919267,ovarian neoplasm,disease,C04;C13;C19,Neoplastic Process,0.36,1.0,1998.0,2014.0,0,0,CGI
17081,2099,ESR1,0.355,0.897,C1140680,Malignant neoplasm of ovary,disease,C04;C13;C19,Neoplastic Process,0.4,0.9298245614035091,1994.0,2018.0,0,0,CGI
17082,2099,ESR1,0.355,0.897,C1257925,"Mammary Carcinoma, Animal",disease,C04;C22,Neoplastic Process,0.3,,2005.0,2007.0,2,0,CTD_human
17083,2099,ESR1,0.355,0.897,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2008.0,2016.0,14,0,CTD_human
17084,2099,ESR1,0.355,0.897,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.7,0.964769647696477,1988.0,2018.0,14,5,CTD_human
17085,2099,ESR1,0.355,0.897,C1563937,Atherogenesis,phenotype,C14,Pathologic Function,0.3,,2002.0,2002.0,1,0,CTD_human
17086,2099,ESR1,0.355,0.897,C1704230,Grade I Astrocytoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
17087,2099,ESR1,0.355,0.897,C1704377,Bright Disease,disease,C12;C13,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
17088,2099,ESR1,0.355,0.897,C1720887,Female Urogenital Diseases,group,C13,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
17089,2099,ESR1,0.355,0.897,C1956346,Coronary Artery Disease,disease,C14,Disease or Syndrome,0.5,0.9259259259259259,1998.0,2014.0,2,0,CTD_human
17090,2099,ESR1,0.355,0.897,C2239176,Liver carcinoma,disease,C04;C06,Neoplastic Process,0.4,1.0,1995.0,2018.0,1,0,CTD_human
17091,2099,ESR1,0.355,0.897,C3809250,ESTROGEN RESISTANCE,disease,,Disease or Syndrome,0.7,1.0,1994.0,2017.0,2,3,ORPHANET;UNIPROT
17092,2099,ESR1,0.355,0.897,C3887485,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1",phenotype,,Finding,0.3,,,,0,0,CTD_human
17093,2099,ESR1,0.355,0.897,C4302111,Familial Ménière disease,disease,,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,GENOMICS_ENGLAND
24497,3181,HNRNPA2B1,0.607,0.655,C0023493,Adult T-Cell Lymphoma/Leukemia,disease,C04;C15;C20,Neoplastic Process,0.3,,2016.0,2016.0,1,0,CTD_human
24498,3181,HNRNPA2B1,0.607,0.655,C1833662,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA,disease,C05;C10;C16;C18;F03,Disease or Syndrome,0.5,,,,0,0,CTD_human;ORPHANET
24499,3181,HNRNPA2B1,0.607,0.655,C3809468,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2,disease,,Disease or Syndrome,0.4,,2002.0,2013.0,1,1,UNIPROT
78006,221895,JAZF1,0.616,0.44799999999999995,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",disease,C18;C19,Disease or Syndrome,0.5,0.9375,2008.0,2018.0,1,4,CTD_human
78007,221895,JAZF1,0.616,0.44799999999999995,C0014170,Endometrial Neoplasms,group,C04;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
78008,221895,JAZF1,0.616,0.44799999999999995,C0024141,"Lupus Erythematosus, Systemic",disease,C17;C20,Disease or Syndrome,0.43,0.6666667,2009.0,2016.0,1,3,CTD_human
78009,221895,JAZF1,0.616,0.44799999999999995,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
78010,221895,JAZF1,0.616,0.44799999999999995,C0206630,Endometrial Stromal Sarcoma,disease,C04;C13,Neoplastic Process,0.4,0.9,2006.0,2016.0,0,0,ORPHANET
78011,221895,JAZF1,0.616,0.44799999999999995,C0242380,Libman-Sacks Disease,disease,C17;C20,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
78012,221895,JAZF1,0.616,0.44799999999999995,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.37,0.8571429,2008.0,2015.0,1,0,CTD_human
78013,221895,JAZF1,0.616,0.44799999999999995,C0476089,Endometrial Carcinoma,disease,C04;C13,Neoplastic Process,0.31,1.0,2008.0,2008.0,1,0,CTD_human
64480,23362,PSD3,0.685,0.379,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,GENOMICS_ENGLAND
64481,23362,PSD3,0.685,0.379,C0017638,Glioma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64482,23362,PSD3,0.685,0.379,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2013.0,2016.0,1,1,PSYGENET
64483,23362,PSD3,0.685,0.379,C0236733,Amphetamine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64484,23362,PSD3,0.685,0.379,C0236804,Amphetamine Addiction,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64485,23362,PSD3,0.685,0.379,C0236807,Amphetamine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2008.0,1,0,CTD_human
64486,23362,PSD3,0.685,0.379,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64487,23362,PSD3,0.685,0.379,C0555198,Malignant Glioma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
64488,23362,PSD3,0.685,0.379,C1867439,"Pterygium, Antecubital",disease,C05;C16,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CLINGEN
63137,11160,ERLIN2,0.696,0.44799999999999995,C0020796,Profound Mental Retardation,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
63138,11160,ERLIN2,0.696,0.44799999999999995,C0025363,"Mental Retardation, Psychosocial",disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
63139,11160,ERLIN2,0.696,0.44799999999999995,C0037773,"Spastic Paraplegia, Hereditary",disease,C10;C16,Disease or Syndrome,0.4,,2018.0,2018.0,0,1,GENOMICS_ENGLAND
63140,11160,ERLIN2,0.696,0.44799999999999995,C0917816,Mental deficiency,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
63141,11160,ERLIN2,0.696,0.44799999999999995,C1853396,Primary lateral sclerosis juvenile,disease,C10,Disease or Syndrome,0.31,1.0,2013.0,2013.0,0,0,ORPHANET
63142,11160,ERLIN2,0.696,0.44799999999999995,C2749936,"SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE (disorder)",disease,C05;C10;C16;C23;F01;F03,Disease or Syndrome,0.6,,2011.0,2013.0,0,2,CTD_human;ORPHANET
63143,11160,ERLIN2,0.696,0.44799999999999995,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.51,1.0,2011.0,2016.0,10,0,CTD_human;GENOMICS_ENGLAND
73065,79581,SLC52A2,0.528,0.759,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
73066,79581,SLC52A2,0.528,0.759,C0796274,Brown-Vialetto-Van Laere syndrome,disease,C09;C10;C23,Disease or Syndrome,0.54,1.0,2013.0,2017.0,0,0,CTD_human;ORPHANET
73067,79581,SLC52A2,0.528,0.759,C1849094,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,ORPHANET
73068,79581,SLC52A2,0.528,0.759,C3553538,BROWN-VIALETTO-VAN LAERE SYNDROME 2,disease,,Disease or Syndrome,0.4,,1993.0,2017.0,5,18,UNIPROT
64327,23299,BICD2,0.72,0.414,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.41,1.0,2015.0,2017.0,0,1,GENOMICS_ENGLAND
64328,23299,BICD2,0.72,0.414,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
64329,23299,BICD2,0.72,0.414,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
64330,23299,BICD2,0.72,0.414,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
64331,23299,BICD2,0.72,0.414,C3809049,"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMAL DOMINANT",disease,,Disease or Syndrome,0.6,,1994.0,2017.0,3,7,ORPHANET;UNIPROT
72709,65217,PCDH15,0.627,0.44799999999999995,C0009197,Cochlear Diseases,group,C09,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72710,65217,PCDH15,0.627,0.44799999999999995,C0011052,Prelingual Deafness,disease,C09;C10;C23,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72711,65217,PCDH15,0.627,0.44799999999999995,C0011053,Deafness,phenotype,C09;C10;C23,Finding,0.41,,2000.0,2008.0,1,0,CTD_human
72712,65217,PCDH15,0.627,0.44799999999999995,C0013146,Drug abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72713,65217,PCDH15,0.627,0.44799999999999995,C0013170,Drug habituation,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72714,65217,PCDH15,0.627,0.44799999999999995,C0013222,Drug Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72715,65217,PCDH15,0.627,0.44799999999999995,C0029231,"Organic Mental Disorders, Substance-Induced",disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72716,65217,PCDH15,0.627,0.44799999999999995,C0038580,Substance Dependence,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72717,65217,PCDH15,0.627,0.44799999999999995,C0038586,Substance Use Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72718,65217,PCDH15,0.627,0.44799999999999995,C0086395,"Hearing Loss, Extreme",phenotype,C09;C10;C23,Sign or Symptom,0.3,,2000.0,2000.0,1,0,CTD_human
72719,65217,PCDH15,0.627,0.44799999999999995,C0236969,Substance-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72720,65217,PCDH15,0.627,0.44799999999999995,C0271097,Usher Syndrome,disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.47,1.0,2001.0,2015.0,1,1,CTD_human
72721,65217,PCDH15,0.627,0.44799999999999995,C0581883,Complete Hearing Loss,phenotype,C09;C10;C23,Finding,0.3,,2000.0,2000.0,1,0,CTD_human
72722,65217,PCDH15,0.627,0.44799999999999995,C0740858,Substance abuse problem,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72723,65217,PCDH15,0.627,0.44799999999999995,C0751068,"Deafness, Acquired",disease,C09;C10;C23,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72724,65217,PCDH15,0.627,0.44799999999999995,C1510472,Drug Dependence,phenotype,C25;F03,Mental or Behavioral Dysfunction,0.3,,2010.0,2010.0,1,0,CTD_human
72725,65217,PCDH15,0.627,0.44799999999999995,C1568247,"Usher Syndrome, Type I",disease,,Disease or Syndrome,0.49,0.8888889000000001,1993.0,2015.0,0,3,ORPHANET
72726,65217,PCDH15,0.627,0.44799999999999995,C1568248,"Usher Syndrome, Type III",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
72727,65217,PCDH15,0.627,0.44799999999999995,C1568249,"Usher Syndrome, Type II",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.3,,2009.0,2009.0,1,0,CTD_human
72728,65217,PCDH15,0.627,0.44799999999999995,C1832845,"USHER SYNDROME, TYPE ID",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.4,,2003.0,2017.0,2,3,UNIPROT
72729,65217,PCDH15,0.627,0.44799999999999995,C1836027,"Deafness, Autosomal Recessive 23",disease,C09;C10;C23,Disease or Syndrome,0.82,1.0,2003.0,2017.0,3,6,CTD_human;UNIPROT
72730,65217,PCDH15,0.627,0.44799999999999995,C1865885,"Usher Syndrome, Type IF",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.87,1.0,2001.0,2017.0,9,49,CLINGEN;UNIPROT
72731,65217,PCDH15,0.627,0.44799999999999995,C2931205,"Usher syndrome, type 1A",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.34,1.0,2008.0,2012.0,1,0,CTD_human
72732,65217,PCDH15,0.627,0.44799999999999995,C2931208,"Usher syndrome, type 1D",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.3,,,,0,0,CTD_human
72733,65217,PCDH15,0.627,0.44799999999999995,C2931210,"Usher syndrome, type 1F",disease,C09;C10;C11;C16;C23,Disease or Syndrome,0.38,0.875,2001.0,2016.0,0,0,CTD_human
72734,65217,PCDH15,0.627,0.44799999999999995,C3152102,"USH1D/F, CDH23/PCDH15, DIGENIC",disease,,Disease or Syndrome,0.3,,2005.0,2008.0,2,0,UNIPROT
72735,65217,PCDH15,0.627,0.44799999999999995,C3275872,"USHER SYNDROME, TYPE ID/F, CDH23/PCDH15, DIGENIC",disease,,Disease or Syndrome,0.3,,2005.0,2008.0,2,0,UNIPROT
72736,65217,PCDH15,0.627,0.44799999999999995,C3665473,Bilateral Deafness,phenotype,C09;C10;C23,Finding,0.3,,2000.0,2000.0,1,0,CTD_human
72737,65217,PCDH15,0.627,0.44799999999999995,C4082305,Deaf Mutism,disease,C09;C10;C23,Disease or Syndrome,0.3,,2000.0,2000.0,1,0,CTD_human
72738,65217,PCDH15,0.627,0.44799999999999995,C4316881,Prescription Drug Abuse,phenotype,C25;F03,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
8176,953,ENTPD1,0.569,0.655,C0020796,Profound Mental Retardation,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
8177,953,ENTPD1,0.569,0.655,C0025363,"Mental Retardation, Psychosocial",disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
8178,953,ENTPD1,0.569,0.655,C0037773,"Spastic Paraplegia, Hereditary",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
8179,953,ENTPD1,0.569,0.655,C0917816,Mental deficiency,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2012.0,2012.0,1,0,CTD_human
8180,953,ENTPD1,0.569,0.655,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.6,,2012.0,2012.0,1,0,CTD_human;GENOMICS_ENGLAND
8181,953,ENTPD1,0.569,0.655,C3810289,"SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE",disease,,Disease or Syndrome,0.7,,2014.0,2014.0,1,1,CTD_human;ORPHANET;UNIPROT
63809,22978,NT5C2,0.5720000000000001,0.7240000000000001,C0006826,Malignant Neoplasms,group,C04,Neoplastic Process,0.3,,,,0,0,CGI
63810,22978,NT5C2,0.5720000000000001,0.7240000000000001,C0023452,Childhood Acute Lymphoblastic Leukemia,disease,C04;C15;C20,Neoplastic Process,0.31,1.0,2013.0,2013.0,1,0,CTD_human
63811,22978,NT5C2,0.5720000000000001,0.7240000000000001,C0023453,"Leukemia, Lymphocytic, Acute, L2",disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
63812,22978,NT5C2,0.5720000000000001,0.7240000000000001,C0037773,"Spastic Paraplegia, Hereditary",disease,C10;C16,Disease or Syndrome,0.31,1.0,2018.0,2018.0,0,0,GENOMICS_ENGLAND
63813,22978,NT5C2,0.5720000000000001,0.7240000000000001,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.31,1.0,1983.0,2013.0,1,0,CTD_human
63814,22978,NT5C2,0.5720000000000001,0.7240000000000001,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,1993.0,2014.0,3,0,GENOMICS_ENGLAND
63815,22978,NT5C2,0.5720000000000001,0.7240000000000001,C3888209,"SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE",disease,,Disease or Syndrome,0.71,1.0,2009.0,2018.0,2,5,CTD_human;ORPHANET;UNIPROT
62922,10984,KCNQ1OT1,0.604,0.586,C0004903,Beckwith-Wiedemann Syndrome,disease,C16,Disease or Syndrome,0.4,0.9782609,1999.0,2016.0,0,0,CTD_human
62923,10984,KCNQ1OT1,0.604,0.586,C0332890,Congenital hemihypertrophy,disease,,Congenital Abnormality,0.4,,,,0,0,ORPHANET
62924,10984,KCNQ1OT1,0.604,0.586,C1856184,"HEMIHYPERPLASIA, ISOLATED",disease,C23,Disease or Syndrome,0.31,1.0,2008.0,2008.0,0,0,ORPHANET
75150,85363,TRIM5,0.799,0.24100000000000002,C0019693,HIV Infections,group,C02;C20,Disease or Syndrome,0.36,1.0,2004.0,2015.0,1,0,CTD_human
75151,85363,TRIM5,0.799,0.24100000000000002,C4505456,HIV Coinfection,disease,C02;C20,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
28412,3611,ILK,0.534,0.69,C0007193,"Cardiomyopathy, Dilated",group,C14,Disease or Syndrome,0.51,1.0,2007.0,2007.0,0,0,GENOMICS_ENGLAND
28413,3611,ILK,0.534,0.69,C0007787,Transient Ischemic Attack,disease,C10;C14,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
28414,3611,ILK,0.534,0.69,C0009171,Cocaine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2010.0,2,0,CTD_human
28415,3611,ILK,0.534,0.69,C0009376,Colonic Polyps,phenotype,C23,Anatomical Abnormality,0.3,,2001.0,2001.0,1,0,CTD_human
28416,3611,ILK,0.534,0.69,C0014544,Epilepsy,disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
28417,3611,ILK,0.534,0.69,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2006.0,2006.0,1,0,CTD_human
28418,3611,ILK,0.534,0.69,C0039978,Thoracic Diseases,group,C08,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
28419,3611,ILK,0.534,0.69,C0086237,"Epilepsy, Cryptogenic",disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
28420,3611,ILK,0.534,0.69,C0236018,Aura,phenotype,C10,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
28421,3611,ILK,0.534,0.69,C0236736,Cocaine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2010.0,2,0,CTD_human
28422,3611,ILK,0.534,0.69,C0264886,Conduction disorder of the heart,group,C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
28423,3611,ILK,0.534,0.69,C0345967,Malignant mesothelioma,disease,C04;C08,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
28424,3611,ILK,0.534,0.69,C0472381,Posterior Circulation Transient Ischemic Attack,disease,C10;C14,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
28425,3611,ILK,0.534,0.69,C0600427,Cocaine Dependence,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2008.0,2010.0,2,0,CTD_human
28426,3611,ILK,0.534,0.69,C0751019,Carotid Circulation Transient Ischemic Attack,disease,C10;C14,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
28427,3611,ILK,0.534,0.69,C0751020,"Transient Ischemic Attack, Vertebrobasilar Circulation",disease,C10;C14,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
28428,3611,ILK,0.534,0.69,C0751021,Crescendo Transient Ischemic Attacks,disease,C10;C14,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
28429,3611,ILK,0.534,0.69,C0751022,"Brain Stem Ischemia, Transient",disease,C10;C14,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
28430,3611,ILK,0.534,0.69,C0751111,Awakening Epilepsy,disease,C10,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
28431,3611,ILK,0.534,0.69,C0917805,Transient Cerebral Ischemia,disease,C10;C14,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
28432,3611,ILK,0.534,0.69,C1527335,"Transient Ischemic Attack, Anterior Circulation",disease,C10;C14,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
59228,9415,FADS2,0.627,0.552,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.41,1.0,2011.0,2018.0,1,2,PSYGENET
59229,9415,FADS2,0.627,0.552,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
59230,9415,FADS2,0.627,0.552,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.3,,2014.0,2014.0,1,0,CTD_human
59231,9415,FADS2,0.627,0.552,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2015.0,2015.0,1,0,CTD_human
59232,9415,FADS2,0.627,0.552,C0023794,Lipoidosis,disease,C16;C18,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
59233,9415,FADS2,0.627,0.552,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,2009.0,2009.0,1,0,PSYGENET
59234,9415,FADS2,0.627,0.552,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59235,9415,FADS2,0.627,0.552,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59236,9415,FADS2,0.627,0.552,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.4,,2014.0,2018.0,1,1,CTD_human
59237,9415,FADS2,0.627,0.552,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59238,9415,FADS2,0.627,0.552,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
59239,9415,FADS2,0.627,0.552,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
65218,23705,CADM1,0.537,0.655,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.31,,2008.0,2008.0,1,0,CTD_human
65219,23705,CADM1,0.537,0.655,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.33,1.0,2002.0,2013.0,1,0,CTD_human
65220,23705,CADM1,0.537,0.655,C0011573,Endogenous depression,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65221,23705,CADM1,0.537,0.655,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65222,23705,CADM1,0.537,0.655,C0025193,Melancholia,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65223,23705,CADM1,0.537,0.655,C0041696,Unipolar Depression,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65224,23705,CADM1,0.537,0.655,C0086133,Depressive Syndrome,disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65225,23705,CADM1,0.537,0.655,C0282126,"Depression, Neurotic",disease,F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
65226,23705,CADM1,0.537,0.655,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.32,1.0,2002.0,2007.0,1,0,CTD_human
65227,23705,CADM1,0.537,0.655,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
65228,23705,CADM1,0.537,0.655,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.32,,2002.0,2007.0,1,0,CTD_human
44870,6038,RNASE4,0.8340000000000001,0.207,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2007.0,2007.0,1,0,CTD_human
44871,6038,RNASE4,0.8340000000000001,0.207,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
44872,6038,RNASE4,0.8340000000000001,0.207,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
2686,283,ANG,0.547,0.69,C0001349,Acute-Phase Reaction,phenotype,C23,Pathologic Function,0.3,,1998.0,1998.0,1,0,CTD_human
2687,283,ANG,0.547,0.69,C0002736,Amyotrophic Lateral Sclerosis,disease,C10;C18,Disease or Syndrome,0.5,0.96969696969697,2005.0,2017.0,0,0,ORPHANET
2688,283,ANG,0.547,0.69,C0010093,Corpus Luteum Cyst,disease,C04;C13;C19,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
2689,283,ANG,0.547,0.69,C0029927,Ovarian Cysts,disease,C04;C13;C19,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
2690,283,ANG,0.547,0.69,C2678468,Amyotrophic Lateral Sclerosis 9,disease,C10;C18,Disease or Syndrome,0.6,,2005.0,2015.0,8,10,CTD_human;UNIPROT
12834,1544,CYP1A2,0.509,0.828,C0007137,Squamous cell carcinoma,disease,C04,Neoplastic Process,0.33,0.666666666666667,2007.0,2012.0,1,0,CTD_human
12835,1544,CYP1A2,0.509,0.828,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12836,1544,CYP1A2,0.509,0.828,C0009402,Colorectal Carcinoma,disease,C04;C06,Neoplastic Process,0.4,1.0,1993.0,2015.0,1,0,CTD_human
12837,1544,CYP1A2,0.509,0.828,C0009404,Colorectal Neoplasms,group,C04;C06,Neoplastic Process,0.32,,2007.0,2011.0,1,0,CTD_human
12838,1544,CYP1A2,0.509,0.828,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",disease,C18;C19,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
12839,1544,CYP1A2,0.509,0.828,C0011999,Diastematomyelia,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12840,1544,CYP1A2,0.509,0.828,C0013221,Drug toxicity,group,C25,Injury or Poisoning,0.3,,1999.0,1999.0,1,0,CTD_human
12841,1544,CYP1A2,0.509,0.828,C0018273,Growth Disorders,group,C23,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
12842,1544,CYP1A2,0.509,0.828,C0019193,"Hepatitis, Toxic",disease,C06;C25,Injury or Poisoning,0.3,,2018.0,2018.0,1,0,CTD_human
12843,1544,CYP1A2,0.509,0.828,C0019207,"Hepatoma, Morris",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12844,1544,CYP1A2,0.509,0.828,C0019208,"Hepatoma, Novikoff",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12845,1544,CYP1A2,0.509,0.828,C0019209,Hepatomegaly,phenotype,C06;C23,Finding,0.3,,1999.0,1999.0,1,0,CTD_human
12846,1544,CYP1A2,0.509,0.828,C0023452,Childhood Acute Lymphoblastic Leukemia,disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12847,1544,CYP1A2,0.509,0.828,C0023453,"Leukemia, Lymphocytic, Acute, L2",disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12848,1544,CYP1A2,0.509,0.828,C0023890,Liver Cirrhosis,disease,C06,Disease or Syndrome,0.31,1.0,1995.0,2017.0,1,0,CTD_human
12849,1544,CYP1A2,0.509,0.828,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2007.0,2007.0,1,0,CTD_human
12850,1544,CYP1A2,0.509,0.828,C0023895,Liver diseases,group,C06,Disease or Syndrome,0.3,,2004.0,2004.0,1,0,CTD_human
12851,1544,CYP1A2,0.509,0.828,C0023904,"Liver Neoplasms, Experimental",group,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12852,1544,CYP1A2,0.509,0.828,C0024117,Chronic Obstructive Airway Disease,disease,C08,Disease or Syndrome,0.33,1.0,2008.0,2010.0,1,0,CTD_human
12853,1544,CYP1A2,0.509,0.828,C0024121,Lung Neoplasms,group,C04;C08,Neoplastic Process,0.31,,2007.0,2012.0,1,0,CTD_human
12854,1544,CYP1A2,0.509,0.828,C0025637,Methemoglobinemia,disease,C15,Disease or Syndrome,0.3,,2002.0,2002.0,1,0,CTD_human
12855,1544,CYP1A2,0.509,0.828,C0027794,Neural Tube Defects,group,C10;C16,Congenital Abnormality,0.31,1.0,2010.0,2010.0,1,0,CTD_human
12856,1544,CYP1A2,0.509,0.828,C0027806,Neurenteric Cyst,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12857,1544,CYP1A2,0.509,0.828,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.4,1.0,2000.0,2014.0,1,0,PSYGENET
12858,1544,CYP1A2,0.509,0.828,C0037997,Splenic Diseases,group,C15,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
12859,1544,CYP1A2,0.509,0.828,C0038002,Splenomegaly,phenotype,C23,Finding,0.3,,1999.0,1999.0,1,0,CTD_human
12860,1544,CYP1A2,0.509,0.828,C0041755,Adverse reaction to drug,group,C25,Pathologic Function,0.3,,1999.0,1999.0,1,0,CTD_human
12861,1544,CYP1A2,0.509,0.828,C0080218,Tethered Cord Syndrome,disease,C10;C16,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
12862,1544,CYP1A2,0.509,0.828,C0086404,Experimental Hepatoma,disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2001.0,2011.0,2,0,CTD_human
12863,1544,CYP1A2,0.509,0.828,C0086565,Liver Dysfunction,phenotype,C06,Finding,0.3,,2004.0,2004.0,1,0,CTD_human
12864,1544,CYP1A2,0.509,0.828,C0152234,Iniencephaly,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12865,1544,CYP1A2,0.509,0.828,C0152426,Craniorachischisis,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12866,1544,CYP1A2,0.509,0.828,C0162566,Porphyria Cutanea Tarda,disease,C06;C16;C17;C18,Disease or Syndrome,0.36,0.666666666666667,2001.0,2012.0,1,0,CTD_human
12867,1544,CYP1A2,0.509,0.828,C0239946,"Fibrosis, Liver",disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12868,1544,CYP1A2,0.509,0.828,C0242379,Malignant neoplasm of lung,disease,C04;C08,Neoplastic Process,0.39,0.8888888888888891,2001.0,2016.0,1,0,CTD_human
12869,1544,CYP1A2,0.509,0.828,C0266453,Exencephaly,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12870,1544,CYP1A2,0.509,0.828,C0273115,Lung Injury,disease,C08;C26,Injury or Poisoning,0.3,,2015.0,2015.0,1,0,CTD_human
12871,1544,CYP1A2,0.509,0.828,C0333641,Atrophic,phenotype,C23,Pathologic Function,0.3,,2011.0,2011.0,1,0,CTD_human
12872,1544,CYP1A2,0.509,0.828,C0344479,Spinal Cord Myelodysplasia,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12873,1544,CYP1A2,0.509,0.828,C0400966,Non-alcoholic Fatty Liver Disease,disease,C06,Disease or Syndrome,0.31,1.0,2010.0,2017.0,1,0,CTD_human
12874,1544,CYP1A2,0.509,0.828,C0702169,Acrania,disease,C10;C16,Congenital Abnormality,0.3,,2010.0,2010.0,1,0,CTD_human
12875,1544,CYP1A2,0.509,0.828,C0809983,Schizophrenia and related disorders,group,,Disease or Syndrome,0.31,1.0,2011.0,2011.0,1,0,PSYGENET
12876,1544,CYP1A2,0.509,0.828,C0860207,Drug-Induced Liver Disease,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12877,1544,CYP1A2,0.509,0.828,C1262760,"Hepatitis, Drug-Induced",disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12878,1544,CYP1A2,0.509,0.828,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.4,1.0,1993.0,2015.0,1,0,CTD_human
12879,1544,CYP1A2,0.509,0.828,C1527303,Chronic Airflow Obstruction,disease,C08,Disease or Syndrome,0.3,,2010.0,2010.0,1,0,CTD_human
12880,1544,CYP1A2,0.509,0.828,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
12881,1544,CYP1A2,0.509,0.828,C2350344,Chronic Lung Injury,disease,C08;C26,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
12882,1544,CYP1A2,0.509,0.828,C3241937,Nonalcoholic Steatohepatitis,disease,C06,Disease or Syndrome,0.3,,2017.0,2017.0,1,0,CTD_human
12883,1544,CYP1A2,0.509,0.828,C3658290,Drug-Induced Acute Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12884,1544,CYP1A2,0.509,0.828,C4277682,Chemical and Drug Induced Liver Injury,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
12885,1544,CYP1A2,0.509,0.828,C4279912,Chemically-Induced Liver Toxicity,disease,C06;C25,Disease or Syndrome,0.3,,2018.0,2018.0,1,0,CTD_human
75788,112476,PRRT2,0.491,0.7929999999999999,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
75789,112476,PRRT2,0.491,0.7929999999999999,C0020796,Profound Mental Retardation,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
75790,112476,PRRT2,0.491,0.7929999999999999,C0025363,"Mental Retardation, Psychosocial",disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
75791,112476,PRRT2,0.491,0.7929999999999999,C0220669,Familial benign neonatal epilepsy,disease,C10;C16,Disease or Syndrome,0.38,0.875,2012.0,2015.0,0,0,ORPHANET
75792,112476,PRRT2,0.491,0.7929999999999999,C0270862,Hemiplegic migraine,disease,,Disease or Syndrome,0.39,1.0,2012.0,2016.0,0,0,ORPHANET
75793,112476,PRRT2,0.491,0.7929999999999999,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
75794,112476,PRRT2,0.491,0.7929999999999999,C0917816,Mental deficiency,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2012.0,2012.0,1,0,CTD_human
75795,112476,PRRT2,0.491,0.7929999999999999,C1842534,DYSTONIA 18 (disorder),disease,C10,Disease or Syndrome,0.31,1.0,2000.0,2000.0,0,0,ORPHANET
75796,112476,PRRT2,0.491,0.7929999999999999,C1853995,"SEIZURES, BENIGN FAMILIAL INFANTILE, 2",disease,C10,Disease or Syndrome,0.4,,1993.0,2016.0,3,7,UNIPROT
75797,112476,PRRT2,0.491,0.7929999999999999,C1865926,"Infantile convulsions and paroxysmal choreoathetosis, familial (disorder)",disease,C10;C16;C23,Disease or Syndrome,0.7,0.9333333,1993.0,2017.0,2,9,ORPHANET;UNIPROT
75798,112476,PRRT2,0.491,0.7929999999999999,C1868682,Paroxysmal kinesigenic choreoathetosis,disease,C10;C23,Disease or Syndrome,0.8,0.9636364,1993.0,2018.0,6,14,CTD_human;ORPHANET;UNIPROT
75799,112476,PRRT2,0.491,0.7929999999999999,C1869117,Paroxysmal nonkinesigenic dyskinesia,disease,C10;C23,Disease or Syndrome,0.31,1.0,2014.0,2014.0,0,0,ORPHANET
75800,112476,PRRT2,0.491,0.7929999999999999,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.55,1.0,2012.0,2016.0,4,0,CTD_human;GENOMICS_ENGLAND
73355,79759,ZNF668,0.773,0.069,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.31,1.0,2011.0,2011.0,0,0,UNIPROT
73356,79759,ZNF668,0.773,0.069,C0014474,Ependymoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
73357,79759,ZNF668,0.773,0.069,C0205769,Myxopapillary ependymoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
73358,79759,ZNF668,0.773,0.069,C0280788,Anaplastic Ependymoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
73359,79759,ZNF668,0.773,0.069,C0334578,Papillary ependymoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
73360,79759,ZNF668,0.773,0.069,C1384403,Cellular Ependymoma,disease,C04,Neoplastic Process,0.3,,2015.0,2015.0,1,0,CTD_human
69327,54903,MKS1,0.546,0.69,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
69328,54903,MKS1,0.546,0.69,C0152427,Polydactyly,disease,C05;C16,Congenital Abnormality,0.43,1.0,2002.0,2013.0,0,0,GENOMICS_ENGLAND
69329,54903,MKS1,0.546,0.69,C0265215,Meckel-Gruber syndrome,disease,,Disease or Syndrome,0.43,1.0,2007.0,2017.0,0,3,ORPHANET
69330,54903,MKS1,0.546,0.69,C0431399,Familial aplasia of the vermis,disease,C11;C12;C13;C16,Disease or Syndrome,0.45,1.0,2006.0,2017.0,0,14,ORPHANET
69331,54903,MKS1,0.546,0.69,C0752166,Bardet-Biedl Syndrome,disease,C10;C16,Disease or Syndrome,0.54,1.0,2005.0,2012.0,1,0,CTD_human;ORPHANET
69332,54903,MKS1,0.546,0.69,C1112213,Cholestasis in newborn,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
69333,54903,MKS1,0.546,0.69,C1691228,Cystic Kidney Diseases,group,C12;C13,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
69334,54903,MKS1,0.546,0.69,C2673873,BARDET-BIEDL SYNDROME 13,disease,C10;C16,Disease or Syndrome,0.6,,2008.0,2014.0,1,5,CTD_human;UNIPROT
69335,54903,MKS1,0.546,0.69,C3714506,Meckel syndrome type 1,disease,C08;C09;C10;C12;C13;C16;C23,Disease or Syndrome,0.7,0.9473684000000001,2004.0,2017.0,3,25,CTD_human;UNIPROT
69336,54903,MKS1,0.546,0.69,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2006.0,2007.0,2,0,GENOMICS_ENGLAND
69337,54903,MKS1,0.546,0.69,C4274118,Joubert syndrome with ocular defect,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
69338,54903,MKS1,0.546,0.69,C4277690,Ciliopathies,group,C16,Congenital Abnormality,0.34,1.0,2007.0,2014.0,0,0,GENOMICS_ENGLAND
18112,2235,FECH,0.636,0.414,C0005395,Bile Duct Diseases,group,C06,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
18113,2235,FECH,0.636,0.414,C0016059,Fibrosis,phenotype,C23,Pathologic Function,0.3,,1999.0,1999.0,1,0,CTD_human
18114,2235,FECH,0.636,0.414,C0162568,Erythropoietic Protoporphyria,disease,C06;C16;C17;C18,Disease or Syndrome,1.0,0.956043956043956,1982.0,2018.0,17,18,CTD_human;ORPHANET;UNIPROT
18115,2235,FECH,0.636,0.414,C0349426,Ferrochelatase deficiency,disease,C06;C16;C17;C18,Disease or Syndrome,0.5,,1992.0,2007.0,17,8,CTD_human;UNIPROT
18116,2235,FECH,0.636,0.414,C1623038,Cirrhosis,disease,C23,Disease or Syndrome,0.3,,1999.0,1999.0,1,0,CTD_human
42473,5621,PRNP,0.474,0.897,C0002395,Alzheimer's Disease,disease,C10;F03,Disease or Syndrome,0.4,0.9104478000000001,1986.0,2016.0,1,0,CTD_human
42474,5621,PRNP,0.474,0.897,C0004138,"Ataxias, Hereditary",group,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
42475,5621,PRNP,0.474,0.897,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
42476,5621,PRNP,0.474,0.897,C0011265,Presenile dementia,disease,C10;F03,Mental or Behavioral Dysfunction,0.4,0.9032258,1990.0,2015.0,1,0,CTD_human
42477,5621,PRNP,0.474,0.897,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.4,1.0,2012.0,2012.0,1,0,PSYGENET
42478,5621,PRNP,0.474,0.897,C0013364,"Dysautonomia, Familial",disease,C10;C16,Congenital Abnormality; Disease or Syndrome,0.3,,1992.0,2005.0,2,0,GENOMICS_ENGLAND
42479,5621,PRNP,0.474,0.897,C0017495,Gerstmann-Straussler-Scheinker Disease,disease,C10;C16,Disease or Syndrome,1.0,0.9826087,1989.0,2017.0,12,13,CTD_human;ORPHANET;UNIPROT
42480,5621,PRNP,0.474,0.897,C0019202,Hepatolenticular Degeneration,disease,C06;C10;C16;C18,Disease or Syndrome,0.32,1.0,2006.0,2006.0,1,0,CTD_human
42481,5621,PRNP,0.474,0.897,C0022336,Creutzfeldt-Jakob disease,disease,C10;F03,Disease or Syndrome,1.0,0.9463601999999999,1988.0,2018.0,12,10,CTD_human;ORPHANET;UNIPROT
42482,5621,PRNP,0.474,0.897,C0022802,Kuru,disease,C10,Disease or Syndrome,0.5,,,,0,0,CTD_human;ORPHANET
42483,5621,PRNP,0.474,0.897,C0023893,"Liver Cirrhosis, Experimental",disease,C06,Experimental Model of Disease,0.3,,2015.0,2015.0,1,0,CTD_human
42484,5621,PRNP,0.474,0.897,C0024623,Malignant neoplasm of stomach,disease,C04;C06,Neoplastic Process,0.36,1.0,2005.0,2015.0,1,0,CTD_human
42485,5621,PRNP,0.474,0.897,C0027540,Necrosis,phenotype,C23,Organ or Tissue Function,0.3,,2008.0,2008.0,1,0,CTD_human
42486,5621,PRNP,0.474,0.897,C0027627,Neoplasm Metastasis,phenotype,C04;C23,Neoplastic Process,0.34,1.0,2008.0,2017.0,1,0,CTD_human
42487,5621,PRNP,0.474,0.897,C0027659,"Neoplasms, Experimental",group,C04,Experimental Model of Disease; Neoplastic Process,0.3,,2011.0,2011.0,1,0,CTD_human
42488,5621,PRNP,0.474,0.897,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.31,1.0,2000.0,2007.0,1,0,CTD_human
42489,5621,PRNP,0.474,0.897,C0036457,Scrapie,disease,C10;C22,Disease or Syndrome,0.35,1.0,1994.0,2011.0,4,0,CTD_human
42490,5621,PRNP,0.474,0.897,C0038356,Stomach Neoplasms,group,C04;C06,Neoplastic Process,0.33,,2006.0,2008.0,1,0,CTD_human
42491,5621,PRNP,0.474,0.897,C0162534,Prion Diseases,group,C10,Disease or Syndrome,0.5,0.9562363000000002,1988.0,2018.0,4,15,CTD_human
42492,5621,PRNP,0.474,0.897,C0206042,Fatal Familial Insomnia,disease,C10,Disease or Syndrome,1.0,0.9577465000000001,1989.0,2017.0,3,2,CTD_human;ORPHANET;UNIPROT
42493,5621,PRNP,0.474,0.897,C0276496,Familial Alzheimer Disease (FAD),disease,C10;F03,Disease or Syndrome,0.32,0.5,2000.0,2012.0,1,0,CTD_human
42494,5621,PRNP,0.474,0.897,C0376329,New Variant Creutzfeldt-Jakob Disease,disease,C10;F03,Disease or Syndrome,0.7,0.875,1990.0,2016.0,12,8,CTD_human;ORPHANET;UNIPROT
42495,5621,PRNP,0.474,0.897,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
42496,5621,PRNP,0.474,0.897,C0391976,Pain Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,2013.0,2017.0,4,0,GENOMICS_ENGLAND
42497,5621,PRNP,0.474,0.897,C0494463,"Alzheimer Disease, Late Onset",disease,C10;F03,Mental or Behavioral Dysfunction,0.31,1.0,2007.0,2015.0,1,0,CTD_human
42498,5621,PRNP,0.474,0.897,C0525045,Mood Disorders,group,F03,Mental or Behavioral Dysfunction,0.3,1.0,2012.0,2012.0,1,0,PSYGENET
42499,5621,PRNP,0.474,0.897,C0546126,Acute Confusional Senile Dementia,disease,C10;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
42500,5621,PRNP,0.474,0.897,C0750900,"Alzheimer's Disease, Focal Onset",disease,C10;F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
42501,5621,PRNP,0.474,0.897,C0750901,"Alzheimer Disease, Early Onset",disease,C10;F03,Disease or Syndrome,0.32,1.0,2000.0,2007.0,1,0,CTD_human
42502,5621,PRNP,0.474,0.897,C0751254,"Creutzfeldt-Jakob Disease, Familial",disease,C10;F03,Disease or Syndrome,0.7,1.0,1990.0,2018.0,12,8,CTD_human;ORPHANET;UNIPROT
42503,5621,PRNP,0.474,0.897,C0751645,"Human Transmissible Spongiform Encephalopathies, Inherited",disease,C10,Disease or Syndrome,0.31,1.0,1998.0,2007.0,4,0,CTD_human
42504,5621,PRNP,0.474,0.897,C0751776,Atypical Inclusion-Body Disease,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42505,5621,PRNP,0.474,0.897,C0751777,Familial Progressive Myoclonic Epilepsy,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42506,5621,PRNP,0.474,0.897,C0751778,"Myoclonic Epilepsies, Progressive",disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42507,5621,PRNP,0.474,0.897,C0751779,Action Myoclonus-Renal Failure Syndrome,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42508,5621,PRNP,0.474,0.897,C0751780,Biotin-Responsive Encephalopathy,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42509,5621,PRNP,0.474,0.897,C0751781,Dentatorubral-Pallidoluysian Atrophy,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42510,5621,PRNP,0.474,0.897,C0751782,May-White Syndrome,disease,C10,Disease or Syndrome,0.3,,2015.0,2015.0,1,0,CTD_human
42511,5621,PRNP,0.474,0.897,C1527352,Hepatic Form of Wilson Disease,disease,C06;C10;C16;C18,Disease or Syndrome,0.3,,2006.0,2006.0,1,0,CTD_human
42512,5621,PRNP,0.474,0.897,C1708349,Hereditary Diffuse Gastric Cancer,disease,C04;C06,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
42513,5621,PRNP,0.474,0.897,C1847650,SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES,disease,C10;C16;F03,Disease or Syndrome,0.6,,1997.0,2006.0,2,3,CTD_human;UNIPROT
42514,5621,PRNP,0.474,0.897,C1852467,"Creutzfeldt-Jakob Disease, Sporadic",disease,C10;F03,Disease or Syndrome,0.6,0.9722221999999999,1990.0,2016.0,10,8,ORPHANET;UNIPROT
42515,5621,PRNP,0.474,0.897,C1864112,HUNTINGTON DISEASE-LIKE 1,disease,C10;C16;F03,Disease or Syndrome,0.6,,1989.0,2017.0,0,3,CTD_human;ORPHANET
42516,5621,PRNP,0.474,0.897,C1969957,"Creutzfeldt-Jakob Disease, Heidenhain Variant",disease,C10;C11;C23;F03,Disease or Syndrome,0.5,,1990.0,2010.0,10,8,ORPHANET;UNIPROT
42517,5621,PRNP,0.474,0.897,C2362914,clinical depression,disease,,Mental or Behavioral Dysfunction,0.3,1.0,2015.0,2015.0,1,0,PSYGENET
42518,5621,PRNP,0.474,0.897,C2931022,"Amyloidosis, Cerebral, with Spongiform Encephalopathy",disease,C10;F03,Disease or Syndrome,0.33,0.6666667,1989.0,2010.0,11,8,UNIPROT
42519,5621,PRNP,0.474,0.897,C3805618,"CEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED",disease,,Disease or Syndrome,0.4,,1989.0,2011.0,11,11,UNIPROT
42520,5621,PRNP,0.474,0.897,C4303482,Familial Alzheimer-like prion disease,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
58729,9217,VAPB,0.672,0.414,C0002736,Amyotrophic Lateral Sclerosis,disease,C10;C18,Disease or Syndrome,0.5,0.9583333,2005.0,2017.0,0,0,ORPHANET
58730,9217,VAPB,0.672,0.414,C1837728,AMYOTROPHIC LATERAL SCLEROSIS 8 (disorder),disease,C10;C18,Disease or Syndrome,0.62,0.5,2005.0,2015.0,4,2,CTD_human;UNIPROT
58731,9217,VAPB,0.672,0.414,C1854058,"SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE",disease,C10,Disease or Syndrome,0.6,,2005.0,2012.0,1,1,ORPHANET;UNIPROT
58732,9217,VAPB,0.672,0.414,C1866777,"Spinal Muscular Atrophy, Proximal, Adult, Autosomal Dominant",disease,C10,Disease or Syndrome,0.5,,,,0,0,CTD_human;ORPHANET
7616,861,RUNX1,0.467,0.69,C0003873,Rheumatoid Arthritis,disease,C05;C17;C20,Disease or Syndrome,0.38,0.875,2004.0,2013.0,1,0,CTD_human
7617,861,RUNX1,0.467,0.69,C0006413,Burkitt Lymphoma,disease,C02;C04;C15;C20,Neoplastic Process,0.3,,,,0,0,ORPHANET
7618,861,RUNX1,0.467,0.69,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,2008.0,2012.0,3,0,GENOMICS_ENGLAND
7619,861,RUNX1,0.467,0.69,C0017636,Glioblastoma,disease,C04,Neoplastic Process,0.32,1.0,2012.0,2017.0,1,0,CTD_human
7620,861,RUNX1,0.467,0.69,C0023452,Childhood Acute Lymphoblastic Leukemia,disease,C04;C15;C20,Neoplastic Process,0.4,0.97979797979798,1996.0,2018.0,1,0,CTD_human
7621,861,RUNX1,0.467,0.69,C0023453,"Leukemia, Lymphocytic, Acute, L2",disease,C04;C15;C20,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
7622,861,RUNX1,0.467,0.69,C0023467,"Leukemia, Myelocytic, Acute",disease,C04,Neoplastic Process,0.7,0.9829059829059829,1990.0,2018.0,2,4,CGI;CTD_human
7623,861,RUNX1,0.467,0.69,C0023473,"Myeloid Leukemia, Chronic",disease,C04;C15,Neoplastic Process,0.4,1.0,1993.0,2014.0,0,0,ORPHANET
7624,861,RUNX1,0.467,0.69,C0023485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.38,1.0,1999.0,2016.0,2,0,CTD_human
7625,861,RUNX1,0.467,0.69,C0026998,"Acute Myeloid Leukemia, M1",disease,C04,Neoplastic Process,0.3,,2008.0,2016.0,2,0,CTD_human
7626,861,RUNX1,0.467,0.69,C0032197,Platelet Storage Pool Deficiency,disease,C15,Disease or Syndrome,0.32,1.0,2004.0,2018.0,0,0,ORPHANET
7627,861,RUNX1,0.467,0.69,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
7628,861,RUNX1,0.467,0.69,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,2008.0,2012.0,3,0,GENOMICS_ENGLAND
7629,861,RUNX1,0.467,0.69,C0334588,Giant Cell Glioblastoma,disease,C04,Neoplastic Process,0.3,,2013.0,2013.0,1,0,CTD_human
7630,861,RUNX1,0.467,0.69,C0349639,Juvenile Myelomonocytic Leukemia,disease,C04;C15,Neoplastic Process,0.33,1.0,1998.0,2016.0,1,0,CTD_human
7631,861,RUNX1,0.467,0.69,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.32,1.0,2007.0,2016.0,1,0,CTD_human
7632,861,RUNX1,0.467,0.69,C0376545,Hematologic Neoplasms,group,C04;C15,Neoplastic Process,0.4,1.0,1998.0,2017.0,2,0,GENOMICS_ENGLAND
7633,861,RUNX1,0.467,0.69,C1292769,Precursor B-cell lymphoblastic leukemia,disease,,Neoplastic Process,0.4,0.95,1997.0,2016.0,0,0,ORPHANET
7634,861,RUNX1,0.467,0.69,C1621958,Glioblastoma Multiforme,disease,C04,Neoplastic Process,0.31,1.0,2013.0,2017.0,1,0,CTD_human
7635,861,RUNX1,0.467,0.69,C1832388,"Platelet Disorder, Familial, with Associated Myeloid Malignancy",disease,C04;C15;C16,Disease or Syndrome,0.72,1.0,1999.0,2017.0,7,11,CLINGEN;CTD_human;ORPHANET;UNIPROT
7636,861,RUNX1,0.467,0.69,C1879321,Acute Myeloid Leukemia (AML-M2),disease,C04,Neoplastic Process,0.34,1.0,1994.0,2016.0,2,0,CTD_human
7637,861,RUNX1,0.467,0.69,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,disease,C04;C15;C20,Neoplastic Process,0.4,1.0,1994.0,2017.0,1,0,CTD_human
7638,861,RUNX1,0.467,0.69,C2713368,Hematopoetic Myelodysplasia,disease,C15,Pathologic Function,0.3,,2017.0,2017.0,1,0,CTD_human
7639,861,RUNX1,0.467,0.69,C2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,disease,C11;C15;C16;C17;C18,Disease or Syndrome,0.3,,,,0,0,ORPHANET
7640,861,RUNX1,0.467,0.69,C3463824,MYELODYSPLASTIC SYNDROME,group,C15,Neoplastic Process,0.5,0.9859154929577459,1993.0,2017.0,1,0,CTD_human
10892,1312,COMT,0.426,0.897,C0001723,"Affective Disorders, Psychotic",group,F03,Mental or Behavioral Dysfunction,0.35,1.0,2007.0,2011.0,5,0,PSYGENET
10893,1312,COMT,0.426,0.897,C0001956,Alcohol Use Disorder,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,1999.0,1999.0,1,0,CTD_human
10894,1312,COMT,0.426,0.897,C0001973,"Alcoholic Intoxication, Chronic",disease,C25;F03,Mental or Behavioral Dysfunction,0.4,0.956521739130435,1999.0,2016.0,1,0,CTD_human
10895,1312,COMT,0.426,0.897,C0004352,Autistic Disorder,group,F03,Mental or Behavioral Dysfunction,0.32,1.0,2001.0,2011.0,1,0,CTD_human
10896,1312,COMT,0.426,0.897,C0004930,Behavior Disorders,group,F03,Mental or Behavioral Dysfunction,0.31,1.0,2004.0,2007.0,1,0,CTD_human
10897,1312,COMT,0.426,0.897,C0004936,Mental disorders,group,F03,Mental or Behavioral Dysfunction,0.4,1.0,1998.0,2017.0,1,0,CTD_human
10898,1312,COMT,0.426,0.897,C0005586,Bipolar Disorder,disease,F03,Mental or Behavioral Dysfunction,0.6,1.0,1997.0,2018.0,6,0,CTD_human;PSYGENET
10899,1312,COMT,0.426,0.897,C0005587,"Depression, Bipolar",disease,F03,Mental or Behavioral Dysfunction,0.51,0.5,2002.0,2006.0,3,0,CTD_human;PSYGENET
10900,1312,COMT,0.426,0.897,C0006142,Malignant neoplasm of breast,disease,C04;C17,Neoplastic Process,0.4,0.983050847457627,1998.0,2017.0,3,0,CTD_human
10901,1312,COMT,0.426,0.897,C0009171,Cocaine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2009.0,2009.0,1,0,CTD_human
10902,1312,COMT,0.426,0.897,C0009241,Cognition Disorders,group,F03,Mental or Behavioral Dysfunction,0.4,0.8,2006.0,2016.0,1,0,CTD_human
10903,1312,COMT,0.426,0.897,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.4,1.0,1983.0,2018.0,5,0,PSYGENET
10904,1312,COMT,0.426,0.897,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.4,1.0,1983.0,2018.0,5,0,PSYGENET
10905,1312,COMT,0.426,0.897,C0012236,DiGeorge Syndrome,disease,C05;C14;C15;C16;C19,Disease or Syndrome,0.6,0.866666666666667,1997.0,2011.0,1,0,CTD_human;ORPHANET
10906,1312,COMT,0.426,0.897,C0015934,Fetal Growth Retardation,phenotype,C13;C16;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
10907,1312,COMT,0.426,0.897,C0020429,Hyperalgesia,phenotype,C10;C23,Sign or Symptom,0.3,,2016.0,2016.0,1,0,CTD_human
10908,1312,COMT,0.426,0.897,C0024667,Animal Mammary Neoplasms,group,C04;C22,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
10909,1312,COMT,0.426,0.897,C0024713,Manic Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,2002.0,2002.0,1,0,CTD_human
10910,1312,COMT,0.426,0.897,C0024809,Marijuana Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.4,1.0,2005.0,2016.0,3,0,PSYGENET
10911,1312,COMT,0.426,0.897,C0025261,Memory Disorders,disease,C10;C23;F01,Mental or Behavioral Dysfunction,0.3,,2016.0,2016.0,1,0,CTD_human
10912,1312,COMT,0.426,0.897,C0026858,Musculoskeletal Pain,phenotype,C05;C23,Finding,0.3,,2015.0,2015.0,1,0,CTD_human
10913,1312,COMT,0.426,0.897,C0030193,Pain,phenotype,C23,Sign or Symptom,0.4,0.927710843373494,2003.0,2017.0,1,0,CTD_human
10914,1312,COMT,0.426,0.897,C0030319,Panic Disorder,disease,F03,Mental or Behavioral Dysfunction,0.4,1.0,2002.0,2016.0,0,0,CTD_human
10915,1312,COMT,0.426,0.897,C0031511,Pheochromocytoma,disease,C04,Neoplastic Process,0.31,1.0,2012.0,2012.0,1,0,CTD_human
10916,1312,COMT,0.426,0.897,C0033578,Prostatic Neoplasms,group,C04;C12,Neoplastic Process,0.3,,2007.0,2007.0,1,0,CTD_human
10917,1312,COMT,0.426,0.897,C0036341,Schizophrenia,disease,F03,Mental or Behavioral Dysfunction,0.4,0.923076923076923,1984.0,2018.0,4,0,CTD_human
10918,1312,COMT,0.426,0.897,C0039494,Temporomandibular Joint Disorders,group,C05;C07,Disease or Syndrome,0.39,1.0,2007.0,2015.0,1,0,CTD_human
10919,1312,COMT,0.426,0.897,C0041671,Attention Deficit Disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,,1999.0,1999.0,1,0,CTD_human
10920,1312,COMT,0.426,0.897,C0041696,Unipolar Depression,disease,F03,Mental or Behavioral Dysfunction,0.4,1.0,1998.0,2016.0,5,0,PSYGENET
10921,1312,COMT,0.426,0.897,C0085762,Alcohol abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.31,1.0,1999.0,2015.0,1,0,CTD_human
10922,1312,COMT,0.426,0.897,C0086133,Depressive Syndrome,disease,F03,Mental or Behavioral Dysfunction,0.31,1.0,1983.0,1983.0,1,0,PSYGENET
10923,1312,COMT,0.426,0.897,C0086769,Panic Attacks,disease,F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,CTD_human
10924,1312,COMT,0.426,0.897,C0178417,Anhedonia,disease,C10;C23;F01,Mental or Behavioral Dysfunction,0.31,1.0,2009.0,2009.0,1,0,PSYGENET
10925,1312,COMT,0.426,0.897,C0220704,Shprintzen syndrome,disease,C05;C14;C15;C16;C19,Disease or Syndrome,0.6,0.85,1997.0,2012.0,1,0,CTD_human;ORPHANET
10926,1312,COMT,0.426,0.897,C0233477,Dysphoric mood,disease,,Mental or Behavioral Dysfunction,0.32,1.0,2005.0,2007.0,2,0,PSYGENET
10927,1312,COMT,0.426,0.897,C0233794,Memory impairment,phenotype,C10;C23;F01,Mental or Behavioral Dysfunction,0.33,1.0,2008.0,2016.0,1,0,CTD_human
10928,1312,COMT,0.426,0.897,C0234230,"Pain, Burning",phenotype,C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
10929,1312,COMT,0.426,0.897,C0234238,Ache,phenotype,C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
10930,1312,COMT,0.426,0.897,C0234254,Radiating pain,phenotype,C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
10931,1312,COMT,0.426,0.897,C0236733,Amphetamine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2005.0,2005.0,1,0,CTD_human
10932,1312,COMT,0.426,0.897,C0236736,Cocaine-Related Disorders,group,C25;F03,Mental or Behavioral Dysfunction,0.3,,2009.0,2009.0,1,0,CTD_human
10933,1312,COMT,0.426,0.897,C0236804,Amphetamine Addiction,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2005.0,2005.0,1,0,CTD_human
10934,1312,COMT,0.426,0.897,C0236807,Amphetamine Abuse,disease,C25;F03,Mental or Behavioral Dysfunction,0.3,,2005.0,2005.0,1,0,CTD_human
10935,1312,COMT,0.426,0.897,C0338831,Manic,disease,F03,Mental or Behavioral Dysfunction,0.33,1.0,2002.0,2012.0,1,0,CTD_human
10936,1312,COMT,0.426,0.897,C0376338,"Diagnosis, Psychiatric",disease,F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
10937,1312,COMT,0.426,0.897,C0376358,Malignant neoplasm of prostate,disease,C04;C12,Neoplastic Process,0.35,1.0,2006.0,2015.0,1,0,CTD_human
10938,1312,COMT,0.426,0.897,C0431406,Asymmetric crying face association,disease,C07;C10;C23,Disease or Syndrome,0.3,,,,0,0,ORPHANET
10939,1312,COMT,0.426,0.897,C0458247,Allodynia,phenotype,C10;C23,Finding,0.3,,2016.0,2016.0,1,0,CTD_human
10940,1312,COMT,0.426,0.897,C0458257,"Pain, Splitting",phenotype,C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
10941,1312,COMT,0.426,0.897,C0458259,"Pain, Crushing",phenotype,C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
10942,1312,COMT,0.426,0.897,C0525045,Mood Disorders,group,F03,Mental or Behavioral Dysfunction,0.4,0.8,1982.0,2015.0,5,0,PSYGENET
10943,1312,COMT,0.426,0.897,C0525046,Schizophrenia Spectrum and Other Psychotic Disorders,group,F03,Mental or Behavioral Dysfunction,0.3,,2016.0,2016.0,1,0,CTD_human
10944,1312,COMT,0.426,0.897,C0600427,Cocaine Dependence,disease,C25;F03,Mental or Behavioral Dysfunction,0.52,1.0,2009.0,2011.0,3,0,CTD_human;PSYGENET
10945,1312,COMT,0.426,0.897,C0678222,Breast Carcinoma,disease,C04;C17,Neoplastic Process,0.4,0.983050847457627,1998.0,2017.0,3,0,CTD_human
10946,1312,COMT,0.426,0.897,C0751211,"Hyperalgesia, Primary",phenotype,C10;C23,Sign or Symptom,0.3,,2016.0,2016.0,1,0,CTD_human
10947,1312,COMT,0.426,0.897,C0751212,"Hyperalgesia, Secondary",phenotype,C10;C23,Sign or Symptom,0.3,,2016.0,2016.0,1,0,CTD_human
10948,1312,COMT,0.426,0.897,C0751213,Tactile Allodynia,phenotype,C10;C23,Sign or Symptom,0.3,,2016.0,2016.0,1,0,CTD_human
10949,1312,COMT,0.426,0.897,C0751214,"Hyperalgesia, Thermal",phenotype,C10;C23,Sign or Symptom,0.3,,2016.0,2016.0,1,0,CTD_human
10950,1312,COMT,0.426,0.897,C0751292,Age-Related Memory Disorders,disease,C10;C23;F01,Mental or Behavioral Dysfunction,0.3,,2016.0,2016.0,1,0,CTD_human
10951,1312,COMT,0.426,0.897,C0751293,"Memory Disorder, Semantic",disease,C10;C23;F01,Mental or Behavioral Dysfunction,0.3,,2016.0,2016.0,1,0,CTD_human
10952,1312,COMT,0.426,0.897,C0751294,"Memory Disorder, Spatial",disease,C10;C23;F01,Mental or Behavioral Dysfunction,0.3,,2016.0,2016.0,1,0,CTD_human
10953,1312,COMT,0.426,0.897,C0751295,Memory Loss,phenotype,C10;C23;F01,Sign or Symptom,0.3,,2016.0,2016.0,1,0,CTD_human
10954,1312,COMT,0.426,0.897,C0751407,"Pain, Migratory",phenotype,C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
10955,1312,COMT,0.426,0.897,C0751408,"Suffering, Physical",phenotype,C23,Sign or Symptom,0.3,,2010.0,2010.0,1,0,CTD_human
10956,1312,COMT,0.426,0.897,C0795907,CONOTRUNCAL ANOMALY FACE SYNDROME,disease,C05;C14;C15;C16;C19,Disease or Syndrome,0.5,,1997.0,1997.0,1,0,CTD_human;ORPHANET
10957,1312,COMT,0.426,0.897,C1257877,"Pheochromocytoma, Extra-Adrenal",disease,C04,Neoplastic Process,0.3,,2012.0,2012.0,1,0,CTD_human
10958,1312,COMT,0.426,0.897,C1257925,"Mammary Carcinoma, Animal",disease,C04;C22,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
10959,1312,COMT,0.426,0.897,C1257931,"Mammary Neoplasms, Human",group,C04;C17,Neoplastic Process,0.3,,1998.0,2005.0,3,0,CTD_human
10960,1312,COMT,0.426,0.897,C1263846,Attention deficit hyperactivity disorder,disease,F03,Mental or Behavioral Dysfunction,0.5,0.918367346938776,1996.0,2018.0,1,0,CTD_human
10961,1312,COMT,0.426,0.897,C1269683,Major Depressive Disorder,disease,F03,Mental or Behavioral Dysfunction,0.4,1.0,2004.0,2018.0,5,0,PSYGENET
10962,1312,COMT,0.426,0.897,C1306067,Drug-induced paranoid state,disease,,Mental or Behavioral Dysfunction,0.3,1.0,2012.0,2012.0,1,0,PSYGENET
10963,1312,COMT,0.426,0.897,C1321905,Minimal Brain Dysfunction,disease,F03,Mental or Behavioral Dysfunction,0.3,,1999.0,1999.0,1,0,CTD_human
10964,1312,COMT,0.426,0.897,C1458155,Mammary Neoplasms,group,C04;C17,Neoplastic Process,0.38,,1998.0,2008.0,3,0,CTD_human
10965,1312,COMT,0.426,0.897,C2239176,Liver carcinoma,disease,C04;C06,Neoplastic Process,0.32,1.0,1991.0,2004.0,1,0,CTD_human
10966,1312,COMT,0.426,0.897,C2750088,"HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO",phenotype,,Finding,0.3,,2010.0,2010.0,1,0,CTD_human
10967,1312,COMT,0.426,0.897,C2936346,22q11 Deletion Syndrome,disease,C05;C14;C15;C16;C19,Disease or Syndrome,0.36,1.0,2001.0,2011.0,0,0,ORPHANET
10968,1312,COMT,0.426,0.897,C2936719,Mechanical Allodynia,phenotype,C10;C23,Sign or Symptom,0.3,,2016.0,2016.0,1,0,CTD_human
10969,1312,COMT,0.426,0.897,C3160814,Cannabis use,disease,,Mental or Behavioral Dysfunction,0.32,1.0,2014.0,2018.0,2,0,PSYGENET
10970,1312,COMT,0.426,0.897,C3266101,22q11 partial monosomy syndrome,disease,,Disease or Syndrome,0.3,,,,0,0,ORPHANET
10971,1312,COMT,0.426,0.897,C4046029,"Mental Disorders, Severe",group,F03,Mental or Behavioral Dysfunction,0.3,,2007.0,2007.0,1,0,CTD_human
31178,3976,LIF,0.528,0.655,C0000786,Spontaneous abortion,phenotype,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
31179,3976,LIF,0.528,0.655,C0000822,"Abortion, Tubal",disease,C13,Pathologic Function,0.3,,2009.0,2009.0,1,0,CTD_human
31180,3976,LIF,0.528,0.655,C0011206,Delirium,disease,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,0.6666667,2007.0,2011.0,3,0,PSYGENET
31181,3976,LIF,0.528,0.655,C0011570,Mental Depression,disease,F01,Mental or Behavioral Dysfunction,0.3,1.0,2004.0,2004.0,1,0,PSYGENET
31182,3976,LIF,0.528,0.655,C0011581,Depressive disorder,disease,F03,Mental or Behavioral Dysfunction,0.3,1.0,2004.0,2004.0,1,0,PSYGENET
31183,3976,LIF,0.528,0.655,C0012684,Blastocyst Disintegration,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31184,3976,LIF,0.528,0.655,C0018800,Cardiomegaly,phenotype,C14;C23,Finding,0.3,,2004.0,2004.0,1,0,CTD_human
31185,3976,LIF,0.528,0.655,C0021361,Female infertility,phenotype,C13,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31186,3976,LIF,0.528,0.655,C0032460,Polycystic Ovary Syndrome,disease,C04;C13;C19,Disease or Syndrome,0.31,1.0,2011.0,2011.0,1,0,CTD_human
31187,3976,LIF,0.528,0.655,C0038279,"Sterility, Postpartum",phenotype,C13,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31188,3976,LIF,0.528,0.655,C0341869,"Subfertility, Female",disease,C13,Disease or Syndrome,0.3,,2013.0,2013.0,1,0,CTD_human
31189,3976,LIF,0.528,0.655,C0400966,Non-alcoholic Fatty Liver Disease,disease,C06,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
31190,3976,LIF,0.528,0.655,C0752351,Embryo Loss,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31191,3976,LIF,0.528,0.655,C0917730,Female sterility,phenotype,C13,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
31192,3976,LIF,0.528,0.655,C1136082,Embryo Disintegration,phenotype,C13;C23,Pathologic Function,0.3,,2013.0,2013.0,1,0,CTD_human
31193,3976,LIF,0.528,0.655,C1136382,Sclerocystic Ovaries,disease,C04;C13;C19,Disease or Syndrome,0.3,,2011.0,2011.0,1,0,CTD_human
31194,3976,LIF,0.528,0.655,C1262477,Weight decreased,phenotype,C23,Finding,0.3,,2013.0,2013.0,1,0,CTD_human
31195,3976,LIF,0.528,0.655,C1383860,Cardiac Hypertrophy,phenotype,C14;C23,Pathologic Function,0.3,,2004.0,2004.0,1,0,CTD_human
31196,3976,LIF,0.528,0.655,C1720887,Female Urogenital Diseases,group,C13,Disease or Syndrome,0.3,,2005.0,2005.0,1,0,CTD_human
31197,3976,LIF,0.528,0.655,C3241937,Nonalcoholic Steatohepatitis,disease,C06,Disease or Syndrome,0.3,,2012.0,2012.0,1,0,CTD_human
74201,81887,LAS1L,0.696,0.552,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
74202,81887,LAS1L,0.696,0.552,C1527249,Colorectal Cancer,disease,C04;C06,Neoplastic Process,0.3,,,,0,0,UNIPROT
74203,81887,LAS1L,0.696,0.552,C1839736,WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME,disease,C10;C16;C17;C18;C23,Disease or Syndrome,0.6,,2016.0,2016.0,1,1,CTD_human;ORPHANET;UNIPROT
74204,81887,LAS1L,0.696,0.552,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.4,,2016.0,2016.0,2,0,GENOMICS_ENGLAND
20969,2705,GJB1,0.527,0.621,C0001430,Adenoma,group,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20970,2705,GJB1,0.527,0.621,C0007134,Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.4,1.0,2003.0,2010.0,1,0,CTD_human
20971,2705,GJB1,0.527,0.621,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.6,0.9702970297029699,1994.0,2018.0,0,0,GENOMICS_ENGLAND
20972,2705,GJB1,0.527,0.621,C0011195,Dejerine-Sottas Disease (disorder),disease,C10;C16,Disease or Syndrome,0.62,1.0,1996.0,2006.0,1,1,UNIPROT
20973,2705,GJB1,0.527,0.621,C0019207,"Hepatoma, Morris",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20974,2705,GJB1,0.527,0.621,C0019208,"Hepatoma, Novikoff",disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20975,2705,GJB1,0.527,0.621,C0023903,Liver neoplasms,group,C04;C06,Neoplastic Process,0.38,0.875,1990.0,2016.0,1,0,CTD_human
20976,2705,GJB1,0.527,0.621,C0023904,"Liver Neoplasms, Experimental",group,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20977,2705,GJB1,0.527,0.621,C0024121,Lung Neoplasms,group,C04;C08,Neoplastic Process,0.31,,2004.0,2007.0,2,0,CTD_human
20978,2705,GJB1,0.527,0.621,C0027627,Neoplasm Metastasis,phenotype,C04;C23,Neoplastic Process,0.34,1.0,2007.0,2016.0,1,0,CTD_human
20979,2705,GJB1,0.527,0.621,C0032927,Precancerous Conditions,group,C04,Neoplastic Process,0.3,,1990.0,1990.0,1,0,CTD_human
20980,2705,GJB1,0.527,0.621,C0035126,Reperfusion Injury,disease,C14;C23,Injury or Poisoning,0.3,,2016.0,2016.0,1,0,CTD_human
20981,2705,GJB1,0.527,0.621,C0086404,Experimental Hepatoma,disease,C04;C06,Experimental Model of Disease; Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20982,2705,GJB1,0.527,0.621,C0205646,"Adenoma, Basal Cell",disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20983,2705,GJB1,0.527,0.621,C0205647,Follicular adenoma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20984,2705,GJB1,0.527,0.621,C0205648,"Adenoma, Microcystic",disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20985,2705,GJB1,0.527,0.621,C0205649,"Adenoma, Monomorphic",disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20986,2705,GJB1,0.527,0.621,C0205650,Papillary adenoma,disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20987,2705,GJB1,0.527,0.621,C0205651,"Adenoma, Trabecular",disease,C04,Neoplastic Process,0.3,,2006.0,2006.0,1,0,CTD_human
20988,2705,GJB1,0.527,0.621,C0242379,Malignant neoplasm of lung,disease,C04;C08,Neoplastic Process,0.31,1.0,2004.0,2007.0,2,0,CTD_human
20989,2705,GJB1,0.527,0.621,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20990,2705,GJB1,0.527,0.621,C0282313,"Condition, Preneoplastic",phenotype,C04,Neoplastic Process,0.3,,1990.0,1990.0,1,0,CTD_human
20991,2705,GJB1,0.527,0.621,C0345904,Malignant neoplasm of liver,disease,C04;C06,Neoplastic Process,0.3,,1990.0,1990.0,1,0,CTD_human
20992,2705,GJB1,0.527,0.621,C0393808,"Charcot-Marie-Tooth disease, X-linked, 1",disease,C10;C16,Disease or Syndrome,1.0,1.0,1979.0,2018.0,58,58,CTD_human;ORPHANET;UNIPROT
20993,2705,GJB1,0.527,0.621,C0796205,"SPINOCEREBELLAR ATAXIA, X-LINKED 1",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,ORPHANET
20994,2705,GJB1,0.527,0.621,C1266042,Chromophobe Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20995,2705,GJB1,0.527,0.621,C1266043,Sarcomatoid Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20996,2705,GJB1,0.527,0.621,C1266044,Collecting Duct Carcinoma of the Kidney,disease,C04;C12;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20997,2705,GJB1,0.527,0.621,C1306837,Papillary Renal Cell Carcinoma,disease,C04;C12;C13,Neoplastic Process,0.3,,2008.0,2008.0,1,0,CTD_human
20998,2705,GJB1,0.527,0.621,C2239176,Liver carcinoma,disease,C04;C06,Neoplastic Process,0.4,1.0,1990.0,2017.0,1,0,CTD_human
20999,2705,GJB1,0.527,0.621,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,2013.0,2016.0,3,0,GENOMICS_ENGLAND
47873,6567,SLC16A2,0.619,0.44799999999999995,C0008370,Cholestasis,disease,C06,Disease or Syndrome,0.3,,2016.0,2016.0,1,0,CTD_human
47874,6567,SLC16A2,0.619,0.44799999999999995,C0023520,Leukodystrophy,disease,,Disease or Syndrome,0.42,1.0,2009.0,2016.0,0,0,GENOMICS_ENGLAND
47875,6567,SLC16A2,0.619,0.44799999999999995,C0037773,"Spastic Paraplegia, Hereditary",disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
47876,6567,SLC16A2,0.619,0.44799999999999995,C0543888,Epileptic encephalopathy,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
47877,6567,SLC16A2,0.619,0.44799999999999995,C0795889,Allan-Herndon-Dudley syndrome (AHDS),disease,C10;C16;C23,Disease or Syndrome,1.0,1.0,1992.0,2017.0,8,28,CTD_human;ORPHANET;UNIPROT
47878,6567,SLC16A2,0.619,0.44799999999999995,C1510586,Autism Spectrum Disorders,disease,F03,Mental or Behavioral Dysfunction,0.3,,2014.0,2014.0,1,0,CTD_human
47879,6567,SLC16A2,0.619,0.44799999999999995,C2940786,Thyroid Hormone Resistance Syndrome,disease,C19,Disease or Syndrome,0.31,1.0,2008.0,2014.0,1,0,GENOMICS_ENGLAND
47880,6567,SLC16A2,0.619,0.44799999999999995,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.33,1.0,2006.0,2016.0,0,0,GENOMICS_ENGLAND
55300,7547,ZIC3,0.6,0.44799999999999995,C0003886,Arthrogryposis,disease,C05;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
55301,7547,ZIC3,0.6,0.44799999999999995,C0005941,"Bone Diseases, Developmental",group,C05,Disease or Syndrome,0.3,,2007.0,2007.0,1,0,CTD_human
55302,7547,ZIC3,0.6,0.44799999999999995,C0011813,Dextrocardia,disease,C14;C16,Congenital Abnormality,0.4,,2007.0,2007.0,1,0,CTD_human
55303,7547,ZIC3,0.6,0.44799999999999995,C0020255,Hydrocephalus,disease,C10,Disease or Syndrome,0.4,,2010.0,2011.0,2,0,GENOMICS_ENGLAND
55304,7547,ZIC3,0.6,0.44799999999999995,C0266642,Situs ambiguus,disease,C14;C15;C16,Congenital Abnormality,0.4,1.0,1997.0,2014.0,0,0,ORPHANET
55305,7547,ZIC3,0.6,0.44799999999999995,C0376634,Craniofacial Abnormalities,group,C05;C16,Congenital Abnormality,0.3,,2007.0,2007.0,1,0,CTD_human
55306,7547,ZIC3,0.6,0.44799999999999995,C1167664,Situs ambiguous,disease,,Congenital Abnormality,0.3,,,,0,0,ORPHANET
55307,7547,ZIC3,0.6,0.44799999999999995,C1306710,Facial asymmetry,phenotype,C23,Finding,0.3,,2007.0,2007.0,1,0,CTD_human
55308,7547,ZIC3,0.6,0.44799999999999995,C1531773,Currarino triad,disease,C06;C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
55309,7547,ZIC3,0.6,0.44799999999999995,C1844020,"HETEROTAXY, VISCERAL, 1, X-LINKED",disease,C14;C15;C16,Disease or Syndrome,0.81,1.0,1952.0,2015.0,6,10,CTD_human;UNIPROT
55310,7547,ZIC3,0.6,0.44799999999999995,C1848599,VACTERL Association With Hydrocephalus,disease,C05;C06;C10;C14;C16,Disease or Syndrome,0.3,,,,0,0,CTD_human
55311,7547,ZIC3,0.6,0.44799999999999995,C2931228,"VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS",disease,,Disease or Syndrome,0.3,,2010.0,2014.0,2,0,UNIPROT
55312,7547,ZIC3,0.6,0.44799999999999995,C3151867,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED",disease,,Disease or Syndrome,0.6,,1952.0,2014.0,6,7,UNIPROT
55313,7547,ZIC3,0.6,0.44799999999999995,C3495537,"Heterotaxy, Visceral, 5, Autosomal",disease,C14;C15;C16,Congenital Abnormality,0.3,,,,0,0,CTD_human
55314,7547,ZIC3,0.6,0.44799999999999995,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,,,0,0,GENOMICS_ENGLAND
55315,7547,ZIC3,0.6,0.44799999999999995,C4025414,Radial club hand,disease,,Congenital Abnormality,0.3,,2010.0,2011.0,2,0,GENOMICS_ENGLAND
55316,7547,ZIC3,0.6,0.44799999999999995,C4277690,Ciliopathies,group,C16,Congenital Abnormality,0.3,,,,0,0,GENOMICS_ENGLAND
77877,203547,VMA21,0.8340000000000001,0.172,C0270960,Congenital myopathy (disorder),group,,Congenital Abnormality,0.3,,2013.0,2013.0,1,0,GENOMICS_ENGLAND
77878,203547,VMA21,0.8340000000000001,0.172,C1839615,X-linked myopathy with excessive autophagy,disease,C05;C10;C16,Disease or Syndrome,0.6,,2006.0,2015.0,0,7,CTD_human;ORPHANET
77879,203547,VMA21,0.8340000000000001,0.172,C2931230,Vacuolar myopathy,disease,C05;C10;C16;C18,Disease or Syndrome,0.32,1.0,2013.0,2014.0,0,0,ORPHANET
50424,6901,TAZ,0.5429999999999999,0.655,C0007193,"Cardiomyopathy, Dilated",group,C14,Disease or Syndrome,0.46,1.0,2002.0,2014.0,0,0,GENOMICS_ENGLAND
50425,6901,TAZ,0.5429999999999999,0.655,C0007959,Charcot-Marie-Tooth Disease,disease,C10;C16,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50426,6901,TAZ,0.5429999999999999,0.655,C0010828,Cytopenia,phenotype,,Pathologic Function,0.3,,,,0,0,GENOMICS_ENGLAND
50427,6901,TAZ,0.5429999999999999,0.655,C0158995,Congenital anemia,disease,,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50428,6901,TAZ,0.5429999999999999,0.655,C0220994,Hyperammonemia,phenotype,C23,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50429,6901,TAZ,0.5429999999999999,0.655,C0264886,Conduction disorder of the heart,group,C14,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50430,6901,TAZ,0.5429999999999999,0.655,C0340427,Familial dilated cardiomyopathy,disease,C14,Disease or Syndrome,0.3,,,,0,0,ORPHANET
50431,6901,TAZ,0.5429999999999999,0.655,C0574083,3-Methylglutaconic aciduria type 2,disease,C14;C16;C18,Disease or Syndrome,0.8,0.9574468,1973.0,2017.0,5,18,CTD_human;ORPHANET;UNIPROT
50432,6901,TAZ,0.5429999999999999,0.655,C0751651,Mitochondrial Diseases,group,C18,Disease or Syndrome,0.3,,,,0,0,GENOMICS_ENGLAND
50433,6901,TAZ,0.5429999999999999,0.655,C3714756,Intellectual Disability,group,C10;C23;F01;F03,Mental or Behavioral Dysfunction,0.3,,1996.0,1996.0,1,0,GENOMICS_ENGLAND
50434,6901,TAZ,0.5429999999999999,0.655,C4021133,Left ventricular noncompaction cardiomyopathy,disease,,Disease or Syndrome,0.31,1.0,2010.0,2010.0,0,0,GENOMICS_ENGLAND
